id	sid	tid	token	lemma	pos
gsrj-41	1	1	increasing	increase	VERB
gsrj-41	1	2	covid-19	covid-19	PROPN
gsrj-41	1	3	vaccine	vaccine	NOUN
gsrj-41	1	4	uptake	uptake	ADJ
gsrj-41	1	5	in	in	ADP
gsrj-41	1	6	the	the	DET
gsrj-41	1	7	united	united	PROPN
gsrj-41	1	8	states	states	PROPN
gsrj-41	1	9	:	:	PUNCT
gsrj-41	1	10	addressing	address	VERB
gsrj-41	1	11	reasons	reason	NOUN
gsrj-41	1	12	for	for	ADP
gsrj-41	1	13	vaccine	vaccine	NOUN
gsrj-41	1	14	hesitancy	hesitancy	NOUN
gsrj-41	1	15	through	through	ADP
gsrj-41	1	16	effective	effective	ADJ
gsrj-41	1	17	communications	communication	NOUN
gsrj-41	1	18	&	&	CCONJ
gsrj-41	1	19	reform	reform	PROPN
gsrj-41	1	20	miranda	miranda	PROPN
gsrj-41	1	21	wesley	wesley	PROPN
gsrj-41	1	22	volume	volume	PROPN
gsrj-41	1	23	two	two	NUM
gsrj-41	1	24	edition	edition	NOUN
gsrj-41	1	25	two	two	NUM
gsrj-41	1	26	spring	spring	NOUN
gsrj-41	1	27	2022	2022	NUM
gsrj-41	1	28	georgetown	georgetown	PROPN
gsrj-41	1	29	scientific	scientific	PROPN
gsrj-41	1	30	research	research	PROPN
gsrj-41	1	31	journal	journal	PROPN
gsrj-41	1	32	6	6	NUM
gsrj-41	1	33	georgetown	georgetown	PROPN
gsrj-41	1	34	scientific	scientific	PROPN
gsrj-41	1	35	research	research	NOUN
gsrj-41	1	36	journal	journal	NOUN
gsrj-41	1	37	increasing	increase	VERB
gsrj-41	1	38	covid-19	covid-19	PROPN
gsrj-41	1	39	vaccine	vaccine	NOUN
gsrj-41	1	40	uptake	uptake	ADJ
gsrj-41	1	41	in	in	ADP
gsrj-41	1	42	the	the	DET
gsrj-41	1	43	united	united	PROPN
gsrj-41	1	44	states	states	PROPN
gsrj-41	1	45	:	:	PUNCT
gsrj-41	1	46	addressing	address	VERB
gsrj-41	1	47	reasons	reason	NOUN
gsrj-41	1	48	for	for	ADP
gsrj-41	1	49	vaccine	vaccine	NOUN
gsrj-41	1	50	hesitancy	hesitancy	NOUN
gsrj-41	1	51	through	through	ADP
gsrj-41	1	52	effective	effective	ADJ
gsrj-41	1	53	communications	communication	NOUN
gsrj-41	1	54	&	&	CCONJ
gsrj-41	1	55	reform	reform	PROPN
gsrj-41	1	56	miranda	miranda	PROPN
gsrj-41	1	57	wesley	wesley	PROPN
gsrj-41	1	58	department	department	PROPN
gsrj-41	1	59	of	of	ADP
gsrj-41	1	60	international	international	PROPN
gsrj-41	1	61	health	health	PROPN
gsrj-41	1	62	,	,	PUNCT
gsrj-41	1	63	georgetown	georgetown	PROPN
gsrj-41	1	64	university	university	PROPN
gsrj-41	1	65	,	,	PUNCT
gsrj-41	1	66	washington	washington	PROPN
gsrj-41	1	67	,	,	PUNCT
gsrj-41	1	68	d.c	d.c	PROPN
gsrj-41	1	69	.	.	PUNCT
gsrj-41	2	1	e	e	X
gsrj-41	2	2	-	-	NOUN
gsrj-41	2	3	mail	mail	NOUN
gsrj-41	2	4	:	:	PUNCT
gsrj-41	2	5	mdw92@georgetown.edu	mdw92@georgetown.edu	PROPN
gsrj-41	2	6	https://doi.org/10.48091/gsr.v2i2.41	https://doi.org/10.48091/gsr.v2i2.41	PROPN
gsrj-41	2	7	abstract	abstract	VERB
gsrj-41	2	8	the	the	DET
gsrj-41	2	9	covid-19	covid-19	PROPN
gsrj-41	2	10	pandemic	pandemic	NOUN
gsrj-41	2	11	has	have	AUX
gsrj-41	2	12	and	and	CCONJ
gsrj-41	2	13	is	be	AUX
gsrj-41	2	14	still	still	ADV
gsrj-41	2	15	adding	add	VERB
gsrj-41	2	16	tremendous	tremendous	ADJ
gsrj-41	2	17	morbidity	morbidity	NOUN
gsrj-41	2	18	and	and	CCONJ
gsrj-41	2	19	mortality	mortality	NOUN
gsrj-41	2	20	globally	globally	ADV
gsrj-41	2	21	.	.	PUNCT
gsrj-41	3	1	although	although	SCONJ
gsrj-41	3	2	vaccines	vaccine	NOUN
gsrj-41	3	3	are	be	AUX
gsrj-41	3	4	a	a	DET
gsrj-41	3	5	major	major	ADJ
gsrj-41	3	6	component	component	NOUN
gsrj-41	3	7	in	in	ADP
gsrj-41	3	8	combatting	combat	VERB
gsrj-41	3	9	covid-19	covid-19	PROPN
gsrj-41	3	10	and	and	CCONJ
gsrj-41	3	11	are	be	AUX
gsrj-41	3	12	widely	widely	ADV
gsrj-41	3	13	available	available	ADJ
gsrj-41	3	14	in	in	ADP
gsrj-41	3	15	the	the	DET
gsrj-41	3	16	u.s	u.s	PROPN
gsrj-41	3	17	.	.	PROPN
gsrj-41	3	18	,	,	PUNCT
gsrj-41	3	19	vaccine	vaccine	NOUN
gsrj-41	3	20	uptake	uptake	ADJ
gsrj-41	3	21	is	be	AUX
gsrj-41	3	22	a	a	DET
gsrj-41	3	23	major	major	ADJ
gsrj-41	3	24	hurdle	hurdle	NOUN
gsrj-41	3	25	with	with	ADP
gsrj-41	3	26	24	24	NUM
gsrj-41	3	27	%	%	NOUN
gsrj-41	3	28	of	of	ADP
gsrj-41	3	29	the	the	DET
gsrj-41	3	30	population	population	NOUN
gsrj-41	3	31	having	having	AUX
gsrj-41	3	32	not	not	PART
gsrj-41	3	33	received	receive	VERB
gsrj-41	3	34	any	any	DET
gsrj-41	3	35	dose	dose	NOUN
gsrj-41	3	36	of	of	ADP
gsrj-41	3	37	a	a	DET
gsrj-41	3	38	covid-19	covid-19	PROPN
gsrj-41	3	39	vaccine	vaccine	NOUN
gsrj-41	3	40	.	.	PUNCT
gsrj-41	4	1	literature	literature	NOUN
gsrj-41	4	2	review	review	NOUN
gsrj-41	4	3	of	of	ADP
gsrj-41	4	4	reasons	reason	NOUN
gsrj-41	4	5	for	for	ADP
gsrj-41	4	6	covid-19	covid-19	PROPN
gsrj-41	4	7	vaccine	vaccine	NOUN
gsrj-41	4	8	hesitancy	hesitancy	NOUN
gsrj-41	4	9	among	among	ADP
gsrj-41	4	10	adults	adult	NOUN
gsrj-41	4	11	in	in	ADP
gsrj-41	4	12	the	the	DET
gsrj-41	4	13	united	united	PROPN
gsrj-41	4	14	states	states	PROPN
gsrj-41	4	15	.	.	PUNCT
gsrj-41	5	1	27	27	NUM
gsrj-41	5	2	articles	article	NOUN
gsrj-41	5	3	included	include	VERB
gsrj-41	5	4	from	from	ADP
gsrj-41	5	5	pubmed	pubmed	PROPN
gsrj-41	5	6	and	and	CCONJ
gsrj-41	5	7	analyzed	analyze	VERB
gsrj-41	5	8	to	to	PART
gsrj-41	5	9	find	find	VERB
gsrj-41	5	10	date	date	NOUN
gsrj-41	5	11	of	of	ADP
gsrj-41	5	12	study	study	NOUN
gsrj-41	5	13	,	,	PUNCT
gsrj-41	5	14	method	method	NOUN
gsrj-41	5	15	of	of	ADP
gsrj-41	5	16	survey	survey	NOUN
gsrj-41	5	17	,	,	PUNCT
gsrj-41	5	18	population	population	NOUN
gsrj-41	5	19	studied	study	VERB
gsrj-41	5	20	and	and	CCONJ
gsrj-41	5	21	generalization	generalization	NOUN
gsrj-41	5	22	ability	ability	NOUN
gsrj-41	5	23	,	,	PUNCT
gsrj-41	5	24	and	and	CCONJ
gsrj-41	5	25	reasons	reason	NOUN
gsrj-41	5	26	for	for	ADP
gsrj-41	5	27	vaccine	vaccine	NOUN
gsrj-41	5	28	hesitancy	hesitancy	NOUN
gsrj-41	5	29	or	or	CCONJ
gsrj-41	5	30	refusal	refusal	NOUN
gsrj-41	5	31	.	.	PUNCT
gsrj-41	6	1	most	most	ADJ
gsrj-41	6	2	studies	study	NOUN
gsrj-41	6	3	were	be	AUX
gsrj-41	6	4	cross	cross	ADJ
gsrj-41	6	5	-	-	ADJ
gsrj-41	6	6	sectional	sectional	ADJ
gsrj-41	6	7	surveys	survey	NOUN
gsrj-41	6	8	(	(	PUNCT
gsrj-41	6	9	88.89	88.89	NUM
gsrj-41	6	10	%	%	NOUN
gsrj-41	6	11	)	)	PUNCT
gsrj-41	6	12	and	and	CCONJ
gsrj-41	6	13	conducted	conduct	VERB
gsrj-41	6	14	online	online	ADV
gsrj-41	6	15	(	(	PUNCT
gsrj-41	6	16	59.25	59.25	NUM
gsrj-41	6	17	%	%	NOUN
gsrj-41	6	18	)	)	PUNCT
gsrj-41	6	19	.	.	PUNCT
gsrj-41	7	1	sample	sample	NOUN
gsrj-41	7	2	size	size	NOUN
gsrj-41	7	3	ranged	range	VERB
gsrj-41	7	4	from	from	ADP
gsrj-41	7	5	58	58	NUM
gsrj-41	7	6	to	to	ADP
gsrj-41	7	7	458,235	458,235	NUM
gsrj-41	7	8	.	.	PUNCT
gsrj-41	8	1	populations	population	NOUN
gsrj-41	8	2	studied	study	VERB
gsrj-41	8	3	include	include	VERB
gsrj-41	8	4	nationally	nationally	ADV
gsrj-41	8	5	representative	representative	ADJ
gsrj-41	8	6	u.s	u.s	PROPN
gsrj-41	8	7	.	.	PROPN
gsrj-41	8	8	(	(	PUNCT
gsrj-41	8	9	25.9	25.9	NUM
gsrj-41	8	10	%	%	NOUN
gsrj-41	8	11	)	)	PUNCT
gsrj-41	8	12	,	,	PUNCT
gsrj-41	8	13	specific	specific	ADJ
gsrj-41	8	14	populations	population	NOUN
gsrj-41	8	15	within	within	ADP
gsrj-41	8	16	the	the	DET
gsrj-41	8	17	u.s	u.s	PROPN
gsrj-41	8	18	.	.	PROPN
gsrj-41	8	19	(	(	PUNCT
gsrj-41	8	20	37.0	37.0	NUM
gsrj-41	8	21	%	%	NOUN
gsrj-41	8	22	)	)	PUNCT
gsrj-41	8	23	,	,	PUNCT
gsrj-41	8	24	specific	specific	ADJ
gsrj-41	8	25	locations	location	NOUN
gsrj-41	8	26	within	within	ADP
gsrj-41	8	27	the	the	DET
gsrj-41	8	28	u.s	u.s	PROPN
gsrj-41	8	29	.	.	PROPN
gsrj-41	8	30	(	(	PUNCT
gsrj-41	8	31	22.2	22.2	NUM
gsrj-41	8	32	%	%	NOUN
gsrj-41	8	33	)	)	PUNCT
gsrj-41	8	34	,	,	PUNCT
gsrj-41	8	35	and	and	CCONJ
gsrj-41	8	36	healthcare	healthcare	PROPN
gsrj-41	8	37	workers	worker	NOUN
gsrj-41	8	38	(	(	PUNCT
gsrj-41	8	39	14.8	14.8	NUM
gsrj-41	8	40	%	%	NOUN
gsrj-41	8	41	)	)	PUNCT
gsrj-41	8	42	.	.	PUNCT
gsrj-41	9	1	the	the	DET
gsrj-41	9	2	most	most	ADV
gsrj-41	9	3	common	common	ADJ
gsrj-41	9	4	reason	reason	NOUN
gsrj-41	9	5	for	for	ADP
gsrj-41	9	6	covid-19	covid-19	PROPN
gsrj-41	9	7	vaccine	vaccine	NOUN
gsrj-41	9	8	hesitancy	hesitancy	NOUN
gsrj-41	9	9	is	be	AUX
gsrj-41	9	10	concern	concern	NOUN
gsrj-41	9	11	about	about	ADP
gsrj-41	9	12	side	side	NOUN
gsrj-41	9	13	effects	effect	NOUN
gsrj-41	9	14	and	and	CCONJ
gsrj-41	9	15	general	general	ADJ
gsrj-41	9	16	safety	safety	NOUN
gsrj-41	9	17	concerns	concern	NOUN
gsrj-41	9	18	(	(	PUNCT
gsrj-41	9	19	57.14	57.14	NUM
gsrj-41	9	20	%	%	NOUN
gsrj-41	9	21	)	)	PUNCT
gsrj-41	9	22	.	.	PUNCT
gsrj-41	10	1	other	other	ADJ
gsrj-41	10	2	significant	significant	ADJ
gsrj-41	10	3	reasons	reason	NOUN
gsrj-41	10	4	include	include	VERB
gsrj-41	10	5	:	:	PUNCT
gsrj-41	10	6	additional	additional	ADJ
gsrj-41	10	7	information	information	NOUN
gsrj-41	10	8	needed	need	VERB
gsrj-41	10	9	(	(	PUNCT
gsrj-41	10	10	21.42	21.42	NUM
gsrj-41	10	11	%	%	NOUN
gsrj-41	10	12	)	)	PUNCT
gsrj-41	10	13	,	,	PUNCT
gsrj-41	10	14	distrust	distrust	NOUN
gsrj-41	10	15	(	(	PUNCT
gsrj-41	10	16	14.28	14.28	NUM
gsrj-41	10	17	%	%	NOUN
gsrj-41	10	18	)	)	PUNCT
gsrj-41	10	19	,	,	PUNCT
gsrj-41	10	20	no	no	DET
gsrj-41	10	21	reason	reason	NOUN
gsrj-41	10	22	/	/	SYM
gsrj-41	10	23	don’t	don’t	NUM
gsrj-41	10	24	know	know	NOUN
gsrj-41	10	25	(	(	PUNCT
gsrj-41	10	26	3.57	3.57	NUM
gsrj-41	10	27	%	%	NOUN
gsrj-41	10	28	)	)	PUNCT
gsrj-41	10	29	,	,	PUNCT
gsrj-41	10	30	and	and	CCONJ
gsrj-41	10	31	antivaccine	antivaccine	NOUN
gsrj-41	10	32	beliefs	belief	NOUN
gsrj-41	10	33	(	(	PUNCT
gsrj-41	10	34	3.57	3.57	NUM
gsrj-41	10	35	%	%	NOUN
gsrj-41	10	36	)	)	PUNCT
gsrj-41	10	37	.	.	PUNCT
gsrj-41	11	1	just	just	ADV
gsrj-41	11	2	over	over	ADP
gsrj-41	11	3	half	half	NOUN
gsrj-41	11	4	(	(	PUNCT
gsrj-41	11	5	51.8	51.8	NUM
gsrj-41	11	6	%	%	NOUN
gsrj-41	11	7	)	)	PUNCT
gsrj-41	11	8	of	of	ADP
gsrj-41	11	9	studies	study	NOUN
gsrj-41	11	10	were	be	AUX
gsrj-41	11	11	conducted	conduct	VERB
gsrj-41	11	12	before	before	ADP
gsrj-41	11	13	the	the	DET
gsrj-41	11	14	fda	fda	PROPN
gsrj-41	11	15	eua	eua	PROPN
gsrj-41	11	16	of	of	ADP
gsrj-41	11	17	the	the	DET
gsrj-41	11	18	pfizer	pfizer	NOUN
gsrj-41	11	19	-	-	PUNCT
gsrj-41	11	20	biontech	biontech	NOUN
gsrj-41	11	21	covid-19	covid-19	PROPN
gsrj-41	11	22	vaccine	vaccine	NOUN
gsrj-41	11	23	,	,	PUNCT
gsrj-41	11	24	while	while	SCONJ
gsrj-41	11	25	37.0	37.0	NUM
gsrj-41	11	26	%	%	NOUN
gsrj-41	11	27	were	be	AUX
gsrj-41	11	28	after	after	ADV
gsrj-41	11	29	,	,	PUNCT
gsrj-41	11	30	and	and	CCONJ
gsrj-41	11	31	11.1	11.1	NUM
gsrj-41	11	32	%	%	NOUN
gsrj-41	11	33	spanned	span	VERB
gsrj-41	11	34	the	the	DET
gsrj-41	11	35	time	time	NOUN
gsrj-41	11	36	period	period	NOUN
gsrj-41	11	37	or	or	CCONJ
gsrj-41	11	38	had	have	VERB
gsrj-41	11	39	follow	follow	VERB
gsrj-41	11	40	-	-	PUNCT
gsrj-41	11	41	up	up	ADP
gsrj-41	11	42	surveys	survey	NOUN
gsrj-41	11	43	.	.	PUNCT
gsrj-41	12	1	to	to	PART
gsrj-41	12	2	increase	increase	VERB
gsrj-41	12	3	uptake	uptake	ADJ
gsrj-41	12	4	among	among	ADP
gsrj-41	12	5	those	those	PRON
gsrj-41	12	6	who	who	PRON
gsrj-41	12	7	are	be	AUX
gsrj-41	12	8	still	still	ADV
gsrj-41	12	9	hesitant	hesitant	ADJ
gsrj-41	12	10	of	of	ADP
gsrj-41	12	11	covid-19	covid-19	PROPN
gsrj-41	12	12	vaccines	vaccine	NOUN
gsrj-41	12	13	,	,	PUNCT
gsrj-41	12	14	the	the	DET
gsrj-41	12	15	american	american	PROPN
gsrj-41	12	16	healthcare	healthcare	PROPN
gsrj-41	12	17	and	and	CCONJ
gsrj-41	12	18	education	education	NOUN
gsrj-41	12	19	system	system	NOUN
gsrj-41	12	20	must	must	AUX
gsrj-41	12	21	go	go	VERB
gsrj-41	12	22	through	through	ADP
gsrj-41	12	23	reform	reform	NOUN
gsrj-41	12	24	to	to	PART
gsrj-41	12	25	ensure	ensure	VERB
gsrj-41	12	26	healthcare	healthcare	NOUN
gsrj-41	12	27	for	for	ADP
gsrj-41	12	28	all	all	PRON
gsrj-41	12	29	and	and	CCONJ
gsrj-41	12	30	address	address	VERB
gsrj-41	12	31	systemic	systemic	ADJ
gsrj-41	12	32	racism	racism	NOUN
gsrj-41	12	33	.	.	PUNCT
gsrj-41	13	1	while	while	SCONJ
gsrj-41	13	2	increasing	increase	VERB
gsrj-41	13	3	representation	representation	NOUN
gsrj-41	13	4	in	in	ADP
gsrj-41	13	5	health	health	NOUN
gsrj-41	13	6	fields	field	NOUN
gsrj-41	13	7	,	,	PUNCT
gsrj-41	13	8	already	already	ADV
gsrj-41	13	9	working	work	VERB
gsrj-41	13	10	clinicians	clinician	NOUN
gsrj-41	13	11	can	can	AUX
gsrj-41	13	12	promote	promote	VERB
gsrj-41	13	13	vaccinations	vaccination	NOUN
gsrj-41	13	14	through	through	ADP
gsrj-41	13	15	strengthening	strengthen	VERB
gsrj-41	13	16	their	their	PRON
gsrj-41	13	17	patient	patient	ADJ
gsrj-41	13	18	relationships	relationship	NOUN
gsrj-41	13	19	,	,	PUNCT
gsrj-41	13	20	following	follow	VERB
gsrj-41	13	21	up	up	ADP
gsrj-41	13	22	on	on	ADP
gsrj-41	13	23	vaccination	vaccination	NOUN
gsrj-41	13	24	status	status	NOUN
gsrj-41	13	25	,	,	PUNCT
gsrj-41	13	26	sharing	share	VERB
gsrj-41	13	27	educational	educational	ADJ
gsrj-41	13	28	resources	resource	NOUN
gsrj-41	13	29	and	and	CCONJ
gsrj-41	13	30	personal	personal	ADJ
gsrj-41	13	31	stories	story	NOUN
gsrj-41	13	32	,	,	PUNCT
gsrj-41	13	33	and	and	CCONJ
gsrj-41	13	34	promoting	promote	VERB
gsrj-41	13	35	community	community	NOUN
gsrj-41	13	36	efforts	effort	NOUN
gsrj-41	13	37	.	.	PUNCT
gsrj-41	14	1	teachers	teacher	NOUN
gsrj-41	14	2	and	and	CCONJ
gsrj-41	14	3	schools	school	NOUN
gsrj-41	14	4	can	can	AUX
gsrj-41	14	5	implement	implement	VERB
gsrj-41	14	6	lessons	lesson	NOUN
gsrj-41	14	7	on	on	ADP
gsrj-41	14	8	immunizations	immunization	NOUN
gsrj-41	14	9	and	and	CCONJ
gsrj-41	14	10	disease	disease	NOUN
gsrj-41	14	11	.	.	PUNCT
gsrj-41	15	1	communication	communication	NOUN
gsrj-41	15	2	efforts	effort	NOUN
gsrj-41	15	3	from	from	ADP
gsrj-41	15	4	institutions	institution	NOUN
gsrj-41	15	5	and	and	CCONJ
gsrj-41	15	6	local	local	ADJ
gsrj-41	15	7	community	community	NOUN
gsrj-41	15	8	organizations	organization	NOUN
gsrj-41	15	9	must	must	AUX
gsrj-41	15	10	work	work	VERB
gsrj-41	15	11	to	to	PART
gsrj-41	15	12	increase	increase	VERB
gsrj-41	15	13	trust	trust	NOUN
gsrj-41	15	14	,	,	PUNCT
gsrj-41	15	15	address	address	VERB
gsrj-41	15	16	fear	fear	NOUN
gsrj-41	15	17	of	of	ADP
gsrj-41	15	18	side	side	NOUN
gsrj-41	15	19	effects	effect	NOUN
gsrj-41	15	20	,	,	PUNCT
gsrj-41	15	21	and	and	CCONJ
gsrj-41	15	22	combat	combat	NOUN
gsrj-41	15	23	misinformation	misinformation	NOUN
gsrj-41	15	24	.	.	PUNCT
gsrj-41	16	1	promotion	promotion	NOUN
gsrj-41	16	2	of	of	ADP
gsrj-41	16	3	social	social	ADJ
gsrj-41	16	4	values	value	NOUN
gsrj-41	16	5	and	and	CCONJ
gsrj-41	16	6	self	self	NOUN
gsrj-41	16	7	-	-	PUNCT
gsrj-41	16	8	efficacy	efficacy	NOUN
gsrj-41	16	9	,	,	PUNCT
gsrj-41	16	10	as	as	ADV
gsrj-41	16	11	well	well	ADV
gsrj-41	16	12	as	as	ADP
gsrj-41	16	13	authentic	authentic	ADJ
gsrj-41	16	14	community	community	NOUN
gsrj-41	16	15	investment	investment	NOUN
gsrj-41	16	16	and	and	CCONJ
gsrj-41	16	17	engagement	engagement	NOUN
gsrj-41	16	18	,	,	PUNCT
gsrj-41	16	19	can	can	AUX
gsrj-41	16	20	increase	increase	VERB
gsrj-41	16	21	trust	trust	NOUN
gsrj-41	16	22	and	and	CCONJ
gsrj-41	16	23	vaccination	vaccination	NOUN
gsrj-41	16	24	levels	level	NOUN
gsrj-41	16	25	.	.	PUNCT
gsrj-41	17	1	keywords	keyword	NOUN
gsrj-41	17	2	:	:	PUNCT
gsrj-41	17	3	covid-19	covid-19	PROPN
gsrj-41	17	4	,	,	PUNCT
gsrj-41	17	5	vaccine	vaccine	NOUN
gsrj-41	17	6	hesitancy	hesitancy	NOUN
gsrj-41	17	7	,	,	PUNCT
gsrj-41	17	8	communication	communication	NOUN
gsrj-41	17	9	7	7	NUM
gsrj-41	17	10	georgetown	georgetown	PROPN
gsrj-41	17	11	scientific	scientific	ADJ
gsrj-41	17	12	research	research	PROPN
gsrj-41	17	13	journal	journal	NOUN
gsrj-41	17	14	1	1	NUM
gsrj-41	17	15	.	.	PUNCT
gsrj-41	17	16	background	background	NOUN
gsrj-41	17	17	the	the	DET
gsrj-41	17	18	covid-19	covid-19	PROPN
gsrj-41	17	19	pandemic	pandemic	NOUN
gsrj-41	17	20	has	have	AUX
gsrj-41	17	21	caused	cause	VERB
gsrj-41	17	22	tremendous	tremendous	ADJ
gsrj-41	17	23	morbidity	morbidity	NOUN
gsrj-41	17	24	and	and	CCONJ
gsrj-41	17	25	mortality	mortality	NOUN
gsrj-41	17	26	around	around	ADP
gsrj-41	17	27	the	the	DET
gsrj-41	17	28	world	world	NOUN
gsrj-41	17	29	,	,	PUNCT
gsrj-41	17	30	with	with	ADP
gsrj-41	17	31	the	the	DET
gsrj-41	17	32	united	united	PROPN
gsrj-41	17	33	states	states	PROPN
gsrj-41	17	34	being	be	AUX
gsrj-41	17	35	severely	severely	ADV
gsrj-41	17	36	affected	affect	VERB
gsrj-41	17	37	.	.	PUNCT
gsrj-41	18	1	in	in	ADP
gsrj-41	18	2	the	the	DET
gsrj-41	18	3	u.s	u.s	PROPN
gsrj-41	18	4	.	.	PROPN
gsrj-41	18	5	,	,	PUNCT
gsrj-41	18	6	there	there	PRON
gsrj-41	18	7	have	have	AUX
gsrj-41	18	8	been	be	AUX
gsrj-41	18	9	a	a	DET
gsrj-41	18	10	total	total	NOUN
gsrj-41	18	11	of	of	ADP
gsrj-41	18	12	77	77	NUM
gsrj-41	18	13	million	million	NUM
gsrj-41	18	14	cases	case	NOUN
gsrj-41	18	15	and	and	CCONJ
gsrj-41	18	16	920,097	920,097	NUM
gsrj-41	18	17	deaths	death	NOUN
gsrj-41	18	18	as	as	ADP
gsrj-41	18	19	of	of	ADP
gsrj-41	18	20	february	february	PROPN
gsrj-41	18	21	15	15	NUM
gsrj-41	18	22	,	,	PUNCT
gsrj-41	18	23	2022.1	2022.1	NUM
gsrj-41	18	24	although	although	SCONJ
gsrj-41	18	25	most	most	ADJ
gsrj-41	18	26	americans	americans	PROPN
gsrj-41	18	27	have	have	VERB
gsrj-41	18	28	access	access	NOUN
gsrj-41	18	29	to	to	ADP
gsrj-41	18	30	vaccines	vaccine	NOUN
gsrj-41	18	31	,	,	PUNCT
gsrj-41	18	32	there	there	PRON
gsrj-41	18	33	are	be	VERB
gsrj-41	18	34	still	still	ADV
gsrj-41	18	35	around	around	ADP
gsrj-41	18	36	146,921	146,921	NUM
gsrj-41	18	37	daily	daily	ADJ
gsrj-41	18	38	cases	case	NOUN
gsrj-41	18	39	according	accord	VERB
gsrj-41	18	40	to	to	ADP
gsrj-41	18	41	the	the	DET
gsrj-41	18	42	7	7	NUM
gsrj-41	18	43	-	-	PUNCT
gsrj-41	18	44	day	day	NOUN
gsrj-41	18	45	moving	move	VERB
gsrj-41	18	46	average	average	ADJ
gsrj-41	18	47	cases	case	NOUN
gsrj-41	18	48	and	and	CCONJ
gsrj-41	18	49	around	around	ADP
gsrj-41	18	50	2,208	2,208	NUM
gsrj-41	18	51	daily	daily	ADJ
gsrj-41	18	52	deaths	death	NOUN
gsrj-41	18	53	according	accord	VERB
gsrj-41	18	54	to	to	ADP
gsrj-41	18	55	the	the	DET
gsrj-41	18	56	7day	7day	PROPN
gsrj-41	18	57	moving	move	VERB
gsrj-41	18	58	average	average	ADJ
gsrj-41	18	59	deaths	death	NOUN
gsrj-41	18	60	as	as	ADP
gsrj-41	18	61	of	of	ADP
gsrj-41	18	62	february	february	PROPN
gsrj-41	18	63	15	15	NUM
gsrj-41	18	64	,	,	PUNCT
gsrj-41	18	65	2021.1	2021.1	NUM
gsrj-41	18	66	the	the	DET
gsrj-41	18	67	available	available	ADJ
gsrj-41	18	68	covid-19	covid-19	PROPN
gsrj-41	18	69	vaccines	vaccine	NOUN
gsrj-41	18	70	in	in	ADP
gsrj-41	18	71	the	the	DET
gsrj-41	18	72	u.s	u.s	PROPN
gsrj-41	18	73	.	.	PROPN
gsrj-41	18	74	include	include	VERB
gsrj-41	18	75	pfizer	pfizer	NOUN
gsrj-41	18	76	-	-	PUNCT
gsrj-41	18	77	biontech	biontech	PROPN
gsrj-41	18	78	,	,	PUNCT
gsrj-41	18	79	moderna	moderna	PROPN
gsrj-41	18	80	,	,	PUNCT
gsrj-41	18	81	and	and	CCONJ
gsrj-41	18	82	johnson	johnson	PROPN
gsrj-41	18	83	&	&	CCONJ
gsrj-41	18	84	johnson	johnson	PROPN
gsrj-41	18	85	.	.	PUNCT
gsrj-41	19	1	the	the	DET
gsrj-41	19	2	first	first	ADJ
gsrj-41	19	3	approval	approval	NOUN
gsrj-41	19	4	issued	issue	VERB
gsrj-41	19	5	by	by	ADP
gsrj-41	19	6	fda	fda	PROPN
gsrj-41	19	7	was	be	AUX
gsrj-41	19	8	the	the	DET
gsrj-41	19	9	emergency	emergency	NOUN
gsrj-41	19	10	use	use	NOUN
gsrj-41	19	11	authorization	authorization	NOUN
gsrj-41	19	12	(	(	PUNCT
gsrj-41	19	13	eua	eua	PROPN
gsrj-41	19	14	)	)	PUNCT
gsrj-41	19	15	of	of	ADP
gsrj-41	19	16	the	the	DET
gsrj-41	19	17	pfizer	pfizer	NOUN
gsrj-41	19	18	-	-	PUNCT
gsrj-41	19	19	biontech	biontech	NOUN
gsrj-41	19	20	covid-19	covid-19	PROPN
gsrj-41	19	21	vaccine	vaccine	NOUN
gsrj-41	19	22	on	on	ADP
gsrj-41	19	23	december	december	PROPN
gsrj-41	19	24	11	11	NUM
gsrj-41	19	25	,	,	PUNCT
gsrj-41	19	26	2020.2	2020.2	NUM
gsrj-41	19	27	shortly	shortly	ADV
gsrj-41	19	28	after	after	ADV
gsrj-41	19	29	,	,	PUNCT
gsrj-41	19	30	both	both	CCONJ
gsrj-41	19	31	the	the	DET
gsrj-41	19	32	moderna	moderna	PROPN
gsrj-41	19	33	and	and	CCONJ
gsrj-41	19	34	johnson	johnson	PROPN
gsrj-41	19	35	&	&	CCONJ
gsrj-41	19	36	johnson	johnson	PROPN
gsrj-41	19	37	vaccines	vaccine	NOUN
gsrj-41	19	38	were	be	AUX
gsrj-41	19	39	approved	approve	VERB
gsrj-41	19	40	for	for	ADP
gsrj-41	19	41	emergency	emergency	NOUN
gsrj-41	19	42	use	use	NOUN
gsrj-41	19	43	(	(	PUNCT
gsrj-41	19	44	see	see	VERB
gsrj-41	19	45	figure	figure	VERB
gsrj-41	19	46	1).3	1).3	NUM
gsrj-41	19	47	the	the	DET
gsrj-41	19	48	pfizer	pfizer	NOUN
gsrj-41	19	49	-	-	PUNCT
gsrj-41	19	50	biontech	biontech	ADJ
gsrj-41	19	51	vaccine	vaccine	NOUN
gsrj-41	19	52	for	for	ADP
gsrj-41	19	53	children	child	NOUN
gsrj-41	19	54	ages	age	NOUN
gsrj-41	19	55	12	12	NUM
gsrj-41	19	56	to	to	PART
gsrj-41	19	57	15	15	NUM
gsrj-41	19	58	and	and	CCONJ
gsrj-41	19	59	5	5	NUM
gsrj-41	19	60	to	to	PART
gsrj-41	19	61	11	11	NUM
gsrj-41	19	62	received	receive	VERB
gsrj-41	19	63	euas	euas	NOUN
gsrj-41	19	64	on	on	ADP
gsrj-41	19	65	may	may	PROPN
gsrj-41	19	66	10th	10th	ADJ
gsrj-41	19	67	and	and	CCONJ
gsrj-41	19	68	october	october	PROPN
gsrj-41	19	69	29th	29th	NOUN
gsrj-41	19	70	,	,	PUNCT
gsrj-41	19	71	2021	2021	NUM
gsrj-41	19	72	,	,	PUNCT
gsrj-41	19	73	respectively	respectively	ADV
gsrj-41	19	74	(	(	PUNCT
gsrj-41	19	75	see	see	AUX
gsrj-41	19	76	figure	figure	NOUN
gsrj-41	19	77	1).3	1).3	NUM
gsrj-41	19	78	the	the	DET
gsrj-41	19	79	pfizer	pfizer	NOUN
gsrj-41	19	80	-	-	PUNCT
gsrj-41	19	81	biontech	biontech	ADJ
gsrj-41	19	82	vaccine	vaccine	NOUN
gsrj-41	19	83	received	receive	VERB
gsrj-41	19	84	official	official	ADJ
gsrj-41	19	85	approval	approval	NOUN
gsrj-41	19	86	from	from	ADP
gsrj-41	19	87	the	the	DET
gsrj-41	19	88	fda	fda	PROPN
gsrj-41	19	89	for	for	ADP
gsrj-41	19	90	adults	adult	NOUN
gsrj-41	19	91	on	on	ADP
gsrj-41	19	92	august	august	PROPN
gsrj-41	19	93	23rd	23rd	NOUN
gsrj-41	19	94	,	,	PUNCT
gsrj-41	19	95	2021.2	2021.2	NUM
gsrj-41	19	96	the	the	DET
gsrj-41	19	97	timeline	timeline	NOUN
gsrj-41	19	98	of	of	ADP
gsrj-41	19	99	approvals	approval	NOUN
gsrj-41	19	100	for	for	ADP
gsrj-41	19	101	different	different	ADJ
gsrj-41	19	102	populations	population	NOUN
gsrj-41	19	103	and	and	CCONJ
gsrj-41	19	104	age	age	NOUN
gsrj-41	19	105	groups	group	NOUN
gsrj-41	19	106	is	be	AUX
gsrj-41	19	107	important	important	ADJ
gsrj-41	19	108	for	for	ADP
gsrj-41	19	109	research	research	NOUN
gsrj-41	19	110	on	on	ADP
gsrj-41	19	111	vaccine	vaccine	NOUN
gsrj-41	19	112	hesitancy	hesitancy	NOUN
gsrj-41	19	113	because	because	SCONJ
gsrj-41	19	114	the	the	DET
gsrj-41	19	115	fda	fda	PROPN
gsrj-41	19	116	plays	play	VERB
gsrj-41	19	117	a	a	DET
gsrj-41	19	118	significant	significant	ADJ
gsrj-41	19	119	role	role	NOUN
gsrj-41	19	120	in	in	ADP
gsrj-41	19	121	the	the	DET
gsrj-41	19	122	establishment	establishment	NOUN
gsrj-41	19	123	of	of	ADP
gsrj-41	19	124	trust	trust	NOUN
gsrj-41	19	125	and	and	CCONJ
gsrj-41	19	126	transparency	transparency	NOUN
gsrj-41	19	127	of	of	ADP
gsrj-41	19	128	safety	safety	NOUN
gsrj-41	19	129	and	and	CCONJ
gsrj-41	19	130	effectiveness	effectiveness	NOUN
gsrj-41	19	131	data	datum	NOUN
gsrj-41	19	132	.	.	PUNCT
gsrj-41	20	1	however	however	ADV
gsrj-41	20	2	,	,	PUNCT
gsrj-41	20	3	the	the	DET
gsrj-41	20	4	actual	actual	ADJ
gsrj-41	20	5	rollout	rollout	NOUN
gsrj-41	20	6	based	base	VERB
gsrj-41	20	7	on	on	ADP
gsrj-41	20	8	priority	priority	NOUN
gsrj-41	20	9	groups	group	NOUN
gsrj-41	20	10	and	and	CCONJ
gsrj-41	20	11	ages	age	NOUN
gsrj-41	20	12	differed	differ	VERB
gsrj-41	20	13	between	between	ADP
gsrj-41	20	14	states	state	NOUN
gsrj-41	20	15	in	in	ADP
gsrj-41	20	16	the	the	DET
gsrj-41	20	17	u.s.3	u.s.3	ADJ
gsrj-41	20	18	figure	figure	NOUN
gsrj-41	20	19	1	1	NUM
gsrj-41	20	20	:	:	PUNCT
gsrj-41	20	21	timeline	timeline	NOUN
gsrj-41	20	22	of	of	ADP
gsrj-41	20	23	u.s	u.s	PROPN
gsrj-41	20	24	.	.	PROPN
gsrj-41	20	25	covid-19	covid-19	PROPN
gsrj-41	20	26	vaccine	vaccine	NOUN
gsrj-41	20	27	approval	approval	NOUN
gsrj-41	20	28	from	from	ADP
gsrj-41	20	29	december	december	PROPN
gsrj-41	20	30	2020	2020	NUM
gsrj-41	20	31	to	to	ADP
gsrj-41	20	32	november	november	PROPN
gsrj-41	20	33	2021.2	2021.2	NUM
gsrj-41	20	34	-	-	SYM
gsrj-41	20	35	3	3	NUM
gsrj-41	20	36	pfizerbiontech	pfizerbiontech	NOUN
gsrj-41	20	37	vaccine	vaccine	NOUN
gsrj-41	20	38	received	receive	VERB
gsrj-41	20	39	fda	fda	PROPN
gsrj-41	20	40	eua	eua	PROPN
gsrj-41	20	41	on	on	ADP
gsrj-41	20	42	december	december	PROPN
gsrj-41	20	43	11th	11th	NUM
gsrj-41	20	44	,	,	PUNCT
gsrj-41	20	45	2020	2020	NUM
gsrj-41	20	46	.	.	X
gsrj-41	21	1	8	8	NUM
gsrj-41	21	2	georgetown	georgetown	PROPN
gsrj-41	21	3	scientific	scientific	PROPN
gsrj-41	21	4	research	research	PROPN
gsrj-41	21	5	journal	journal	PROPN
gsrj-41	21	6	vaccines	vaccine	NOUN
gsrj-41	21	7	are	be	AUX
gsrj-41	21	8	essential	essential	ADJ
gsrj-41	21	9	in	in	ADP
gsrj-41	21	10	combatting	combat	VERB
gsrj-41	21	11	the	the	DET
gsrj-41	21	12	spread	spread	NOUN
gsrj-41	21	13	of	of	ADP
gsrj-41	21	14	the	the	DET
gsrj-41	21	15	virus	virus	NOUN
gsrj-41	21	16	and	and	CCONJ
gsrj-41	21	17	deaths	death	NOUN
gsrj-41	21	18	due	due	ADJ
gsrj-41	21	19	to	to	ADP
gsrj-41	21	20	covid-19.4	covid-19.4	NOUN
gsrj-41	21	21	compared	compare	VERB
gsrj-41	21	22	to	to	ADP
gsrj-41	21	23	vaccinated	vaccinated	ADJ
gsrj-41	21	24	patients	patient	NOUN
gsrj-41	21	25	in	in	ADP
gsrj-41	21	26	a	a	DET
gsrj-41	21	27	certain	certain	ADJ
gsrj-41	21	28	health	health	NOUN
gsrj-41	21	29	system	system	NOUN
gsrj-41	21	30	,	,	PUNCT
gsrj-41	21	31	unvaccinated	unvaccinate	VERB
gsrj-41	21	32	patients	patient	NOUN
gsrj-41	21	33	were	be	AUX
gsrj-41	21	34	three	three	NUM
gsrj-41	21	35	times	time	NOUN
gsrj-41	21	36	more	more	ADV
gsrj-41	21	37	likely	likely	ADJ
gsrj-41	21	38	to	to	PART
gsrj-41	21	39	be	be	AUX
gsrj-41	21	40	infected	infect	VERB
gsrj-41	21	41	with	with	ADP
gsrj-41	21	42	covid-19	covid-19	PROPN
gsrj-41	21	43	,	,	PUNCT
gsrj-41	21	44	twice	twice	ADV
gsrj-41	21	45	as	as	ADV
gsrj-41	21	46	likely	likely	ADJ
gsrj-41	21	47	to	to	PART
gsrj-41	21	48	be	be	AUX
gsrj-41	21	49	hospitalized	hospitalize	VERB
gsrj-41	21	50	with	with	ADP
gsrj-41	21	51	covid-19	covid-19	PROPN
gsrj-41	21	52	,	,	PUNCT
gsrj-41	21	53	and	and	CCONJ
gsrj-41	21	54	seven	seven	NUM
gsrj-41	21	55	times	time	NOUN
gsrj-41	21	56	more	more	ADV
gsrj-41	21	57	likely	likely	ADJ
gsrj-41	21	58	to	to	PART
gsrj-41	21	59	die	die	VERB
gsrj-41	21	60	from	from	ADP
gsrj-41	21	61	covid19.5	covid19.5	NOUN
gsrj-41	21	62	the	the	DET
gsrj-41	21	63	stark	stark	ADJ
gsrj-41	21	64	difference	difference	NOUN
gsrj-41	21	65	in	in	ADP
gsrj-41	21	66	clinical	clinical	ADJ
gsrj-41	21	67	outcomes	outcome	NOUN
gsrj-41	21	68	based	base	VERB
gsrj-41	21	69	on	on	ADP
gsrj-41	21	70	vaccination	vaccination	NOUN
gsrj-41	21	71	status	status	NOUN
gsrj-41	21	72	demonstrate	demonstrate	VERB
gsrj-41	21	73	that	that	SCONJ
gsrj-41	21	74	vaccines	vaccine	NOUN
gsrj-41	21	75	are	be	AUX
gsrj-41	21	76	essential	essential	ADJ
gsrj-41	21	77	to	to	ADP
gsrj-41	21	78	both	both	CCONJ
gsrj-41	21	79	the	the	DET
gsrj-41	21	80	health	health	NOUN
gsrj-41	21	81	of	of	ADP
gsrj-41	21	82	the	the	DET
gsrj-41	21	83	population	population	NOUN
gsrj-41	21	84	and	and	CCONJ
gsrj-41	21	85	the	the	DET
gsrj-41	21	86	burden	burden	NOUN
gsrj-41	21	87	on	on	ADP
gsrj-41	21	88	the	the	DET
gsrj-41	21	89	healthcare	healthcare	NOUN
gsrj-41	21	90	system	system	NOUN
gsrj-41	21	91	.	.	PUNCT
gsrj-41	22	1	in	in	ADP
gsrj-41	22	2	the	the	DET
gsrj-41	22	3	u.s	u.s	PROPN
gsrj-41	22	4	.	.	PROPN
gsrj-41	22	5	,	,	PUNCT
gsrj-41	22	6	64.5	64.5	NUM
gsrj-41	22	7	%	%	NOUN
gsrj-41	22	8	of	of	ADP
gsrj-41	22	9	the	the	DET
gsrj-41	22	10	population	population	NOUN
gsrj-41	22	11	are	be	AUX
gsrj-41	22	12	up	up	ADP
gsrj-41	22	13	to	to	ADP
gsrj-41	22	14	date	date	NOUN
gsrj-41	22	15	with	with	ADP
gsrj-41	22	16	the	the	DET
gsrj-41	22	17	covid-19	covid-19	PROPN
gsrj-41	22	18	vaccine	vaccine	NOUN
gsrj-41	22	19	,	,	PUNCT
gsrj-41	22	20	meaning	mean	VERB
gsrj-41	22	21	they	they	PRON
gsrj-41	22	22	are	be	AUX
gsrj-41	22	23	fully	fully	ADV
gsrj-41	22	24	vaccinated	vaccinate	VERB
gsrj-41	22	25	,	,	PUNCT
gsrj-41	22	26	and	and	CCONJ
gsrj-41	22	27	76	76	NUM
gsrj-41	22	28	%	%	NOUN
gsrj-41	22	29	have	have	VERB
gsrj-41	22	30	at	at	ADV
gsrj-41	22	31	least	least	ADV
gsrj-41	22	32	one	one	NUM
gsrj-41	22	33	dose	dose	NOUN
gsrj-41	22	34	,	,	PUNCT
gsrj-41	22	35	as	as	ADP
gsrj-41	22	36	of	of	ADP
gsrj-41	22	37	february	february	PROPN
gsrj-41	22	38	15	15	NUM
gsrj-41	22	39	,	,	PUNCT
gsrj-41	22	40	2022.6	2022.6	NUM
gsrj-41	22	41	most	most	ADJ
gsrj-41	22	42	of	of	ADP
gsrj-41	22	43	the	the	DET
gsrj-41	22	44	24	24	NUM
gsrj-41	22	45	%	%	NOUN
gsrj-41	22	46	that	that	PRON
gsrj-41	22	47	have	have	AUX
gsrj-41	22	48	not	not	PART
gsrj-41	22	49	received	receive	VERB
gsrj-41	22	50	one	one	NUM
gsrj-41	22	51	dose	dose	NOUN
gsrj-41	22	52	makes	make	VERB
gsrj-41	22	53	up	up	ADP
gsrj-41	22	54	the	the	DET
gsrj-41	22	55	vaccine	vaccine	NOUN
gsrj-41	22	56	hesitant	hesitant	ADJ
gsrj-41	22	57	,	,	PUNCT
gsrj-41	22	58	or	or	CCONJ
gsrj-41	22	59	those	those	PRON
gsrj-41	22	60	with	with	ADP
gsrj-41	22	61	low	low	ADJ
gsrj-41	22	62	vaccine	vaccine	NOUN
gsrj-41	22	63	confidence.7	confidence.7	NOUN
gsrj-41	22	64	breaking	break	VERB
gsrj-41	22	65	this	this	PRON
gsrj-41	22	66	down	down	ADP
gsrj-41	22	67	by	by	ADP
gsrj-41	22	68	demographic	demographic	ADJ
gsrj-41	22	69	characteristics	characteristic	NOUN
gsrj-41	22	70	,	,	PUNCT
gsrj-41	22	71	more	more	ADJ
gsrj-41	22	72	of	of	ADP
gsrj-41	22	73	the	the	DET
gsrj-41	22	74	asian	asian	ADJ
gsrj-41	22	75	population	population	NOUN
gsrj-41	22	76	,	,	PUNCT
gsrj-41	22	77	female	female	NOUN
gsrj-41	22	78	,	,	PUNCT
gsrj-41	22	79	and	and	CCONJ
gsrj-41	22	80	older	old	ADJ
gsrj-41	22	81	populations	population	NOUN
gsrj-41	22	82	are	be	AUX
gsrj-41	22	83	vaccinated	vaccinate	VERB
gsrj-41	22	84	(	(	PUNCT
gsrj-41	22	85	see	see	VERB
gsrj-41	22	86	figures	figure	NOUN
gsrj-41	22	87	3	3	NUM
gsrj-41	22	88	-	-	SYM
gsrj-41	22	89	5).8	5).8	NUM
gsrj-41	22	90	40.2	40.2	NUM
gsrj-41	22	91	%	%	NOUN
gsrj-41	22	92	of	of	ADP
gsrj-41	22	93	the	the	DET
gsrj-41	22	94	black	black	ADJ
gsrj-41	22	95	population	population	NOUN
gsrj-41	22	96	is	be	AUX
gsrj-41	22	97	fully	fully	ADV
gsrj-41	22	98	vaccinated	vaccinate	VERB
gsrj-41	22	99	,	,	PUNCT
gsrj-41	22	100	while	while	SCONJ
gsrj-41	22	101	47.6	47.6	NUM
gsrj-41	22	102	%	%	NOUN
gsrj-41	22	103	of	of	ADP
gsrj-41	22	104	the	the	DET
gsrj-41	22	105	white	white	ADJ
gsrj-41	22	106	population	population	NOUN
gsrj-41	22	107	in	in	ADP
gsrj-41	22	108	the	the	DET
gsrj-41	22	109	u.s	u.s	PROPN
gsrj-41	22	110	.	.	PROPN
gsrj-41	22	111	is	be	AUX
gsrj-41	22	112	fully	fully	ADV
gsrj-41	22	113	vaccinated	vaccinate	VERB
gsrj-41	22	114	(	(	PUNCT
gsrj-41	22	115	see	see	VERB
gsrj-41	22	116	figure	figure	NOUN
gsrj-41	22	117	5).8	5).8	NUM
gsrj-41	22	118	however	however	ADV
gsrj-41	22	119	,	,	PUNCT
gsrj-41	22	120	the	the	DET
gsrj-41	22	121	differences	difference	NOUN
gsrj-41	22	122	between	between	ADP
gsrj-41	22	123	racial	racial	ADJ
gsrj-41	22	124	groups	group	NOUN
gsrj-41	22	125	are	be	AUX
gsrj-41	22	126	decreasing	decrease	VERB
gsrj-41	22	127	as	as	SCONJ
gsrj-41	22	128	vaccines	vaccine	NOUN
gsrj-41	22	129	become	become	VERB
gsrj-41	22	130	more	more	ADV
gsrj-41	22	131	available	available	ADJ
gsrj-41	22	132	with	with	ADP
gsrj-41	22	133	increased	increase	VERB
gsrj-41	22	134	uptake	uptake	NOUN
gsrj-41	22	135	.	.	PUNCT
gsrj-41	23	1	there	there	PRON
gsrj-41	23	2	is	be	VERB
gsrj-41	23	3	also	also	ADV
gsrj-41	23	4	a	a	DET
gsrj-41	23	5	correlation	correlation	NOUN
gsrj-41	23	6	between	between	ADP
gsrj-41	23	7	counties	county	NOUN
gsrj-41	23	8	with	with	ADP
gsrj-41	23	9	high	high	ADJ
gsrj-41	23	10	social	social	ADJ
gsrj-41	23	11	vulnerability	vulnerability	NOUN
gsrj-41	23	12	indices	index	NOUN
gsrj-41	23	13	and	and	CCONJ
gsrj-41	23	14	low	low	ADJ
gsrj-41	23	15	rate	rate	NOUN
gsrj-41	23	16	of	of	ADP
gsrj-41	23	17	vaccination	vaccination	NOUN
gsrj-41	23	18	,	,	PUNCT
gsrj-41	23	19	meaning	mean	VERB
gsrj-41	23	20	that	that	SCONJ
gsrj-41	23	21	poverty	poverty	NOUN
gsrj-41	23	22	levels	level	NOUN
gsrj-41	23	23	are	be	AUX
gsrj-41	23	24	a	a	DET
gsrj-41	23	25	predictor	predictor	NOUN
gsrj-41	23	26	of	of	ADP
gsrj-41	23	27	vaccine	vaccine	NOUN
gsrj-41	23	28	uptake.9	uptake.9	VERB
gsrj-41	23	29	states	state	NOUN
gsrj-41	23	30	with	with	ADP
gsrj-41	23	31	the	the	DET
gsrj-41	23	32	lowest	low	ADJ
gsrj-41	23	33	total	total	ADJ
gsrj-41	23	34	doses	dose	NOUN
gsrj-41	23	35	administered	administer	VERB
gsrj-41	23	36	reported	report	VERB
gsrj-41	23	37	to	to	ADP
gsrj-41	23	38	cdc	cdc	PROPN
gsrj-41	23	39	include	include	VERB
gsrj-41	23	40	idaho	idaho	PROPN
gsrj-41	23	41	,	,	PUNCT
gsrj-41	23	42	west	west	PROPN
gsrj-41	23	43	virginia	virginia	PROPN
gsrj-41	23	44	,	,	PUNCT
gsrj-41	23	45	and	and	CCONJ
gsrj-41	23	46	many	many	ADJ
gsrj-41	23	47	states	state	NOUN
gsrj-41	23	48	in	in	ADP
gsrj-41	23	49	the	the	DET
gsrj-41	23	50	southeast	southeast	ADJ
gsrj-41	23	51	region	region	NOUN
gsrj-41	23	52	,	,	PUNCT
gsrj-41	23	53	as	as	ADV
gsrj-41	23	54	well	well	ADV
gsrj-41	23	55	as	as	ADP
gsrj-41	23	56	certain	certain	ADJ
gsrj-41	23	57	states	state	NOUN
gsrj-41	23	58	in	in	ADP
gsrj-41	23	59	the	the	DET
gsrj-41	23	60	midwest	midwest	NOUN
gsrj-41	23	61	(	(	PUNCT
gsrj-41	23	62	see	see	VERB
gsrj-41	23	63	figure	figure	NOUN
gsrj-41	23	64	2).10	2).10	NUM
gsrj-41	23	65	there	there	PRON
gsrj-41	23	66	is	be	VERB
gsrj-41	23	67	also	also	ADV
gsrj-41	23	68	a	a	DET
gsrj-41	23	69	stark	stark	ADJ
gsrj-41	23	70	difference	difference	NOUN
gsrj-41	23	71	in	in	ADP
gsrj-41	23	72	urban	urban	ADJ
gsrj-41	23	73	and	and	CCONJ
gsrj-41	23	74	rural	rural	ADJ
gsrj-41	23	75	regions	region	NOUN
gsrj-41	23	76	.	.	PUNCT
gsrj-41	24	1	as	as	ADP
gsrj-41	24	2	of	of	ADP
gsrj-41	24	3	december	december	PROPN
gsrj-41	24	4	2021	2021	NUM
gsrj-41	24	5	,	,	PUNCT
gsrj-41	24	6	81.9	81.9	NUM
gsrj-41	24	7	%	%	NOUN
gsrj-41	24	8	of	of	ADP
gsrj-41	24	9	adults	adult	NOUN
gsrj-41	24	10	in	in	ADP
gsrj-41	24	11	urban	urban	ADJ
gsrj-41	24	12	areas	area	NOUN
gsrj-41	24	13	were	be	AUX
gsrj-41	24	14	vaccinated	vaccinate	VERB
gsrj-41	24	15	,	,	PUNCT
gsrj-41	24	16	while	while	SCONJ
gsrj-41	24	17	only	only	ADV
gsrj-41	24	18	69.3	69.3	NUM
gsrj-41	24	19	%	%	NOUN
gsrj-41	24	20	of	of	ADP
gsrj-41	24	21	adults	adult	NOUN
gsrj-41	24	22	in	in	ADP
gsrj-41	24	23	rural	rural	ADJ
gsrj-41	24	24	counties	county	NOUN
gsrj-41	24	25	were	be	AUX
gsrj-41	24	26	fully	fully	ADV
gsrj-41	24	27	vaccinated.11	vaccinated.11	ADJ
gsrj-41	24	28	figure	figure	NOUN
gsrj-41	24	29	2	2	NUM
gsrj-41	24	30	:	:	PUNCT
gsrj-41	24	31	percent	percent	NOUN
gsrj-41	24	32	of	of	ADP
gsrj-41	24	33	total	total	ADJ
gsrj-41	24	34	population	population	NOUN
gsrj-41	24	35	with	with	ADP
gsrj-41	24	36	at	at	ADV
gsrj-41	24	37	least	least	ADV
gsrj-41	24	38	one	one	NUM
gsrj-41	24	39	dose	dose	NOUN
gsrj-41	24	40	of	of	ADP
gsrj-41	24	41	all	all	DET
gsrj-41	24	42	counties	county	NOUN
gsrj-41	24	43	in	in	ADP
gsrj-41	24	44	us	we	PRON
gsrj-41	24	45	.	.	PUNCT
gsrj-41	25	1	map	map	VERB
gsrj-41	25	2	displays	display	VERB
gsrj-41	25	3	higher	high	ADJ
gsrj-41	25	4	vaccination	vaccination	NOUN
gsrj-41	25	5	rates	rate	NOUN
gsrj-41	25	6	in	in	ADP
gsrj-41	25	7	urban	urban	ADJ
gsrj-41	25	8	counties	county	NOUN
gsrj-41	25	9	when	when	SCONJ
gsrj-41	25	10	compared	compare	VERB
gsrj-41	25	11	to	to	ADP
gsrj-41	25	12	rural	rural	ADJ
gsrj-41	25	13	counties	county	NOUN
gsrj-41	25	14	.	.	PUNCT
gsrj-41	26	1	vaccination	vaccination	NOUN
gsrj-41	26	2	rates	rate	NOUN
gsrj-41	26	3	also	also	ADV
gsrj-41	26	4	differ	differ	VERB
gsrj-41	26	5	by	by	ADP
gsrj-41	26	6	region	region	NOUN
gsrj-41	26	7	of	of	ADP
gsrj-41	26	8	the	the	DET
gsrj-41	26	9	u.s.10	u.s.10	ADJ
gsrj-41	26	10	figure	figure	NOUN
gsrj-41	26	11	3	3	NUM
gsrj-41	26	12	:	:	PUNCT
gsrj-41	26	13	percent	percent	NOUN
gsrj-41	26	14	of	of	ADP
gsrj-41	26	15	u.s	u.s	PROPN
gsrj-41	26	16	.	.	PROPN
gsrj-41	26	17	population	population	NOUN
gsrj-41	26	18	vaccinated	vaccinate	VERB
gsrj-41	26	19	by	by	ADP
gsrj-41	26	20	age	age	NOUN
gsrj-41	26	21	group	group	NOUN
gsrj-41	26	22	.	.	PUNCT
gsrj-41	27	1	graph	graph	NOUN
gsrj-41	27	2	displays	display	NOUN
gsrj-41	27	3	increasing	increase	VERB
gsrj-41	27	4	vaccination	vaccination	NOUN
gsrj-41	27	5	rates	rate	NOUN
gsrj-41	27	6	among	among	ADP
gsrj-41	27	7	older	old	ADJ
gsrj-41	27	8	age	age	NOUN
gsrj-41	27	9	groups.8	groups.8	PROPN
gsrj-41	27	10	figure	figure	NOUN
gsrj-41	27	11	4	4	NUM
gsrj-41	27	12	:	:	PUNCT
gsrj-41	27	13	percent	percent	NOUN
gsrj-41	27	14	of	of	ADP
gsrj-41	27	15	u.s	u.s	PROPN
gsrj-41	27	16	.	.	PROPN
gsrj-41	27	17	population	population	NOUN
gsrj-41	27	18	vaccinated	vaccinate	VERB
gsrj-41	27	19	by	by	ADP
gsrj-41	27	20	sex	sex	NOUN
gsrj-41	27	21	.	.	PUNCT
gsrj-41	28	1	graph	graph	NOUN
gsrj-41	28	2	displays	display	NOUN
gsrj-41	28	3	that	that	SCONJ
gsrj-41	28	4	females	female	NOUN
gsrj-41	28	5	are	be	AUX
gsrj-41	28	6	more	more	ADV
gsrj-41	28	7	vaccinated	vaccinated	ADJ
gsrj-41	28	8	than	than	ADP
gsrj-41	28	9	males.8	males.8	PROPN
gsrj-41	28	10	9	9	NUM
gsrj-41	28	11	georgetown	georgetown	PROPN
gsrj-41	28	12	scientific	scientific	PROPN
gsrj-41	28	13	research	research	PROPN
gsrj-41	28	14	journal	journal	NOUN
gsrj-41	28	15	figure	figure	NOUN
gsrj-41	28	16	5	5	NUM
gsrj-41	28	17	:	:	PUNCT
gsrj-41	28	18	percent	percent	NOUN
gsrj-41	28	19	of	of	ADP
gsrj-41	28	20	u.s	u.s	PROPN
gsrj-41	28	21	.	.	PROPN
gsrj-41	28	22	population	population	NOUN
gsrj-41	28	23	vaccinated	vaccinate	VERB
gsrj-41	28	24	by	by	ADP
gsrj-41	28	25	race	race	NOUN
gsrj-41	28	26	/	/	SYM
gsrj-41	28	27	ethnicity	ethnicity	NOUN
gsrj-41	28	28	.	.	PUNCT
gsrj-41	29	1	graph	graph	NOUN
gsrj-41	29	2	displays	display	NOUN
gsrj-41	29	3	race	race	NOUN
gsrj-41	29	4	/	/	SYM
gsrj-41	29	5	ethnicity	ethnicity	NOUN
gsrj-41	29	6	distributions	distribution	NOUN
gsrj-41	29	7	of	of	ADP
gsrj-41	29	8	the	the	DET
gsrj-41	29	9	77.6	77.6	NUM
gsrj-41	29	10	%	%	NOUN
gsrj-41	29	11	of	of	ADP
gsrj-41	29	12	those	those	PRON
gsrj-41	29	13	fully	fully	ADV
gsrj-41	29	14	vaccinated	vaccinate	VERB
gsrj-41	29	15	with	with	ADP
gsrj-41	29	16	race	race	NOUN
gsrj-41	29	17	/	/	SYM
gsrj-41	29	18	ethnicity	ethnicity	NOUN
gsrj-41	29	19	known	know	VERB
gsrj-41	29	20	.	.	PUNCT
gsrj-41	30	1	the	the	DET
gsrj-41	30	2	asian	asian	ADJ
gsrj-41	30	3	population	population	NOUN
gsrj-41	30	4	has	have	VERB
gsrj-41	30	5	the	the	DET
gsrj-41	30	6	highest	high	ADJ
gsrj-41	30	7	full	full	ADJ
gsrj-41	30	8	vaccination	vaccination	NOUN
gsrj-41	30	9	rate	rate	NOUN
gsrj-41	30	10	(	(	PUNCT
gsrj-41	30	11	59.5	59.5	NUM
gsrj-41	30	12	%	%	NOUN
gsrj-41	30	13	)	)	PUNCT
gsrj-41	30	14	,	,	PUNCT
gsrj-41	30	15	followed	follow	VERB
gsrj-41	30	16	by	by	ADP
gsrj-41	30	17	american	american	PROPN
gsrj-41	30	18	indian	indian	PROPN
gsrj-41	30	19	/	/	SYM
gsrj-41	30	20	alaska	alaska	PROPN
gsrj-41	30	21	native	native	NOUN
gsrj-41	30	22	(	(	PUNCT
gsrj-41	30	23	58.0	58.0	NUM
gsrj-41	30	24	%	%	NOUN
gsrj-41	30	25	)	)	PUNCT
gsrj-41	30	26	,	,	PUNCT
gsrj-41	30	27	native	native	ADJ
gsrj-41	30	28	hawaiian	hawaiian	NOUN
gsrj-41	30	29	or	or	CCONJ
gsrj-41	30	30	other	other	ADJ
gsrj-41	30	31	pacific	pacific	PROPN
gsrj-41	30	32	islander	islander	NOUN
gsrj-41	30	33	(	(	PUNCT
gsrj-41	30	34	57.4	57.4	NUM
gsrj-41	30	35	%	%	NOUN
gsrj-41	30	36	)	)	PUNCT
gsrj-41	30	37	,	,	PUNCT
gsrj-41	30	38	hispanic	hispanic	ADJ
gsrj-41	30	39	/	/	SYM
gsrj-41	30	40	latino	latino	NOUN
gsrj-41	30	41	(	(	PUNCT
gsrj-41	30	42	51.1	51.1	NUM
gsrj-41	30	43	%	%	NOUN
gsrj-41	30	44	)	)	PUNCT
gsrj-41	30	45	,	,	PUNCT
gsrj-41	30	46	white	white	X
gsrj-41	30	47	(	(	PUNCT
gsrj-41	30	48	47.6	47.6	NUM
gsrj-41	30	49	%	%	NOUN
gsrj-41	30	50	)	)	PUNCT
gsrj-41	30	51	,	,	PUNCT
gsrj-41	30	52	and	and	CCONJ
gsrj-41	30	53	black	black	ADJ
gsrj-41	30	54	(	(	PUNCT
gsrj-41	30	55	40.2%).8	40.2%).8	NUM
gsrj-41	30	56	increased	increase	VERB
gsrj-41	30	57	vaccination	vaccination	NOUN
gsrj-41	30	58	rates	rate	NOUN
gsrj-41	30	59	are	be	AUX
gsrj-41	30	60	needed	need	VERB
gsrj-41	30	61	to	to	PART
gsrj-41	30	62	protect	protect	VERB
gsrj-41	30	63	the	the	DET
gsrj-41	30	64	population	population	NOUN
gsrj-41	30	65	from	from	ADP
gsrj-41	30	66	severe	severe	ADJ
gsrj-41	30	67	disease	disease	NOUN
gsrj-41	30	68	and	and	CCONJ
gsrj-41	30	69	reach	reach	VERB
gsrj-41	30	70	herd	herd	NOUN
gsrj-41	30	71	immunity.5	immunity.5	PROPN
gsrj-41	30	72	,	,	PUNCT
gsrj-41	30	73	13	13	NUM
gsrj-41	30	74	herd	herd	NOUN
gsrj-41	30	75	immunity	immunity	NOUN
gsrj-41	30	76	is	be	AUX
gsrj-41	30	77	when	when	SCONJ
gsrj-41	30	78	enough	enough	ADJ
gsrj-41	30	79	of	of	ADP
gsrj-41	30	80	the	the	DET
gsrj-41	30	81	population	population	NOUN
gsrj-41	30	82	becomes	become	VERB
gsrj-41	30	83	immune	immune	ADJ
gsrj-41	30	84	to	to	ADP
gsrj-41	30	85	a	a	DET
gsrj-41	30	86	disease	disease	NOUN
gsrj-41	30	87	,	,	PUNCT
gsrj-41	30	88	through	through	ADP
gsrj-41	30	89	either	either	PRON
gsrj-41	30	90	natural	natural	ADJ
gsrj-41	30	91	infection	infection	NOUN
gsrj-41	30	92	or	or	CCONJ
gsrj-41	30	93	vaccination	vaccination	NOUN
gsrj-41	30	94	,	,	PUNCT
gsrj-41	30	95	so	so	SCONJ
gsrj-41	30	96	that	that	SCONJ
gsrj-41	30	97	there	there	PRON
gsrj-41	30	98	is	be	VERB
gsrj-41	30	99	much	much	ADV
gsrj-41	30	100	less	less	ADJ
gsrj-41	30	101	spread	spread	VERB
gsrj-41	30	102	through	through	ADP
gsrj-41	30	103	the	the	DET
gsrj-41	30	104	community.12	community.12	NOUN
gsrj-41	30	105	high	high	ADJ
gsrj-41	30	106	immunity	immunity	NOUN
gsrj-41	30	107	levels	level	NOUN
gsrj-41	30	108	in	in	ADP
gsrj-41	30	109	the	the	DET
gsrj-41	30	110	community	community	NOUN
gsrj-41	30	111	lead	lead	NOUN
gsrj-41	30	112	to	to	ADP
gsrj-41	30	113	indirect	indirect	ADJ
gsrj-41	30	114	protection	protection	NOUN
gsrj-41	30	115	to	to	ADP
gsrj-41	30	116	those	those	PRON
gsrj-41	30	117	who	who	PRON
gsrj-41	30	118	are	be	AUX
gsrj-41	30	119	not	not	PART
gsrj-41	30	120	immune.13	immune.13	NOUN
gsrj-41	30	121	the	the	DET
gsrj-41	30	122	percentage	percentage	NOUN
gsrj-41	30	123	vaccinated	vaccinate	VERB
gsrj-41	30	124	and/or	and/or	CCONJ
gsrj-41	30	125	infected	infect	VERB
gsrj-41	30	126	to	to	PART
gsrj-41	30	127	establish	establish	VERB
gsrj-41	30	128	herd	herd	ADJ
gsrj-41	30	129	immunity	immunity	NOUN
gsrj-41	30	130	against	against	ADP
gsrj-41	30	131	covid-19	covid-19	PROPN
gsrj-41	30	132	is	be	AUX
gsrj-41	30	133	not	not	PART
gsrj-41	30	134	clear	clear	ADJ
gsrj-41	30	135	,	,	PUNCT
gsrj-41	30	136	as	as	SCONJ
gsrj-41	30	137	variants	variant	NOUN
gsrj-41	30	138	and	and	CCONJ
gsrj-41	30	139	changing	change	VERB
gsrj-41	30	140	protection	protection	NOUN
gsrj-41	30	141	affect	affect	VERB
gsrj-41	30	142	this	this	DET
gsrj-41	30	143	number	number	NOUN
gsrj-41	30	144	.	.	PUNCT
gsrj-41	31	1	however	however	ADV
gsrj-41	31	2	,	,	PUNCT
gsrj-41	31	3	increasing	increase	VERB
gsrj-41	31	4	the	the	DET
gsrj-41	31	5	number	number	NOUN
gsrj-41	31	6	of	of	ADP
gsrj-41	31	7	vaccinated	vaccinated	ADJ
gsrj-41	31	8	individuals	individual	NOUN
gsrj-41	31	9	can	can	AUX
gsrj-41	31	10	make	make	VERB
gsrj-41	31	11	the	the	DET
gsrj-41	31	12	effects	effect	NOUN
gsrj-41	31	13	of	of	ADP
gsrj-41	31	14	covid-19	covid-19	PROPN
gsrj-41	31	15	manageable	manageable	ADJ
gsrj-41	31	16	,	,	PUNCT
gsrj-41	31	17	as	as	SCONJ
gsrj-41	31	18	the	the	DET
gsrj-41	31	19	risk	risk	NOUN
gsrj-41	31	20	of	of	ADP
gsrj-41	31	21	severe	severe	ADJ
gsrj-41	31	22	illness	illness	NOUN
gsrj-41	31	23	decreases	decrease	NOUN
gsrj-41	31	24	and	and	CCONJ
gsrj-41	31	25	waves	wave	NOUN
gsrj-41	31	26	will	will	AUX
gsrj-41	31	27	not	not	PART
gsrj-41	31	28	be	be	AUX
gsrj-41	31	29	as	as	ADP
gsrj-41	31	30	disruptive.13	disruptive.13	NOUN
gsrj-41	31	31	even	even	ADV
gsrj-41	31	32	so	so	ADV
gsrj-41	31	33	,	,	PUNCT
gsrj-41	31	34	the	the	DET
gsrj-41	31	35	novelty	novelty	NOUN
gsrj-41	31	36	of	of	ADP
gsrj-41	31	37	the	the	DET
gsrj-41	31	38	virus	virus	NOUN
gsrj-41	31	39	and	and	CCONJ
gsrj-41	31	40	chance	chance	NOUN
gsrj-41	31	41	of	of	ADP
gsrj-41	31	42	breakthrough	breakthrough	ADJ
gsrj-41	31	43	infection	infection	NOUN
gsrj-41	31	44	and	and	CCONJ
gsrj-41	31	45	re	re	NOUN
gsrj-41	31	46	-	-	NOUN
gsrj-41	31	47	infection	infection	NOUN
gsrj-41	31	48	can	can	AUX
gsrj-41	31	49	make	make	VERB
gsrj-41	31	50	this	this	PRON
gsrj-41	31	51	an	an	DET
gsrj-41	31	52	impossible	impossible	ADJ
gsrj-41	31	53	task	task	NOUN
gsrj-41	31	54	.	.	PUNCT
gsrj-41	32	1	even	even	ADV
gsrj-41	32	2	with	with	ADP
gsrj-41	32	3	adequate	adequate	ADJ
gsrj-41	32	4	resources	resource	NOUN
gsrj-41	32	5	to	to	PART
gsrj-41	32	6	vaccinate	vaccinate	VERB
gsrj-41	32	7	the	the	DET
gsrj-41	32	8	whole	whole	ADJ
gsrj-41	32	9	population	population	NOUN
gsrj-41	32	10	,	,	PUNCT
gsrj-41	32	11	the	the	DET
gsrj-41	32	12	u.s	u.s	PROPN
gsrj-41	32	13	.	.	PROPN
gsrj-41	32	14	demonstrates	demonstrate	VERB
gsrj-41	32	15	the	the	DET
gsrj-41	32	16	need	need	NOUN
gsrj-41	32	17	to	to	PART
gsrj-41	32	18	combat	combat	VERB
gsrj-41	32	19	vaccine	vaccine	NOUN
gsrj-41	32	20	hesitancy	hesitancy	NOUN
gsrj-41	32	21	everywhere	everywhere	ADV
gsrj-41	32	22	to	to	PART
gsrj-41	32	23	stop	stop	VERB
gsrj-41	32	24	the	the	DET
gsrj-41	32	25	impact	impact	NOUN
gsrj-41	32	26	of	of	ADP
gsrj-41	32	27	covid-19.14	covid-19.14	PROPN
gsrj-41	32	28	vaccination	vaccination	NOUN
gsrj-41	32	29	is	be	AUX
gsrj-41	32	30	necessary	necessary	ADJ
gsrj-41	32	31	for	for	ADP
gsrj-41	32	32	safety	safety	NOUN
gsrj-41	32	33	of	of	ADP
gsrj-41	32	34	those	those	PRON
gsrj-41	32	35	most	most	ADJ
gsrj-41	32	36	at	at	ADP
gsrj-41	32	37	-	-	PUNCT
gsrj-41	32	38	risk	risk	NOUN
gsrj-41	32	39	by	by	ADP
gsrj-41	32	40	decreasing	decrease	VERB
gsrj-41	32	41	transmission	transmission	NOUN
gsrj-41	32	42	,	,	PUNCT
gsrj-41	32	43	as	as	ADV
gsrj-41	32	44	well	well	ADV
gsrj-41	32	45	as	as	ADP
gsrj-41	32	46	personal	personal	ADJ
gsrj-41	32	47	protection	protection	NOUN
gsrj-41	32	48	against	against	ADP
gsrj-41	32	49	severe	severe	ADJ
gsrj-41	32	50	disease.5	disease.5	NOUN
gsrj-41	32	51	,	,	PUNCT
gsrj-41	32	52	13	13	NUM
gsrj-41	32	53	however	however	ADV
gsrj-41	32	54	,	,	PUNCT
gsrj-41	32	55	there	there	PRON
gsrj-41	32	56	is	be	VERB
gsrj-41	32	57	still	still	ADV
gsrj-41	32	58	a	a	DET
gsrj-41	32	59	large	large	ADJ
gsrj-41	32	60	unvaccinated	unvaccinated	ADJ
gsrj-41	32	61	population	population	NOUN
gsrj-41	32	62	in	in	ADP
gsrj-41	32	63	the	the	DET
gsrj-41	32	64	u.s	u.s	PROPN
gsrj-41	32	65	.	.	PROPN
gsrj-41	32	66	to	to	PART
gsrj-41	32	67	determine	determine	VERB
gsrj-41	32	68	the	the	DET
gsrj-41	32	69	reasoning	reasoning	NOUN
gsrj-41	32	70	of	of	ADP
gsrj-41	32	71	those	those	PRON
gsrj-41	32	72	who	who	PRON
gsrj-41	32	73	are	be	AUX
gsrj-41	32	74	still	still	ADV
gsrj-41	32	75	unvaccinated	unvaccinate	VERB
gsrj-41	32	76	,	,	PUNCT
gsrj-41	32	77	a	a	DET
gsrj-41	32	78	literature	literature	NOUN
gsrj-41	32	79	review	review	NOUN
gsrj-41	32	80	of	of	ADP
gsrj-41	32	81	existing	exist	VERB
gsrj-41	32	82	research	research	NOUN
gsrj-41	32	83	on	on	ADP
gsrj-41	32	84	reasons	reason	NOUN
gsrj-41	32	85	for	for	ADP
gsrj-41	32	86	being	be	AUX
gsrj-41	32	87	unvaccinated	unvaccinate	VERB
gsrj-41	32	88	against	against	ADP
gsrj-41	32	89	covid-19	covid-19	PROPN
gsrj-41	32	90	in	in	ADP
gsrj-41	32	91	the	the	DET
gsrj-41	32	92	u.s	u.s	PROPN
gsrj-41	32	93	.	.	PROPN
gsrj-41	32	94	was	be	AUX
gsrj-41	32	95	conducted	conduct	VERB
gsrj-41	32	96	.	.	PUNCT
gsrj-41	33	1	these	these	DET
gsrj-41	33	2	explanations	explanation	NOUN
gsrj-41	33	3	will	will	AUX
gsrj-41	33	4	help	help	VERB
gsrj-41	33	5	policymakers	policymaker	NOUN
gsrj-41	33	6	and	and	CCONJ
gsrj-41	33	7	health	health	NOUN
gsrj-41	33	8	communicators	communicator	NOUN
gsrj-41	33	9	discover	discover	VERB
gsrj-41	33	10	what	what	PRON
gsrj-41	33	11	messages	message	NOUN
gsrj-41	33	12	and	and	CCONJ
gsrj-41	33	13	incentives	incentive	NOUN
gsrj-41	33	14	work	work	VERB
gsrj-41	33	15	best	good	ADJ
gsrj-41	33	16	to	to	PART
gsrj-41	33	17	vaccinate	vaccinate	VERB
gsrj-41	33	18	the	the	DET
gsrj-41	33	19	entire	entire	ADJ
gsrj-41	33	20	u.s	u.s	PROPN
gsrj-41	33	21	.	.	PROPN
gsrj-41	33	22	population	population	NOUN
gsrj-41	33	23	against	against	ADP
gsrj-41	33	24	this	this	DET
gsrj-41	33	25	deadly	deadly	ADJ
gsrj-41	33	26	virus	virus	NOUN
gsrj-41	33	27	.	.	PUNCT
gsrj-41	34	1	the	the	DET
gsrj-41	34	2	original	original	ADJ
gsrj-41	34	3	hypothesis	hypothesis	NOUN
gsrj-41	34	4	is	be	AUX
gsrj-41	34	5	that	that	SCONJ
gsrj-41	34	6	reasons	reason	NOUN
gsrj-41	34	7	for	for	ADP
gsrj-41	34	8	covid-19	covid-19	PROPN
gsrj-41	34	9	vaccine	vaccine	NOUN
gsrj-41	34	10	hesitancy	hesitancy	NOUN
gsrj-41	34	11	in	in	ADP
gsrj-41	34	12	the	the	DET
gsrj-41	34	13	us	us	PROPN
gsrj-41	34	14	include	include	VERB
gsrj-41	34	15	distrust	distrust	NOUN
gsrj-41	34	16	,	,	PUNCT
gsrj-41	34	17	misinformation	misinformation	NOUN
gsrj-41	34	18	,	,	PUNCT
gsrj-41	34	19	and	and	CCONJ
gsrj-41	34	20	lack	lack	NOUN
gsrj-41	34	21	of	of	ADP
gsrj-41	34	22	access	access	NOUN
gsrj-41	34	23	.	.	PUNCT
gsrj-41	35	1	therefore	therefore	ADV
gsrj-41	35	2	,	,	PUNCT
gsrj-41	35	3	these	these	PRON
gsrj-41	35	4	can	can	AUX
gsrj-41	35	5	be	be	AUX
gsrj-41	35	6	best	well	ADV
gsrj-41	35	7	combatted	combat	VERB
gsrj-41	35	8	with	with	ADP
gsrj-41	35	9	general	general	ADJ
gsrj-41	35	10	healthcare	healthcare	NOUN
gsrj-41	35	11	reform	reform	NOUN
gsrj-41	35	12	and	and	CCONJ
gsrj-41	35	13	community	community	NOUN
gsrj-41	35	14	engagement	engagement	NOUN
gsrj-41	35	15	,	,	PUNCT
gsrj-41	35	16	in	in	ADP
gsrj-41	35	17	person	person	NOUN
gsrj-41	35	18	and	and	CCONJ
gsrj-41	35	19	on	on	ADP
gsrj-41	35	20	the	the	DET
gsrj-41	35	21	internet	internet	NOUN
gsrj-41	35	22	.	.	PUNCT
gsrj-41	36	1	2	2	X
gsrj-41	36	2	.	.	X
gsrj-41	36	3	methods	method	NOUN
gsrj-41	36	4	the	the	DET
gsrj-41	36	5	a	a	DET
gsrj-41	36	6	scoping	scoping	NOUN
gsrj-41	36	7	,	,	PUNCT
gsrj-41	36	8	systematic	systematic	ADJ
gsrj-41	36	9	review	review	NOUN
gsrj-41	36	10	of	of	ADP
gsrj-41	36	11	published	publish	VERB
gsrj-41	36	12	literature	literature	NOUN
gsrj-41	36	13	on	on	ADP
gsrj-41	36	14	pubmed	pubmed	PROPN
gsrj-41	36	15	regarding	regard	VERB
gsrj-41	36	16	reasons	reason	NOUN
gsrj-41	36	17	for	for	ADP
gsrj-41	36	18	covid-19	covid-19	PROPN
gsrj-41	36	19	vaccine	vaccine	NOUN
gsrj-41	36	20	hesitancy	hesitancy	NOUN
gsrj-41	36	21	in	in	ADP
gsrj-41	36	22	the	the	DET
gsrj-41	36	23	united	united	PROPN
gsrj-41	36	24	states	states	PROPN
gsrj-41	36	25	was	be	AUX
gsrj-41	36	26	conducted	conduct	VERB
gsrj-41	36	27	from	from	ADP
gsrj-41	36	28	september	september	PROPN
gsrj-41	36	29	1	1	NUM
gsrj-41	36	30	,	,	PUNCT
gsrj-41	36	31	2021	2021	NUM
gsrj-41	36	32	,	,	PUNCT
gsrj-41	36	33	to	to	ADP
gsrj-41	36	34	november	november	PROPN
gsrj-41	36	35	24	24	NUM
gsrj-41	36	36	,	,	PUNCT
gsrj-41	36	37	2021	2021	NUM
gsrj-41	36	38	.	.	PUNCT
gsrj-41	37	1	2.1	2.1	NUM
gsrj-41	37	2	research	research	NOUN
gsrj-41	37	3	questions	question	NOUN
gsrj-41	37	4	&	&	CCONJ
gsrj-41	37	5	purpose	purpose	NOUN
gsrj-41	37	6	of	of	ADP
gsrj-41	37	7	review	review	NOUN
gsrj-41	37	8	the	the	DET
gsrj-41	37	9	primary	primary	ADJ
gsrj-41	37	10	question	question	NOUN
gsrj-41	37	11	in	in	ADP
gsrj-41	37	12	this	this	DET
gsrj-41	37	13	literature	literature	NOUN
gsrj-41	37	14	review	review	NOUN
gsrj-41	37	15	is	be	AUX
gsrj-41	37	16	:	:	PUNCT
gsrj-41	37	17	what	what	PRON
gsrj-41	37	18	are	be	AUX
gsrj-41	37	19	the	the	DET
gsrj-41	37	20	most	most	ADV
gsrj-41	37	21	frequently	frequently	ADV
gsrj-41	37	22	given	give	VERB
gsrj-41	37	23	/	/	SYM
gsrj-41	37	24	most	most	ADV
gsrj-41	37	25	common	common	ADJ
gsrj-41	37	26	reasons	reason	NOUN
gsrj-41	37	27	for	for	ADP
gsrj-41	37	28	vaccine	vaccine	NOUN
gsrj-41	37	29	hesitancy	hesitancy	NOUN
gsrj-41	37	30	and	and	CCONJ
gsrj-41	37	31	refusal	refusal	NOUN
gsrj-41	37	32	among	among	ADP
gsrj-41	37	33	the	the	DET
gsrj-41	37	34	u.s	u.s	PROPN
gsrj-41	37	35	.	.	PROPN
gsrj-41	37	36	population	population	NOUN
gsrj-41	37	37	?	?	PUNCT
gsrj-41	38	1	the	the	DET
gsrj-41	38	2	secondary	secondary	ADJ
gsrj-41	38	3	question	question	NOUN
gsrj-41	38	4	is	be	AUX
gsrj-41	38	5	:	:	PUNCT
gsrj-41	38	6	how	how	SCONJ
gsrj-41	38	7	are	be	AUX
gsrj-41	38	8	these	these	DET
gsrj-41	38	9	reasons	reason	NOUN
gsrj-41	38	10	impacted	impact	VERB
gsrj-41	38	11	by	by	ADP
gsrj-41	38	12	timing	timing	NOUN
gsrj-41	38	13	of	of	ADP
gsrj-41	38	14	the	the	DET
gsrj-41	38	15	study	study	NOUN
gsrj-41	38	16	and	and	CCONJ
gsrj-41	38	17	participant	participant	ADJ
gsrj-41	38	18	population	population	NOUN
gsrj-41	38	19	?	?	PUNCT
gsrj-41	39	1	having	having	AUX
gsrj-41	39	2	identified	identify	VERB
gsrj-41	39	3	the	the	DET
gsrj-41	39	4	reasons	reason	NOUN
gsrj-41	39	5	,	,	PUNCT
gsrj-41	39	6	the	the	DET
gsrj-41	39	7	paper	paper	NOUN
gsrj-41	39	8	discusses	discuss	VERB
gsrj-41	39	9	how	how	SCONJ
gsrj-41	39	10	this	this	DET
gsrj-41	39	11	information	information	NOUN
gsrj-41	39	12	and	and	CCONJ
gsrj-41	39	13	nuance	nuance	NOUN
gsrj-41	39	14	might	might	AUX
gsrj-41	39	15	be	be	AUX
gsrj-41	39	16	used	use	VERB
gsrj-41	39	17	to	to	PART
gsrj-41	39	18	increase	increase	VERB
gsrj-41	39	19	vaccine	vaccine	NOUN
gsrj-41	39	20	uptake	uptake	ADJ
gsrj-41	39	21	.	.	PUNCT
gsrj-41	40	1	by	by	ADP
gsrj-41	40	2	pulling	pull	VERB
gsrj-41	40	3	literature	literature	NOUN
gsrj-41	40	4	surrounding	surround	VERB
gsrj-41	40	5	general	general	ADJ
gsrj-41	40	6	low	low	ADJ
gsrj-41	40	7	vaccine	vaccine	NOUN
gsrj-41	40	8	confidence	confidence	NOUN
gsrj-41	40	9	and	and	CCONJ
gsrj-41	40	10	health	health	NOUN
gsrj-41	40	11	communication	communication	NOUN
gsrj-41	40	12	theories	theory	NOUN
gsrj-41	40	13	,	,	PUNCT
gsrj-41	40	14	creative	creative	ADJ
gsrj-41	40	15	ways	way	NOUN
gsrj-41	40	16	are	be	AUX
gsrj-41	40	17	found	find	VERB
gsrj-41	40	18	to	to	PART
gsrj-41	40	19	combat	combat	VERB
gsrj-41	40	20	the	the	DET
gsrj-41	40	21	current	current	ADJ
gsrj-41	40	22	hesitancy	hesitancy	NOUN
gsrj-41	40	23	effecting	effect	VERB
gsrj-41	40	24	around	around	ADP
gsrj-41	40	25	24	24	NUM
gsrj-41	40	26	%	%	NOUN
gsrj-41	40	27	of	of	ADP
gsrj-41	40	28	the	the	DET
gsrj-41	40	29	u.s	u.s	PROPN
gsrj-41	40	30	.	.	PROPN
gsrj-41	40	31	population	population	NOUN
gsrj-41	40	32	who	who	PRON
gsrj-41	40	33	have	have	AUX
gsrj-41	40	34	not	not	PART
gsrj-41	40	35	received	receive	VERB
gsrj-41	40	36	one	one	NUM
gsrj-41	40	37	dose	dose	NOUN
gsrj-41	40	38	of	of	ADP
gsrj-41	40	39	the	the	DET
gsrj-41	40	40	covid-19	covid-19	PROPN
gsrj-41	40	41	vaccine	vaccine	NOUN
gsrj-41	40	42	,	,	PUNCT
gsrj-41	40	43	and	and	CCONJ
gsrj-41	40	44	19.2	19.2	NUM
gsrj-41	40	45	%	%	NOUN
gsrj-41	40	46	of	of	ADP
gsrj-41	40	47	people	people	NOUN
gsrj-41	40	48	ages	age	NOUN
gsrj-41	40	49	5	5	NUM
gsrj-41	40	50	and	and	CCONJ
gsrj-41	40	51	older	old	ADJ
gsrj-41	40	52	who	who	PRON
gsrj-41	40	53	have	have	AUX
gsrj-41	40	54	not	not	PART
gsrj-41	40	55	received	receive	VERB
gsrj-41	40	56	even	even	ADV
gsrj-41	40	57	one	one	NUM
gsrj-41	40	58	dose.7	dose.7	NOUN
gsrj-41	40	59	10	10	NUM
gsrj-41	40	60	georgetown	georgetown	PROPN
gsrj-41	40	61	scientific	scientific	PROPN
gsrj-41	40	62	research	research	NOUN
gsrj-41	40	63	journal	journal	NOUN
gsrj-41	40	64	the	the	DET
gsrj-41	40	65	purpose	purpose	NOUN
gsrj-41	40	66	of	of	ADP
gsrj-41	40	67	this	this	DET
gsrj-41	40	68	literature	literature	NOUN
gsrj-41	40	69	review	review	NOUN
gsrj-41	40	70	is	be	AUX
gsrj-41	40	71	to	to	PART
gsrj-41	40	72	find	find	VERB
gsrj-41	40	73	the	the	DET
gsrj-41	40	74	most	most	ADV
gsrj-41	40	75	frequently	frequently	ADV
gsrj-41	40	76	given	give	VERB
gsrj-41	40	77	reasons	reason	NOUN
gsrj-41	40	78	for	for	ADP
gsrj-41	40	79	covid-19	covid-19	PROPN
gsrj-41	40	80	vaccine	vaccine	NOUN
gsrj-41	40	81	hesitancy	hesitancy	NOUN
gsrj-41	40	82	across	across	ADP
gsrj-41	40	83	the	the	DET
gsrj-41	40	84	u.s	u.s	PROPN
gsrj-41	40	85	.	.	PROPN
gsrj-41	40	86	population	population	NOUN
gsrj-41	40	87	,	,	PUNCT
gsrj-41	40	88	in	in	ADP
gsrj-41	40	89	order	order	NOUN
gsrj-41	40	90	to	to	PART
gsrj-41	40	91	identify	identify	VERB
gsrj-41	40	92	most	most	ADV
gsrj-41	40	93	effective	effective	ADJ
gsrj-41	40	94	interventions	intervention	NOUN
gsrj-41	40	95	to	to	PART
gsrj-41	40	96	increase	increase	VERB
gsrj-41	40	97	uptake	uptake	ADJ
gsrj-41	40	98	.	.	PUNCT
gsrj-41	41	1	objectives	objective	NOUN
gsrj-41	41	2	of	of	ADP
gsrj-41	41	3	this	this	DET
gsrj-41	41	4	review	review	NOUN
gsrj-41	41	5	include	include	VERB
gsrj-41	41	6	:	:	PUNCT
gsrj-41	41	7	1	1	X
gsrj-41	41	8	)	)	PUNCT
gsrj-41	41	9	to	to	PART
gsrj-41	41	10	assess	assess	VERB
gsrj-41	41	11	most	most	ADV
gsrj-41	41	12	common	common	ADJ
gsrj-41	41	13	reasons	reason	NOUN
gsrj-41	41	14	for	for	ADP
gsrj-41	41	15	covid-19	covid-19	PROPN
gsrj-41	41	16	vaccine	vaccine	NOUN
gsrj-41	41	17	hesitancy	hesitancy	NOUN
gsrj-41	41	18	among	among	ADP
gsrj-41	41	19	u.s	u.s	PROPN
gsrj-41	41	20	.	.	PROPN
gsrj-41	41	21	adults	adult	NOUN
gsrj-41	41	22	,	,	PUNCT
gsrj-41	41	23	and	and	CCONJ
gsrj-41	41	24	2	2	NUM
gsrj-41	41	25	)	)	PUNCT
gsrj-41	41	26	to	to	PART
gsrj-41	41	27	analyze	analyze	VERB
gsrj-41	41	28	the	the	DET
gsrj-41	41	29	best	good	ADJ
gsrj-41	41	30	measures	measure	NOUN
gsrj-41	41	31	to	to	PART
gsrj-41	41	32	combat	combat	VERB
gsrj-41	41	33	these	these	DET
gsrj-41	41	34	specific	specific	ADJ
gsrj-41	41	35	reasons	reason	NOUN
gsrj-41	41	36	.	.	PUNCT
gsrj-41	42	1	2.2	2.2	NUM
gsrj-41	42	2	search	search	NOUN
gsrj-41	42	3	&	&	CCONJ
gsrj-41	42	4	analysis	analysis	NOUN
gsrj-41	42	5	process	process	NOUN
gsrj-41	42	6	the	the	DET
gsrj-41	42	7	advanced	advanced	ADJ
gsrj-41	42	8	search	search	NOUN
gsrj-41	42	9	terms	term	NOUN
gsrj-41	42	10	on	on	ADP
gsrj-41	42	11	pubmed	pubmed	PROPN
gsrj-41	42	12	were	be	AUX
gsrj-41	42	13	“	"	PUNCT
gsrj-41	42	14	(	(	PUNCT
gsrj-41	42	15	(	(	PUNCT
gsrj-41	42	16	(	(	PUNCT
gsrj-41	42	17	covid-19	covid-19	PROPN
gsrj-41	42	18	)	)	PUNCT
gsrj-41	42	19	and	and	CCONJ
gsrj-41	42	20	(	(	PUNCT
gsrj-41	42	21	united	united	PROPN
gsrj-41	42	22	states	states	PROPN
gsrj-41	42	23	)	)	PUNCT
gsrj-41	42	24	)	)	PUNCT
gsrj-41	43	1	and	and	CCONJ
gsrj-41	43	2	(	(	PUNCT
gsrj-41	43	3	vaccine	vaccine	NOUN
gsrj-41	43	4	hesitancy	hesitancy	NOUN
gsrj-41	43	5	)	)	PUNCT
gsrj-41	43	6	)	)	PUNCT
gsrj-41	44	1	and	and	CCONJ
gsrj-41	44	2	(	(	PUNCT
gsrj-41	44	3	reasons	reason	NOUN
gsrj-41	44	4	)	)	PUNCT
gsrj-41	44	5	.	.	PUNCT
gsrj-41	44	6	”	"	PUNCT
gsrj-41	45	1	this	this	PRON
gsrj-41	45	2	resulted	result	VERB
gsrj-41	45	3	in	in	ADP
gsrj-41	45	4	a	a	DET
gsrj-41	45	5	total	total	NOUN
gsrj-41	45	6	of	of	ADP
gsrj-41	45	7	38	38	NUM
gsrj-41	45	8	results	result	NOUN
gsrj-41	45	9	,	,	PUNCT
gsrj-41	45	10	which	which	PRON
gsrj-41	45	11	were	be	AUX
gsrj-41	45	12	reduced	reduce	VERB
gsrj-41	45	13	to	to	ADP
gsrj-41	45	14	27	27	NUM
gsrj-41	45	15	because	because	SCONJ
gsrj-41	45	16	of	of	ADP
gsrj-41	45	17	exclusion	exclusion	NOUN
gsrj-41	45	18	criteria	criterion	NOUN
gsrj-41	45	19	detailed	detail	VERB
gsrj-41	45	20	below	below	ADV
gsrj-41	45	21	.	.	PUNCT
gsrj-41	46	1	the	the	DET
gsrj-41	46	2	inclusion	inclusion	NOUN
gsrj-41	46	3	criteria	criterion	NOUN
gsrj-41	46	4	consist	consist	VERB
gsrj-41	46	5	of	of	ADP
gsrj-41	46	6	adult	adult	NOUN
gsrj-41	46	7	population	population	NOUN
gsrj-41	46	8	from	from	ADP
gsrj-41	46	9	the	the	DET
gsrj-41	46	10	united	united	PROPN
gsrj-41	46	11	states	states	PROPN
gsrj-41	46	12	that	that	PRON
gsrj-41	46	13	include	include	VERB
gsrj-41	46	14	reasons	reason	NOUN
gsrj-41	46	15	for	for	ADP
gsrj-41	46	16	vaccine	vaccine	NOUN
gsrj-41	46	17	hesitancy	hesitancy	NOUN
gsrj-41	46	18	.	.	PUNCT
gsrj-41	47	1	the	the	DET
gsrj-41	47	2	exclusion	exclusion	NOUN
gsrj-41	47	3	criteria	criterion	NOUN
gsrj-41	47	4	include	include	VERB
gsrj-41	47	5	:	:	PUNCT
gsrj-41	47	6	duplicates	duplicate	NOUN
gsrj-41	47	7	(	(	PUNCT
gsrj-41	47	8	1	1	NUM
gsrj-41	47	9	)	)	PUNCT
gsrj-41	47	10	,	,	PUNCT
gsrj-41	47	11	articles	article	NOUN
gsrj-41	47	12	on	on	ADP
gsrj-41	47	13	non	non	ADJ
gsrj-41	47	14	-	-	ADJ
gsrj-41	47	15	u.s	u.s	ADJ
gsrj-41	47	16	.	.	PROPN
gsrj-41	47	17	populations	population	NOUN
gsrj-41	47	18	(	(	PUNCT
gsrj-41	47	19	4	4	NUM
gsrj-41	47	20	)	)	PUNCT
gsrj-41	47	21	,	,	PUNCT
gsrj-41	47	22	non	non	ADJ
gsrj-41	47	23	-	-	ADJ
gsrj-41	47	24	covid-19	covid-19	ADJ
gsrj-41	47	25	specific	specific	ADJ
gsrj-41	47	26	data	datum	NOUN
gsrj-41	47	27	(	(	PUNCT
gsrj-41	47	28	2	2	NUM
gsrj-41	47	29	)	)	PUNCT
gsrj-41	47	30	,	,	PUNCT
gsrj-41	47	31	did	do	AUX
gsrj-41	47	32	not	not	PART
gsrj-41	47	33	include	include	VERB
gsrj-41	47	34	reasons	reason	NOUN
gsrj-41	47	35	but	but	CCONJ
gsrj-41	47	36	only	only	ADV
gsrj-41	47	37	incentives	incentive	NOUN
gsrj-41	47	38	or	or	CCONJ
gsrj-41	47	39	prioritization	prioritization	NOUN
gsrj-41	47	40	(	(	PUNCT
gsrj-41	47	41	2	2	NUM
gsrj-41	47	42	)	)	PUNCT
gsrj-41	47	43	,	,	PUNCT
gsrj-41	47	44	study	study	NOUN
gsrj-41	47	45	framing	framing	NOUN
gsrj-41	47	46	and	and	CCONJ
gsrj-41	47	47	not	not	PART
gsrj-41	47	48	actual	actual	ADJ
gsrj-41	47	49	data	datum	NOUN
gsrj-41	47	50	(	(	PUNCT
gsrj-41	47	51	1	1	NUM
gsrj-41	47	52	)	)	PUNCT
gsrj-41	47	53	,	,	PUNCT
gsrj-41	47	54	mental	mental	ADJ
gsrj-41	47	55	health	health	NOUN
gsrj-41	47	56	(	(	PUNCT
gsrj-41	47	57	1	1	NUM
gsrj-41	47	58	)	)	PUNCT
gsrj-41	47	59	.	.	PUNCT
gsrj-41	48	1	38	38	NUM
gsrj-41	48	2	articles	article	NOUN
gsrj-41	48	3	were	be	AUX
gsrj-41	48	4	scanned	scan	VERB
gsrj-41	48	5	by	by	ADP
gsrj-41	48	6	both	both	DET
gsrj-41	48	7	title	title	NOUN
gsrj-41	48	8	and	and	CCONJ
gsrj-41	48	9	abstract	abstract	ADJ
gsrj-41	48	10	for	for	ADP
gsrj-41	48	11	correct	correct	ADJ
gsrj-41	48	12	information	information	NOUN
gsrj-41	48	13	relevant	relevant	ADJ
gsrj-41	48	14	to	to	ADP
gsrj-41	48	15	the	the	DET
gsrj-41	48	16	research	research	NOUN
gsrj-41	48	17	question	question	NOUN
gsrj-41	48	18	and	and	CCONJ
gsrj-41	48	19	hypothesis	hypothesis	NOUN
gsrj-41	48	20	.	.	PUNCT
gsrj-41	49	1	the	the	DET
gsrj-41	49	2	27	27	NUM
gsrj-41	49	3	articles	article	NOUN
gsrj-41	49	4	included	include	VERB
gsrj-41	49	5	were	be	AUX
gsrj-41	49	6	analyzed	analyze	VERB
gsrj-41	49	7	,	,	PUNCT
gsrj-41	49	8	and	and	CCONJ
gsrj-41	49	9	information	information	NOUN
gsrj-41	49	10	on	on	ADP
gsrj-41	49	11	the	the	DET
gsrj-41	49	12	following	following	NOUN
gsrj-41	49	13	was	be	AUX
gsrj-41	49	14	extracted	extract	VERB
gsrj-41	49	15	using	use	VERB
gsrj-41	49	16	a	a	DET
gsrj-41	49	17	table	table	NOUN
gsrj-41	49	18	:	:	PUNCT
gsrj-41	49	19	date	date	NOUN
gsrj-41	49	20	of	of	ADP
gsrj-41	49	21	study	study	NOUN
gsrj-41	49	22	,	,	PUNCT
gsrj-41	49	23	method	method	NOUN
gsrj-41	49	24	of	of	ADP
gsrj-41	49	25	survey	survey	NOUN
gsrj-41	49	26	,	,	PUNCT
gsrj-41	49	27	population	population	NOUN
gsrj-41	49	28	studied	study	VERB
gsrj-41	49	29	and	and	CCONJ
gsrj-41	49	30	generalizability	generalizability	NOUN
gsrj-41	49	31	,	,	PUNCT
gsrj-41	49	32	and	and	CCONJ
gsrj-41	49	33	reasons	reason	NOUN
gsrj-41	49	34	for	for	ADP
gsrj-41	49	35	vaccine	vaccine	NOUN
gsrj-41	49	36	hesitancy	hesitancy	NOUN
gsrj-41	49	37	or	or	CCONJ
gsrj-41	49	38	refusal	refusal	NOUN
gsrj-41	49	39	.	.	PUNCT
gsrj-41	50	1	the	the	DET
gsrj-41	50	2	results	result	NOUN
gsrj-41	50	3	table	table	NOUN
gsrj-41	50	4	(	(	PUNCT
gsrj-41	50	5	table	table	NOUN
gsrj-41	50	6	a1	a1	NOUN
gsrj-41	50	7	)	)	PUNCT
gsrj-41	50	8	was	be	AUX
gsrj-41	50	9	created	create	VERB
gsrj-41	50	10	with	with	ADP
gsrj-41	50	11	this	this	DET
gsrj-41	50	12	information	information	NOUN
gsrj-41	50	13	.	.	PUNCT
gsrj-41	51	1	in	in	ADP
gsrj-41	51	2	addition	addition	NOUN
gsrj-41	51	3	,	,	PUNCT
gsrj-41	51	4	a	a	DET
gsrj-41	51	5	variable	variable	NOUN
gsrj-41	51	6	was	be	AUX
gsrj-41	51	7	created	create	VERB
gsrj-41	51	8	,	,	PUNCT
gsrj-41	51	9	included	include	VERB
gsrj-41	51	10	in	in	ADP
gsrj-41	51	11	the	the	DET
gsrj-41	51	12	table	table	NOUN
gsrj-41	51	13	,	,	PUNCT
gsrj-41	51	14	based	base	VERB
gsrj-41	51	15	on	on	ADP
gsrj-41	51	16	the	the	DET
gsrj-41	51	17	date	date	NOUN
gsrj-41	51	18	of	of	ADP
gsrj-41	51	19	survey	survey	NOUN
gsrj-41	51	20	on	on	ADP
gsrj-41	51	21	whether	whether	SCONJ
gsrj-41	51	22	the	the	DET
gsrj-41	51	23	study	study	NOUN
gsrj-41	51	24	was	be	AUX
gsrj-41	51	25	done	do	VERB
gsrj-41	51	26	before	before	ADP
gsrj-41	51	27	or	or	CCONJ
gsrj-41	51	28	after	after	ADP
gsrj-41	51	29	the	the	DET
gsrj-41	51	30	fda	fda	PROPN
gsrj-41	51	31	eua	eua	PROPN
gsrj-41	51	32	and	and	CCONJ
gsrj-41	51	33	actual	actual	ADJ
gsrj-41	51	34	roll	roll	NOUN
gsrj-41	51	35	-	-	PUNCT
gsrj-41	51	36	out	out	NOUN
gsrj-41	51	37	to	to	ADP
gsrj-41	51	38	the	the	DET
gsrj-41	51	39	general	general	ADJ
gsrj-41	51	40	population	population	NOUN
gsrj-41	51	41	.	.	PUNCT
gsrj-41	52	1	3	3	X
gsrj-41	52	2	.	.	NOUN
gsrj-41	52	3	results	result	VERB
gsrj-41	52	4	the	the	DET
gsrj-41	52	5	purpose	purpose	NOUN
gsrj-41	52	6	of	of	ADP
gsrj-41	52	7	the	the	DET
gsrj-41	52	8	27	27	NUM
gsrj-41	52	9	included	include	VERB
gsrj-41	52	10	articles	article	NOUN
gsrj-41	52	11	was	be	AUX
gsrj-41	52	12	to	to	PART
gsrj-41	52	13	conduct	conduct	VERB
gsrj-41	52	14	surveys	survey	NOUN
gsrj-41	52	15	to	to	PART
gsrj-41	52	16	identify	identify	VERB
gsrj-41	52	17	the	the	DET
gsrj-41	52	18	number	number	NOUN
gsrj-41	52	19	and	and	CCONJ
gsrj-41	52	20	percentage	percentage	NOUN
gsrj-41	52	21	of	of	ADP
gsrj-41	52	22	vaccine	vaccine	NOUN
gsrj-41	52	23	accepting	accept	VERB
gsrj-41	52	24	,	,	PUNCT
gsrj-41	52	25	hesitant	hesitant	ADJ
gsrj-41	52	26	,	,	PUNCT
gsrj-41	52	27	or	or	CCONJ
gsrj-41	52	28	refusers	refuser	NOUN
gsrj-41	52	29	within	within	ADP
gsrj-41	52	30	a	a	DET
gsrj-41	52	31	certain	certain	ADJ
gsrj-41	52	32	population	population	NOUN
gsrj-41	52	33	or	or	CCONJ
gsrj-41	52	34	general	general	ADJ
gsrj-41	52	35	americans	americans	PROPN
gsrj-41	52	36	,	,	PUNCT
gsrj-41	52	37	as	as	ADV
gsrj-41	52	38	well	well	ADV
gsrj-41	52	39	as	as	ADP
gsrj-41	52	40	find	find	VERB
gsrj-41	52	41	the	the	DET
gsrj-41	52	42	reasons	reason	NOUN
gsrj-41	52	43	for	for	ADP
gsrj-41	52	44	not	not	PART
gsrj-41	52	45	being	be	AUX
gsrj-41	52	46	vaccinated	vaccinate	VERB
gsrj-41	52	47	.	.	PUNCT
gsrj-41	53	1	3.1	3.1	NUM
gsrj-41	53	2	type	type	NOUN
gsrj-41	53	3	of	of	ADP
gsrj-41	53	4	study	study	NOUN
gsrj-41	53	5	the	the	DET
gsrj-41	53	6	majority	majority	NOUN
gsrj-41	53	7	of	of	ADP
gsrj-41	53	8	the	the	DET
gsrj-41	53	9	studies	study	NOUN
gsrj-41	53	10	were	be	AUX
gsrj-41	53	11	crosssectional	crosssectional	ADJ
gsrj-41	53	12	surveys	survey	NOUN
gsrj-41	53	13	conducted	conduct	VERB
gsrj-41	53	14	online	online	ADV
gsrj-41	53	15	(	(	PUNCT
gsrj-41	53	16	59.25	59.25	NUM
gsrj-41	53	17	%	%	NOUN
gsrj-41	53	18	)	)	PUNCT
gsrj-41	53	19	,	,	PUNCT
gsrj-41	53	20	as	as	ADV
gsrj-41	53	21	well	well	ADV
gsrj-41	53	22	as	as	ADP
gsrj-41	53	23	some	some	PRON
gsrj-41	53	24	in	in	ADP
gsrj-41	53	25	-	-	PUNCT
gsrj-41	53	26	person	person	NOUN
gsrj-41	53	27	and	and	CCONJ
gsrj-41	53	28	on	on	ADP
gsrj-41	53	29	the	the	DET
gsrj-41	53	30	phone	phone	NOUN
gsrj-41	53	31	(	(	PUNCT
gsrj-41	53	32	see	see	VERB
gsrj-41	53	33	table	table	NOUN
gsrj-41	53	34	1	1	NUM
gsrj-41	53	35	)	)	PUNCT
gsrj-41	53	36	.	.	PUNCT
gsrj-41	54	1	there	there	PRON
gsrj-41	54	2	was	be	VERB
gsrj-41	54	3	one	one	NUM
gsrj-41	54	4	qualitative	qualitative	ADJ
gsrj-41	54	5	study	study	NOUN
gsrj-41	54	6	with	with	ADP
gsrj-41	54	7	focus	focus	NOUN
gsrj-41	54	8	groups	group	NOUN
gsrj-41	54	9	,	,	PUNCT
gsrj-41	54	10	as	as	ADV
gsrj-41	54	11	well	well	ADV
gsrj-41	54	12	as	as	ADP
gsrj-41	54	13	two	two	NUM
gsrj-41	54	14	studies	study	NOUN
gsrj-41	54	15	which	which	PRON
gsrj-41	54	16	incorporated	incorporate	VERB
gsrj-41	54	17	a	a	DET
gsrj-41	54	18	primary	primary	ADJ
gsrj-41	54	19	survey	survey	NOUN
gsrj-41	54	20	with	with	ADP
gsrj-41	54	21	a	a	DET
gsrj-41	54	22	follow	follow	VERB
gsrj-41	54	23	-	-	PUNCT
gsrj-41	54	24	up	up	ADP
gsrj-41	54	25	survey	survey	NOUN
gsrj-41	54	26	after	after	ADP
gsrj-41	54	27	a	a	DET
gsrj-41	54	28	few	few	ADJ
gsrj-41	54	29	months	month	NOUN
gsrj-41	54	30	(	(	PUNCT
gsrj-41	54	31	see	see	VERB
gsrj-41	54	32	table	table	NOUN
gsrj-41	54	33	1	1	NUM
gsrj-41	54	34	)	)	PUNCT
gsrj-41	54	35	.	.	PUNCT
gsrj-41	55	1	sample	sample	NOUN
gsrj-41	55	2	sizes	size	NOUN
gsrj-41	55	3	ranged	range	VERB
gsrj-41	55	4	from	from	ADP
gsrj-41	55	5	participants	participant	NOUN
gsrj-41	55	6	of	of	ADP
gsrj-41	55	7	58	58	NUM
gsrj-41	55	8	in	in	ADP
gsrj-41	55	9	qualitative	qualitative	ADJ
gsrj-41	55	10	interviews	interview	NOUN
gsrj-41	55	11	(	(	PUNCT
gsrj-41	55	12	harrison	harrison	NOUN
gsrj-41	55	13	et	et	PROPN
gsrj-41	55	14	al	al	PROPN
gsrj-41	55	15	.	.	PROPN
gsrj-41	55	16	,	,	PUNCT
gsrj-41	55	17	2021)23	2021)23	NUM
gsrj-41	55	18	to	to	ADP
gsrj-41	55	19	458,235	458,235	NUM
gsrj-41	55	20	from	from	ADP
gsrj-41	55	21	a	a	DET
gsrj-41	55	22	census	census	NOUN
gsrj-41	55	23	survey	survey	NOUN
gsrj-41	55	24	(	(	PUNCT
gsrj-41	55	25	tram	tram	PROPN
gsrj-41	55	26	et	et	PROPN
gsrj-41	55	27	al	al	PROPN
gsrj-41	55	28	.	.	PROPN
gsrj-41	55	29	,	,	PUNCT
gsrj-41	55	30	2021)20	2021)20	NUM
gsrj-41	55	31	(	(	PUNCT
gsrj-41	55	32	see	see	VERB
gsrj-41	55	33	table	table	NOUN
gsrj-41	55	34	2	2	NUM
gsrj-41	55	35	)	)	PUNCT
gsrj-41	55	36	.	.	PUNCT
gsrj-41	56	1	11	11	NUM
gsrj-41	56	2	georgetown	georgetown	PROPN
gsrj-41	56	3	scientific	scientific	PROPN
gsrj-41	56	4	research	research	PROPN
gsrj-41	56	5	journal	journal	NOUN
gsrj-41	56	6	table	table	NOUN
gsrj-41	56	7	1	1	NUM
gsrj-41	56	8	:	:	PUNCT
gsrj-41	56	9	type	type	NOUN
gsrj-41	56	10	of	of	ADP
gsrj-41	56	11	study	study	NOUN
gsrj-41	56	12	by	by	ADP
gsrj-41	56	13	number	number	NOUN
gsrj-41	56	14	and	and	CCONJ
gsrj-41	56	15	percentage	percentage	NOUN
gsrj-41	56	16	of	of	ADP
gsrj-41	56	17	articles	article	NOUN
gsrj-41	56	18	(	(	PUNCT
gsrj-41	56	19	n	n	NOUN
gsrj-41	56	20	=	=	NUM
gsrj-41	56	21	27	27	NUM
gsrj-41	56	22	)	)	PUNCT
gsrj-41	56	23	.	.	PUNCT
gsrj-41	57	1	the	the	DET
gsrj-41	57	2	majority	majority	NOUN
gsrj-41	57	3	of	of	ADP
gsrj-41	57	4	studies	study	NOUN
gsrj-41	57	5	were	be	AUX
gsrj-41	57	6	cross	cross	ADJ
gsrj-41	57	7	-	-	ADJ
gsrj-41	57	8	sectional	sectional	ADJ
gsrj-41	57	9	surveys	survey	NOUN
gsrj-41	57	10	(	(	PUNCT
gsrj-41	57	11	88.89	88.89	NUM
gsrj-41	57	12	%	%	NOUN
gsrj-41	57	13	)	)	PUNCT
gsrj-41	57	14	,	,	PUNCT
gsrj-41	57	15	followed	follow	VERB
gsrj-41	57	16	by	by	ADP
gsrj-41	57	17	those	those	PRON
gsrj-41	57	18	with	with	ADP
gsrj-41	57	19	follow	follow	VERB
gsrj-41	57	20	-	-	PUNCT
gsrj-41	57	21	up	up	ADP
gsrj-41	57	22	surveys	survey	NOUN
gsrj-41	57	23	(	(	PUNCT
gsrj-41	57	24	14.81	14.81	NUM
gsrj-41	57	25	%	%	NOUN
gsrj-41	57	26	)	)	PUNCT
gsrj-41	57	27	,	,	PUNCT
gsrj-41	57	28	and	and	CCONJ
gsrj-41	57	29	focus	focus	NOUN
gsrj-41	57	30	group	group	NOUN
gsrj-41	57	31	(	(	PUNCT
gsrj-41	57	32	7.40	7.40	NUM
gsrj-41	57	33	%	%	NOUN
gsrj-41	57	34	)	)	PUNCT
gsrj-41	57	35	.	.	PUNCT
gsrj-41	58	1	type	type	NOUN
gsrj-41	58	2	of	of	ADP
gsrj-41	58	3	study	study	NOUN
gsrj-41	58	4	n	n	CCONJ
gsrj-41	58	5	(	(	PUNCT
gsrj-41	58	6	%	%	INTJ
gsrj-41	58	7	)	)	PUNCT
gsrj-41	58	8	references	reference	NOUN
gsrj-41	58	9	cross	cross	ADJ
gsrj-41	58	10	-	-	ADJ
gsrj-41	58	11	sectional	sectional	ADJ
gsrj-41	58	12	survey	survey	NOUN
gsrj-41	58	13	24	24	NUM
gsrj-41	58	14	(	(	PUNCT
gsrj-41	58	15	88.89	88.89	NUM
gsrj-41	58	16	%	%	NOUN
gsrj-41	58	17	)	)	PUNCT
gsrj-41	59	1	online	online	ADV
gsrj-41	59	2	16	16	NUM
gsrj-41	59	3	(	(	PUNCT
gsrj-41	59	4	59.25	59.25	NUM
gsrj-41	59	5	%	%	NOUN
gsrj-41	59	6	)	)	PUNCT
gsrj-41	59	7	16	16	NUM
gsrj-41	59	8	,	,	PUNCT
gsrj-41	59	9	18	18	NUM
gsrj-41	59	10	,	,	PUNCT
gsrj-41	59	11	20	20	NUM
gsrj-41	59	12	,	,	PUNCT
gsrj-41	59	13	21	21	NUM
gsrj-41	59	14	,	,	PUNCT
gsrj-41	59	15	22	22	NUM
gsrj-41	59	16	,	,	PUNCT
gsrj-41	59	17	24	24	NUM
gsrj-41	59	18	,	,	PUNCT
gsrj-41	59	19	27	27	NUM
gsrj-41	59	20	,	,	PUNCT
gsrj-41	59	21	26	26	NUM
gsrj-41	59	22	,	,	PUNCT
gsrj-41	59	23	28	28	NUM
gsrj-41	59	24	,	,	PUNCT
gsrj-41	59	25	30	30	NUM
gsrj-41	59	26	,	,	PUNCT
gsrj-41	59	27	31	31	NUM
gsrj-41	59	28	,	,	PUNCT
gsrj-41	59	29	33	33	NUM
gsrj-41	59	30	,	,	PUNCT
gsrj-41	59	31	36	36	NUM
gsrj-41	59	32	,	,	PUNCT
gsrj-41	59	33	38	38	NUM
gsrj-41	59	34	,	,	PUNCT
gsrj-41	59	35	39	39	NUM
gsrj-41	59	36	,	,	PUNCT
gsrj-41	59	37	40	40	NUM
gsrj-41	59	38	in	in	ADP
gsrj-41	59	39	-	-	PUNCT
gsrj-41	59	40	person	person	NOUN
gsrj-41	59	41	2	2	NUM
gsrj-41	59	42	(	(	PUNCT
gsrj-41	59	43	7.40	7.40	NUM
gsrj-41	59	44	%	%	NOUN
gsrj-41	59	45	)	)	PUNCT
gsrj-41	59	46	34	34	NUM
gsrj-41	59	47	,	,	PUNCT
gsrj-41	59	48	35	35	NUM
gsrj-41	59	49	online	online	NOUN
gsrj-41	59	50	&	&	CCONJ
gsrj-41	59	51	phone	phone	PROPN
gsrj-41	59	52	4	4	NUM
gsrj-41	59	53	(	(	PUNCT
gsrj-41	59	54	14.81	14.81	NUM
gsrj-41	59	55	%	%	NOUN
gsrj-41	59	56	)	)	PUNCT
gsrj-41	59	57	15	15	NUM
gsrj-41	59	58	,	,	PUNCT
gsrj-41	59	59	17	17	NUM
gsrj-41	59	60	,	,	PUNCT
gsrj-41	59	61	25	25	NUM
gsrj-41	59	62	,	,	PUNCT
gsrj-41	59	63	32	32	NUM
gsrj-41	59	64	online	online	ADJ
gsrj-41	59	65	,	,	PUNCT
gsrj-41	59	66	phone	phone	NOUN
gsrj-41	59	67	,	,	PUNCT
gsrj-41	59	68	&	&	CCONJ
gsrj-41	59	69	inperson	inperson	PROPN
gsrj-41	59	70	1	1	NUM
gsrj-41	59	71	(	(	PUNCT
gsrj-41	59	72	7.40	7.40	NUM
gsrj-41	59	73	%	%	NOUN
gsrj-41	59	74	)	)	PUNCT
gsrj-41	59	75	37	37	NUM
gsrj-41	59	76	mail	mail	NOUN
gsrj-41	59	77	1	1	NUM
gsrj-41	59	78	(	(	PUNCT
gsrj-41	59	79	7.40	7.40	NUM
gsrj-41	59	80	%	%	NOUN
gsrj-41	59	81	)	)	PUNCT
gsrj-41	59	82	29	29	NUM
gsrj-41	59	83	focus	focus	NOUN
gsrj-41	59	84	group	group	NOUN
gsrj-41	59	85	1	1	NUM
gsrj-41	59	86	(	(	PUNCT
gsrj-41	59	87	7.40	7.40	NUM
gsrj-41	59	88	%	%	NOUN
gsrj-41	59	89	)	)	PUNCT
gsrj-41	59	90	23	23	NUM
gsrj-41	59	91	follow	follow	VERB
gsrj-41	59	92	-	-	PUNCT
gsrj-41	59	93	up	up	NOUN
gsrj-41	59	94	surveys	survey	NOUN
gsrj-41	59	95	2	2	NUM
gsrj-41	59	96	(	(	PUNCT
gsrj-41	59	97	14.81	14.81	NUM
gsrj-41	59	98	%	%	NOUN
gsrj-41	59	99	)	)	PUNCT
gsrj-41	59	100	online	online	ADV
gsrj-41	59	101	1	1	NUM
gsrj-41	59	102	(	(	PUNCT
gsrj-41	59	103	7.40	7.40	NUM
gsrj-41	59	104	%	%	NOUN
gsrj-41	59	105	)	)	PUNCT
gsrj-41	59	106	19	19	NUM
gsrj-41	59	107	phone	phone	NOUN
gsrj-41	59	108	1	1	NUM
gsrj-41	59	109	(	(	PUNCT
gsrj-41	59	110	6.40	6.40	NUM
gsrj-41	59	111	%	%	NOUN
gsrj-41	59	112	)	)	PUNCT
gsrj-41	59	113	41	41	NUM
gsrj-41	59	114	table	table	NOUN
gsrj-41	59	115	2	2	NUM
gsrj-41	59	116	:	:	PUNCT
gsrj-41	59	117	number	number	NOUN
gsrj-41	59	118	of	of	ADP
gsrj-41	59	119	study	study	NOUN
gsrj-41	59	120	participants	participant	NOUN
gsrj-41	59	121	by	by	ADP
gsrj-41	59	122	number	number	NOUN
gsrj-41	59	123	and	and	CCONJ
gsrj-41	59	124	percentage	percentage	NOUN
gsrj-41	59	125	of	of	ADP
gsrj-41	59	126	articles	article	NOUN
gsrj-41	59	127	(	(	PUNCT
gsrj-41	59	128	n	n	NOUN
gsrj-41	59	129	=	=	NUM
gsrj-41	59	130	27	27	NUM
gsrj-41	59	131	)	)	PUNCT
gsrj-41	59	132	.	.	PUNCT
gsrj-41	60	1	sample	sample	NOUN
gsrj-41	60	2	sizes	size	NOUN
gsrj-41	60	3	ranged	range	VERB
gsrj-41	60	4	greatly	greatly	ADV
gsrj-41	60	5	.	.	PUNCT
gsrj-41	61	1	the	the	DET
gsrj-41	61	2	majority	majority	NOUN
gsrj-41	61	3	of	of	ADP
gsrj-41	61	4	sample	sample	NOUN
gsrj-41	61	5	sizes	size	NOUN
gsrj-41	61	6	were	be	AUX
gsrj-41	61	7	between	between	ADP
gsrj-41	61	8	1001	1001	NUM
gsrj-41	61	9	-	-	SYM
gsrj-41	61	10	5000	5000	NUM
gsrj-41	61	11	participants	participant	NOUN
gsrj-41	61	12	(	(	PUNCT
gsrj-41	61	13	29.62	29.62	NUM
gsrj-41	61	14	%	%	NOUN
gsrj-41	61	15	of	of	ADP
gsrj-41	61	16	articles	article	NOUN
gsrj-41	61	17	)	)	PUNCT
gsrj-41	61	18	.	.	PUNCT
gsrj-41	62	1	range	range	NOUN
gsrj-41	62	2	of	of	ADP
gsrj-41	62	3	number	number	NOUN
gsrj-41	62	4	of	of	ADP
gsrj-41	62	5	study	study	NOUN
gsrj-41	62	6	participants	participant	NOUN
gsrj-41	62	7	n	n	PRON
gsrj-41	62	8	(	(	PUNCT
gsrj-41	62	9	%	%	INTJ
gsrj-41	62	10	)	)	PUNCT
gsrj-41	62	11	references	reference	NOUN
gsrj-41	62	12	<	<	VERB
gsrj-41	62	13	50	50	NUM
gsrj-41	62	14	1	1	NUM
gsrj-41	62	15	(	(	PUNCT
gsrj-41	62	16	3.70	3.70	NUM
gsrj-41	62	17	%	%	NOUN
gsrj-41	62	18	)	)	PUNCT
gsrj-41	62	19	41	41	NUM
gsrj-41	63	1	50	50	NUM
gsrj-41	63	2	-	-	SYM
gsrj-41	63	3	100	100	NUM
gsrj-41	63	4	1	1	NUM
gsrj-41	63	5	(	(	PUNCT
gsrj-41	63	6	3.70	3.70	NUM
gsrj-41	63	7	%	%	NOUN
gsrj-41	63	8	)	)	PUNCT
gsrj-41	63	9	23	23	NUM
gsrj-41	63	10	101	101	NUM
gsrj-41	63	11	-	-	SYM
gsrj-41	63	12	500	500	NUM
gsrj-41	63	13	5	5	NUM
gsrj-41	63	14	(	(	PUNCT
gsrj-41	63	15	18.51	18.51	NUM
gsrj-41	63	16	%	%	NOUN
gsrj-41	63	17	)	)	PUNCT
gsrj-41	63	18	17	17	NUM
gsrj-41	63	19	,	,	PUNCT
gsrj-41	63	20	18	18	NUM
gsrj-41	63	21	,	,	PUNCT
gsrj-41	63	22	19	19	NUM
gsrj-41	63	23	,	,	PUNCT
gsrj-41	63	24	29	29	NUM
gsrj-41	63	25	,	,	PUNCT
gsrj-41	63	26	31	31	NUM
gsrj-41	63	27	501	501	NUM
gsrj-41	63	28	-	-	SYM
gsrj-41	63	29	1000	1000	NUM
gsrj-41	63	30	4	4	NUM
gsrj-41	63	31	(	(	PUNCT
gsrj-41	63	32	14.81	14.81	NUM
gsrj-41	63	33	%	%	NOUN
gsrj-41	63	34	)	)	PUNCT
gsrj-41	63	35	15	15	NUM
gsrj-41	63	36	,	,	PUNCT
gsrj-41	63	37	28	28	NUM
gsrj-41	63	38	,	,	PUNCT
gsrj-41	63	39	33	33	NUM
gsrj-41	63	40	,	,	PUNCT
gsrj-41	63	41	36	36	NUM
gsrj-41	63	42	1001	1001	NUM
gsrj-41	63	43	-	-	SYM
gsrj-41	63	44	5000	5000	NUM
gsrj-41	63	45	8	8	NUM
gsrj-41	63	46	(	(	PUNCT
gsrj-41	63	47	29.62	29.62	NUM
gsrj-41	63	48	%	%	NOUN
gsrj-41	63	49	)	)	PUNCT
gsrj-41	63	50	21	21	NUM
gsrj-41	63	51	,	,	PUNCT
gsrj-41	63	52	27	27	NUM
gsrj-41	63	53	,	,	PUNCT
gsrj-41	63	54	26	26	NUM
gsrj-41	63	55	,	,	PUNCT
gsrj-41	63	56	32	32	NUM
gsrj-41	63	57	,	,	PUNCT
gsrj-41	63	58	34	34	NUM
gsrj-41	63	59	,	,	PUNCT
gsrj-41	63	60	38	38	NUM
gsrj-41	63	61	,	,	PUNCT
gsrj-41	63	62	39	39	NUM
gsrj-41	63	63	,	,	PUNCT
gsrj-41	63	64	40	40	NUM
gsrj-41	63	65	5001	5001	NUM
gsrj-41	63	66	-	-	SYM
gsrj-41	63	67	10000	10000	NUM
gsrj-41	63	68	2	2	NUM
gsrj-41	63	69	(	(	PUNCT
gsrj-41	63	70	7.40	7.40	NUM
gsrj-41	63	71	%	%	NOUN
gsrj-41	63	72	)	)	PUNCT
gsrj-41	63	73	16	16	NUM
gsrj-41	63	74	,	,	PUNCT
gsrj-41	63	75	35	35	NUM
gsrj-41	63	76	>	>	SYM
gsrj-41	63	77	10000	10000	NUM
gsrj-41	63	78	6	6	NUM
gsrj-41	63	79	(	(	PUNCT
gsrj-41	63	80	22.22	22.22	NUM
gsrj-41	63	81	%	%	NOUN
gsrj-41	63	82	)	)	PUNCT
gsrj-41	63	83	20	20	NUM
gsrj-41	63	84	,	,	PUNCT
gsrj-41	63	85	22	22	NUM
gsrj-41	63	86	,	,	PUNCT
gsrj-41	63	87	24	24	NUM
gsrj-41	63	88	,	,	PUNCT
gsrj-41	63	89	25	25	NUM
gsrj-41	63	90	,	,	PUNCT
gsrj-41	63	91	30	30	NUM
gsrj-41	63	92	,	,	PUNCT
gsrj-41	63	93	37	37	NUM
gsrj-41	63	94	12	12	NUM
gsrj-41	63	95	georgetown	georgetown	NOUN
gsrj-41	63	96	scientific	scientific	ADJ
gsrj-41	63	97	research	research	NOUN
gsrj-41	63	98	journal	journal	NOUN
gsrj-41	63	99	3.2	3.2	NUM
gsrj-41	63	100	populations	population	NOUN
gsrj-41	63	101	studied	study	VERB
gsrj-41	63	102	out	out	ADP
gsrj-41	63	103	of	of	ADP
gsrj-41	63	104	the	the	DET
gsrj-41	63	105	27	27	NUM
gsrj-41	63	106	articles	article	NOUN
gsrj-41	63	107	included	include	VERB
gsrj-41	63	108	in	in	ADP
gsrj-41	63	109	this	this	DET
gsrj-41	63	110	literature	literature	NOUN
gsrj-41	63	111	review	review	NOUN
gsrj-41	63	112	,	,	PUNCT
gsrj-41	63	113	seven	seven	NUM
gsrj-41	63	114	(	(	PUNCT
gsrj-41	63	115	25.9	25.9	NUM
gsrj-41	63	116	%	%	NOUN
gsrj-41	63	117	)	)	PUNCT
gsrj-41	63	118	were	be	AUX
gsrj-41	63	119	nationally	nationally	ADV
gsrj-41	63	120	representative	representative	ADJ
gsrj-41	63	121	of	of	ADP
gsrj-41	63	122	the	the	DET
gsrj-41	63	123	united	united	PROPN
gsrj-41	63	124	states	states	PROPN
gsrj-41	63	125	population	population	NOUN
gsrj-41	63	126	.	.	PUNCT
gsrj-41	64	1	ten	ten	NUM
gsrj-41	64	2	(	(	PUNCT
gsrj-41	64	3	37.0	37.0	NUM
gsrj-41	64	4	%	%	NOUN
gsrj-41	64	5	)	)	PUNCT
gsrj-41	64	6	surveyed	survey	VERB
gsrj-41	64	7	specific	specific	ADJ
gsrj-41	64	8	populations	population	NOUN
gsrj-41	64	9	across	across	ADP
gsrj-41	64	10	the	the	DET
gsrj-41	64	11	united	united	PROPN
gsrj-41	64	12	states	states	PROPN
gsrj-41	64	13	,	,	PUNCT
gsrj-41	64	14	while	while	SCONJ
gsrj-41	64	15	six	six	NUM
gsrj-41	64	16	(	(	PUNCT
gsrj-41	64	17	22.2	22.2	NUM
gsrj-41	64	18	%	%	NOUN
gsrj-41	64	19	)	)	PUNCT
gsrj-41	64	20	surveyed	survey	VERB
gsrj-41	64	21	a	a	DET
gsrj-41	64	22	specific	specific	ADJ
gsrj-41	64	23	location	location	NOUN
gsrj-41	64	24	within	within	ADP
gsrj-41	64	25	the	the	DET
gsrj-41	64	26	united	united	PROPN
gsrj-41	64	27	states	states	PROPN
gsrj-41	64	28	.	.	PUNCT
gsrj-41	65	1	four	four	NUM
gsrj-41	65	2	(	(	PUNCT
gsrj-41	65	3	14.8	14.8	NUM
gsrj-41	65	4	%	%	NOUN
gsrj-41	65	5	)	)	PUNCT
gsrj-41	65	6	of	of	ADP
gsrj-41	65	7	the	the	DET
gsrj-41	65	8	articles	article	NOUN
gsrj-41	65	9	focused	focus	VERB
gsrj-41	65	10	on	on	ADP
gsrj-41	65	11	healthcare	healthcare	NOUN
gsrj-41	65	12	workers	worker	NOUN
gsrj-41	65	13	,	,	PUNCT
gsrj-41	65	14	one	one	NUM
gsrj-41	65	15	being	be	AUX
gsrj-41	65	16	nationally	nationally	ADV
gsrj-41	65	17	representative	representative	ADJ
gsrj-41	65	18	and	and	CCONJ
gsrj-41	65	19	the	the	DET
gsrj-41	65	20	others	other	NOUN
gsrj-41	65	21	surveying	survey	VERB
gsrj-41	65	22	specific	specific	ADJ
gsrj-41	65	23	locations	location	NOUN
gsrj-41	65	24	(	(	PUNCT
gsrj-41	65	25	table	table	NOUN
gsrj-41	65	26	3	3	NUM
gsrj-41	65	27	)	)	PUNCT
gsrj-41	65	28	.	.	PUNCT
gsrj-41	66	1	table	table	NOUN
gsrj-41	66	2	3	3	NUM
gsrj-41	66	3	:	:	PUNCT
gsrj-41	66	4	number	number	NOUN
gsrj-41	66	5	and	and	CCONJ
gsrj-41	66	6	percentage	percentage	NOUN
gsrj-41	66	7	of	of	ADP
gsrj-41	66	8	articles	article	NOUN
gsrj-41	66	9	by	by	ADP
gsrj-41	66	10	population	population	NOUN
gsrj-41	66	11	studied	study	VERB
gsrj-41	66	12	(	(	PUNCT
gsrj-41	66	13	n	n	NOUN
gsrj-41	66	14	=	=	NUM
gsrj-41	66	15	27	27	NUM
gsrj-41	66	16	)	)	PUNCT
gsrj-41	66	17	.	.	PUNCT
gsrj-41	67	1	the	the	DET
gsrj-41	67	2	majority	majority	NOUN
gsrj-41	67	3	of	of	ADP
gsrj-41	67	4	populations	population	NOUN
gsrj-41	67	5	studied	study	VERB
gsrj-41	67	6	were	be	AUX
gsrj-41	67	7	specific	specific	ADJ
gsrj-41	67	8	population	population	NOUN
gsrj-41	67	9	across	across	ADP
gsrj-41	67	10	u.s	u.s	PROPN
gsrj-41	67	11	.	.	PROPN
gsrj-41	67	12	(	(	PUNCT
gsrj-41	67	13	37.0	37.0	NUM
gsrj-41	67	14	%	%	NOUN
gsrj-41	67	15	)	)	PUNCT
gsrj-41	67	16	,	,	PUNCT
gsrj-41	67	17	followed	follow	VERB
gsrj-41	67	18	by	by	ADP
gsrj-41	67	19	nationally	nationally	ADV
gsrj-41	67	20	representative	representative	ADJ
gsrj-41	67	21	u.s	u.s	PROPN
gsrj-41	67	22	.	.	PROPN
gsrj-41	67	23	population	population	NOUN
gsrj-41	67	24	(	(	PUNCT
gsrj-41	67	25	25.9	25.9	NUM
gsrj-41	67	26	%	%	NOUN
gsrj-41	67	27	)	)	PUNCT
gsrj-41	67	28	,	,	PUNCT
gsrj-41	67	29	specific	specific	ADJ
gsrj-41	67	30	location	location	NOUN
gsrj-41	67	31	within	within	ADP
gsrj-41	67	32	u.s	u.s	PROPN
gsrj-41	67	33	.	.	PROPN
gsrj-41	67	34	(	(	PUNCT
gsrj-41	67	35	22.2	22.2	NUM
gsrj-41	67	36	%	%	NOUN
gsrj-41	67	37	)	)	PUNCT
gsrj-41	67	38	,	,	PUNCT
gsrj-41	67	39	and	and	CCONJ
gsrj-41	67	40	healthcare	healthcare	PROPN
gsrj-41	67	41	workers	worker	NOUN
gsrj-41	67	42	(	(	PUNCT
gsrj-41	67	43	14.8	14.8	NUM
gsrj-41	67	44	%	%	NOUN
gsrj-41	67	45	)	)	PUNCT
gsrj-41	67	46	.	.	PUNCT
gsrj-41	68	1	population	population	NOUN
gsrj-41	68	2	studied	study	VERB
gsrj-41	68	3	number	number	NOUN
gsrj-41	68	4	of	of	ADP
gsrj-41	68	5	articles	article	NOUN
gsrj-41	68	6	n	n	PROPN
gsrj-41	68	7	(	(	PUNCT
gsrj-41	68	8	%	%	INTJ
gsrj-41	68	9	)	)	PUNCT
gsrj-41	68	10	references	reference	NOUN
gsrj-41	68	11	&	&	CCONJ
gsrj-41	68	12	specifics	specifics	PROPN
gsrj-41	68	13	u.s	u.s	PROPN
gsrj-41	68	14	.	.	PROPN
gsrj-41	68	15	population	population	NOUN
gsrj-41	68	16	(	(	PUNCT
gsrj-41	68	17	nationally	nationally	ADV
gsrj-41	68	18	representative	representative	NOUN
gsrj-41	68	19	)	)	PUNCT
gsrj-41	68	20	7	7	NUM
gsrj-41	68	21	(	(	PUNCT
gsrj-41	68	22	25.9	25.9	NUM
gsrj-41	68	23	%	%	NOUN
gsrj-41	68	24	)	)	PUNCT
gsrj-41	68	25	15	15	NUM
gsrj-41	68	26	,	,	PUNCT
gsrj-41	68	27	18	18	NUM
gsrj-41	68	28	,	,	PUNCT
gsrj-41	68	29	20	20	NUM
gsrj-41	68	30	,	,	PUNCT
gsrj-41	68	31	26	26	NUM
gsrj-41	68	32	,	,	PUNCT
gsrj-41	68	33	25	25	NUM
gsrj-41	68	34	,	,	PUNCT
gsrj-41	68	35	32	32	NUM
gsrj-41	68	36	,	,	PUNCT
gsrj-41	68	37	38	38	NUM
gsrj-41	68	38	specific	specific	ADJ
gsrj-41	68	39	population	population	NOUN
gsrj-41	68	40	across	across	ADP
gsrj-41	68	41	u.s	u.s	PROPN
gsrj-41	68	42	.	.	PROPN
gsrj-41	68	43	10	10	NUM
gsrj-41	68	44	(	(	PUNCT
gsrj-41	68	45	37.0	37.0	NUM
gsrj-41	68	46	%	%	NOUN
gsrj-41	68	47	)	)	PUNCT
gsrj-41	68	48	•	•	NUM
gsrj-41	68	49	refugees17	refugees17	NOUN
gsrj-41	69	1	•	•	NUM
gsrj-41	69	2	adults	adult	NOUN
gsrj-41	69	3	with	with	ADP
gsrj-41	69	4	multiple	multiple	ADJ
gsrj-41	69	5	sclerosis19	sclerosis19	ADJ
gsrj-41	69	6	•	•	ADP
gsrj-41	69	7	employees22	employees22	NOUN
gsrj-41	69	8	•	•	ADP
gsrj-41	69	9	black	black	ADJ
gsrj-41	69	10	community31	community31	NOUN
gsrj-41	69	11	•	•	ADP
gsrj-41	69	12	emergency	emergency	NOUN
gsrj-41	69	13	department	department	NOUN
gsrj-41	69	14	patients34	patients34	ADV
gsrj-41	69	15	•	•	NUM
gsrj-41	69	16	incarcerated	incarcerate	VERB
gsrj-41	69	17	population	population	NOUN
gsrj-41	69	18	in	in	ADP
gsrj-41	69	19	four	four	NUM
gsrj-41	69	20	states35	states35	NOUN
gsrj-41	69	21	•	•	ADP
gsrj-41	69	22	patients	patient	NOUN
gsrj-41	69	23	with	with	ADP
gsrj-41	69	24	ibs36	ibs36	ADJ
gsrj-41	69	25	•	•	ADJ
gsrj-41	69	26	parents	parent	NOUN
gsrj-41	69	27	of	of	ADP
gsrj-41	69	28	children	child	NOUN
gsrj-41	69	29	who	who	PRON
gsrj-41	69	30	had	have	AUX
gsrj-41	69	31	covid-1941	covid-1941	VERB
gsrj-41	69	32	•	•	ADJ
gsrj-41	69	33	parents	parent	NOUN
gsrj-41	69	34	of	of	ADP
gsrj-41	69	35	children	child	NOUN
gsrj-41	69	36	under	under	ADP
gsrj-41	69	37	1240	1240	NUM
gsrj-41	69	38	•	•	NOUN
gsrj-41	69	39	groups	group	NOUN
gsrj-41	69	40	prioritized	prioritize	VERB
gsrj-41	69	41	for	for	ADP
gsrj-41	69	42	covid-19	covid-19	PROPN
gsrj-41	69	43	vaccination27	vaccination27	NOUN
gsrj-41	69	44	specific	specific	ADJ
gsrj-41	69	45	location	location	NOUN
gsrj-41	69	46	within	within	ADP
gsrj-41	69	47	u.s	u.s	PROPN
gsrj-41	69	48	.	.	PROPN
gsrj-41	69	49	6	6	NUM
gsrj-41	69	50	(	(	PUNCT
gsrj-41	69	51	22.2	22.2	NUM
gsrj-41	69	52	%	%	NOUN
gsrj-41	69	53	)	)	PUNCT
gsrj-41	69	54	•	•	NUM
gsrj-41	69	55	nyc	nyc	PROPN
gsrj-41	69	56	&	&	CCONJ
gsrj-41	69	57	phoenix21	phoenix21	PROPN
gsrj-41	69	58	•	•	ADP
gsrj-41	69	59	intellectual	intellectual	ADJ
gsrj-41	69	60	and	and	CCONJ
gsrj-41	69	61	development	development	NOUN
gsrj-41	69	62	disabilities	disability	NOUN
gsrj-41	69	63	community	community	NOUN
gsrj-41	69	64	in	in	ADP
gsrj-41	69	65	new	new	ADJ
gsrj-41	69	66	york28	york28	NOUN
gsrj-41	69	67	•	•	PROPN
gsrj-41	69	68	ohio	ohio	PROPN
gsrj-41	69	69	amish29	amish29	PROPN
gsrj-41	69	70	•	•	PROPN
gsrj-41	69	71	tennessee	tennessee	PROPN
gsrj-41	69	72	adults33	adults33	PROPN
gsrj-41	69	73	•	•	ADP
gsrj-41	69	74	california	california	PROPN
gsrj-41	69	75	adults37	adults37	PROPN
gsrj-41	69	76	•	•	ADP
gsrj-41	69	77	parents	parent	NOUN
gsrj-41	69	78	of	of	ADP
gsrj-41	69	79	children	child	NOUN
gsrj-41	69	80	in	in	ADP
gsrj-41	69	81	nyc39	nyc39	NOUN
gsrj-41	69	82	healthcare	healthcare	NOUN
gsrj-41	69	83	workers	worker	NOUN
gsrj-41	69	84	4	4	NUM
gsrj-41	69	85	(	(	PUNCT
gsrj-41	69	86	14.8	14.8	NUM
gsrj-41	69	87	%	%	NOUN
gsrj-41	69	88	)	)	PUNCT
gsrj-41	69	89	•	•	NOUN
gsrj-41	69	90	nursing	nursing	NOUN
gsrj-41	69	91	home	home	NOUN
gsrj-41	69	92	and	and	CCONJ
gsrj-41	69	93	assisted	assist	VERB
gsrj-41	69	94	living	living	NOUN
gsrj-41	69	95	facility	facility	NOUN
gsrj-41	69	96	staff	staff	NOUN
gsrj-41	69	97	in	in	ADP
gsrj-41	69	98	indiana16	indiana16	NOUN
gsrj-41	69	99	•	•	ADP
gsrj-41	69	100	skilled	skilled	ADJ
gsrj-41	69	101	nursing	nursing	NOUN
gsrj-41	69	102	facility	facility	NOUN
gsrj-41	69	103	staff23	staff23	NOUN
gsrj-41	69	104	•	•	CCONJ
gsrj-41	69	105	hospital	hospital	NOUN
gsrj-41	69	106	workers	worker	NOUN
gsrj-41	69	107	in	in	ADP
gsrj-41	69	108	philadelphia24	philadelphia24	PROPN
gsrj-41	69	109	•	•	ADP
gsrj-41	69	110	general	general	PROPN
gsrj-41	69	111	healthcare	healthcare	PROPN
gsrj-41	69	112	workers30	workers30	PROPN
gsrj-41	69	113	13	13	NUM
gsrj-41	69	114	georgetown	georgetown	PROPN
gsrj-41	69	115	scientific	scientific	PROPN
gsrj-41	69	116	research	research	NOUN
gsrj-41	69	117	journal	journal	NOUN
gsrj-41	69	118	3.3	3.3	NUM
gsrj-41	69	119	top	top	ADJ
gsrj-41	69	120	reasons	reason	NOUN
gsrj-41	69	121	for	for	ADP
gsrj-41	69	122	hesitancy	hesitancy	NOUN
gsrj-41	69	123	the	the	DET
gsrj-41	69	124	majority	majority	NOUN
gsrj-41	69	125	of	of	ADP
gsrj-41	69	126	articles	article	NOUN
gsrj-41	69	127	(	(	PUNCT
gsrj-41	69	128	57.14	57.14	NUM
gsrj-41	69	129	%	%	NOUN
gsrj-41	69	130	)	)	PUNCT
gsrj-41	69	131	stated	state	VERB
gsrj-41	69	132	concern	concern	NOUN
gsrj-41	69	133	about	about	ADP
gsrj-41	69	134	side	side	NOUN
gsrj-41	69	135	effects	effect	NOUN
gsrj-41	69	136	and	and	CCONJ
gsrj-41	69	137	general	general	ADJ
gsrj-41	69	138	safety	safety	NOUN
gsrj-41	69	139	as	as	ADP
gsrj-41	69	140	the	the	DET
gsrj-41	69	141	top	top	ADJ
gsrj-41	69	142	reason	reason	NOUN
gsrj-41	69	143	for	for	ADP
gsrj-41	69	144	hesitancy	hesitancy	NOUN
gsrj-41	69	145	.	.	PUNCT
gsrj-41	70	1	of	of	ADP
gsrj-41	70	2	these	these	DET
gsrj-41	70	3	16	16	NUM
gsrj-41	70	4	articles	article	NOUN
gsrj-41	70	5	stating	state	VERB
gsrj-41	70	6	side	side	NOUN
gsrj-41	70	7	effects	effect	NOUN
gsrj-41	70	8	as	as	ADP
gsrj-41	70	9	the	the	DET
gsrj-41	70	10	main	main	ADJ
gsrj-41	70	11	reason	reason	NOUN
gsrj-41	70	12	for	for	ADP
gsrj-41	70	13	hesitancy	hesitancy	NOUN
gsrj-41	70	14	,	,	PUNCT
gsrj-41	70	15	twelve	twelve	NUM
gsrj-41	70	16	included	include	VERB
gsrj-41	70	17	general	general	ADJ
gsrj-41	70	18	side	side	NOUN
gsrj-41	70	19	effects	effect	NOUN
gsrj-41	70	20	,	,	PUNCT
gsrj-41	70	21	two	two	NUM
gsrj-41	70	22	included	include	VERB
gsrj-41	70	23	adverse	adverse	ADJ
gsrj-41	70	24	/	/	SYM
gsrj-41	70	25	unknown	unknown	ADJ
gsrj-41	70	26	effects	effect	NOUN
gsrj-41	70	27	,	,	PUNCT
gsrj-41	70	28	and	and	CCONJ
gsrj-41	70	29	two	two	NUM
gsrj-41	70	30	included	include	VERB
gsrj-41	70	31	general	general	ADJ
gsrj-41	70	32	safety	safety	NOUN
gsrj-41	70	33	and	and	CCONJ
gsrj-41	70	34	effectiveness	effectiveness	NOUN
gsrj-41	70	35	(	(	PUNCT
gsrj-41	70	36	see	see	VERB
gsrj-41	70	37	table	table	NOUN
gsrj-41	70	38	4	4	NUM
gsrj-41	70	39	)	)	PUNCT
gsrj-41	70	40	.	.	PUNCT
gsrj-41	71	1	only	only	ADV
gsrj-41	71	2	five	five	NUM
gsrj-41	71	3	articles	article	NOUN
gsrj-41	71	4	analyzed	analyze	VERB
gsrj-41	71	5	side	side	ADJ
gsrj-41	71	6	effect	effect	NOUN
gsrj-41	71	7	concerns	concern	NOUN
gsrj-41	71	8	,	,	PUNCT
gsrj-41	71	9	which	which	PRON
gsrj-41	71	10	include	include	VERB
gsrj-41	71	11	well	well	ADV
gsrj-41	71	12	-	-	PUNCT
gsrj-41	71	13	documented	document	VERB
gsrj-41	71	14	flu	flu	NOUN
gsrj-41	71	15	-	-	PUNCT
gsrj-41	71	16	like	like	ADJ
gsrj-41	71	17	symptoms	symptom	NOUN
gsrj-41	71	18	after	after	ADP
gsrj-41	71	19	receiving	receive	VERB
gsrj-41	71	20	the	the	DET
gsrj-41	71	21	covid-19	covid-19	PROPN
gsrj-41	71	22	vaccine,17	vaccine,17	NOUN
gsrj-41	71	23	,	,	PUNCT
gsrj-41	71	24	18	18	NUM
gsrj-41	71	25	,	,	PUNCT
gsrj-41	71	26	30	30	NUM
gsrj-41	71	27	rare	rare	ADJ
gsrj-41	71	28	severe	severe	ADJ
gsrj-41	71	29	adverse	adverse	ADJ
gsrj-41	71	30	reactions	reaction	NOUN
gsrj-41	71	31	such	such	ADJ
gsrj-41	71	32	as	as	ADP
gsrj-41	71	33	allergic	allergic	ADJ
gsrj-41	71	34	reactions	reaction	NOUN
gsrj-41	71	35	and	and	CCONJ
gsrj-41	71	36	thrombosis,22	thrombosis,22	X
gsrj-41	71	37	,	,	PUNCT
gsrj-41	71	38	18	18	NUM
gsrj-41	71	39	and	and	CCONJ
gsrj-41	71	40	unknown	unknown	ADJ
gsrj-41	71	41	and/or	and/or	CCONJ
gsrj-41	71	42	long	long	ADJ
gsrj-41	71	43	-	-	PUNCT
gsrj-41	71	44	term	term	NOUN
gsrj-41	71	45	effects.30	effects.30	NOUN
gsrj-41	71	46	,	,	PUNCT
gsrj-41	71	47	36	36	NUM
gsrj-41	71	48	,	,	PUNCT
gsrj-41	71	49	17	17	NUM
gsrj-41	71	50	21.42	21.42	NUM
gsrj-41	71	51	%	%	NOUN
gsrj-41	71	52	of	of	ADP
gsrj-41	71	53	the	the	DET
gsrj-41	71	54	articles	article	NOUN
gsrj-41	71	55	found	find	VERB
gsrj-41	71	56	additional	additional	ADJ
gsrj-41	71	57	information	information	NOUN
gsrj-41	71	58	needed	need	VERB
gsrj-41	71	59	as	as	ADP
gsrj-41	71	60	the	the	DET
gsrj-41	71	61	top	top	ADJ
gsrj-41	71	62	reason	reason	NOUN
gsrj-41	71	63	for	for	ADP
gsrj-41	71	64	hesitancy	hesitancy	NOUN
gsrj-41	71	65	among	among	ADP
gsrj-41	71	66	their	their	PRON
gsrj-41	71	67	population	population	NOUN
gsrj-41	71	68	.	.	PUNCT
gsrj-41	72	1	this	this	DET
gsrj-41	72	2	percentage	percentage	NOUN
gsrj-41	72	3	includes	include	VERB
gsrj-41	72	4	those	those	PRON
gsrj-41	72	5	who	who	PRON
gsrj-41	72	6	“	"	PUNCT
gsrj-41	72	7	plan	plan	VERB
gsrj-41	72	8	to	to	PART
gsrj-41	72	9	wait	wait	VERB
gsrj-41	72	10	and	and	CCONJ
gsrj-41	72	11	see	see	VERB
gsrj-41	72	12	if	if	SCONJ
gsrj-41	72	13	it	it	PRON
gsrj-41	72	14	is	be	AUX
gsrj-41	72	15	safe	safe	ADJ
gsrj-41	72	16	to	to	PART
gsrj-41	72	17	get	get	VERB
gsrj-41	72	18	later	later	ADV
gsrj-41	72	19	”	"	PUNCT
gsrj-41	72	20	and	and	CCONJ
gsrj-41	72	21	those	those	PRON
gsrj-41	72	22	who	who	PRON
gsrj-41	72	23	cited	cite	VERB
gsrj-41	72	24	lack	lack	NOUN
gsrj-41	72	25	of	of	ADP
gsrj-41	72	26	evidence	evidence	NOUN
gsrj-41	72	27	.	.	PUNCT
gsrj-41	73	1	10.71	10.71	NUM
gsrj-41	73	2	%	%	NOUN
gsrj-41	73	3	of	of	ADP
gsrj-41	73	4	articles	article	NOUN
gsrj-41	73	5	stated	state	VERB
gsrj-41	73	6	“	"	PUNCT
gsrj-41	73	7	mistrust	mistrust	NOUN
gsrj-41	73	8	in	in	ADP
gsrj-41	73	9	the	the	DET
gsrj-41	73	10	vaccine	vaccine	NOUN
gsrj-41	73	11	itself	itself	PRON
gsrj-41	73	12	”	"	PUNCT
gsrj-41	73	13	as	as	ADP
gsrj-41	73	14	the	the	DET
gsrj-41	73	15	main	main	ADJ
gsrj-41	73	16	reason	reason	NOUN
gsrj-41	73	17	for	for	ADP
gsrj-41	73	18	hesitancy	hesitancy	NOUN
gsrj-41	73	19	,	,	PUNCT
gsrj-41	73	20	while	while	SCONJ
gsrj-41	73	21	one	one	NUM
gsrj-41	73	22	article	article	NOUN
gsrj-41	73	23	stated	state	VERB
gsrj-41	73	24	“	"	PUNCT
gsrj-41	73	25	distrust	distrust	NOUN
gsrj-41	73	26	of	of	ADP
gsrj-41	73	27	healthcare	healthcare	NOUN
gsrj-41	73	28	and	and	CCONJ
gsrj-41	73	29	other	other	ADJ
gsrj-41	73	30	institutions	institution	NOUN
gsrj-41	73	31	”	"	PUNCT
gsrj-41	73	32	(	(	PUNCT
gsrj-41	73	33	see	see	VERB
gsrj-41	73	34	table	table	NOUN
gsrj-41	73	35	4	4	NUM
gsrj-41	73	36	)	)	PUNCT
gsrj-41	73	37	.	.	PUNCT
gsrj-41	74	1	another	another	DET
gsrj-41	74	2	article	article	NOUN
gsrj-41	74	3	stated	state	VERB
gsrj-41	74	4	“	"	PUNCT
gsrj-41	74	5	no	no	DET
gsrj-41	74	6	reason	reason	NOUN
gsrj-41	74	7	”	"	PUNCT
gsrj-41	74	8	or	or	CCONJ
gsrj-41	74	9	“	"	PUNCT
gsrj-41	74	10	do	do	AUX
gsrj-41	74	11	n’t	not	PART
gsrj-41	74	12	know	know	VERB
gsrj-41	74	13	”	"	PUNCT
gsrj-41	74	14	as	as	ADP
gsrj-41	74	15	the	the	DET
gsrj-41	74	16	top	top	ADJ
gsrj-41	74	17	reason	reason	NOUN
gsrj-41	74	18	,	,	PUNCT
gsrj-41	74	19	and	and	CCONJ
gsrj-41	74	20	one	one	NUM
gsrj-41	74	21	stated	state	VERB
gsrj-41	74	22	“	"	PUNCT
gsrj-41	74	23	antivaccine	antivaccine	NOUN
gsrj-41	74	24	attitudes	attitude	NOUN
gsrj-41	74	25	,	,	PUNCT
gsrj-41	74	26	beliefs	belief	NOUN
gsrj-41	74	27	,	,	PUNCT
gsrj-41	74	28	or	or	CCONJ
gsrj-41	74	29	emotions	emotion	NOUN
gsrj-41	74	30	”	"	PUNCT
gsrj-41	74	31	as	as	ADP
gsrj-41	74	32	the	the	DET
gsrj-41	74	33	top	top	ADJ
gsrj-41	74	34	reason	reason	NOUN
gsrj-41	74	35	among	among	ADP
gsrj-41	74	36	refusers	refuser	NOUN
gsrj-41	74	37	(	(	PUNCT
gsrj-41	74	38	see	see	VERB
gsrj-41	74	39	table	table	NOUN
gsrj-41	74	40	4	4	NUM
gsrj-41	74	41	)	)	PUNCT
gsrj-41	74	42	.	.	PUNCT
gsrj-41	75	1	antivaccine	antivaccine	NOUN
gsrj-41	75	2	attitudes	attitude	NOUN
gsrj-41	75	3	,	,	PUNCT
gsrj-41	75	4	beliefs	belief	NOUN
gsrj-41	75	5	,	,	PUNCT
gsrj-41	75	6	or	or	CCONJ
gsrj-41	75	7	emotions	emotion	NOUN
gsrj-41	75	8	are	be	AUX
gsrj-41	75	9	defined	define	VERB
gsrj-41	75	10	as	as	ADP
gsrj-41	75	11	not	not	PART
gsrj-41	75	12	liking	like	VERB
gsrj-41	75	13	,	,	PUNCT
gsrj-41	75	14	wanting	want	VERB
gsrj-41	75	15	,	,	PUNCT
gsrj-41	75	16	or	or	CCONJ
gsrj-41	75	17	believing	believe	VERB
gsrj-41	75	18	in	in	ADP
gsrj-41	75	19	vaccines	vaccine	NOUN
gsrj-41	75	20	and/or	and/or	CCONJ
gsrj-41	75	21	misinformation	misinformation	NOUN
gsrj-41	75	22	regarding	regard	VERB
gsrj-41	75	23	vaccines	vaccine	NOUN
gsrj-41	75	24	causing	cause	VERB
gsrj-41	75	25	certain	certain	ADJ
gsrj-41	75	26	disorders.15	disorders.15	NOUN
gsrj-41	75	27	other	other	ADJ
gsrj-41	75	28	important	important	ADJ
gsrj-41	75	29	reasons	reason	NOUN
gsrj-41	75	30	with	with	ADP
gsrj-41	75	31	percentages	percentage	NOUN
gsrj-41	75	32	in	in	ADP
gsrj-41	75	33	close	close	ADJ
gsrj-41	75	34	proximity	proximity	NOUN
gsrj-41	75	35	to	to	ADP
gsrj-41	75	36	the	the	DET
gsrj-41	75	37	top	top	ADJ
gsrj-41	75	38	rationale	rationale	NOUN
gsrj-41	75	39	include	include	VERB
gsrj-41	75	40	swiftness	swiftness	NOUN
gsrj-41	75	41	of	of	ADP
gsrj-41	75	42	development	development	NOUN
gsrj-41	75	43	among	among	ADP
gsrj-41	75	44	skilled	skilled	ADJ
gsrj-41	75	45	nursing	nursing	NOUN
gsrj-41	75	46	facility	facility	NOUN
gsrj-41	75	47	staff	staff	NOUN
gsrj-41	75	48	and	and	CCONJ
gsrj-41	75	49	new	new	PROPN
gsrj-41	75	50	york	york	PROPN
gsrj-41	75	51	’s	’s	PART
gsrj-41	75	52	intellectual	intellectual	ADJ
gsrj-41	75	53	and	and	CCONJ
gsrj-41	75	54	developmental	developmental	ADJ
gsrj-41	75	55	disabilities	disability	NOUN
gsrj-41	75	56	community.28	community.28	NOUN
gsrj-41	75	57	,	,	PUNCT
gsrj-41	75	58	23	23	NUM
gsrj-41	75	59	in	in	ADP
gsrj-41	75	60	addition	addition	NOUN
gsrj-41	75	61	,	,	PUNCT
gsrj-41	75	62	distrust	distrust	NOUN
gsrj-41	75	63	in	in	ADP
gsrj-41	75	64	covid-19	covid-19	PROPN
gsrj-41	75	65	vaccines	vaccine	NOUN
gsrj-41	75	66	closely	closely	ADV
gsrj-41	75	67	followed	follow	VERB
gsrj-41	75	68	side	side	NOUN
gsrj-41	75	69	effects	effect	NOUN
gsrj-41	75	70	as	as	ADP
gsrj-41	75	71	the	the	DET
gsrj-41	75	72	top	top	ADJ
gsrj-41	75	73	reason	reason	NOUN
gsrj-41	75	74	among	among	ADP
gsrj-41	75	75	the	the	DET
gsrj-41	75	76	general	general	ADJ
gsrj-41	75	77	employed	employ	VERB
gsrj-41	75	78	u.s	u.s	PROPN
gsrj-41	75	79	.	.	PROPN
gsrj-41	75	80	population.22	population.22	NOUN
gsrj-41	75	81	one	one	NUM
gsrj-41	75	82	article	article	NOUN
gsrj-41	75	83	also	also	ADV
gsrj-41	75	84	found	find	VERB
gsrj-41	75	85	that	that	SCONJ
gsrj-41	75	86	concerns	concern	NOUN
gsrj-41	75	87	about	about	ADP
gsrj-41	75	88	becoming	becoming	AUX
gsrj-41	75	89	infected	infect	VERB
gsrj-41	75	90	from	from	ADP
gsrj-41	75	91	the	the	DET
gsrj-41	75	92	vaccine	vaccine	NOUN
gsrj-41	75	93	and	and	CCONJ
gsrj-41	75	94	finding	find	VERB
gsrj-41	75	95	the	the	DET
gsrj-41	75	96	virus	virus	NOUN
gsrj-41	75	97	to	to	PART
gsrj-41	75	98	be	be	AUX
gsrj-41	75	99	less	less	ADV
gsrj-41	75	100	serious	serious	ADJ
gsrj-41	75	101	than	than	ADP
gsrj-41	75	102	public	public	ADJ
gsrj-41	75	103	speculation	speculation	NOUN
gsrj-41	75	104	differed	differ	VERB
gsrj-41	75	105	between	between	ADP
gsrj-41	75	106	races	race	NOUN
gsrj-41	75	107	as	as	ADP
gsrj-41	75	108	some	some	PRON
gsrj-41	75	109	of	of	ADP
gsrj-41	75	110	the	the	DET
gsrj-41	75	111	main	main	ADJ
gsrj-41	75	112	reasons	reason	NOUN
gsrj-41	75	113	for	for	ADP
gsrj-41	75	114	vaccine	vaccine	NOUN
gsrj-41	75	115	hesitancy.32	hesitancy.32	VERB
gsrj-41	75	116	14	14	NUM
gsrj-41	75	117	georgetown	georgetown	PROPN
gsrj-41	75	118	scientific	scientific	PROPN
gsrj-41	75	119	research	research	PROPN
gsrj-41	75	120	journal	journal	NOUN
gsrj-41	75	121	table	table	NOUN
gsrj-41	75	122	4	4	NUM
gsrj-41	75	123	:	:	PUNCT
gsrj-41	75	124	top	top	ADJ
gsrj-41	75	125	reason	reason	NOUN
gsrj-41	75	126	for	for	ADP
gsrj-41	75	127	hesitancy	hesitancy	NOUN
gsrj-41	75	128	by	by	ADP
gsrj-41	75	129	number	number	NOUN
gsrj-41	75	130	and	and	CCONJ
gsrj-41	75	131	percentage	percentage	NOUN
gsrj-41	75	132	of	of	ADP
gsrj-41	75	133	articles	article	NOUN
gsrj-41	75	134	(	(	PUNCT
gsrj-41	75	135	n	n	NOUN
gsrj-41	75	136	=	=	SYM
gsrj-41	75	137	28	28	NUM
gsrj-41	75	138	)	)	PUNCT
gsrj-41	75	139	*	*	PUNCT
gsrj-41	75	140	.	.	PUNCT
gsrj-41	76	1	the	the	DET
gsrj-41	76	2	majority	majority	NOUN
gsrj-41	76	3	of	of	ADP
gsrj-41	76	4	articles	article	NOUN
gsrj-41	76	5	state	state	NOUN
gsrj-41	76	6	concern	concern	NOUN
gsrj-41	76	7	of	of	ADP
gsrj-41	76	8	side	side	NOUN
gsrj-41	76	9	effects	effect	NOUN
gsrj-41	76	10	and	and	CCONJ
gsrj-41	76	11	general	general	ADJ
gsrj-41	76	12	safety	safety	NOUN
gsrj-41	76	13	as	as	ADP
gsrj-41	76	14	the	the	DET
gsrj-41	76	15	top	top	ADJ
gsrj-41	76	16	reason	reason	NOUN
gsrj-41	76	17	for	for	ADP
gsrj-41	76	18	hesitancy	hesitancy	NOUN
gsrj-41	76	19	(	(	PUNCT
gsrj-41	76	20	57.14	57.14	NUM
gsrj-41	76	21	%	%	NOUN
gsrj-41	76	22	)	)	PUNCT
gsrj-41	76	23	,	,	PUNCT
gsrj-41	76	24	followed	follow	VERB
gsrj-41	76	25	by	by	ADP
gsrj-41	76	26	additional	additional	ADJ
gsrj-41	76	27	information	information	NOUN
gsrj-41	76	28	needed	need	VERB
gsrj-41	76	29	(	(	PUNCT
gsrj-41	76	30	21.42	21.42	NUM
gsrj-41	76	31	%	%	NOUN
gsrj-41	76	32	)	)	PUNCT
gsrj-41	76	33	,	,	PUNCT
gsrj-41	76	34	distrust	distrust	NOUN
gsrj-41	76	35	(	(	PUNCT
gsrj-41	76	36	14.28	14.28	NUM
gsrj-41	76	37	%	%	NOUN
gsrj-41	76	38	)	)	PUNCT
gsrj-41	76	39	,	,	PUNCT
gsrj-41	76	40	no	no	DET
gsrj-41	76	41	reason	reason	NOUN
gsrj-41	76	42	/	/	SYM
gsrj-41	76	43	don’t	don’t	NUM
gsrj-41	76	44	(	(	PUNCT
gsrj-41	76	45	3.57	3.57	NUM
gsrj-41	76	46	%	%	NOUN
gsrj-41	76	47	)	)	PUNCT
gsrj-41	76	48	,	,	PUNCT
gsrj-41	76	49	and	and	CCONJ
gsrj-41	76	50	antivaccine	antivaccine	NOUN
gsrj-41	76	51	attitudes	attitude	NOUN
gsrj-41	76	52	,	,	PUNCT
gsrj-41	76	53	beliefs	belief	NOUN
gsrj-41	76	54	,	,	PUNCT
gsrj-41	76	55	or	or	CCONJ
gsrj-41	76	56	emotions	emotion	NOUN
gsrj-41	76	57	(	(	PUNCT
gsrj-41	76	58	3.57	3.57	NUM
gsrj-41	76	59	%	%	NOUN
gsrj-41	76	60	)	)	PUNCT
gsrj-41	76	61	.	.	PUNCT
gsrj-41	77	1	top	top	ADJ
gsrj-41	77	2	reason	reason	NOUN
gsrj-41	77	3	for	for	ADP
gsrj-41	77	4	hesitancy	hesitancy	NOUN
gsrj-41	77	5	number	number	NOUN
gsrj-41	77	6	of	of	ADP
gsrj-41	77	7	articles	article	NOUN
gsrj-41	77	8	n	n	PROPN
gsrj-41	77	9	(	(	PUNCT
gsrj-41	77	10	%	%	INTJ
gsrj-41	77	11	)	)	PUNCT
gsrj-41	77	12	references	reference	NOUN
gsrj-41	77	13	concern	concern	NOUN
gsrj-41	77	14	about	about	ADP
gsrj-41	77	15	side	side	NOUN
gsrj-41	77	16	effects	effect	NOUN
gsrj-41	77	17	&	&	CCONJ
gsrj-41	77	18	general	general	ADJ
gsrj-41	77	19	safety	safety	PROPN
gsrj-41	77	20	16	16	NUM
gsrj-41	77	21	(	(	PUNCT
gsrj-41	77	22	57.14	57.14	NUM
gsrj-41	77	23	%	%	NOUN
gsrj-41	77	24	)	)	PUNCT
gsrj-41	77	25	general	general	ADJ
gsrj-41	77	26	side	side	NOUN
gsrj-41	77	27	effects	effect	NOUN
gsrj-41	77	28	12	12	NUM
gsrj-41	77	29	42.8	42.8	NUM
gsrj-41	77	30	%	%	NOUN
gsrj-41	77	31	)	)	PUNCT
gsrj-41	77	32	•	•	NUM
gsrj-41	77	33	16	16	NUM
gsrj-41	77	34	,	,	PUNCT
gsrj-41	77	35	17	17	NUM
gsrj-41	77	36	,	,	PUNCT
gsrj-41	77	37	18	18	NUM
gsrj-41	77	38	,	,	PUNCT
gsrj-41	77	39	22	22	NUM
gsrj-41	77	40	,	,	PUNCT
gsrj-41	77	41	24	24	NUM
gsrj-41	77	42	,	,	PUNCT
gsrj-41	77	43	27	27	NUM
gsrj-41	77	44	,	,	PUNCT
gsrj-41	77	45	26	26	NUM
gsrj-41	77	46	,	,	PUNCT
gsrj-41	77	47	28	28	NUM
gsrj-41	77	48	,	,	PUNCT
gsrj-41	77	49	29	29	NUM
gsrj-41	77	50	,	,	PUNCT
gsrj-41	77	51	34	34	NUM
gsrj-41	77	52	,	,	PUNCT
gsrj-41	77	53	41	41	NUM
gsrj-41	77	54	•	•	NOUN
gsrj-41	77	55	“	"	PUNCT
gsrj-41	77	56	not	not	PART
gsrj-41	77	57	sure	sure	ADJ
gsrj-41	77	58	”	"	PUNCT
gsrj-41	77	59	group15	group15	PROPN
gsrj-41	77	60	unknown	unknown	ADJ
gsrj-41	77	61	and/or	and/or	CCONJ
gsrj-41	77	62	long	long	ADJ
gsrj-41	77	63	-	-	PUNCT
gsrj-41	77	64	term	term	NOUN
gsrj-41	77	65	effects	effect	NOUN
gsrj-41	77	66	2	2	NUM
gsrj-41	77	67	(	(	PUNCT
gsrj-41	77	68	7.14	7.14	NUM
gsrj-41	77	69	%	%	NOUN
gsrj-41	77	70	)	)	PUNCT
gsrj-41	77	71	•	•	NUM
gsrj-41	77	72	30	30	NUM
gsrj-41	77	73	,	,	PUNCT
gsrj-41	77	74	36	36	NUM
gsrj-41	77	75	safety	safety	NOUN
gsrj-41	77	76	&	&	CCONJ
gsrj-41	77	77	effectiveness	effectiveness	PROPN
gsrj-41	77	78	2	2	NUM
gsrj-41	77	79	(	(	PUNCT
gsrj-41	77	80	7.14	7.14	NUM
gsrj-41	77	81	%	%	NOUN
gsrj-41	77	82	)	)	PUNCT
gsrj-41	77	83	•	•	NUM
gsrj-41	77	84	39	39	NUM
gsrj-41	77	85	,	,	PUNCT
gsrj-41	77	86	40	40	NUM
gsrj-41	77	87	additional	additional	ADJ
gsrj-41	77	88	information	information	NOUN
gsrj-41	77	89	needed	need	VERB
gsrj-41	77	90	(	(	PUNCT
gsrj-41	77	91	includes	include	VERB
gsrj-41	77	92	“	"	PUNCT
gsrj-41	77	93	plan	plan	NOUN
gsrj-41	77	94	to	to	PART
gsrj-41	77	95	wait	wait	VERB
gsrj-41	77	96	and	and	CCONJ
gsrj-41	77	97	see	see	VERB
gsrj-41	77	98	if	if	SCONJ
gsrj-41	77	99	it	it	PRON
gsrj-41	77	100	is	be	AUX
gsrj-41	77	101	safe	safe	ADJ
gsrj-41	77	102	to	to	PART
gsrj-41	77	103	get	get	VERB
gsrj-41	77	104	later	later	ADV
gsrj-41	77	105	”	"	PUNCT
gsrj-41	77	106	&	&	CCONJ
gsrj-41	77	107	lack	lack	NOUN
gsrj-41	77	108	of	of	ADP
gsrj-41	77	109	evidence	evidence	NOUN
gsrj-41	77	110	)	)	PUNCT
gsrj-41	77	111	6	6	NUM
gsrj-41	77	112	(	(	PUNCT
gsrj-41	77	113	21.42	21.42	NUM
gsrj-41	77	114	%	%	NOUN
gsrj-41	77	115	)	)	PUNCT
gsrj-41	77	116	•	•	NUM
gsrj-41	77	117	19	19	NUM
gsrj-41	77	118	,	,	PUNCT
gsrj-41	77	119	33	33	NUM
gsrj-41	77	120	•	•	NOUN
gsrj-41	77	121	“	"	PUNCT
gsrj-41	77	122	probably	probably	ADV
gsrj-41	77	123	not	not	PART
gsrj-41	77	124	”	"	PUNCT
gsrj-41	77	125	group20	group20	VERB
gsrj-41	77	126	•	•	NUM
gsrj-41	77	127	phoenix	phoenix	PROPN
gsrj-41	77	128	adults21	adults21	PROPN
gsrj-41	77	129	•	•	ADP
gsrj-41	77	130	“	"	PUNCT
gsrj-41	77	131	probably	probably	ADV
gsrj-41	77	132	will	will	AUX
gsrj-41	77	133	not	not	PART
gsrj-41	77	134	”	"	PUNCT
gsrj-41	77	135	group25	group25	VERB
gsrj-41	77	136	•	•	ADV
gsrj-41	77	137	hesitant	hesitant	ADJ
gsrj-41	77	138	group35	group35	NOUN
gsrj-41	77	139	distrust	distrust	NOUN
gsrj-41	77	140	4	4	NUM
gsrj-41	77	141	(	(	PUNCT
gsrj-41	77	142	14.28	14.28	NUM
gsrj-41	77	143	%	%	NOUN
gsrj-41	77	144	)	)	PUNCT
gsrj-41	77	145	in	in	ADP
gsrj-41	77	146	the	the	DET
gsrj-41	77	147	vaccine	vaccine	NOUN
gsrj-41	77	148	3	3	NUM
gsrj-41	77	149	(	(	PUNCT
gsrj-41	77	150	10.71	10.71	NUM
gsrj-41	77	151	%	%	NOUN
gsrj-41	77	152	)	)	PUNCT
gsrj-41	77	153	•	•	NUM
gsrj-41	77	154	31	31	NUM
gsrj-41	77	155	•	•	NOUN
gsrj-41	77	156	“	"	PUNCT
gsrj-41	77	157	definitely	definitely	ADV
gsrj-41	77	158	not	not	PART
gsrj-41	77	159	”	"	PUNCT
gsrj-41	77	160	group20	group20	VERB
gsrj-41	77	161	•	•	NOUN
gsrj-41	77	162	“	"	PUNCT
gsrj-41	77	163	definitely	definitely	ADV
gsrj-41	77	164	not	not	PART
gsrj-41	77	165	”	"	PUNCT
gsrj-41	77	166	group25	group25	NOUN
gsrj-41	77	167	in	in	ADP
gsrj-41	77	168	healthcare	healthcare	NOUN
gsrj-41	77	169	or	or	CCONJ
gsrj-41	77	170	other	other	ADJ
gsrj-41	77	171	institutions	institution	NOUN
gsrj-41	77	172	1	1	NUM
gsrj-41	77	173	(	(	PUNCT
gsrj-41	77	174	3.57	3.57	NUM
gsrj-41	77	175	%	%	NOUN
gsrj-41	77	176	)	)	PUNCT
gsrj-41	77	177	•	•	NOUN
gsrj-41	77	178	refusers35	refusers35	NOUN
gsrj-41	77	179	no	no	DET
gsrj-41	77	180	reason	reason	NOUN
gsrj-41	77	181	/	/	SYM
gsrj-41	77	182	don’t	don’t	NOUN
gsrj-41	77	183	know	know	NOUN
gsrj-41	77	184	1	1	NUM
gsrj-41	77	185	(	(	PUNCT
gsrj-41	77	186	3.57	3.57	NUM
gsrj-41	77	187	%	%	NOUN
gsrj-41	77	188	)	)	PUNCT
gsrj-41	77	189	•	•	NUM
gsrj-41	77	190	nyc	nyc	PROPN
gsrj-41	77	191	adults21	adults21	PROPN
gsrj-41	77	192	antivaccine	antivaccine	NOUN
gsrj-41	77	193	attitudes	attitude	NOUN
gsrj-41	77	194	,	,	PUNCT
gsrj-41	77	195	beliefs	belief	NOUN
gsrj-41	77	196	,	,	PUNCT
gsrj-41	77	197	or	or	CCONJ
gsrj-41	77	198	emotions	emotion	NOUN
gsrj-41	77	199	1	1	NUM
gsrj-41	77	200	(	(	PUNCT
gsrj-41	77	201	3.57	3.57	NUM
gsrj-41	77	202	%	%	NOUN
gsrj-41	77	203	)	)	PUNCT
gsrj-41	77	204	•	•	NOUN
gsrj-41	77	205	refusers15	refusers15	NOUN
gsrj-41	77	206	*	*	PUNCT
gsrj-41	77	207	4	4	NUM
gsrj-41	77	208	articles	article	NOUN
gsrj-41	77	209	stratified	stratify	VERB
gsrj-41	77	210	the	the	DET
gsrj-41	77	211	population	population	NOUN
gsrj-41	77	212	into	into	ADP
gsrj-41	77	213	hesitant	hesitant	ADJ
gsrj-41	77	214	and	and	CCONJ
gsrj-41	77	215	refusers	refuser	NOUN
gsrj-41	77	216	with	with	ADP
gsrj-41	77	217	separate	separate	ADJ
gsrj-41	77	218	top	top	ADJ
gsrj-41	77	219	reasons	reason	NOUN
gsrj-41	77	220	for	for	ADP
gsrj-41	77	221	hesitancy.15	hesitancy.15	NOUN
gsrj-41	77	222	,	,	PUNCT
gsrj-41	77	223	20	20	NUM
gsrj-41	77	224	,	,	PUNCT
gsrj-41	77	225	25	25	NUM
gsrj-41	77	226	,	,	PUNCT
gsrj-41	77	227	35	35	NUM
gsrj-41	77	228	1	1	NUM
gsrj-41	77	229	article	article	NOUN
gsrj-41	77	230	has	have	VERB
gsrj-41	77	231	different	different	ADJ
gsrj-41	77	232	top	top	ADJ
gsrj-41	77	233	reasons	reason	NOUN
gsrj-41	77	234	based	base	VERB
gsrj-41	77	235	on	on	ADP
gsrj-41	77	236	location.21	location.21	PROPN
gsrj-41	77	237	*	*	ADJ
gsrj-41	77	238	4	4	NUM
gsrj-41	77	239	articles	article	NOUN
gsrj-41	77	240	were	be	AUX
gsrj-41	77	241	not	not	PART
gsrj-41	77	242	included	include	VERB
gsrj-41	77	243	because	because	SCONJ
gsrj-41	77	244	of	of	ADP
gsrj-41	77	245	results	result	NOUN
gsrj-41	77	246	without	without	ADP
gsrj-41	77	247	clear	clear	ADJ
gsrj-41	77	248	top	top	ADJ
gsrj-41	77	249	reason.23	reason.23	NOUN
gsrj-41	77	250	,	,	PUNCT
gsrj-41	77	251	32	32	NUM
gsrj-41	77	252	,	,	PUNCT
gsrj-41	77	253	37	37	NUM
gsrj-41	77	254	,	,	PUNCT
gsrj-41	77	255	38	38	NUM
gsrj-41	77	256	3.4	3.4	NUM
gsrj-41	77	257	separating	separate	VERB
gsrj-41	77	258	the	the	DET
gsrj-41	77	259	hesitant	hesitant	PROPN
gsrj-41	77	260	&	&	CCONJ
gsrj-41	77	261	refusers	refuser	NOUN
gsrj-41	77	262	four	four	NUM
gsrj-41	77	263	articles	article	NOUN
gsrj-41	77	264	with	with	ADP
gsrj-41	77	265	top	top	ADJ
gsrj-41	77	266	reasons	reason	NOUN
gsrj-41	77	267	for	for	ADP
gsrj-41	77	268	low	low	ADJ
gsrj-41	77	269	vaccine	vaccine	NOUN
gsrj-41	77	270	confidence	confidence	NOUN
gsrj-41	77	271	separated	separate	VERB
gsrj-41	77	272	the	the	DET
gsrj-41	77	273	participants	participant	NOUN
gsrj-41	77	274	between	between	ADP
gsrj-41	77	275	the	the	DET
gsrj-41	77	276	hesitant	hesitant	ADJ
gsrj-41	77	277	and	and	CCONJ
gsrj-41	77	278	refusers	refuser	NOUN
gsrj-41	77	279	with	with	ADP
gsrj-41	77	280	different	different	ADJ
gsrj-41	77	281	top	top	ADJ
gsrj-41	77	282	reasons	reason	NOUN
gsrj-41	77	283	for	for	ADP
gsrj-41	77	284	lack	lack	NOUN
gsrj-41	77	285	of	of	ADP
gsrj-41	77	286	vaccine	vaccine	NOUN
gsrj-41	77	287	uptake	uptake	ADJ
gsrj-41	77	288	.	.	PUNCT
gsrj-41	78	1	the	the	DET
gsrj-41	78	2	remaining	remain	VERB
gsrj-41	78	3	nineteen	nineteen	NUM
gsrj-41	78	4	articles	article	NOUN
gsrj-41	78	5	differentiated	differentiate	VERB
gsrj-41	78	6	between	between	ADP
gsrj-41	78	7	those	those	PRON
gsrj-41	78	8	who	who	PRON
gsrj-41	78	9	intended	intend	VERB
gsrj-41	78	10	or	or	CCONJ
gsrj-41	78	11	had	have	AUX
gsrj-41	78	12	been	be	AUX
gsrj-41	78	13	vaccinated	vaccinate	VERB
gsrj-41	78	14	and	and	CCONJ
gsrj-41	78	15	those	those	PRON
gsrj-41	78	16	who	who	PRON
gsrj-41	78	17	did	do	AUX
gsrj-41	78	18	not	not	PART
gsrj-41	78	19	intend	intend	VERB
gsrj-41	78	20	and/or	and/or	CCONJ
gsrj-41	78	21	showed	show	VERB
gsrj-41	78	22	hesitancy	hesitancy	NOUN
gsrj-41	78	23	(	(	PUNCT
gsrj-41	78	24	including	include	VERB
gsrj-41	78	25	hesitancy	hesitancy	NOUN
gsrj-41	78	26	and	and	CCONJ
gsrj-41	78	27	refusal	refusal	NOUN
gsrj-41	78	28	)	)	PUNCT
gsrj-41	78	29	.	.	PUNCT
gsrj-41	79	1	articles	article	NOUN
gsrj-41	79	2	that	that	PRON
gsrj-41	79	3	separated	separate	VERB
gsrj-41	79	4	between	between	ADP
gsrj-41	79	5	hesitant	hesitant	ADJ
gsrj-41	79	6	and	and	CCONJ
gsrj-41	79	7	refusers	refuser	NOUN
gsrj-41	79	8	found	find	VERB
gsrj-41	79	9	that	that	SCONJ
gsrj-41	79	10	the	the	DET
gsrj-41	79	11	most	most	ADV
gsrj-41	79	12	frequently	frequently	ADV
gsrj-41	79	13	stated	state	VERB
gsrj-41	79	14	reason	reason	NOUN
gsrj-41	79	15	for	for	ADP
gsrj-41	79	16	vaccine	vaccine	NOUN
gsrj-41	79	17	hesitancy	hesitancy	NOUN
gsrj-41	79	18	among	among	ADP
gsrj-41	79	19	the	the	DET
gsrj-41	79	20	hesitant	hesitant	ADJ
gsrj-41	79	21	or	or	CCONJ
gsrj-41	79	22	unsure	unsure	ADJ
gsrj-41	79	23	is	be	AUX
gsrj-41	79	24	side	side	ADJ
gsrj-41	79	25	effect	effect	NOUN
gsrj-41	79	26	and	and	CCONJ
gsrj-41	79	27	safety	safety	NOUN
gsrj-41	79	28	concerns	concern	NOUN
gsrj-41	79	29	,	,	PUNCT
gsrj-41	79	30	as	as	ADV
gsrj-41	79	31	well	well	ADV
gsrj-41	79	32	as	as	ADP
gsrj-41	79	33	waiting	wait	VERB
gsrj-41	79	34	to	to	PART
gsrj-41	79	35	see	see	VERB
gsrj-41	79	36	if	if	SCONJ
gsrj-41	79	37	it	it	PRON
gsrj-41	79	38	is	be	AUX
gsrj-41	79	39	safe.15	safe.15	NOUN
gsrj-41	79	40	,	,	PUNCT
gsrj-41	79	41	20	20	NUM
gsrj-41	79	42	,	,	PUNCT
gsrj-41	79	43	25	25	NUM
gsrj-41	79	44	,	,	PUNCT
gsrj-41	79	45	35	35	NUM
gsrj-41	79	46	these	these	DET
gsrj-41	79	47	same	same	ADJ
gsrj-41	79	48	articles	article	NOUN
gsrj-41	79	49	found	find	VERB
gsrj-41	79	50	that	that	SCONJ
gsrj-41	79	51	the	the	DET
gsrj-41	79	52	most	most	ADV
gsrj-41	79	53	frequently	frequently	ADV
gsrj-41	79	54	stated	state	VERB
gsrj-41	79	55	reason	reason	NOUN
gsrj-41	79	56	for	for	ADP
gsrj-41	79	57	vaccine	vaccine	NOUN
gsrj-41	79	58	hesitancy	hesitancy	NOUN
gsrj-41	79	59	among	among	ADP
gsrj-41	79	60	the	the	DET
gsrj-41	79	61	refusers	refuser	NOUN
gsrj-41	79	62	or	or	CCONJ
gsrj-41	79	63	“	"	PUNCT
gsrj-41	79	64	absolutely	absolutely	ADV
gsrj-41	79	65	not	not	PART
gsrj-41	79	66	”	"	PUNCT
gsrj-41	79	67	include	include	VERB
gsrj-41	79	68	distrust	distrust	NOUN
gsrj-41	79	69	and	and	CCONJ
gsrj-41	79	70	beliefs	belief	NOUN
gsrj-41	79	71	.	.	PUNCT
gsrj-41	80	1	for	for	ADP
gsrj-41	80	2	example	example	NOUN
gsrj-41	80	3	,	,	PUNCT
gsrj-41	80	4	the	the	DET
gsrj-41	80	5	study	study	NOUN
gsrj-41	80	6	by	by	ADP
gsrj-41	80	7	fisher	fisher	PROPN
gsrj-41	80	8	et	et	PROPN
gsrj-41	80	9	al	al	PROPN
gsrj-41	80	10	.	.	PROPN
gsrj-41	81	1	(	(	PUNCT
gsrj-41	81	2	2021	2021	NUM
gsrj-41	81	3	)	)	PUNCT
gsrj-41	81	4	found	find	VERB
gsrj-41	81	5	that	that	SCONJ
gsrj-41	81	6	among	among	ADP
gsrj-41	81	7	a	a	DET
gsrj-41	81	8	representative	representative	ADJ
gsrj-41	81	9	sample	sample	NOUN
gsrj-41	81	10	of	of	ADP
gsrj-41	81	11	u.s	u.s	PROPN
gsrj-41	81	12	.	.	PROPN
gsrj-41	81	13	adults	adult	NOUN
gsrj-41	81	14	,	,	PUNCT
gsrj-41	81	15	31.6	31.6	NUM
gsrj-41	81	16	%	%	NOUN
gsrj-41	81	17	of	of	ADP
gsrj-41	81	18	participants	participant	NOUN
gsrj-41	81	19	were	be	AUX
gsrj-41	81	20	not	not	PART
gsrj-41	81	21	sure	sure	ADJ
gsrj-41	81	22	and/or	and/or	CCONJ
gsrj-41	81	23	hesitant	hesitant	ADJ
gsrj-41	81	24	about	about	ADP
gsrj-41	81	25	getting	get	VERB
gsrj-41	81	26	the	the	DET
gsrj-41	81	27	covid-19	covid-19	PROPN
gsrj-41	81	28	vaccine	vaccine	NOUN
gsrj-41	81	29	,	,	PUNCT
gsrj-41	81	30	and	and	CCONJ
gsrj-41	81	31	10.8	10.8	NUM
gsrj-41	81	32	%	%	NOUN
gsrj-41	81	33	did	do	AUX
gsrj-41	81	34	not	not	PART
gsrj-41	81	35	intend	intend	VERB
gsrj-41	81	36	,	,	PUNCT
gsrj-41	81	37	or	or	CCONJ
gsrj-41	81	38	refused	refuse	VERB
gsrj-41	81	39	.	.	PUNCT
gsrj-41	82	1	15	15	NUM
gsrj-41	82	2	georgetown	georgetown	PROPN
gsrj-41	82	3	scientific	scientific	PROPN
gsrj-41	82	4	research	research	PROPN
gsrj-41	82	5	journal	journal	NOUN
gsrj-41	82	6	the	the	DET
gsrj-41	82	7	most	most	ADV
gsrj-41	82	8	frequently	frequently	ADV
gsrj-41	82	9	stated	state	VERB
gsrj-41	82	10	reason	reason	NOUN
gsrj-41	82	11	for	for	ADP
gsrj-41	82	12	being	be	AUX
gsrj-41	82	13	unsure	unsure	ADJ
gsrj-41	82	14	or	or	CCONJ
gsrj-41	82	15	hesitant	hesitant	ADJ
gsrj-41	82	16	was	be	AUX
gsrj-41	82	17	concern	concern	NOUN
gsrj-41	82	18	about	about	ADP
gsrj-41	82	19	side	side	NOUN
gsrj-41	82	20	effects	effect	NOUN
gsrj-41	82	21	and	and	CCONJ
gsrj-41	82	22	safety	safety	NOUN
gsrj-41	82	23	(	(	PUNCT
gsrj-41	82	24	34.1	34.1	NUM
gsrj-41	82	25	%	%	NOUN
gsrj-41	82	26	)	)	PUNCT
gsrj-41	82	27	,	,	PUNCT
gsrj-41	82	28	while	while	SCONJ
gsrj-41	82	29	the	the	DET
gsrj-41	82	30	reason	reason	NOUN
gsrj-41	82	31	for	for	ADP
gsrj-41	82	32	refusal	refusal	NOUN
gsrj-41	82	33	was	be	AUX
gsrj-41	82	34	“	"	PUNCT
gsrj-41	82	35	do	do	AUX
gsrj-41	82	36	n’t	not	PART
gsrj-41	82	37	believe	believe	VERB
gsrj-41	82	38	in	in	ADP
gsrj-41	82	39	,	,	PUNCT
gsrj-41	82	40	want	want	VERB
gsrj-41	82	41	,	,	PUNCT
gsrj-41	82	42	or	or	CCONJ
gsrj-41	82	43	feel	feel	VERB
gsrj-41	82	44	comfortable	comfortable	ADJ
gsrj-41	82	45	with	with	ADP
gsrj-41	82	46	vaccines	vaccine	NOUN
gsrj-41	82	47	”	"	PUNCT
gsrj-41	82	48	(	(	PUNCT
gsrj-41	82	49	21.7%).15	21.7%).15	NUM
gsrj-41	82	50	second	second	ADJ
gsrj-41	82	51	,	,	PUNCT
gsrj-41	82	52	the	the	DET
gsrj-41	82	53	study	study	NOUN
gsrj-41	82	54	by	by	ADP
gsrj-41	82	55	tram	tram	PROPN
gsrj-41	82	56	et	et	PROPN
gsrj-41	82	57	al	al	PROPN
gsrj-41	82	58	.	.	PROPN
gsrj-41	83	1	(	(	PUNCT
gsrj-41	83	2	2021	2021	NUM
gsrj-41	83	3	)	)	PUNCT
gsrj-41	83	4	found	find	VERB
gsrj-41	83	5	that	that	SCONJ
gsrj-41	83	6	among	among	ADP
gsrj-41	83	7	a	a	DET
gsrj-41	83	8	representative	representative	ADJ
gsrj-41	83	9	sample	sample	NOUN
gsrj-41	83	10	of	of	ADP
gsrj-41	83	11	u.s	u.s	PROPN
gsrj-41	83	12	.	.	PROPN
gsrj-41	83	13	adults	adult	NOUN
gsrj-41	83	14	,	,	PUNCT
gsrj-41	83	15	10.2	10.2	NUM
gsrj-41	83	16	%	%	NOUN
gsrj-41	83	17	stated	state	VERB
gsrj-41	83	18	that	that	SCONJ
gsrj-41	83	19	they	they	PRON
gsrj-41	83	20	would	would	AUX
gsrj-41	83	21	probably	probably	ADV
gsrj-41	83	22	not	not	PART
gsrj-41	83	23	get	get	VERB
gsrj-41	83	24	the	the	DET
gsrj-41	83	25	vaccine	vaccine	NOUN
gsrj-41	83	26	,	,	PUNCT
gsrj-41	83	27	while	while	SCONJ
gsrj-41	83	28	8.2	8.2	NUM
gsrj-41	83	29	%	%	NOUN
gsrj-41	83	30	stated	state	VERB
gsrj-41	83	31	that	that	SCONJ
gsrj-41	83	32	they	they	PRON
gsrj-41	83	33	would	would	AUX
gsrj-41	83	34	definitely	definitely	ADV
gsrj-41	83	35	not	not	PART
gsrj-41	83	36	.	.	PUNCT
gsrj-41	84	1	the	the	DET
gsrj-41	84	2	majority	majority	NOUN
gsrj-41	84	3	of	of	ADP
gsrj-41	84	4	probably	probably	ADV
gsrj-41	84	5	not	not	PART
gsrj-41	84	6	(	(	PUNCT
gsrj-41	84	7	57.0	57.0	NUM
gsrj-41	84	8	%	%	NOUN
gsrj-41	84	9	)	)	PUNCT
gsrj-41	84	10	stated	state	VERB
gsrj-41	84	11	“	"	PUNCT
gsrj-41	84	12	plan	plan	NOUN
gsrj-41	84	13	to	to	PART
gsrj-41	84	14	wait	wait	VERB
gsrj-41	84	15	and	and	CCONJ
gsrj-41	84	16	see	see	VERB
gsrj-41	84	17	if	if	SCONJ
gsrj-41	84	18	it	it	PRON
gsrj-41	84	19	is	be	AUX
gsrj-41	84	20	safe	safe	ADJ
gsrj-41	84	21	and	and	CCONJ
gsrj-41	84	22	may	may	AUX
gsrj-41	84	23	get	get	VERB
gsrj-41	84	24	it	it	PRON
gsrj-41	84	25	later	later	ADV
gsrj-41	84	26	”	"	PUNCT
gsrj-41	84	27	as	as	ADP
gsrj-41	84	28	the	the	DET
gsrj-41	84	29	main	main	ADJ
gsrj-41	84	30	reason	reason	NOUN
gsrj-41	84	31	,	,	PUNCT
gsrj-41	84	32	while	while	SCONJ
gsrj-41	84	33	the	the	DET
gsrj-41	84	34	majority	majority	NOUN
gsrj-41	84	35	(	(	PUNCT
gsrj-41	84	36	49.0	49.0	NUM
gsrj-41	84	37	%	%	NOUN
gsrj-41	84	38	)	)	PUNCT
gsrj-41	84	39	of	of	ADP
gsrj-41	84	40	“	"	PUNCT
gsrj-41	84	41	definitely	definitely	ADV
gsrj-41	84	42	not	not	PART
gsrj-41	84	43	”	"	PUNCT
gsrj-41	84	44	stated	state	VERB
gsrj-41	84	45	“	"	PUNCT
gsrj-41	84	46	do	do	AUX
gsrj-41	84	47	not	not	PART
gsrj-41	84	48	trust	trust	VERB
gsrj-41	84	49	the	the	DET
gsrj-41	84	50	covid-19	covid-19	PROPN
gsrj-41	84	51	vaccine	vaccine	NOUN
gsrj-41	84	52	”	"	PUNCT
gsrj-41	84	53	as	as	ADP
gsrj-41	84	54	the	the	DET
gsrj-41	84	55	main	main	ADJ
gsrj-41	84	56	reason.20	reason.20	NOUN
gsrj-41	84	57	third	third	NOUN
gsrj-41	84	58	,	,	PUNCT
gsrj-41	84	59	the	the	DET
gsrj-41	84	60	study	study	NOUN
gsrj-41	84	61	by	by	ADP
gsrj-41	84	62	stern	stern	PROPN
gsrj-41	84	63	et	et	PROPN
gsrj-41	84	64	al	al	PROPN
gsrj-41	84	65	.	.	PROPN
gsrj-41	84	66	(	(	PUNCT
gsrj-41	84	67	2021	2021	NUM
gsrj-41	84	68	)	)	PUNCT
gsrj-41	84	69	found	find	VERB
gsrj-41	84	70	that	that	SCONJ
gsrj-41	84	71	among	among	ADP
gsrj-41	84	72	incarcerated	incarcerated	ADJ
gsrj-41	84	73	individuals	individual	NOUN
gsrj-41	84	74	in	in	ADP
gsrj-41	84	75	washington	washington	PROPN
gsrj-41	84	76	,	,	PUNCT
gsrj-41	84	77	florida	florida	PROPN
gsrj-41	84	78	,	,	PUNCT
gsrj-41	84	79	california	california	PROPN
gsrj-41	84	80	,	,	PUNCT
gsrj-41	84	81	and	and	CCONJ
gsrj-41	84	82	texas	texas	PROPN
gsrj-41	84	83	,	,	PUNCT
gsrj-41	84	84	45.4	45.4	NUM
gsrj-41	84	85	%	%	NOUN
gsrj-41	84	86	would	would	AUX
gsrj-41	84	87	refuse	refuse	VERB
gsrj-41	84	88	the	the	DET
gsrj-41	84	89	vaccine	vaccine	NOUN
gsrj-41	84	90	,	,	PUNCT
gsrj-41	84	91	while	while	SCONJ
gsrj-41	84	92	9.8	9.8	NUM
gsrj-41	84	93	%	%	NOUN
gsrj-41	84	94	would	would	AUX
gsrj-41	84	95	hesitate	hesitate	VERB
gsrj-41	84	96	.	.	PUNCT
gsrj-41	85	1	among	among	ADP
gsrj-41	85	2	the	the	DET
gsrj-41	85	3	hesitant	hesitant	ADJ
gsrj-41	85	4	,	,	PUNCT
gsrj-41	85	5	the	the	DET
gsrj-41	85	6	majority	majority	NOUN
gsrj-41	85	7	were	be	AUX
gsrj-41	85	8	waiting	wait	VERB
gsrj-41	85	9	for	for	ADP
gsrj-41	85	10	more	more	ADJ
gsrj-41	85	11	information	information	NOUN
gsrj-41	85	12	(	(	PUNCT
gsrj-41	85	13	54.8	54.8	NUM
gsrj-41	85	14	%	%	NOUN
gsrj-41	85	15	)	)	PUNCT
gsrj-41	85	16	.	.	PUNCT
gsrj-41	86	1	among	among	ADP
gsrj-41	86	2	the	the	DET
gsrj-41	86	3	refusers	refuser	NOUN
gsrj-41	86	4	,	,	PUNCT
gsrj-41	86	5	distrust	distrust	NOUN
gsrj-41	86	6	of	of	ADP
gsrj-41	86	7	healthcare	healthcare	NOUN
gsrj-41	86	8	,	,	PUNCT
gsrj-41	86	9	correctional	correctional	NOUN
gsrj-41	86	10	,	,	PUNCT
gsrj-41	86	11	or	or	CCONJ
gsrj-41	86	12	government	government	NOUN
gsrj-41	86	13	personnel	personnel	NOUN
gsrj-41	86	14	or	or	CCONJ
gsrj-41	86	15	institutions	institution	NOUN
gsrj-41	86	16	was	be	AUX
gsrj-41	86	17	the	the	DET
gsrj-41	86	18	most	most	ADV
gsrj-41	86	19	common	common	ADJ
gsrj-41	86	20	reason	reason	NOUN
gsrj-41	86	21	(	(	PUNCT
gsrj-41	86	22	20.1%).35	20.1%).35	NUM
gsrj-41	86	23	3.5	3.5	NUM
gsrj-41	86	24	qualitative	qualitative	ADJ
gsrj-41	86	25	data	datum	NOUN
gsrj-41	86	26	&	&	CCONJ
gsrj-41	86	27	predictive	predictive	ADJ
gsrj-41	86	28	factors	factor	NOUN
gsrj-41	86	29	four	four	NUM
gsrj-41	86	30	of	of	ADP
gsrj-41	86	31	the	the	DET
gsrj-41	86	32	twenty	twenty	NUM
gsrj-41	86	33	-	-	PUNCT
gsrj-41	86	34	seven	seven	NUM
gsrj-41	86	35	articles	article	NOUN
gsrj-41	86	36	included	include	VERB
gsrj-41	86	37	were	be	AUX
gsrj-41	86	38	qualitative	qualitative	ADJ
gsrj-41	86	39	or	or	CCONJ
gsrj-41	86	40	found	find	VERB
gsrj-41	86	41	correlations	correlation	NOUN
gsrj-41	86	42	between	between	ADP
gsrj-41	86	43	vaccine	vaccine	NOUN
gsrj-41	86	44	intention	intention	NOUN
gsrj-41	86	45	/	/	SYM
gsrj-41	86	46	uptake	uptake	ADJ
gsrj-41	86	47	and	and	CCONJ
gsrj-41	86	48	predictive	predictive	ADJ
gsrj-41	86	49	factors	factor	NOUN
gsrj-41	86	50	.	.	PUNCT
gsrj-41	87	1	the	the	DET
gsrj-41	87	2	qualitative	qualitative	ADJ
gsrj-41	87	3	study	study	NOUN
gsrj-41	87	4	on	on	ADP
gsrj-41	87	5	skilled	skilled	ADJ
gsrj-41	87	6	nursing	nursing	NOUN
gsrj-41	87	7	facility	facility	NOUN
gsrj-41	87	8	staff	staff	NOUN
gsrj-41	87	9	found	find	VERB
gsrj-41	87	10	different	different	ADJ
gsrj-41	87	11	reasons	reason	NOUN
gsrj-41	87	12	for	for	ADP
gsrj-41	87	13	hesitancy	hesitancy	NOUN
gsrj-41	87	14	and	and	CCONJ
gsrj-41	87	15	gave	give	VERB
gsrj-41	87	16	more	more	ADJ
gsrj-41	87	17	nuance	nuance	NOUN
gsrj-41	87	18	to	to	ADP
gsrj-41	87	19	the	the	DET
gsrj-41	87	20	topic	topic	NOUN
gsrj-41	87	21	.	.	PUNCT
gsrj-41	88	1	these	these	PRON
gsrj-41	88	2	include	include	VERB
gsrj-41	88	3	beliefs	belief	NOUN
gsrj-41	88	4	that	that	SCONJ
gsrj-41	88	5	the	the	DET
gsrj-41	88	6	vaccine	vaccine	NOUN
gsrj-41	88	7	has	have	AUX
gsrj-41	88	8	been	be	AUX
gsrj-41	88	9	developed	develop	VERB
gsrj-41	88	10	too	too	ADV
gsrj-41	88	11	fast	fast	ADJ
gsrj-41	88	12	and	and	CCONJ
gsrj-41	88	13	without	without	ADP
gsrj-41	88	14	sufficient	sufficient	ADJ
gsrj-41	88	15	testing	testing	NOUN
gsrj-41	88	16	,	,	PUNCT
gsrj-41	88	17	personal	personal	ADJ
gsrj-41	88	18	fear	fear	NOUN
gsrj-41	88	19	about	about	ADP
gsrj-41	88	20	preexisting	preexist	VERB
gsrj-41	88	21	medical	medical	ADJ
gsrj-41	88	22	conditions	condition	NOUN
gsrj-41	88	23	,	,	PUNCT
gsrj-41	88	24	and	and	CCONJ
gsrj-41	88	25	general	general	ADJ
gsrj-41	88	26	distrust	distrust	NOUN
gsrj-41	88	27	of	of	ADP
gsrj-41	88	28	the	the	DET
gsrj-41	88	29	government	government	NOUN
gsrj-41	88	30	and	and	CCONJ
gsrj-41	88	31	institutions	institution	NOUN
gsrj-41	88	32	.	.	PUNCT
gsrj-41	89	1	these	these	DET
gsrj-41	89	2	interviews	interview	NOUN
gsrj-41	89	3	also	also	ADV
gsrj-41	89	4	found	find	VERB
gsrj-41	89	5	the	the	DET
gsrj-41	89	6	vaccine	vaccine	NOUN
gsrj-41	89	7	uptake	uptake	ADJ
gsrj-41	89	8	is	be	AUX
gsrj-41	89	9	a	a	DET
gsrj-41	89	10	“	"	PUNCT
gsrj-41	89	11	social	social	ADJ
gsrj-41	89	12	enterprise	enterprise	NOUN
gsrj-41	89	13	”	"	PUNCT
gsrj-41	89	14	and	and	CCONJ
gsrj-41	89	15	influenced	influence	VERB
gsrj-41	89	16	significantly	significantly	ADV
gsrj-41	89	17	by	by	ADP
gsrj-41	89	18	the	the	DET
gsrj-41	89	19	actions	action	NOUN
gsrj-41	89	20	of	of	ADP
gsrj-41	89	21	close	close	ADJ
gsrj-41	89	22	friends	friend	NOUN
gsrj-41	89	23	in	in	ADP
gsrj-41	89	24	a	a	DET
gsrj-41	89	25	social	social	ADJ
gsrj-41	89	26	network.23	network.23	NOUN
gsrj-41	89	27	the	the	DET
gsrj-41	89	28	study	study	NOUN
gsrj-41	89	29	by	by	ADP
gsrj-41	89	30	latkin	latkin	PROPN
gsrj-41	89	31	et	et	PROPN
gsrj-41	89	32	al	al	PROPN
gsrj-41	89	33	.	.	PROPN
gsrj-41	90	1	(	(	PUNCT
gsrj-41	90	2	2021	2021	NUM
gsrj-41	90	3	)	)	PUNCT
gsrj-41	90	4	found	find	VERB
gsrj-41	90	5	differences	difference	NOUN
gsrj-41	90	6	between	between	ADP
gsrj-41	90	7	demographic	demographic	ADJ
gsrj-41	90	8	characteristics	characteristic	NOUN
gsrj-41	90	9	and	and	CCONJ
gsrj-41	90	10	predictive	predictive	ADJ
gsrj-41	90	11	factors	factor	NOUN
gsrj-41	90	12	for	for	ADP
gsrj-41	90	13	covid-19	covid-19	PROPN
gsrj-41	90	14	vaccine	vaccine	NOUN
gsrj-41	90	15	uptake	uptake	ADJ
gsrj-41	90	16	.	.	PUNCT
gsrj-41	91	1	among	among	ADP
gsrj-41	91	2	a	a	DET
gsrj-41	91	3	nationally	nationally	ADV
gsrj-41	91	4	representative	representative	ADJ
gsrj-41	91	5	population	population	NOUN
gsrj-41	91	6	,	,	PUNCT
gsrj-41	91	7	black	black	ADJ
gsrj-41	91	8	,	,	PUNCT
gsrj-41	91	9	hispanic	hispanic	ADJ
gsrj-41	91	10	,	,	PUNCT
gsrj-41	91	11	and	and	CCONJ
gsrj-41	91	12	woman	woman	NOUN
gsrj-41	91	13	-	-	PUNCT
gsrj-41	91	14	identifying	identify	VERB
gsrj-41	91	15	populations	population	NOUN
gsrj-41	91	16	in	in	ADP
gsrj-41	91	17	the	the	DET
gsrj-41	91	18	u.s	u.s	PROPN
gsrj-41	91	19	.	.	PROPN
gsrj-41	91	20	are	be	AUX
gsrj-41	91	21	the	the	DET
gsrj-41	91	22	most	most	ADV
gsrj-41	91	23	hesitant	hesitant	ADJ
gsrj-41	91	24	;	;	PUNCT
gsrj-41	91	25	however	however	ADV
gsrj-41	91	26	,	,	PUNCT
gsrj-41	91	27	reasons	reason	NOUN
gsrj-41	91	28	for	for	ADP
gsrj-41	91	29	hesitancy	hesitancy	NOUN
gsrj-41	91	30	differed	differ	VERB
gsrj-41	91	31	between	between	ADP
gsrj-41	91	32	these	these	DET
gsrj-41	91	33	populations	population	NOUN
gsrj-41	91	34	.	.	PUNCT
gsrj-41	92	1	black	black	ADJ
gsrj-41	92	2	populations	population	NOUN
gsrj-41	92	3	were	be	AUX
gsrj-41	92	4	more	more	ADV
gsrj-41	92	5	likely	likely	ADJ
gsrj-41	92	6	to	to	PART
gsrj-41	92	7	state	state	VERB
gsrj-41	92	8	concerns	concern	NOUN
gsrj-41	92	9	about	about	ADP
gsrj-41	92	10	being	be	AUX
gsrj-41	92	11	infected	infect	VERB
gsrj-41	92	12	from	from	ADP
gsrj-41	92	13	the	the	DET
gsrj-41	92	14	vaccine	vaccine	NOUN
gsrj-41	92	15	itself	itself	PRON
gsrj-41	92	16	,	,	PUNCT
gsrj-41	92	17	while	while	SCONJ
gsrj-41	92	18	white	white	ADJ
gsrj-41	92	19	populations	population	NOUN
gsrj-41	92	20	were	be	AUX
gsrj-41	92	21	more	more	ADV
gsrj-41	92	22	likely	likely	ADJ
gsrj-41	92	23	to	to	PART
gsrj-41	92	24	say	say	VERB
gsrj-41	92	25	that	that	SCONJ
gsrj-41	92	26	covid-19	covid-19	PROPN
gsrj-41	92	27	was	be	AUX
gsrj-41	92	28	not	not	PART
gsrj-41	92	29	as	as	ADV
gsrj-41	92	30	serious	serious	ADJ
gsrj-41	92	31	as	as	SCONJ
gsrj-41	92	32	some	some	PRON
gsrj-41	92	33	say	say	VERB
gsrj-41	92	34	it	it	PRON
gsrj-41	92	35	is.32	is.32	VERB
gsrj-41	92	36	the	the	DET
gsrj-41	92	37	study	study	NOUN
gsrj-41	92	38	by	by	ADP
gsrj-41	92	39	dorman	dorman	PROPN
gsrj-41	92	40	et	et	PROPN
gsrj-41	92	41	al	al	PROPN
gsrj-41	92	42	.	.	PROPN
gsrj-41	93	1	(	(	PUNCT
gsrj-41	93	2	2021	2021	NUM
gsrj-41	93	3	)	)	PUNCT
gsrj-41	93	4	focused	focus	VERB
gsrj-41	93	5	on	on	ADP
gsrj-41	93	6	the	the	DET
gsrj-41	93	7	importance	importance	NOUN
gsrj-41	93	8	of	of	ADP
gsrj-41	93	9	confidence	confidence	NOUN
gsrj-41	93	10	in	in	ADP
gsrj-41	93	11	vaccine	vaccine	NOUN
gsrj-41	93	12	willingness.37	willingness.37	VERB
gsrj-41	93	13	lastly	lastly	ADV
gsrj-41	93	14	,	,	PUNCT
gsrj-41	93	15	the	the	DET
gsrj-41	93	16	study	study	NOUN
gsrj-41	93	17	by	by	ADP
gsrj-41	93	18	allen	allen	PROPN
gsrj-41	93	19	et	et	PROPN
gsrj-41	93	20	al	al	PROPN
gsrj-41	93	21	.	.	PROPN
gsrj-41	94	1	(	(	PUNCT
gsrj-41	94	2	2021	2021	NUM
gsrj-41	94	3	)	)	PUNCT
gsrj-41	94	4	found	find	VERB
gsrj-41	94	5	that	that	SCONJ
gsrj-41	94	6	the	the	DET
gsrj-41	94	7	greatest	great	ADJ
gsrj-41	94	8	predictor	predictor	NOUN
gsrj-41	94	9	of	of	ADP
gsrj-41	94	10	vaccination	vaccination	NOUN
gsrj-41	94	11	was	be	AUX
gsrj-41	94	12	agreement	agreement	NOUN
gsrj-41	94	13	or	or	CCONJ
gsrj-41	94	14	disagreement	disagreement	VERB
gsrj-41	94	15	with	with	ADP
gsrj-41	94	16	the	the	DET
gsrj-41	94	17	statement	statement	NOUN
gsrj-41	94	18	that	that	SCONJ
gsrj-41	94	19	vaccines	vaccine	NOUN
gsrj-41	94	20	are	be	AUX
gsrj-41	94	21	safe	safe	ADJ
gsrj-41	94	22	and	and	CCONJ
gsrj-41	94	23	effective.38	effective.38	NOUN
gsrj-41	94	24	3.6	3.6	NUM
gsrj-41	94	25	timing	timing	NOUN
gsrj-41	94	26	of	of	ADP
gsrj-41	94	27	study	study	NOUN
gsrj-41	94	28	just	just	ADV
gsrj-41	94	29	over	over	ADP
gsrj-41	94	30	half	half	NOUN
gsrj-41	94	31	(	(	PUNCT
gsrj-41	94	32	51.8	51.8	NUM
gsrj-41	94	33	%	%	NOUN
gsrj-41	94	34	;	;	PUNCT
gsrj-41	94	35	14	14	NUM
gsrj-41	94	36	out	out	ADP
gsrj-41	94	37	of	of	ADP
gsrj-41	94	38	27	27	NUM
gsrj-41	94	39	)	)	PUNCT
gsrj-41	94	40	of	of	ADP
gsrj-41	94	41	the	the	DET
gsrj-41	94	42	articles	article	NOUN
gsrj-41	94	43	were	be	AUX
gsrj-41	94	44	done	do	VERB
gsrj-41	94	45	before	before	SCONJ
gsrj-41	94	46	the	the	DET
gsrj-41	94	47	federal	federal	ADJ
gsrj-41	94	48	drug	drug	PROPN
gsrj-41	94	49	administration	administration	NOUN
gsrj-41	94	50	issued	issue	VERB
gsrj-41	94	51	an	an	DET
gsrj-41	94	52	emergency	emergency	NOUN
gsrj-41	94	53	use	use	NOUN
gsrj-41	94	54	authorization	authorization	NOUN
gsrj-41	94	55	for	for	ADP
gsrj-41	94	56	the	the	DET
gsrj-41	94	57	pfizer	pfizer	NOUN
gsrj-41	94	58	-	-	PUNCT
gsrj-41	94	59	biontech	biontech	ADJ
gsrj-41	94	60	vaccine	vaccine	NOUN
gsrj-41	94	61	in	in	ADP
gsrj-41	94	62	the	the	DET
gsrj-41	94	63	united	united	PROPN
gsrj-41	94	64	states	states	PROPN
gsrj-41	94	65	on	on	ADP
gsrj-41	94	66	december	december	PROPN
gsrj-41	94	67	11	11	NUM
gsrj-41	94	68	,	,	PUNCT
gsrj-41	94	69	2020	2020	NUM
gsrj-41	94	70	,	,	PUNCT
gsrj-41	94	71	meaning	mean	VERB
gsrj-41	94	72	before	before	ADP
gsrj-41	94	73	the	the	DET
gsrj-41	94	74	actual	actual	ADJ
gsrj-41	94	75	roll	roll	NOUN
gsrj-41	94	76	-	-	PUNCT
gsrj-41	94	77	out	out	NOUN
gsrj-41	94	78	to	to	ADP
gsrj-41	94	79	the	the	DET
gsrj-41	94	80	public	public	NOUN
gsrj-41	94	81	.	.	PUNCT
gsrj-41	95	1	these	these	DET
gsrj-41	95	2	“	"	PUNCT
gsrj-41	95	3	before	before	ADP
gsrj-41	95	4	”	"	PUNCT
gsrj-41	95	5	surveys	survey	NOUN
gsrj-41	95	6	surrounded	surround	VERB
gsrj-41	95	7	intention	intention	NOUN
gsrj-41	95	8	in	in	ADP
gsrj-41	95	9	a	a	DET
gsrj-41	95	10	time	time	NOUN
gsrj-41	95	11	where	where	SCONJ
gsrj-41	95	12	the	the	DET
gsrj-41	95	13	vaccines	vaccine	NOUN
gsrj-41	95	14	were	be	AUX
gsrj-41	95	15	not	not	PART
gsrj-41	95	16	yet	yet	ADV
gsrj-41	95	17	approved	approve	VERB
gsrj-41	95	18	for	for	ADP
gsrj-41	95	19	public	public	ADJ
gsrj-41	95	20	use	use	NOUN
gsrj-41	95	21	.	.	PUNCT
gsrj-41	96	1	10	10	NUM
gsrj-41	96	2	of	of	ADP
gsrj-41	96	3	the	the	DET
gsrj-41	96	4	27	27	NUM
gsrj-41	96	5	(	(	PUNCT
gsrj-41	96	6	37.0	37.0	NUM
gsrj-41	96	7	%	%	NOUN
gsrj-41	96	8	)	)	PUNCT
gsrj-41	97	1	articles	article	NOUN
gsrj-41	97	2	had	have	VERB
gsrj-41	97	3	surveys	survey	NOUN
gsrj-41	97	4	conducted	conduct	VERB
gsrj-41	97	5	after	after	ADP
gsrj-41	97	6	the	the	DET
gsrj-41	97	7	first	first	PROPN
gsrj-41	97	8	eua	eua	PROPN
gsrj-41	97	9	,	,	PUNCT
gsrj-41	97	10	meaning	mean	VERB
gsrj-41	97	11	that	that	SCONJ
gsrj-41	97	12	safety	safety	NOUN
gsrj-41	97	13	and	and	CCONJ
gsrj-41	97	14	effectiveness	effectiveness	NOUN
gsrj-41	97	15	were	be	AUX
gsrj-41	97	16	proven	prove	VERB
gsrj-41	97	17	by	by	ADP
gsrj-41	97	18	the	the	DET
gsrj-41	97	19	fda	fda	PROPN
gsrj-41	97	20	.	.	PUNCT
gsrj-41	98	1	the	the	DET
gsrj-41	98	2	fda	fda	PROPN
gsrj-41	98	3	eua	eua	PROPN
gsrj-41	98	4	should	should	AUX
gsrj-41	98	5	be	be	AUX
gsrj-41	98	6	proof	proof	NOUN
gsrj-41	98	7	to	to	ADP
gsrj-41	98	8	the	the	DET
gsrj-41	98	9	public	public	NOUN
gsrj-41	98	10	of	of	ADP
gsrj-41	98	11	the	the	DET
gsrj-41	98	12	safety	safety	NOUN
gsrj-41	98	13	and	and	CCONJ
gsrj-41	98	14	effectiveness	effectiveness	NOUN
gsrj-41	98	15	of	of	ADP
gsrj-41	98	16	the	the	DET
gsrj-41	98	17	vaccine	vaccine	NOUN
gsrj-41	98	18	in	in	ADP
gsrj-41	98	19	combatting	combat	VERB
gsrj-41	98	20	covid-19	covid-19	PROPN
gsrj-41	98	21	,	,	PUNCT
gsrj-41	98	22	as	as	SCONJ
gsrj-41	98	23	safety	safety	NOUN
gsrj-41	98	24	and	and	CCONJ
gsrj-41	98	25	effectiveness	effectiveness	NOUN
gsrj-41	98	26	data	datum	NOUN
gsrj-41	98	27	were	be	AUX
gsrj-41	98	28	transparent	transparent	ADJ
gsrj-41	98	29	and	and	CCONJ
gsrj-41	98	30	recommended	recommend	VERB
gsrj-41	98	31	to	to	PART
gsrj-41	98	32	prioritized	prioritize	VERB
gsrj-41	98	33	populations	population	NOUN
gsrj-41	98	34	and	and	CCONJ
gsrj-41	98	35	supported	support	VERB
gsrj-41	98	36	by	by	ADP
gsrj-41	98	37	healthcare	healthcare	NOUN
gsrj-41	98	38	professionals	professional	NOUN
gsrj-41	98	39	(	(	PUNCT
gsrj-41	98	40	fda	fda	PROPN
gsrj-41	98	41	,	,	PUNCT
gsrj-41	98	42	2019).42	2019).42	NUM
gsrj-41	98	43	the	the	DET
gsrj-41	98	44	remaining	remain	VERB
gsrj-41	98	45	three	three	NUM
gsrj-41	98	46	articles	article	NOUN
gsrj-41	98	47	included	include	VERB
gsrj-41	98	48	surveys	survey	NOUN
gsrj-41	98	49	both	both	CCONJ
gsrj-41	98	50	before	before	ADP
gsrj-41	98	51	and	and	CCONJ
gsrj-41	98	52	after	after	ADP
gsrj-41	98	53	the	the	DET
gsrj-41	98	54	eua	eua	PROPN
gsrj-41	98	55	.	.	PUNCT
gsrj-41	99	1	the	the	DET
gsrj-41	99	2	follow	follow	VERB
gsrj-41	99	3	-	-	PUNCT
gsrj-41	99	4	up	up	ADP
gsrj-41	99	5	surveys	survey	NOUN
gsrj-41	99	6	were	be	AUX
gsrj-41	99	7	given	give	VERB
gsrj-41	99	8	after	after	ADP
gsrj-41	99	9	the	the	DET
gsrj-41	99	10	fda	fda	PROPN
gsrj-41	99	11	eua	eua	PROPN
gsrj-41	99	12	to	to	ADP
gsrj-41	99	13	the	the	DET
gsrj-41	99	14	same	same	ADJ
gsrj-41	99	15	participants	participant	NOUN
gsrj-41	99	16	to	to	PART
gsrj-41	99	17	compare	compare	VERB
gsrj-41	99	18	and	and	CCONJ
gsrj-41	99	19	see	see	VERB
gsrj-41	99	20	changes	change	NOUN
gsrj-41	99	21	in	in	ADP
gsrj-41	99	22	vaccine	vaccine	NOUN
gsrj-41	99	23	uptake	uptake	ADJ
gsrj-41	99	24	and	and	CCONJ
gsrj-41	99	25	reasons	reason	NOUN
gsrj-41	99	26	(	(	PUNCT
gsrj-41	99	27	table	table	NOUN
gsrj-41	99	28	5	5	NUM
gsrj-41	99	29	)	)	PUNCT
gsrj-41	99	30	.	.	PUNCT
gsrj-41	100	1	16	16	NUM
gsrj-41	100	2	georgetown	georgetown	PROPN
gsrj-41	100	3	scientific	scientific	PROPN
gsrj-41	100	4	research	research	PROPN
gsrj-41	100	5	journal	journal	NOUN
gsrj-41	100	6	table	table	NOUN
gsrj-41	100	7	5	5	NUM
gsrj-41	100	8	:	:	PUNCT
gsrj-41	100	9	number	number	NOUN
gsrj-41	100	10	and	and	CCONJ
gsrj-41	100	11	percentage	percentage	NOUN
gsrj-41	100	12	of	of	ADP
gsrj-41	100	13	articles	article	NOUN
gsrj-41	100	14	that	that	PRON
gsrj-41	100	15	were	be	AUX
gsrj-41	100	16	before	before	ADP
gsrj-41	100	17	or	or	CCONJ
gsrj-41	100	18	after	after	ADP
gsrj-41	100	19	fda	fda	PROPN
gsrj-41	100	20	eua	eua	PROPN
gsrj-41	100	21	of	of	ADP
gsrj-41	100	22	pfizer	pfizer	PROPN
gsrj-41	100	23	covid-19	covid-19	PROPN
gsrj-41	100	24	vaccine	vaccine	NOUN
gsrj-41	100	25	(	(	PUNCT
gsrj-41	100	26	dec	dec	PROPN
gsrj-41	100	27	11	11	NUM
gsrj-41	100	28	,	,	PUNCT
gsrj-41	100	29	2020	2020	NUM
gsrj-41	100	30	)	)	PUNCT
gsrj-41	100	31	(	(	PUNCT
gsrj-41	100	32	n	n	NOUN
gsrj-41	100	33	=	=	SYM
gsrj-41	100	34	27	27	NUM
gsrj-41	100	35	)	)	PUNCT
gsrj-41	100	36	.	.	PUNCT
gsrj-41	101	1	the	the	DET
gsrj-41	101	2	majority	majority	NOUN
gsrj-41	101	3	of	of	ADP
gsrj-41	101	4	studies	study	NOUN
gsrj-41	101	5	were	be	AUX
gsrj-41	101	6	conducted	conduct	VERB
gsrj-41	101	7	before	before	ADP
gsrj-41	101	8	fda	fda	PROPN
gsrj-41	101	9	eua	eua	PROPN
gsrj-41	101	10	(	(	PUNCT
gsrj-41	101	11	51.8	51.8	NUM
gsrj-41	101	12	%	%	NOUN
gsrj-41	101	13	)	)	PUNCT
gsrj-41	101	14	,	,	PUNCT
gsrj-41	101	15	followed	follow	VERB
gsrj-41	101	16	by	by	ADP
gsrj-41	101	17	after	after	ADP
gsrj-41	101	18	(	(	PUNCT
gsrj-41	101	19	37.0	37.0	NUM
gsrj-41	101	20	%	%	NOUN
gsrj-41	101	21	)	)	PUNCT
gsrj-41	101	22	,	,	PUNCT
gsrj-41	101	23	and	and	CCONJ
gsrj-41	101	24	spanning	span	VERB
gsrj-41	101	25	both	both	CCONJ
gsrj-41	101	26	before	before	ADP
gsrj-41	101	27	and	and	CCONJ
gsrj-41	101	28	after	after	ADP
gsrj-41	101	29	(	(	PUNCT
gsrj-41	101	30	11.1	11.1	NUM
gsrj-41	101	31	%	%	NOUN
gsrj-41	101	32	)	)	PUNCT
gsrj-41	101	33	.	.	PUNCT
gsrj-41	102	1	*	*	PUNCT
gsrj-41	102	2	2	2	NUM
gsrj-41	102	3	articles	article	NOUN
gsrj-41	102	4	were	be	AUX
gsrj-41	102	5	comparisons	comparison	NOUN
gsrj-41	102	6	with	with	ADP
gsrj-41	102	7	follow	follow	NOUN
gsrj-41	102	8	-	-	PUNCT
gsrj-41	102	9	up	up	ADP
gsrj-41	102	10	surveys.41	surveys.41	NOUN
gsrj-41	102	11	,	,	PUNCT
gsrj-41	102	12	19	19	NUM
gsrj-41	102	13	1	1	NUM
gsrj-41	102	14	article	article	NOUN
gsrj-41	102	15	spanned	span	VERB
gsrj-41	102	16	from	from	ADP
gsrj-41	102	17	may	may	PROPN
gsrj-41	102	18	2020	2020	NUM
gsrj-41	102	19	to	to	ADP
gsrj-41	102	20	january	january	PROPN
gsrj-41	102	21	2021.26	2021.26	NUM
gsrj-41	102	22	3.7	3.7	NUM
gsrj-41	102	23	correlations	correlation	NOUN
gsrj-41	102	24	between	between	ADP
gsrj-41	102	25	top	top	ADJ
gsrj-41	102	26	reason	reason	NOUN
gsrj-41	102	27	,	,	PUNCT
gsrj-41	102	28	timing	timing	NOUN
gsrj-41	102	29	,	,	PUNCT
gsrj-41	102	30	&	&	CCONJ
gsrj-41	102	31	population	population	NOUN
gsrj-41	102	32	out	out	ADP
gsrj-41	102	33	of	of	ADP
gsrj-41	102	34	the	the	DET
gsrj-41	102	35	eleven	eleven	NUM
gsrj-41	102	36	studies	study	NOUN
gsrj-41	102	37	conducted	conduct	VERB
gsrj-41	102	38	before	before	ADP
gsrj-41	102	39	the	the	DET
gsrj-41	102	40	fda	fda	PROPN
gsrj-41	102	41	eua	eua	PROPN
gsrj-41	102	42	that	that	PRON
gsrj-41	102	43	included	include	VERB
gsrj-41	102	44	a	a	DET
gsrj-41	102	45	top	top	ADJ
gsrj-41	102	46	reason	reason	NOUN
gsrj-41	102	47	,	,	PUNCT
gsrj-41	102	48	seven	seven	NUM
gsrj-41	102	49	stated	state	VERB
gsrj-41	102	50	side	side	NOUN
gsrj-41	102	51	effects	effect	NOUN
gsrj-41	102	52	as	as	ADP
gsrj-41	102	53	their	their	PRON
gsrj-41	102	54	top	top	ADJ
gsrj-41	102	55	reason	reason	NOUN
gsrj-41	102	56	,	,	PUNCT
gsrj-41	102	57	three	three	NUM
gsrj-41	102	58	stated	stated	ADJ
gsrj-41	102	59	mistrust	mistrust	NOUN
gsrj-41	102	60	,	,	PUNCT
gsrj-41	102	61	three	three	NUM
gsrj-41	102	62	stated	state	VERB
gsrj-41	102	63	more	more	ADJ
gsrj-41	102	64	information	information	NOUN
gsrj-41	102	65	needed	need	VERB
gsrj-41	102	66	,	,	PUNCT
gsrj-41	102	67	and	and	CCONJ
gsrj-41	102	68	one	one	NUM
gsrj-41	102	69	stated	state	VERB
gsrj-41	102	70	no	no	DET
gsrj-41	102	71	reason	reason	NOUN
gsrj-41	102	72	for	for	ADP
gsrj-41	102	73	vaccine	vaccine	NOUN
gsrj-41	102	74	hesitancy	hesitancy	NOUN
gsrj-41	102	75	.	.	PUNCT
gsrj-41	103	1	out	out	ADP
gsrj-41	103	2	of	of	ADP
gsrj-41	103	3	the	the	DET
gsrj-41	103	4	nine	nine	NUM
gsrj-41	103	5	studies	study	NOUN
gsrj-41	103	6	conducted	conduct	VERB
gsrj-41	103	7	after	after	ADP
gsrj-41	103	8	the	the	DET
gsrj-41	103	9	eua	eua	PROPN
gsrj-41	103	10	that	that	PRON
gsrj-41	103	11	included	include	VERB
gsrj-41	103	12	top	top	ADJ
gsrj-41	103	13	reasons	reason	NOUN
gsrj-41	103	14	,	,	PUNCT
gsrj-41	103	15	eight	eight	NUM
gsrj-41	103	16	were	be	AUX
gsrj-41	103	17	side	side	ADJ
gsrj-41	103	18	effects	effect	NOUN
gsrj-41	103	19	and	and	CCONJ
gsrj-41	103	20	two	two	NUM
gsrj-41	103	21	were	be	AUX
gsrj-41	103	22	distrust	distrust	NOUN
gsrj-41	103	23	.	.	PUNCT
gsrj-41	104	1	out	out	ADP
gsrj-41	104	2	of	of	ADP
gsrj-41	104	3	the	the	DET
gsrj-41	104	4	three	three	NUM
gsrj-41	104	5	studies	study	NOUN
gsrj-41	104	6	conducted	conduct	VERB
gsrj-41	104	7	over	over	ADP
gsrj-41	104	8	the	the	DET
gsrj-41	104	9	span	span	NOUN
gsrj-41	104	10	or	or	CCONJ
gsrj-41	104	11	follow	follow	VERB
gsrj-41	104	12	-	-	PUNCT
gsrj-41	104	13	up	up	NOUN
gsrj-41	104	14	both	both	CCONJ
gsrj-41	104	15	before	before	ADV
gsrj-41	104	16	and	and	CCONJ
gsrj-41	104	17	after	after	ADV
gsrj-41	104	18	,	,	PUNCT
gsrj-41	104	19	one	one	NUM
gsrj-41	104	20	stated	state	VERB
gsrj-41	104	21	additional	additional	ADJ
gsrj-41	104	22	information	information	NOUN
gsrj-41	104	23	needed	need	VERB
gsrj-41	104	24	as	as	ADP
gsrj-41	104	25	the	the	DET
gsrj-41	104	26	top	top	ADJ
gsrj-41	104	27	reason	reason	NOUN
gsrj-41	104	28	for	for	ADP
gsrj-41	104	29	hesitancy	hesitancy	NOUN
gsrj-41	104	30	and	and	CCONJ
gsrj-41	104	31	two	two	NUM
gsrj-41	104	32	stated	state	VERB
gsrj-41	104	33	side	side	NOUN
gsrj-41	104	34	effects	effect	NOUN
gsrj-41	104	35	.	.	PUNCT
gsrj-41	105	1	both	both	DET
gsrj-41	105	2	follow	follow	VERB
gsrj-41	105	3	-	-	PUNCT
gsrj-41	105	4	up	up	ADP
gsrj-41	105	5	surveys	survey	NOUN
gsrj-41	105	6	found	find	VERB
gsrj-41	105	7	an	an	DET
gsrj-41	105	8	increase	increase	NOUN
gsrj-41	105	9	in	in	ADP
gsrj-41	105	10	vaccine	vaccine	NOUN
gsrj-41	105	11	willingness	willingness	NOUN
gsrj-41	105	12	over	over	ADP
gsrj-41	105	13	time	time	NOUN
gsrj-41	105	14	,	,	PUNCT
gsrj-41	105	15	as	as	SCONJ
gsrj-41	105	16	seen	see	VERB
gsrj-41	105	17	in	in	ADP
gsrj-41	105	18	the	the	DET
gsrj-41	105	19	general	general	ADJ
gsrj-41	105	20	trend	trend	NOUN
gsrj-41	105	21	in	in	ADP
gsrj-41	105	22	vaccine	vaccine	NOUN
gsrj-41	105	23	uptake	uptake	VERB
gsrj-41	105	24	across	across	ADP
gsrj-41	105	25	the	the	DET
gsrj-41	105	26	u.s.19	u.s.19	NOUN
gsrj-41	105	27	,	,	PUNCT
gsrj-41	105	28	41	41	NUM
gsrj-41	105	29	although	although	SCONJ
gsrj-41	105	30	general	general	ADJ
gsrj-41	105	31	vaccine	vaccine	NOUN
gsrj-41	105	32	willingness	willingness	NOUN
gsrj-41	105	33	increased	increase	VERB
gsrj-41	105	34	,	,	PUNCT
gsrj-41	105	35	the	the	DET
gsrj-41	105	36	fda	fda	PROPN
gsrj-41	105	37	eua	eua	PROPN
gsrj-41	105	38	did	do	AUX
gsrj-41	105	39	not	not	PART
gsrj-41	105	40	result	result	VERB
gsrj-41	105	41	in	in	ADP
gsrj-41	105	42	a	a	DET
gsrj-41	105	43	decrease	decrease	NOUN
gsrj-41	105	44	in	in	ADP
gsrj-41	105	45	concerns	concern	NOUN
gsrj-41	105	46	over	over	ADP
gsrj-41	105	47	side	side	NOUN
gsrj-41	105	48	effects	effect	NOUN
gsrj-41	105	49	among	among	ADP
gsrj-41	105	50	populations	population	NOUN
gsrj-41	105	51	studied	study	VERB
gsrj-41	105	52	in	in	ADP
gsrj-41	105	53	this	this	DET
gsrj-41	105	54	literature	literature	NOUN
gsrj-41	105	55	review	review	NOUN
gsrj-41	105	56	.	.	PUNCT
gsrj-41	106	1	a	a	DET
gsrj-41	106	2	large	large	ADJ
gsrj-41	106	3	number	number	NOUN
gsrj-41	106	4	of	of	ADP
gsrj-41	106	5	hesitant	hesitant	ADJ
gsrj-41	106	6	populations	population	NOUN
gsrj-41	106	7	were	be	AUX
gsrj-41	106	8	still	still	ADV
gsrj-41	106	9	concerned	concerned	ADJ
gsrj-41	106	10	about	about	ADP
gsrj-41	106	11	side	side	NOUN
gsrj-41	106	12	effects	effect	NOUN
gsrj-41	106	13	after	after	ADP
gsrj-41	106	14	the	the	DET
gsrj-41	106	15	official	official	ADJ
gsrj-41	106	16	fda	fda	PROPN
gsrj-41	106	17	eua	eua	PROPN
gsrj-41	106	18	with	with	ADP
gsrj-41	106	19	transparent	transparent	ADJ
gsrj-41	106	20	safety	safety	NOUN
gsrj-41	106	21	data	datum	NOUN
gsrj-41	106	22	and	and	CCONJ
gsrj-41	106	23	cdc	cdc	NOUN
gsrj-41	106	24	recommendations	recommendation	NOUN
gsrj-41	106	25	urging	urge	VERB
gsrj-41	106	26	adults	adult	NOUN
gsrj-41	106	27	to	to	PART
gsrj-41	106	28	get	get	VERB
gsrj-41	106	29	vaccinated	vaccinate	VERB
gsrj-41	106	30	.	.	PUNCT
gsrj-41	107	1	4	4	X
gsrj-41	107	2	.	.	X
gsrj-41	107	3	discussion	discussion	NOUN
gsrj-41	107	4	4.1	4.1	NUM
gsrj-41	107	5	general	general	ADJ
gsrj-41	107	6	trends	trend	NOUN
gsrj-41	107	7	in	in	ADP
gsrj-41	107	8	reasons	reason	NOUN
gsrj-41	107	9	for	for	ADP
gsrj-41	107	10	vaccine	vaccine	NOUN
gsrj-41	107	11	hesitancy	hesitancy	NOUN
gsrj-41	107	12	in	in	ADP
gsrj-41	107	13	the	the	DET
gsrj-41	107	14	us	us	PROPN
gsrj-41	107	15	it	it	PRON
gsrj-41	107	16	is	be	AUX
gsrj-41	107	17	imperative	imperative	ADJ
gsrj-41	107	18	that	that	SCONJ
gsrj-41	107	19	reasons	reason	NOUN
gsrj-41	107	20	for	for	ADP
gsrj-41	107	21	vaccine	vaccine	NOUN
gsrj-41	107	22	hesitancy	hesitancy	NOUN
gsrj-41	107	23	and	and	CCONJ
gsrj-41	107	24	vaccine	vaccine	NOUN
gsrj-41	107	25	refusal	refusal	NOUN
gsrj-41	107	26	in	in	ADP
gsrj-41	107	27	the	the	DET
gsrj-41	107	28	united	united	PROPN
gsrj-41	107	29	states	states	PROPN
gsrj-41	107	30	are	be	AUX
gsrj-41	107	31	addressed	address	VERB
gsrj-41	107	32	.	.	PUNCT
gsrj-41	108	1	there	there	PRON
gsrj-41	108	2	is	be	VERB
gsrj-41	108	3	still	still	ADV
gsrj-41	108	4	a	a	DET
gsrj-41	108	5	significant	significant	ADJ
gsrj-41	108	6	percentage	percentage	NOUN
gsrj-41	108	7	(	(	PUNCT
gsrj-41	108	8	35.5	35.5	NUM
gsrj-41	108	9	%	%	NOUN
gsrj-41	108	10	)	)	PUNCT
gsrj-41	108	11	of	of	ADP
gsrj-41	108	12	the	the	DET
gsrj-41	108	13	population	population	NOUN
gsrj-41	108	14	not	not	PART
gsrj-41	108	15	fully	fully	ADV
gsrj-41	108	16	vaccinated	vaccinate	VERB
gsrj-41	108	17	against	against	ADP
gsrj-41	108	18	covid-19	covid-19	PROPN
gsrj-41	108	19	as	as	ADP
gsrj-41	108	20	of	of	ADP
gsrj-41	108	21	february	february	PROPN
gsrj-41	108	22	15	15	NUM
gsrj-41	108	23	,	,	PUNCT
gsrj-41	108	24	2021.6	2021.6	NUM
gsrj-41	108	25	in	in	ADP
gsrj-41	108	26	addition	addition	NOUN
gsrj-41	108	27	,	,	PUNCT
gsrj-41	108	28	24	24	NUM
gsrj-41	108	29	%	%	NOUN
gsrj-41	108	30	of	of	ADP
gsrj-41	108	31	the	the	DET
gsrj-41	108	32	population	population	NOUN
gsrj-41	108	33	has	have	AUX
gsrj-41	108	34	not	not	PART
gsrj-41	108	35	received	receive	VERB
gsrj-41	108	36	one	one	NUM
gsrj-41	108	37	dose.6	dose.6	NOUN
gsrj-41	108	38	it	it	PRON
gsrj-41	108	39	is	be	AUX
gsrj-41	108	40	important	important	ADJ
gsrj-41	108	41	to	to	PART
gsrj-41	108	42	recognize	recognize	VERB
gsrj-41	108	43	that	that	SCONJ
gsrj-41	108	44	children	child	NOUN
gsrj-41	108	45	recently	recently	ADV
gsrj-41	108	46	became	become	VERB
gsrj-41	108	47	eligible	eligible	ADJ
gsrj-41	108	48	for	for	ADP
gsrj-41	108	49	covid-19	covid-19	PROPN
gsrj-41	108	50	vaccination	vaccination	NOUN
gsrj-41	108	51	,	,	PUNCT
gsrj-41	108	52	making	make	VERB
gsrj-41	108	53	up	up	ADP
gsrj-41	108	54	a	a	DET
gsrj-41	108	55	certain	certain	ADJ
gsrj-41	108	56	percentage	percentage	NOUN
gsrj-41	108	57	of	of	ADP
gsrj-41	108	58	the	the	DET
gsrj-41	108	59	unvaccinated	unvaccinated	ADJ
gsrj-41	108	60	population	population	NOUN
gsrj-41	108	61	(	(	PUNCT
gsrj-41	108	62	see	see	VERB
gsrj-41	108	63	figure	figure	NOUN
gsrj-41	108	64	1	1	NUM
gsrj-41	108	65	)	)	PUNCT
gsrj-41	108	66	.	.	PUNCT
gsrj-41	109	1	the	the	DET
gsrj-41	109	2	majority	majority	NOUN
gsrj-41	109	3	of	of	ADP
gsrj-41	109	4	unvaccinated	unvaccinate	VERB
gsrj-41	109	5	adults	adult	NOUN
gsrj-41	109	6	are	be	AUX
gsrj-41	109	7	those	those	PRON
gsrj-41	109	8	in	in	ADP
gsrj-41	109	9	the	the	DET
gsrj-41	109	10	middle	middle	ADJ
gsrj-41	109	11	-	-	PUNCT
gsrj-41	109	12	age	age	NOUN
gsrj-41	109	13	range	range	NOUN
gsrj-41	109	14	,	,	PUNCT
gsrj-41	109	15	from	from	ADP
gsrj-41	109	16	18	18	NUM
gsrj-41	109	17	-	-	SYM
gsrj-41	109	18	24	24	NUM
gsrj-41	109	19	years	year	NOUN
gsrj-41	109	20	old	old	ADJ
gsrj-41	109	21	and	and	CCONJ
gsrj-41	109	22	25	25	NUM
gsrj-41	109	23	-	-	SYM
gsrj-41	109	24	39	39	NUM
gsrj-41	109	25	years	year	NOUN
gsrj-41	109	26	old	old	ADJ
gsrj-41	109	27	(	(	PUNCT
gsrj-41	109	28	see	see	VERB
gsrj-41	109	29	figure	figure	NOUN
gsrj-41	109	30	3).8	3).8	NUM
gsrj-41	109	31	according	accord	VERB
gsrj-41	109	32	to	to	ADP
gsrj-41	109	33	the	the	DET
gsrj-41	109	34	literature	literature	NOUN
gsrj-41	109	35	review	review	NOUN
gsrj-41	109	36	on	on	ADP
gsrj-41	109	37	reasons	reason	NOUN
gsrj-41	109	38	for	for	ADP
gsrj-41	109	39	covid-19	covid-19	PROPN
gsrj-41	109	40	vaccine	vaccine	NOUN
gsrj-41	109	41	hesitancy	hesitancy	NOUN
gsrj-41	109	42	,	,	PUNCT
gsrj-41	109	43	the	the	DET
gsrj-41	109	44	most	most	ADV
gsrj-41	109	45	cited	cite	VERB
gsrj-41	109	46	reason	reason	NOUN
gsrj-41	109	47	in	in	ADP
gsrj-41	109	48	16	16	NUM
gsrj-41	109	49	out	out	ADP
gsrj-41	109	50	of	of	ADP
gsrj-41	109	51	27	27	NUM
gsrj-41	109	52	(	(	PUNCT
gsrj-41	109	53	57.14	57.14	NUM
gsrj-41	109	54	%	%	NOUN
gsrj-41	109	55	)	)	PUNCT
gsrj-41	109	56	articles	article	NOUN
gsrj-41	109	57	is	be	AUX
gsrj-41	109	58	“	"	PUNCT
gsrj-41	109	59	side	side	ADJ
gsrj-41	109	60	effects	effect	NOUN
gsrj-41	109	61	”	"	PUNCT
gsrj-41	109	62	and	and	CCONJ
gsrj-41	109	63	general	general	ADJ
gsrj-41	109	64	safety	safety	NOUN
gsrj-41	109	65	concerns	concern	NOUN
gsrj-41	109	66	(	(	PUNCT
gsrj-41	109	67	see	see	VERB
gsrj-41	109	68	table	table	NOUN
gsrj-41	109	69	3	3	NUM
gsrj-41	109	70	)	)	PUNCT
gsrj-41	109	71	.	.	PUNCT
gsrj-41	110	1	the	the	DET
gsrj-41	110	2	american	american	ADJ
gsrj-41	110	3	population	population	NOUN
gsrj-41	110	4	expressed	express	VERB
gsrj-41	110	5	concern	concern	NOUN
gsrj-41	110	6	about	about	ADP
gsrj-41	110	7	short	short	ADJ
gsrj-41	110	8	-	-	PUNCT
gsrj-41	110	9	term	term	NOUN
gsrj-41	110	10	side	side	NOUN
gsrj-41	110	11	effects	effect	NOUN
gsrj-41	110	12	,	,	PUNCT
gsrj-41	110	13	including	include	VERB
gsrj-41	110	14	flu	flu	NOUN
gsrj-41	110	15	-	-	PUNCT
gsrj-41	110	16	like	like	ADJ
gsrj-41	110	17	symptoms	symptom	NOUN
gsrj-41	110	18	such	such	ADJ
gsrj-41	110	19	as	as	ADP
gsrj-41	110	20	headache	headache	NOUN
gsrj-41	110	21	and	and	CCONJ
gsrj-41	110	22	fatigue	fatigue	NOUN
gsrj-41	110	23	,	,	PUNCT
gsrj-41	110	24	as	as	ADP
gsrj-41	110	25	a	a	DET
gsrj-41	110	26	reason	reason	NOUN
gsrj-41	110	27	for	for	ADP
gsrj-41	110	28	vaccine	vaccine	NOUN
gsrj-41	110	29	hesitancy.17	hesitancy.17	NOUN
gsrj-41	110	30	,	,	PUNCT
gsrj-41	110	31	18	18	NUM
gsrj-41	110	32	,	,	PUNCT
gsrj-41	110	33	30	30	NUM
gsrj-41	110	34	those	those	PRON
gsrj-41	110	35	who	who	PRON
gsrj-41	110	36	are	be	AUX
gsrj-41	110	37	hesitant	hesitant	ADJ
gsrj-41	110	38	because	because	SCONJ
gsrj-41	110	39	of	of	ADP
gsrj-41	110	40	side	side	NOUN
gsrj-41	110	41	effects	effect	NOUN
gsrj-41	110	42	also	also	ADV
gsrj-41	110	43	expressed	express	VERB
gsrj-41	110	44	concern	concern	NOUN
gsrj-41	110	45	about	about	ADP
gsrj-41	110	46	long	long	ADJ
gsrj-41	110	47	-	-	PUNCT
gsrj-41	110	48	term	term	NOUN
gsrj-41	110	49	impacts	impact	NOUN
gsrj-41	110	50	,	,	PUNCT
gsrj-41	110	51	which	which	PRON
gsrj-41	110	52	include	include	VERB
gsrj-41	110	53	side	side	ADJ
gsrj-41	110	54	effects	effect	NOUN
gsrj-41	110	55	that	that	PRON
gsrj-41	110	56	are	be	AUX
gsrj-41	110	57	“	"	PUNCT
gsrj-41	110	58	unknown	unknown	ADJ
gsrj-41	110	59	”	"	PUNCT
gsrj-41	110	60	and	and	CCONJ
gsrj-41	110	61	could	could	AUX
gsrj-41	110	62	be	be	AUX
gsrj-41	110	63	detrimental	detrimental	ADJ
gsrj-41	110	64	to	to	ADP
gsrj-41	110	65	personal	personal	ADJ
gsrj-41	110	66	health,36	health,36	NOUN
gsrj-41	110	67	,	,	PUNCT
gsrj-41	110	68	30	30	NUM
gsrj-41	110	69	,	,	PUNCT
gsrj-41	110	70	17	17	NUM
gsrj-41	110	71	as	as	ADV
gsrj-41	110	72	well	well	ADV
gsrj-41	110	73	as	as	ADP
gsrj-41	110	74	date	date	NOUN
gsrj-41	110	75	of	of	ADP
gsrj-41	110	76	study	study	NOUN
gsrj-41	110	77	number	number	NOUN
gsrj-41	110	78	of	of	ADP
gsrj-41	110	79	articles	article	NOUN
gsrj-41	110	80	n	n	PROPN
gsrj-41	110	81	(	(	PUNCT
gsrj-41	110	82	%	%	INTJ
gsrj-41	110	83	)	)	PUNCT
gsrj-41	110	84	references	reference	NOUN
gsrj-41	110	85	before	before	ADP
gsrj-41	110	86	14	14	NUM
gsrj-41	110	87	(	(	PUNCT
gsrj-41	110	88	51.8	51.8	NUM
gsrj-41	110	89	%	%	NOUN
gsrj-41	110	90	)	)	PUNCT
gsrj-41	110	91	15	15	NUM
gsrj-41	110	92	,	,	PUNCT
gsrj-41	110	93	16	16	NUM
gsrj-41	110	94	,	,	PUNCT
gsrj-41	110	95	18	18	NUM
gsrj-41	110	96	,	,	PUNCT
gsrj-41	110	97	21	21	NUM
gsrj-41	110	98	,	,	PUNCT
gsrj-41	110	99	24	24	NUM
gsrj-41	110	100	,	,	PUNCT
gsrj-41	110	101	27	27	NUM
gsrj-41	110	102	,	,	PUNCT
gsrj-41	110	103	29	29	NUM
gsrj-41	110	104	,	,	PUNCT
gsrj-41	110	105	30	30	NUM
gsrj-41	110	106	,	,	PUNCT
gsrj-41	110	107	31	31	NUM
gsrj-41	110	108	,	,	PUNCT
gsrj-41	110	109	32	32	NUM
gsrj-41	110	110	,	,	PUNCT
gsrj-41	110	111	33	33	NUM
gsrj-41	110	112	,	,	PUNCT
gsrj-41	110	113	35	35	NUM
gsrj-41	110	114	,	,	PUNCT
gsrj-41	110	115	37	37	NUM
gsrj-41	110	116	,	,	PUNCT
gsrj-41	110	117	38	38	NUM
gsrj-41	110	118	after	after	ADP
gsrj-41	110	119	10	10	NUM
gsrj-41	110	120	(	(	PUNCT
gsrj-41	110	121	37.0	37.0	NUM
gsrj-41	110	122	%	%	NOUN
gsrj-41	110	123	)	)	PUNCT
gsrj-41	110	124	17	17	NUM
gsrj-41	110	125	,	,	PUNCT
gsrj-41	110	126	20	20	NUM
gsrj-41	110	127	,	,	PUNCT
gsrj-41	110	128	22	22	NUM
gsrj-41	110	129	,	,	PUNCT
gsrj-41	110	130	23	23	NUM
gsrj-41	110	131	,	,	PUNCT
gsrj-41	110	132	25	25	NUM
gsrj-41	110	133	,	,	PUNCT
gsrj-41	110	134	28	28	NUM
gsrj-41	110	135	,	,	PUNCT
gsrj-41	110	136	34	34	NUM
gsrj-41	110	137	,	,	PUNCT
gsrj-41	110	138	36	36	NUM
gsrj-41	110	139	,	,	PUNCT
gsrj-41	110	140	39	39	NUM
gsrj-41	110	141	,	,	PUNCT
gsrj-41	110	142	40	40	NUM
gsrj-41	110	143	both	both	PRON
gsrj-41	110	144	*	*	SYM
gsrj-41	110	145	3	3	NUM
gsrj-41	110	146	(	(	PUNCT
gsrj-41	110	147	11.1	11.1	NUM
gsrj-41	110	148	%	%	NOUN
gsrj-41	110	149	)	)	PUNCT
gsrj-41	110	150	19	19	NUM
gsrj-41	110	151	,	,	PUNCT
gsrj-41	110	152	26	26	NUM
gsrj-41	110	153	,	,	PUNCT
gsrj-41	110	154	41	41	NUM
gsrj-41	110	155	17	17	NUM
gsrj-41	110	156	georgetown	georgetown	PROPN
gsrj-41	110	157	scientific	scientific	PROPN
gsrj-41	110	158	research	research	PROPN
gsrj-41	110	159	journal	journal	NOUN
gsrj-41	110	160	severe	severe	ADJ
gsrj-41	110	161	and	and	CCONJ
gsrj-41	110	162	adverse	adverse	ADJ
gsrj-41	110	163	allergic	allergic	ADJ
gsrj-41	110	164	reactions.22	reactions.22	NOUN
gsrj-41	110	165	,	,	PUNCT
gsrj-41	110	166	18	18	NUM
gsrj-41	110	167	fear	fear	NOUN
gsrj-41	110	168	of	of	ADP
gsrj-41	110	169	these	these	DET
gsrj-41	110	170	side	side	NOUN
gsrj-41	110	171	effects	effect	NOUN
gsrj-41	110	172	stem	stem	VERB
gsrj-41	110	173	from	from	ADP
gsrj-41	110	174	transparent	transparent	ADJ
gsrj-41	110	175	data	datum	NOUN
gsrj-41	110	176	on	on	ADP
gsrj-41	110	177	flu	flu	NOUN
gsrj-41	110	178	-	-	PUNCT
gsrj-41	110	179	like	like	ADJ
gsrj-41	110	180	symptoms	symptom	NOUN
gsrj-41	110	181	,	,	PUNCT
gsrj-41	110	182	rare	rare	ADJ
gsrj-41	110	183	allergic	allergic	ADJ
gsrj-41	110	184	reactions	reaction	NOUN
gsrj-41	110	185	,	,	PUNCT
gsrj-41	110	186	and	and	CCONJ
gsrj-41	110	187	rare	rare	ADJ
gsrj-41	110	188	thrombosis	thrombosis	NOUN
gsrj-41	110	189	cases	case	NOUN
gsrj-41	110	190	.	.	PUNCT
gsrj-41	111	1	however	however	ADV
gsrj-41	111	2	,	,	PUNCT
gsrj-41	111	3	fear	fear	NOUN
gsrj-41	111	4	of	of	ADP
gsrj-41	111	5	unknown	unknown	ADJ
gsrj-41	111	6	,	,	PUNCT
gsrj-41	111	7	adverse	adverse	ADJ
gsrj-41	111	8	,	,	PUNCT
gsrj-41	111	9	and	and	CCONJ
gsrj-41	111	10	long	long	ADJ
gsrj-41	111	11	-	-	PUNCT
gsrj-41	111	12	term	term	NOUN
gsrj-41	111	13	effects	effect	NOUN
gsrj-41	111	14	stems	stem	VERB
gsrj-41	111	15	from	from	ADP
gsrj-41	111	16	misinformation	misinformation	NOUN
gsrj-41	111	17	,	,	PUNCT
gsrj-41	111	18	mostly	mostly	ADV
gsrj-41	111	19	found	find	VERB
gsrj-41	111	20	on	on	ADP
gsrj-41	111	21	social	social	ADJ
gsrj-41	111	22	media	medium	NOUN
gsrj-41	111	23	and	and	CCONJ
gsrj-41	111	24	the	the	DET
gsrj-41	111	25	internet.34	internet.34	NOUN
gsrj-41	111	26	,	,	PUNCT
gsrj-41	111	27	41	41	NUM
gsrj-41	111	28	,	,	PUNCT
gsrj-41	111	29	26	26	NUM
gsrj-41	111	30	this	this	DET
gsrj-41	111	31	finding	finding	NOUN
gsrj-41	111	32	is	be	AUX
gsrj-41	111	33	slightly	slightly	ADV
gsrj-41	111	34	different	different	ADJ
gsrj-41	111	35	from	from	ADP
gsrj-41	111	36	the	the	DET
gsrj-41	111	37	original	original	ADJ
gsrj-41	111	38	hypothesis	hypothesis	NOUN
gsrj-41	111	39	that	that	PRON
gsrj-41	111	40	the	the	DET
gsrj-41	111	41	most	most	ADV
gsrj-41	111	42	common	common	ADJ
gsrj-41	111	43	reasons	reason	NOUN
gsrj-41	111	44	for	for	ADP
gsrj-41	111	45	covid-19	covid-19	PROPN
gsrj-41	111	46	vaccine	vaccine	NOUN
gsrj-41	111	47	hesitancy	hesitancy	NOUN
gsrj-41	111	48	in	in	ADP
gsrj-41	111	49	the	the	DET
gsrj-41	111	50	u.s	u.s	PROPN
gsrj-41	111	51	.	.	PROPN
gsrj-41	111	52	include	include	VERB
gsrj-41	111	53	distrust	distrust	NOUN
gsrj-41	111	54	,	,	PUNCT
gsrj-41	111	55	misinformation	misinformation	NOUN
gsrj-41	111	56	,	,	PUNCT
gsrj-41	111	57	and	and	CCONJ
gsrj-41	111	58	lack	lack	NOUN
gsrj-41	111	59	of	of	ADP
gsrj-41	111	60	access	access	NOUN
gsrj-41	111	61	.	.	PUNCT
gsrj-41	112	1	the	the	DET
gsrj-41	112	2	literature	literature	PROPN
gsrj-41	112	3	review	review	PROPN
gsrj-41	112	4	also	also	ADV
gsrj-41	112	5	shows	show	VERB
gsrj-41	112	6	that	that	SCONJ
gsrj-41	112	7	separating	separate	VERB
gsrj-41	112	8	the	the	DET
gsrj-41	112	9	hesitant	hesitant	ADJ
gsrj-41	112	10	from	from	ADP
gsrj-41	112	11	the	the	DET
gsrj-41	112	12	refusers	refuser	NOUN
gsrj-41	112	13	to	to	PART
gsrj-41	112	14	find	find	VERB
gsrj-41	112	15	the	the	DET
gsrj-41	112	16	reasons	reason	NOUN
gsrj-41	112	17	for	for	ADP
gsrj-41	112	18	not	not	PART
gsrj-41	112	19	being	be	AUX
gsrj-41	112	20	vaccinated	vaccinate	VERB
gsrj-41	112	21	is	be	AUX
gsrj-41	112	22	imperative	imperative	ADJ
gsrj-41	112	23	to	to	PART
gsrj-41	112	24	adequately	adequately	ADV
gsrj-41	112	25	address	address	VERB
gsrj-41	112	26	the	the	DET
gsrj-41	112	27	low	low	ADJ
gsrj-41	112	28	uptake	uptake	NOUN
gsrj-41	112	29	in	in	ADP
gsrj-41	112	30	vaccines	vaccine	NOUN
gsrj-41	112	31	in	in	ADP
gsrj-41	112	32	the	the	DET
gsrj-41	112	33	united	united	PROPN
gsrj-41	112	34	states	states	PROPN
gsrj-41	112	35	.	.	PUNCT
gsrj-41	113	1	refusers	refuser	NOUN
gsrj-41	113	2	are	be	AUX
gsrj-41	113	3	more	more	ADV
gsrj-41	113	4	likely	likely	ADJ
gsrj-41	113	5	to	to	PART
gsrj-41	113	6	express	express	VERB
gsrj-41	113	7	feelings	feeling	NOUN
gsrj-41	113	8	of	of	ADP
gsrj-41	113	9	distrust	distrust	NOUN
gsrj-41	113	10	and	and	CCONJ
gsrj-41	113	11	not	not	PART
gsrj-41	113	12	be	be	AUX
gsrj-41	113	13	vaccinated	vaccinate	VERB
gsrj-41	113	14	because	because	SCONJ
gsrj-41	113	15	of	of	ADP
gsrj-41	113	16	beliefs	belief	NOUN
gsrj-41	113	17	,	,	PUNCT
gsrj-41	113	18	while	while	SCONJ
gsrj-41	113	19	the	the	DET
gsrj-41	113	20	hesitant	hesitant	ADJ
gsrj-41	113	21	are	be	AUX
gsrj-41	113	22	more	more	ADV
gsrj-41	113	23	worried	worried	ADJ
gsrj-41	113	24	about	about	ADP
gsrj-41	113	25	personal	personal	ADJ
gsrj-41	113	26	safety	safety	NOUN
gsrj-41	113	27	and	and	CCONJ
gsrj-41	113	28	side	side	NOUN
gsrj-41	113	29	effects.20	effects.20	PROPN
gsrj-41	113	30	,	,	PUNCT
gsrj-41	113	31	15	15	NUM
gsrj-41	113	32	however	however	ADV
gsrj-41	113	33	,	,	PUNCT
gsrj-41	113	34	similarities	similarity	NOUN
gsrj-41	113	35	exist	exist	VERB
gsrj-41	113	36	between	between	ADP
gsrj-41	113	37	ideas	idea	NOUN
gsrj-41	113	38	of	of	ADP
gsrj-41	113	39	concern	concern	NOUN
gsrj-41	113	40	of	of	ADP
gsrj-41	113	41	safety	safety	NOUN
gsrj-41	113	42	and	and	CCONJ
gsrj-41	113	43	mistrust	mistrust	NOUN
gsrj-41	113	44	of	of	ADP
gsrj-41	113	45	the	the	DET
gsrj-41	113	46	vaccines	vaccine	NOUN
gsrj-41	113	47	.	.	PUNCT
gsrj-41	114	1	lasting	last	VERB
gsrj-41	114	2	concerns	concern	NOUN
gsrj-41	114	3	over	over	ADP
gsrj-41	114	4	vaccine	vaccine	NOUN
gsrj-41	114	5	safety	safety	NOUN
gsrj-41	114	6	and	and	CCONJ
gsrj-41	114	7	side	side	NOUN
gsrj-41	114	8	effects	effect	NOUN
gsrj-41	114	9	,	,	PUNCT
gsrj-41	114	10	even	even	ADV
gsrj-41	114	11	with	with	ADP
gsrj-41	114	12	transparent	transparent	ADJ
gsrj-41	114	13	data	datum	NOUN
gsrj-41	114	14	from	from	ADP
gsrj-41	114	15	official	official	ADJ
gsrj-41	114	16	institutions	institution	NOUN
gsrj-41	114	17	,	,	PUNCT
gsrj-41	114	18	suggest	suggest	VERB
gsrj-41	114	19	that	that	SCONJ
gsrj-41	114	20	there	there	PRON
gsrj-41	114	21	is	be	VERB
gsrj-41	114	22	distrust	distrust	NOUN
gsrj-41	114	23	among	among	ADP
gsrj-41	114	24	all	all	DET
gsrj-41	114	25	vaccine	vaccine	NOUN
gsrj-41	114	26	hesitant	hesitant	ADJ
gsrj-41	114	27	.	.	PUNCT
gsrj-41	115	1	most	most	ADJ
gsrj-41	115	2	distrust	distrust	NOUN
gsrj-41	115	3	in	in	ADP
gsrj-41	115	4	covid-19	covid-19	PROPN
gsrj-41	115	5	vaccines	vaccine	NOUN
gsrj-41	115	6	comes	come	VERB
gsrj-41	115	7	from	from	ADP
gsrj-41	115	8	pre	pre	ADJ
gsrj-41	115	9	-	-	ADJ
gsrj-41	115	10	existing	exist	VERB
gsrj-41	115	11	distrust	distrust	NOUN
gsrj-41	115	12	in	in	ADP
gsrj-41	115	13	healthcare	healthcare	PROPN
gsrj-41	115	14	,	,	PUNCT
gsrj-41	115	15	misinformation	misinformation	NOUN
gsrj-41	115	16	and	and	CCONJ
gsrj-41	115	17	conspiracy	conspiracy	NOUN
gsrj-41	115	18	theories	theory	NOUN
gsrj-41	115	19	on	on	ADP
gsrj-41	115	20	social	social	ADJ
gsrj-41	115	21	media	medium	NOUN
gsrj-41	115	22	,	,	PUNCT
gsrj-41	115	23	and	and	CCONJ
gsrj-41	115	24	beliefs	belief	NOUN
gsrj-41	115	25	from	from	ADP
gsrj-41	115	26	one	one	NUM
gsrj-41	115	27	’s	’s	PART
gsrj-41	115	28	social	social	ADJ
gsrj-41	115	29	network.23	network.23	NOUN
gsrj-41	115	30	,	,	PUNCT
gsrj-41	115	31	43	43	NUM
gsrj-41	115	32	4.2	4.2	NUM
gsrj-41	115	33	reasons	reason	NOUN
gsrj-41	115	34	for	for	ADP
gsrj-41	115	35	hesitancy	hesitancy	NOUN
gsrj-41	115	36	among	among	ADP
gsrj-41	115	37	black	black	ADJ
gsrj-41	115	38	populations	population	NOUN
gsrj-41	115	39	distrust	distrust	NOUN
gsrj-41	115	40	in	in	ADP
gsrj-41	115	41	covid-19	covid-19	PROPN
gsrj-41	115	42	vaccines	vaccine	NOUN
gsrj-41	115	43	spans	span	VERB
gsrj-41	115	44	all	all	DET
gsrj-41	115	45	racial	racial	ADJ
gsrj-41	115	46	/	/	SYM
gsrj-41	115	47	ethnic	ethnic	ADJ
gsrj-41	115	48	,	,	PUNCT
gsrj-41	115	49	hesitant	hesitant	ADJ
gsrj-41	115	50	groups	group	NOUN
gsrj-41	115	51	,	,	PUNCT
gsrj-41	115	52	but	but	CCONJ
gsrj-41	115	53	affects	affect	VERB
gsrj-41	115	54	black	black	ADJ
gsrj-41	115	55	populations	population	NOUN
gsrj-41	115	56	at	at	ADP
gsrj-41	115	57	a	a	DET
gsrj-41	115	58	disproportionate	disproportionate	ADJ
gsrj-41	115	59	rate.32	rate.32	ADJ
gsrj-41	115	60	reasons	reason	NOUN
gsrj-41	115	61	for	for	ADP
gsrj-41	115	62	covid-19	covid-19	PROPN
gsrj-41	115	63	vaccine	vaccine	NOUN
gsrj-41	115	64	hesitancy	hesitancy	NOUN
gsrj-41	115	65	among	among	ADP
gsrj-41	115	66	black	black	ADJ
gsrj-41	115	67	americans	americans	PROPN
gsrj-41	115	68	require	require	VERB
gsrj-41	115	69	recognition	recognition	NOUN
gsrj-41	115	70	of	of	ADP
gsrj-41	115	71	structural	structural	ADJ
gsrj-41	115	72	racism	racism	NOUN
gsrj-41	115	73	within	within	ADP
gsrj-41	115	74	the	the	DET
gsrj-41	115	75	medical	medical	ADJ
gsrj-41	115	76	and	and	CCONJ
gsrj-41	115	77	health	health	NOUN
gsrj-41	115	78	fields	field	NOUN
gsrj-41	115	79	.	.	PUNCT
gsrj-41	116	1	the	the	DET
gsrj-41	116	2	history	history	NOUN
gsrj-41	116	3	of	of	ADP
gsrj-41	116	4	racism	racism	NOUN
gsrj-41	116	5	in	in	ADP
gsrj-41	116	6	the	the	DET
gsrj-41	116	7	medical	medical	ADJ
gsrj-41	116	8	and	and	CCONJ
gsrj-41	116	9	health	health	NOUN
gsrj-41	116	10	fields	field	NOUN
gsrj-41	116	11	,	,	PUNCT
gsrj-41	116	12	as	as	ADV
gsrj-41	116	13	well	well	ADV
gsrj-41	116	14	as	as	ADP
gsrj-41	116	15	with	with	ADP
gsrj-41	116	16	many	many	ADJ
gsrj-41	116	17	institutions	institution	NOUN
gsrj-41	116	18	in	in	ADP
gsrj-41	116	19	this	this	DET
gsrj-41	116	20	country	country	NOUN
gsrj-41	116	21	,	,	PUNCT
gsrj-41	116	22	can	can	AUX
gsrj-41	116	23	be	be	AUX
gsrj-41	116	24	a	a	DET
gsrj-41	116	25	cause	cause	NOUN
gsrj-41	116	26	for	for	ADP
gsrj-41	116	27	distrust	distrust	NOUN
gsrj-41	116	28	in	in	ADP
gsrj-41	116	29	medicine.44	medicine.44	PROPN
gsrj-41	116	30	,	,	PUNCT
gsrj-41	116	31	31	31	NUM
gsrj-41	116	32	“	"	PUNCT
gsrj-41	116	33	medical	medical	ADJ
gsrj-41	116	34	mistrust	mistrust	NOUN
gsrj-41	116	35	”	"	PUNCT
gsrj-41	116	36	is	be	AUX
gsrj-41	116	37	“	"	PUNCT
gsrj-41	116	38	an	an	DET
gsrj-41	116	39	understandable	understandable	ADJ
gsrj-41	116	40	,	,	PUNCT
gsrj-41	116	41	rational	rational	ADJ
gsrj-41	116	42	,	,	PUNCT
gsrj-41	116	43	selfprotective	selfprotective	ADJ
gsrj-41	116	44	response	response	NOUN
gsrj-41	116	45	to	to	ADP
gsrj-41	116	46	historical	historical	ADJ
gsrj-41	116	47	and	and	CCONJ
gsrj-41	116	48	ongoing	ongoing	ADJ
gsrj-41	116	49	structural	structural	ADJ
gsrj-41	116	50	and	and	CCONJ
gsrj-41	116	51	interpersonal	interpersonal	ADJ
gsrj-41	116	52	discrimination	discrimination	NOUN
gsrj-41	116	53	and	and	CCONJ
gsrj-41	116	54	racism	racism	NOUN
gsrj-41	116	55	in	in	ADP
gsrj-41	116	56	healthcare	healthcare	NOUN
gsrj-41	116	57	,	,	PUNCT
gsrj-41	116	58	and	and	CCONJ
gsrj-41	116	59	lack	lack	NOUN
gsrj-41	116	60	of	of	ADP
gsrj-41	116	61	trustworthiness	trustworthiness	NOUN
gsrj-41	116	62	of	of	ADP
gsrj-41	116	63	healthcare	healthcare	NOUN
gsrj-41	116	64	system	system	NOUN
gsrj-41	116	65	and	and	CCONJ
gsrj-41	116	66	institutions	institution	NOUN
gsrj-41	116	67	in	in	ADP
gsrj-41	116	68	u.s	u.s	PROPN
gsrj-41	116	69	.	.	PROPN
gsrj-41	116	70	society”.31	society”.31	PUNCT
gsrj-41	116	71	medical	medical	ADJ
gsrj-41	116	72	mistrust	mistrust	NOUN
gsrj-41	116	73	may	may	AUX
gsrj-41	116	74	lead	lead	VERB
gsrj-41	116	75	to	to	ADP
gsrj-41	116	76	a	a	DET
gsrj-41	116	77	decreased	decrease	VERB
gsrj-41	116	78	use	use	NOUN
gsrj-41	116	79	of	of	ADP
gsrj-41	116	80	healthcare	healthcare	NOUN
gsrj-41	116	81	among	among	ADP
gsrj-41	116	82	black	black	ADJ
gsrj-41	116	83	americans	americans	PROPN
gsrj-41	116	84	,	,	PUNCT
gsrj-41	116	85	which	which	PRON
gsrj-41	116	86	includes	include	VERB
gsrj-41	116	87	vaccinations	vaccination	NOUN
gsrj-41	116	88	,	,	PUNCT
gsrj-41	116	89	and	and	CCONJ
gsrj-41	116	90	decreased	decrease	VERB
gsrj-41	116	91	confidence	confidence	NOUN
gsrj-41	116	92	in	in	ADP
gsrj-41	116	93	the	the	DET
gsrj-41	116	94	safety	safety	NOUN
gsrj-41	116	95	and	and	CCONJ
gsrj-41	116	96	efficacy	efficacy	NOUN
gsrj-41	116	97	of	of	ADP
gsrj-41	116	98	the	the	DET
gsrj-41	116	99	covid-19	covid-19	PROPN
gsrj-41	116	100	vaccines.31	vaccines.31	ADJ
gsrj-41	116	101	distrust	distrust	NOUN
gsrj-41	116	102	in	in	ADP
gsrj-41	116	103	covid19	covid19	NOUN
gsrj-41	116	104	vaccines	vaccine	NOUN
gsrj-41	116	105	also	also	ADV
gsrj-41	116	106	includes	include	VERB
gsrj-41	116	107	lack	lack	NOUN
gsrj-41	116	108	of	of	ADP
gsrj-41	116	109	trust	trust	NOUN
gsrj-41	116	110	in	in	ADP
gsrj-41	116	111	the	the	DET
gsrj-41	116	112	government	government	NOUN
gsrj-41	116	113	and	and	CCONJ
gsrj-41	116	114	other	other	ADJ
gsrj-41	116	115	institutions	institution	NOUN
gsrj-41	116	116	.	.	PUNCT
gsrj-41	117	1	bogart	bogart	PROPN
gsrj-41	117	2	et	et	PROPN
gsrj-41	117	3	al	al	PROPN
gsrj-41	117	4	.	.	PROPN
gsrj-41	118	1	(	(	PUNCT
gsrj-41	118	2	2021	2021	NUM
gsrj-41	118	3	)	)	PUNCT
gsrj-41	118	4	found	find	VERB
gsrj-41	118	5	that	that	SCONJ
gsrj-41	118	6	there	there	PRON
gsrj-41	118	7	was	be	VERB
gsrj-41	118	8	a	a	DET
gsrj-41	118	9	significantly	significantly	ADV
gsrj-41	118	10	high	high	ADJ
gsrj-41	118	11	percentage	percentage	NOUN
gsrj-41	118	12	of	of	ADP
gsrj-41	118	13	black	black	ADJ
gsrj-41	118	14	americans	americans	PROPN
gsrj-41	118	15	who	who	PRON
gsrj-41	118	16	were	be	AUX
gsrj-41	118	17	“	"	PUNCT
gsrj-41	118	18	unsure	unsure	ADJ
gsrj-41	118	19	”	"	PUNCT
gsrj-41	118	20	about	about	ADP
gsrj-41	118	21	the	the	DET
gsrj-41	118	22	covid-19	covid-19	PROPN
gsrj-41	118	23	vaccines	vaccine	NOUN
gsrj-41	118	24	,	,	PUNCT
gsrj-41	118	25	rather	rather	ADV
gsrj-41	118	26	than	than	ADP
gsrj-41	118	27	absolute	absolute	ADJ
gsrj-41	118	28	refusers	refuser	NOUN
gsrj-41	118	29	.	.	PUNCT
gsrj-41	119	1	this	this	PRON
gsrj-41	119	2	means	mean	VERB
gsrj-41	119	3	that	that	SCONJ
gsrj-41	119	4	interventions	intervention	NOUN
gsrj-41	119	5	focused	focus	VERB
gsrj-41	119	6	on	on	ADP
gsrj-41	119	7	minority	minority	NOUN
gsrj-41	119	8	,	,	PUNCT
gsrj-41	119	9	specifically	specifically	ADV
gsrj-41	119	10	black	black	ADJ
gsrj-41	119	11	,	,	PUNCT
gsrj-41	119	12	populations	population	NOUN
gsrj-41	119	13	in	in	ADP
gsrj-41	119	14	the	the	DET
gsrj-41	119	15	u.s	u.s	PROPN
gsrj-41	119	16	.	.	PROPN
gsrj-41	119	17	must	must	AUX
gsrj-41	119	18	work	work	VERB
gsrj-41	119	19	on	on	ADP
gsrj-41	119	20	building	build	VERB
gsrj-41	119	21	trust	trust	NOUN
gsrj-41	119	22	through	through	ADP
gsrj-41	119	23	authentic	authentic	ADJ
gsrj-41	119	24	representation	representation	NOUN
gsrj-41	119	25	and	and	CCONJ
gsrj-41	119	26	community	community	NOUN
gsrj-41	119	27	investment	investment	NOUN
gsrj-41	119	28	(	(	PUNCT
gsrj-41	119	29	see	see	VERB
gsrj-41	119	30	recommendations	recommendation	NOUN
gsrj-41	119	31	section	section	NOUN
gsrj-41	119	32	below	below	ADP
gsrj-41	119	33	)	)	PUNCT
gsrj-41	119	34	.	.	PUNCT
gsrj-41	120	1	4.3	4.3	NUM
gsrj-41	120	2	recommendations	recommendation	NOUN
gsrj-41	120	3	this	this	DET
gsrj-41	120	4	literature	literature	NOUN
gsrj-41	120	5	review	review	NOUN
gsrj-41	120	6	found	find	VERB
gsrj-41	120	7	that	that	SCONJ
gsrj-41	120	8	concerns	concern	NOUN
gsrj-41	120	9	around	around	ADP
gsrj-41	120	10	side	side	NOUN
gsrj-41	120	11	effects	effect	NOUN
gsrj-41	120	12	and	and	CCONJ
gsrj-41	120	13	general	general	ADJ
gsrj-41	120	14	safety	safety	NOUN
gsrj-41	120	15	,	,	PUNCT
gsrj-41	120	16	as	as	ADV
gsrj-41	120	17	well	well	ADV
gsrj-41	120	18	as	as	ADP
gsrj-41	120	19	distrust	distrust	NOUN
gsrj-41	120	20	in	in	ADP
gsrj-41	120	21	the	the	DET
gsrj-41	120	22	vaccines	vaccine	NOUN
gsrj-41	120	23	,	,	PUNCT
gsrj-41	120	24	are	be	AUX
gsrj-41	120	25	the	the	DET
gsrj-41	120	26	top	top	ADJ
gsrj-41	120	27	reasons	reason	NOUN
gsrj-41	120	28	for	for	ADP
gsrj-41	120	29	vaccine	vaccine	NOUN
gsrj-41	120	30	hesitancy	hesitancy	NOUN
gsrj-41	120	31	in	in	ADP
gsrj-41	120	32	the	the	DET
gsrj-41	120	33	u.s	u.s	PROPN
gsrj-41	120	34	.	.	PROPN
gsrj-41	120	35	interventions	intervention	NOUN
gsrj-41	120	36	and	and	CCONJ
gsrj-41	120	37	communications	communication	NOUN
gsrj-41	120	38	addressing	address	VERB
gsrj-41	120	39	the	the	DET
gsrj-41	120	40	vaccine	vaccine	NOUN
gsrj-41	120	41	hesitant	hesitant	ADJ
gsrj-41	120	42	and	and	CCONJ
gsrj-41	120	43	refusers	refuser	NOUN
gsrj-41	120	44	must	must	AUX
gsrj-41	120	45	focus	focus	VERB
gsrj-41	120	46	on	on	ADP
gsrj-41	120	47	increasing	increase	VERB
gsrj-41	120	48	trust	trust	NOUN
gsrj-41	120	49	and	and	CCONJ
gsrj-41	120	50	providing	provide	VERB
gsrj-41	120	51	evidence	evidence	NOUN
gsrj-41	120	52	.	.	PUNCT
gsrj-41	121	1	five	five	NUM
gsrj-41	121	2	recommendations	recommendation	NOUN
gsrj-41	121	3	are	be	AUX
gsrj-41	121	4	listed	list	VERB
gsrj-41	121	5	below	below	ADV
gsrj-41	121	6	to	to	PART
gsrj-41	121	7	increase	increase	VERB
gsrj-41	121	8	covid-19	covid-19	PROPN
gsrj-41	121	9	vaccine	vaccine	NOUN
gsrj-41	121	10	uptake	uptake	ADJ
gsrj-41	121	11	in	in	ADP
gsrj-41	121	12	the	the	DET
gsrj-41	121	13	u.s	u.s	PROPN
gsrj-41	121	14	.	.	PROPN
gsrj-41	121	15	communications	communication	NOUN
gsrj-41	121	16	addressing	address	VERB
gsrj-41	121	17	side	side	NOUN
gsrj-41	121	18	effects	effect	NOUN
gsrj-41	121	19	:	:	PUNCT
gsrj-41	121	20	the	the	DET
gsrj-41	121	21	most	most	ADV
gsrj-41	121	22	cited	cite	VERB
gsrj-41	121	23	reason	reason	NOUN
gsrj-41	121	24	for	for	ADP
gsrj-41	121	25	covid-19	covid-19	PROPN
gsrj-41	121	26	vaccine	vaccine	NOUN
gsrj-41	121	27	hesitancy	hesitancy	NOUN
gsrj-41	121	28	in	in	ADP
gsrj-41	121	29	the	the	DET
gsrj-41	121	30	us	us	PROPN
gsrj-41	121	31	is	be	AUX
gsrj-41	121	32	side	side	ADJ
gsrj-41	121	33	effects	effect	NOUN
gsrj-41	121	34	and	and	CCONJ
gsrj-41	121	35	wanting	want	VERB
gsrj-41	121	36	to	to	PART
gsrj-41	121	37	wait	wait	VERB
gsrj-41	121	38	and	and	CCONJ
gsrj-41	121	39	see	see	VERB
gsrj-41	121	40	if	if	SCONJ
gsrj-41	121	41	the	the	DET
gsrj-41	121	42	vaccine	vaccine	NOUN
gsrj-41	121	43	really	really	ADV
gsrj-41	121	44	is	be	AUX
gsrj-41	121	45	safe	safe	ADJ
gsrj-41	121	46	.	.	PUNCT
gsrj-41	122	1	in	in	ADP
gsrj-41	122	2	order	order	NOUN
gsrj-41	122	3	to	to	PART
gsrj-41	122	4	address	address	VERB
gsrj-41	122	5	this	this	PRON
gsrj-41	122	6	,	,	PUNCT
gsrj-41	122	7	communications	communication	NOUN
gsrj-41	122	8	from	from	ADP
gsrj-41	122	9	local	local	ADJ
gsrj-41	122	10	health	health	NOUN
gsrj-41	122	11	providers	provider	NOUN
gsrj-41	122	12	,	,	PUNCT
gsrj-41	122	13	institutions	institution	NOUN
gsrj-41	122	14	,	,	PUNCT
gsrj-41	122	15	and	and	CCONJ
gsrj-41	122	16	community	community	NOUN
gsrj-41	122	17	organizers	organizer	NOUN
gsrj-41	122	18	must	must	AUX
gsrj-41	122	19	focus	focus	VERB
gsrj-41	122	20	on	on	ADP
gsrj-41	122	21	the	the	DET
gsrj-41	122	22	fact	fact	NOUN
gsrj-41	122	23	that	that	SCONJ
gsrj-41	122	24	vaccines	vaccine	NOUN
gsrj-41	122	25	work	work	VERB
gsrj-41	122	26	quickly	quickly	ADV
gsrj-41	122	27	,	,	PUNCT
gsrj-41	122	28	do	do	AUX
gsrj-41	122	29	not	not	PART
gsrj-41	122	30	alter	alter	VERB
gsrj-41	122	31	dna	dna	PROPN
gsrj-41	122	32	,	,	PUNCT
gsrj-41	122	33	and	and	CCONJ
gsrj-41	122	34	give	give	VERB
gsrj-41	122	35	instructions	instruction	NOUN
gsrj-41	122	36	to	to	ADP
gsrj-41	122	37	our	our	PRON
gsrj-41	122	38	cells	cell	NOUN
gsrj-41	122	39	to	to	PART
gsrj-41	122	40	make	make	VERB
gsrj-41	122	41	a	a	DET
gsrj-41	122	42	protein	protein	NOUN
gsrj-41	122	43	that	that	PRON
gsrj-41	122	44	our	our	PRON
gsrj-41	122	45	immune	immune	ADJ
gsrj-41	122	46	cells	cell	NOUN
gsrj-41	122	47	work	work	VERB
gsrj-41	122	48	to	to	PART
gsrj-41	122	49	fight	fight	VERB
gsrj-41	122	50	off	off	ADP
gsrj-41	122	51	providing	provide	VERB
gsrj-41	122	52	future	future	ADJ
gsrj-41	122	53	protection.45	protection.45	ADJ
gsrj-41	122	54	serious	serious	ADJ
gsrj-41	122	55	side	side	NOUN
gsrj-41	122	56	effects	effect	NOUN
gsrj-41	122	57	(	(	PUNCT
gsrj-41	122	58	allergic	allergic	ADJ
gsrj-41	122	59	reactions	reaction	NOUN
gsrj-41	122	60	and	and	CCONJ
gsrj-41	122	61	myocarditis	myocarditis	NOUN
gsrj-41	122	62	)	)	PUNCT
gsrj-41	122	63	from	from	ADP
gsrj-41	122	64	the	the	DET
gsrj-41	122	65	vaccine	vaccine	NOUN
gsrj-41	122	66	are	be	AUX
gsrj-41	122	67	highly	highly	ADV
gsrj-41	122	68	unlikely	unlikely	ADJ
gsrj-41	122	69	,	,	PUNCT
gsrj-41	122	70	and	and	CCONJ
gsrj-41	122	71	those	those	PRON
gsrj-41	122	72	that	that	PRON
gsrj-41	122	73	do	do	VERB
gsrj-41	122	74	18	18	NUM
gsrj-41	122	75	georgetown	georgetown	PROPN
gsrj-41	122	76	scientific	scientific	PROPN
gsrj-41	122	77	research	research	NOUN
gsrj-41	122	78	journal	journal	NOUN
gsrj-41	122	79	occur	occur	VERB
gsrj-41	122	80	happen	happen	VERB
gsrj-41	122	81	within	within	ADP
gsrj-41	122	82	two	two	NUM
gsrj-41	122	83	weeks	week	NOUN
gsrj-41	122	84	of	of	ADP
gsrj-41	122	85	vaccination	vaccination	NOUN
gsrj-41	122	86	.	.	PUNCT
gsrj-41	123	1	most	most	ADJ
gsrj-41	123	2	side	side	ADJ
gsrj-41	123	3	effects	effect	NOUN
gsrj-41	123	4	are	be	AUX
gsrj-41	123	5	flu	flu	NOUN
gsrj-41	123	6	-	-	PUNCT
gsrj-41	123	7	like	like	ADJ
gsrj-41	123	8	symptoms	symptom	NOUN
gsrj-41	123	9	and	and	CCONJ
gsrj-41	123	10	arm	arm	NOUN
gsrj-41	123	11	pain	pain	NOUN
gsrj-41	123	12	for	for	ADP
gsrj-41	123	13	about	about	ADV
gsrj-41	123	14	24	24	NUM
gsrj-41	123	15	hours	hour	NOUN
gsrj-41	123	16	.	.	PUNCT
gsrj-41	124	1	there	there	PRON
gsrj-41	124	2	is	be	VERB
gsrj-41	124	3	a	a	DET
gsrj-41	124	4	risk	risk	NOUN
gsrj-41	124	5	of	of	ADP
gsrj-41	124	6	severe	severe	ADJ
gsrj-41	124	7	allergic	allergic	ADJ
gsrj-41	124	8	reaction	reaction	NOUN
gsrj-41	124	9	that	that	PRON
gsrj-41	124	10	can	can	AUX
gsrj-41	124	11	be	be	AUX
gsrj-41	124	12	mitigated	mitigate	VERB
gsrj-41	124	13	if	if	SCONJ
gsrj-41	124	14	caught	catch	VERB
gsrj-41	124	15	quickly.46	quickly.46	ADJ
gsrj-41	124	16	communication	communication	NOUN
gsrj-41	124	17	must	must	AUX
gsrj-41	124	18	also	also	ADV
gsrj-41	124	19	highlight	highlight	VERB
gsrj-41	124	20	the	the	DET
gsrj-41	124	21	fact	fact	NOUN
gsrj-41	124	22	that	that	SCONJ
gsrj-41	124	23	there	there	PRON
gsrj-41	124	24	is	be	VERB
gsrj-41	124	25	a	a	DET
gsrj-41	124	26	higher	high	ADJ
gsrj-41	124	27	risk	risk	NOUN
gsrj-41	124	28	of	of	ADP
gsrj-41	124	29	long	long	ADJ
gsrj-41	124	30	-	-	PUNCT
gsrj-41	124	31	term	term	NOUN
gsrj-41	124	32	effects	effect	NOUN
gsrj-41	124	33	from	from	ADP
gsrj-41	124	34	infection	infection	NOUN
gsrj-41	124	35	with	with	ADP
gsrj-41	124	36	covid-19	covid-19	PROPN
gsrj-41	124	37	than	than	ADP
gsrj-41	124	38	from	from	ADP
gsrj-41	124	39	the	the	DET
gsrj-41	124	40	vaccine	vaccine	NOUN
gsrj-41	124	41	itself	itself	PRON
gsrj-41	124	42	.	.	PUNCT
gsrj-41	125	1	these	these	PRON
gsrj-41	125	2	include	include	VERB
gsrj-41	125	3	difficulty	difficulty	NOUN
gsrj-41	125	4	breathing	breathing	NOUN
gsrj-41	125	5	or	or	CCONJ
gsrj-41	125	6	shortness	shortness	NOUN
gsrj-41	125	7	of	of	ADP
gsrj-41	125	8	breath	breath	NOUN
gsrj-41	125	9	,	,	PUNCT
gsrj-41	125	10	tiredness	tiredness	NOUN
gsrj-41	125	11	or	or	CCONJ
gsrj-41	125	12	fatigue	fatigue	NOUN
gsrj-41	125	13	,	,	PUNCT
gsrj-41	125	14	difficulty	difficulty	NOUN
gsrj-41	125	15	thinking	think	VERB
gsrj-41	125	16	or	or	CCONJ
gsrj-41	125	17	concentrating	concentrate	VERB
gsrj-41	125	18	,	,	PUNCT
gsrj-41	125	19	cough	cough	NOUN
gsrj-41	125	20	,	,	PUNCT
gsrj-41	125	21	chest	chest	NOUN
gsrj-41	125	22	or	or	CCONJ
gsrj-41	125	23	stomach	stomach	NOUN
gsrj-41	125	24	pain	pain	NOUN
gsrj-41	125	25	,	,	PUNCT
gsrj-41	125	26	and	and	CCONJ
gsrj-41	125	27	myocarditis	myocarditis	PROPN
gsrj-41	125	28	,	,	PUNCT
gsrj-41	125	29	among	among	ADP
gsrj-41	125	30	many	many	ADJ
gsrj-41	125	31	others.47	others.47	NOUN
gsrj-41	125	32	,	,	PUNCT
gsrj-41	125	33	48	48	NUM
gsrj-41	125	34	communications	communication	NOUN
gsrj-41	125	35	must	must	AUX
gsrj-41	125	36	frame	frame	VERB
gsrj-41	125	37	covid-19	covid-19	PROPN
gsrj-41	125	38	vaccination	vaccination	NOUN
gsrj-41	125	39	as	as	ADP
gsrj-41	125	40	the	the	DET
gsrj-41	125	41	main	main	ADJ
gsrj-41	125	42	way	way	NOUN
gsrj-41	125	43	to	to	PART
gsrj-41	125	44	reduce	reduce	VERB
gsrj-41	125	45	the	the	DET
gsrj-41	125	46	risk	risk	NOUN
gsrj-41	125	47	of	of	ADP
gsrj-41	125	48	covid-19	covid-19	PROPN
gsrj-41	125	49	and	and	CCONJ
gsrj-41	125	50	a	a	DET
gsrj-41	125	51	way	way	NOUN
gsrj-41	125	52	to	to	PART
gsrj-41	125	53	increase	increase	VERB
gsrj-41	125	54	self	self	NOUN
gsrj-41	125	55	-	-	PUNCT
gsrj-41	125	56	efficacy	efficacy	NOUN
gsrj-41	125	57	and	and	CCONJ
gsrj-41	125	58	protect	protect	VERB
gsrj-41	125	59	one	one	NUM
gsrj-41	125	60	’s	’s	PART
gsrj-41	125	61	health	health	NOUN
gsrj-41	125	62	,	,	PUNCT
gsrj-41	125	63	as	as	ADV
gsrj-41	125	64	well	well	ADV
gsrj-41	125	65	as	as	ADP
gsrj-41	125	66	the	the	DET
gsrj-41	125	67	health	health	NOUN
gsrj-41	125	68	of	of	ADP
gsrj-41	125	69	the	the	DET
gsrj-41	125	70	community.49	community.49	NOUN
gsrj-41	125	71	in	in	ADP
gsrj-41	125	72	addition	addition	NOUN
gsrj-41	125	73	,	,	PUNCT
gsrj-41	125	74	employers	employer	NOUN
gsrj-41	125	75	must	must	AUX
gsrj-41	125	76	provide	provide	VERB
gsrj-41	125	77	paid	pay	VERB
gsrj-41	125	78	time	time	NOUN
gsrj-41	125	79	-	-	PUNCT
gsrj-41	125	80	off	off	NOUN
gsrj-41	125	81	after	after	ADP
gsrj-41	125	82	vaccination	vaccination	NOUN
gsrj-41	125	83	for	for	ADP
gsrj-41	125	84	known	know	VERB
gsrj-41	125	85	side	side	NOUN
gsrj-41	125	86	effects	effect	NOUN
gsrj-41	125	87	,	,	PUNCT
gsrj-41	125	88	such	such	ADJ
gsrj-41	125	89	as	as	ADP
gsrj-41	125	90	headache	headache	NOUN
gsrj-41	125	91	and	and	CCONJ
gsrj-41	125	92	fatigue.17	fatigue.17	PROPN
gsrj-41	125	93	1	1	NUM
gsrj-41	125	94	.	.	PUNCT
gsrj-41	125	95	interventions	intervention	NOUN
gsrj-41	125	96	addressing	address	VERB
gsrj-41	125	97	misinformation	misinformation	NOUN
gsrj-41	125	98	:	:	PUNCT
gsrj-41	125	99	distrust	distrust	NOUN
gsrj-41	125	100	stems	stem	VERB
gsrj-41	125	101	from	from	ADP
gsrj-41	125	102	either	either	CCONJ
gsrj-41	125	103	medical	medical	ADJ
gsrj-41	125	104	mistrust	mistrust	NOUN
gsrj-41	125	105	or	or	CCONJ
gsrj-41	125	106	misinformation	misinformation	NOUN
gsrj-41	125	107	and	and	CCONJ
gsrj-41	125	108	anti	anti	ADJ
gsrj-41	125	109	-	-	ADJ
gsrj-41	125	110	vaccination	vaccination	ADJ
gsrj-41	125	111	propaganda.31	propaganda.31	NOUN
gsrj-41	125	112	,	,	PUNCT
gsrj-41	125	113	49	49	NUM
gsrj-41	125	114	misinformation	misinformation	NOUN
gsrj-41	125	115	on	on	ADP
gsrj-41	125	116	the	the	DET
gsrj-41	125	117	internet	internet	NOUN
gsrj-41	125	118	and	and	CCONJ
gsrj-41	125	119	social	social	ADJ
gsrj-41	125	120	media	medium	NOUN
gsrj-41	125	121	has	have	AUX
gsrj-41	125	122	become	become	VERB
gsrj-41	125	123	a	a	DET
gsrj-41	125	124	significant	significant	ADJ
gsrj-41	125	125	issue	issue	NOUN
gsrj-41	125	126	during	during	ADP
gsrj-41	125	127	the	the	DET
gsrj-41	125	128	covid-19	covid-19	PROPN
gsrj-41	125	129	pandemic	pandemic	NOUN
gsrj-41	125	130	,	,	PUNCT
gsrj-41	125	131	as	as	SCONJ
gsrj-41	125	132	it	it	PRON
gsrj-41	125	133	preys	prey	VERB
gsrj-41	125	134	on	on	ADP
gsrj-41	125	135	negative	negative	ADJ
gsrj-41	125	136	emotion	emotion	NOUN
gsrj-41	125	137	and	and	CCONJ
gsrj-41	125	138	fear	fear	NOUN
gsrj-41	125	139	.	.	PUNCT
gsrj-41	126	1	institutions	institution	NOUN
gsrj-41	126	2	,	,	PUNCT
gsrj-41	126	3	such	such	ADJ
gsrj-41	126	4	as	as	ADP
gsrj-41	126	5	schools	school	NOUN
gsrj-41	126	6	,	,	PUNCT
gsrj-41	126	7	must	must	AUX
gsrj-41	126	8	provide	provide	VERB
gsrj-41	126	9	citizens	citizen	NOUN
gsrj-41	126	10	with	with	ADP
gsrj-41	126	11	help	help	NOUN
gsrj-41	126	12	in	in	ADP
gsrj-41	126	13	identifying	identify	VERB
gsrj-41	126	14	misinformation	misinformation	NOUN
gsrj-41	126	15	and	and	CCONJ
gsrj-41	126	16	how	how	SCONJ
gsrj-41	126	17	they	they	PRON
gsrj-41	126	18	can	can	AUX
gsrj-41	126	19	have	have	VERB
gsrj-41	126	20	the	the	DET
gsrj-41	126	21	self	self	NOUN
gsrj-41	126	22	-	-	PUNCT
gsrj-41	126	23	efficacy	efficacy	NOUN
gsrj-41	126	24	to	to	PART
gsrj-41	126	25	make	make	VERB
gsrj-41	126	26	the	the	DET
gsrj-41	126	27	decision	decision	NOUN
gsrj-41	126	28	about	about	ADP
gsrj-41	126	29	getting	getting	AUX
gsrj-41	126	30	vaccinated	vaccinate	VERB
gsrj-41	126	31	with	with	ADP
gsrj-41	126	32	the	the	DET
gsrj-41	126	33	correct	correct	ADJ
gsrj-41	126	34	information	information	NOUN
gsrj-41	126	35	.	.	PUNCT
gsrj-41	127	1	this	this	PRON
gsrj-41	127	2	is	be	AUX
gsrj-41	127	3	also	also	ADV
gsrj-41	127	4	called	call	VERB
gsrj-41	127	5	“	"	PUNCT
gsrj-41	127	6	misinformation	misinformation	NOUN
gsrj-41	127	7	literacy”.49	literacy”.49	ADP
gsrj-41	127	8	2	2	NUM
gsrj-41	127	9	.	.	X
gsrj-41	128	1	healthcare	healthcare	NOUN
gsrj-41	128	2	system	system	NOUN
gsrj-41	128	3	reform	reform	NOUN
gsrj-41	128	4	:	:	PUNCT
gsrj-41	128	5	in	in	ADP
gsrj-41	128	6	order	order	NOUN
gsrj-41	128	7	to	to	PART
gsrj-41	128	8	create	create	VERB
gsrj-41	128	9	trust	trust	NOUN
gsrj-41	128	10	in	in	ADP
gsrj-41	128	11	healthcare	healthcare	PROPN
gsrj-41	128	12	,	,	PUNCT
gsrj-41	128	13	there	there	PRON
gsrj-41	128	14	must	must	AUX
gsrj-41	128	15	be	be	AUX
gsrj-41	128	16	complete	complete	ADJ
gsrj-41	128	17	reform	reform	NOUN
gsrj-41	128	18	to	to	ADP
gsrj-41	128	19	universal	universal	ADJ
gsrj-41	128	20	healthcare	healthcare	NOUN
gsrj-41	128	21	with	with	ADP
gsrj-41	128	22	better	well	ADJ
gsrj-41	128	23	primary	primary	ADJ
gsrj-41	128	24	care	care	NOUN
gsrj-41	128	25	and	and	CCONJ
gsrj-41	128	26	health	health	NOUN
gsrj-41	128	27	insurance	insurance	NOUN
gsrj-41	128	28	for	for	ADP
gsrj-41	128	29	all	all	PRON
gsrj-41	128	30	.	.	PUNCT
gsrj-41	129	1	in	in	ADP
gsrj-41	129	2	a	a	DET
gsrj-41	129	3	nationally	nationally	ADV
gsrj-41	129	4	representative	representative	ADJ
gsrj-41	129	5	survey	survey	NOUN
gsrj-41	129	6	in	in	ADP
gsrj-41	129	7	september	september	PROPN
gsrj-41	129	8	of	of	ADP
gsrj-41	129	9	2021	2021	NUM
gsrj-41	129	10	,	,	PUNCT
gsrj-41	129	11	the	the	DET
gsrj-41	129	12	kaiser	kaiser	PROPN
gsrj-41	129	13	family	family	PROPN
gsrj-41	129	14	foundation	foundation	PROPN
gsrj-41	129	15	also	also	ADV
gsrj-41	129	16	found	find	VERB
gsrj-41	129	17	that	that	SCONJ
gsrj-41	129	18	the	the	DET
gsrj-41	129	19	lack	lack	NOUN
gsrj-41	129	20	of	of	ADP
gsrj-41	129	21	health	health	NOUN
gsrj-41	129	22	insurance	insurance	NOUN
gsrj-41	129	23	was	be	AUX
gsrj-41	129	24	the	the	DET
gsrj-41	129	25	most	most	ADV
gsrj-41	129	26	powerful	powerful	ADJ
gsrj-41	129	27	predictor	predictor	NOUN
gsrj-41	129	28	of	of	ADP
gsrj-41	129	29	who	who	PRON
gsrj-41	129	30	remained	remain	VERB
gsrj-41	129	31	unvaccinated.50	unvaccinated.50	PROPN
gsrj-41	129	32	,	,	PUNCT
gsrj-41	129	33	51	51	NUM
gsrj-41	129	34	this	this	PRON
gsrj-41	129	35	further	far	ADV
gsrj-41	129	36	suggests	suggest	VERB
gsrj-41	129	37	the	the	DET
gsrj-41	129	38	need	need	NOUN
gsrj-41	129	39	for	for	ADP
gsrj-41	129	40	a	a	DET
gsrj-41	129	41	trusted	trust	VERB
gsrj-41	129	42	primary	primary	ADJ
gsrj-41	129	43	care	care	NOUN
gsrj-41	129	44	physician	physician	NOUN
gsrj-41	129	45	or	or	CCONJ
gsrj-41	129	46	general	general	ADJ
gsrj-41	129	47	doctor	doctor	NOUN
gsrj-41	129	48	for	for	ADP
gsrj-41	129	49	every	every	DET
gsrj-41	129	50	person	person	NOUN
gsrj-41	129	51	in	in	ADP
gsrj-41	129	52	the	the	DET
gsrj-41	129	53	u.s	u.s	PROPN
gsrj-41	129	54	.	.	PROPN
gsrj-41	129	55	quality	quality	PROPN
gsrj-41	129	56	,	,	PUNCT
gsrj-41	129	57	universal	universal	ADJ
gsrj-41	129	58	healthcare	healthcare	NOUN
gsrj-41	129	59	for	for	ADP
gsrj-41	129	60	all	all	DET
gsrj-41	129	61	americans	americans	PROPN
gsrj-41	129	62	would	would	AUX
gsrj-41	129	63	increase	increase	VERB
gsrj-41	129	64	vaccination	vaccination	NOUN
gsrj-41	129	65	rates	rate	NOUN
gsrj-41	129	66	and	and	CCONJ
gsrj-41	129	67	make	make	VERB
gsrj-41	129	68	for	for	ADP
gsrj-41	129	69	a	a	DET
gsrj-41	129	70	more	more	ADV
gsrj-41	129	71	equitable	equitable	ADJ
gsrj-41	129	72	covid-19	covid-19	PROPN
gsrj-41	129	73	response	response	NOUN
gsrj-41	129	74	.	.	PUNCT
gsrj-41	130	1	more	more	ADV
gsrj-41	130	2	specifically	specifically	ADV
gsrj-41	130	3	,	,	PUNCT
gsrj-41	130	4	systemic	systemic	ADJ
gsrj-41	130	5	racism	racism	NOUN
gsrj-41	130	6	and	and	CCONJ
gsrj-41	130	7	distrust	distrust	NOUN
gsrj-41	130	8	among	among	ADP
gsrj-41	130	9	minority	minority	NOUN
gsrj-41	130	10	populations	population	NOUN
gsrj-41	130	11	due	due	ADP
gsrj-41	130	12	to	to	ADP
gsrj-41	130	13	mistreatment	mistreatment	NOUN
gsrj-41	130	14	and	and	CCONJ
gsrj-41	130	15	underrepresentation	underrepresentation	NOUN
gsrj-41	130	16	must	must	AUX
gsrj-41	130	17	be	be	AUX
gsrj-41	130	18	addressed.44	addressed.44	NOUN
gsrj-41	130	19	the	the	DET
gsrj-41	130	20	medical	medical	ADJ
gsrj-41	130	21	field	field	NOUN
gsrj-41	130	22	must	must	AUX
gsrj-41	130	23	authentically	authentically	ADV
gsrj-41	130	24	increase	increase	VERB
gsrj-41	130	25	representation	representation	NOUN
gsrj-41	130	26	of	of	ADP
gsrj-41	130	27	minority	minority	NOUN
gsrj-41	130	28	populations	population	NOUN
gsrj-41	130	29	in	in	ADP
gsrj-41	130	30	clinical	clinical	ADJ
gsrj-41	130	31	trials	trial	NOUN
gsrj-41	130	32	,	,	PUNCT
gsrj-41	130	33	medical	medical	ADJ
gsrj-41	130	34	schools	school	NOUN
gsrj-41	130	35	,	,	PUNCT
gsrj-41	130	36	doctors	doctor	NOUN
gsrj-41	130	37	,	,	PUNCT
gsrj-41	130	38	and	and	CCONJ
gsrj-41	130	39	institutions	institution	NOUN
gsrj-41	130	40	such	such	ADJ
gsrj-41	130	41	as	as	ADP
gsrj-41	130	42	the	the	DET
gsrj-41	130	43	cdc	cdc	PROPN
gsrj-41	130	44	and	and	CCONJ
gsrj-41	130	45	fda	fda	PROPN
gsrj-41	130	46	.	.	PUNCT
gsrj-41	131	1	clinicians	clinician	NOUN
gsrj-41	131	2	must	must	AUX
gsrj-41	131	3	also	also	ADV
gsrj-41	131	4	promote	promote	VERB
gsrj-41	131	5	vaccinations	vaccination	NOUN
gsrj-41	131	6	to	to	ADP
gsrj-41	131	7	their	their	PRON
gsrj-41	131	8	patients	patient	NOUN
gsrj-41	131	9	through	through	ADP
gsrj-41	131	10	followup	followup	NOUN
gsrj-41	131	11	on	on	ADP
gsrj-41	131	12	vaccination	vaccination	NOUN
gsrj-41	131	13	status	status	NOUN
gsrj-41	131	14	,	,	PUNCT
gsrj-41	131	15	sharing	share	VERB
gsrj-41	131	16	educational	educational	ADJ
gsrj-41	131	17	resources	resource	NOUN
gsrj-41	131	18	stories	story	NOUN
gsrj-41	131	19	,	,	PUNCT
gsrj-41	131	20	and	and	CCONJ
gsrj-41	131	21	promoting	promote	VERB
gsrj-41	131	22	community	community	NOUN
gsrj-41	131	23	efforts.52	efforts.52	NOUN
gsrj-41	131	24	in	in	ADP
gsrj-41	131	25	addition	addition	NOUN
gsrj-41	131	26	,	,	PUNCT
gsrj-41	131	27	doctor	doctor	NOUN
gsrj-41	131	28	-	-	PUNCT
gsrj-41	131	29	patient	patient	NOUN
gsrj-41	131	30	relationships	relationship	NOUN
gsrj-41	131	31	can	can	AUX
gsrj-41	131	32	be	be	AUX
gsrj-41	131	33	strengthened	strengthen	VERB
gsrj-41	131	34	to	to	PART
gsrj-41	131	35	increase	increase	VERB
gsrj-41	131	36	trust	trust	NOUN
gsrj-41	131	37	through	through	ADP
gsrj-41	131	38	personal	personal	ADJ
gsrj-41	131	39	stories	story	NOUN
gsrj-41	131	40	and	and	CCONJ
gsrj-41	131	41	quality	quality	NOUN
gsrj-41	131	42	care.53	care.53	NOUN
gsrj-41	131	43	3	3	NUM
gsrj-41	131	44	.	.	PUNCT
gsrj-41	131	45	education	education	NOUN
gsrj-41	131	46	system	system	NOUN
gsrj-41	131	47	reform	reform	NOUN
gsrj-41	131	48	:	:	PUNCT
gsrj-41	131	49	in	in	ADP
gsrj-41	131	50	addition	addition	NOUN
gsrj-41	131	51	,	,	PUNCT
gsrj-41	131	52	quality	quality	NOUN
gsrj-41	131	53	education	education	NOUN
gsrj-41	131	54	must	must	AUX
gsrj-41	131	55	be	be	AUX
gsrj-41	131	56	free	free	ADJ
gsrj-41	131	57	and	and	CCONJ
gsrj-41	131	58	equitable	equitable	ADJ
gsrj-41	131	59	in	in	ADP
gsrj-41	131	60	all	all	DET
gsrj-41	131	61	parts	part	NOUN
gsrj-41	131	62	of	of	ADP
gsrj-41	131	63	the	the	DET
gsrj-41	131	64	u.s	u.s	PROPN
gsrj-41	131	65	.	.	PROPN
gsrj-41	131	66	and	and	CCONJ
gsrj-41	131	67	world	world	NOUN
gsrj-41	131	68	.	.	PUNCT
gsrj-41	132	1	curricula	curricula	PROPN
gsrj-41	132	2	can	can	AUX
gsrj-41	132	3	teach	teach	VERB
gsrj-41	132	4	about	about	ADP
gsrj-41	132	5	identifying	identify	VERB
gsrj-41	132	6	sources	source	NOUN
gsrj-41	132	7	and	and	CCONJ
gsrj-41	132	8	misinformation	misinformation	NOUN
gsrj-41	132	9	in	in	ADP
gsrj-41	132	10	schools	school	NOUN
gsrj-41	132	11	and	and	CCONJ
gsrj-41	132	12	about	about	ADP
gsrj-41	132	13	how	how	SCONJ
gsrj-41	132	14	vaccines	vaccine	NOUN
gsrj-41	132	15	and	and	CCONJ
gsrj-41	132	16	medications	medication	NOUN
gsrj-41	132	17	work	work	NOUN
gsrj-41	132	18	,	,	PUNCT
gsrj-41	132	19	in	in	ADP
gsrj-41	132	20	order	order	NOUN
gsrj-41	132	21	to	to	PART
gsrj-41	132	22	educate	educate	VERB
gsrj-41	132	23	the	the	DET
gsrj-41	132	24	population	population	NOUN
gsrj-41	132	25	from	from	ADP
gsrj-41	132	26	a	a	DET
gsrj-41	132	27	young	young	ADJ
gsrj-41	132	28	age	age	NOUN
gsrj-41	132	29	about	about	ADP
gsrj-41	132	30	the	the	DET
gsrj-41	132	31	benefits	benefit	NOUN
gsrj-41	132	32	of	of	ADP
gsrj-41	132	33	vaccination	vaccination	NOUN
gsrj-41	132	34	and	and	CCONJ
gsrj-41	132	35	increase	increase	VERB
gsrj-41	132	36	health	health	NOUN
gsrj-41	132	37	literacy.44	literacy.44	NOUN
gsrj-41	132	38	the	the	DET
gsrj-41	132	39	vaccine	vaccine	NOUN
gsrj-41	132	40	makers	maker	NOUN
gsrj-41	132	41	project	project	NOUN
gsrj-41	132	42	has	have	VERB
gsrj-41	132	43	a	a	DET
gsrj-41	132	44	program	program	NOUN
gsrj-41	132	45	that	that	PRON
gsrj-41	132	46	can	can	AUX
gsrj-41	132	47	be	be	AUX
gsrj-41	132	48	implemented	implement	VERB
gsrj-41	132	49	in	in	ADP
gsrj-41	132	50	the	the	DET
gsrj-41	132	51	classroom	classroom	NOUN
gsrj-41	132	52	surrounding	surround	VERB
gsrj-41	132	53	immunizations	immunization	NOUN
gsrj-41	132	54	and	and	CCONJ
gsrj-41	132	55	disease.54	disease.54	ADP
gsrj-41	132	56	4	4	NUM
gsrj-41	132	57	.	.	PUNCT
gsrj-41	133	1	authentic	authentic	ADJ
gsrj-41	133	2	community	community	NOUN
gsrj-41	133	3	investment	investment	NOUN
gsrj-41	133	4	&	&	CCONJ
gsrj-41	133	5	engagement	engagement	NOUN
gsrj-41	133	6	:	:	PUNCT
gsrj-41	133	7	minority	minority	NOUN
gsrj-41	133	8	populations	population	NOUN
gsrj-41	133	9	need	need	VERB
gsrj-41	133	10	to	to	PART
gsrj-41	133	11	be	be	AUX
gsrj-41	133	12	more	more	ADV
gsrj-41	133	13	heavily	heavily	ADV
gsrj-41	133	14	represented	represent	VERB
gsrj-41	133	15	in	in	ADP
gsrj-41	133	16	clinical	clinical	ADJ
gsrj-41	133	17	trials	trial	NOUN
gsrj-41	133	18	for	for	ADP
gsrj-41	133	19	vaccines	vaccine	NOUN
gsrj-41	133	20	and	and	CCONJ
gsrj-41	133	21	medical	medical	ADJ
gsrj-41	133	22	field	field	NOUN
gsrj-41	133	23	research	research	NOUN
gsrj-41	133	24	in	in	ADP
gsrj-41	133	25	general.44	general.44	NOUN
gsrj-41	133	26	trust	trust	NOUN
gsrj-41	133	27	can	can	AUX
gsrj-41	133	28	be	be	AUX
gsrj-41	133	29	built	build	VERB
gsrj-41	133	30	with	with	ADP
gsrj-41	133	31	authentic	authentic	ADJ
gsrj-41	133	32	investment	investment	NOUN
gsrj-41	133	33	in	in	ADP
gsrj-41	133	34	both	both	DET
gsrj-41	133	35	time	time	NOUN
gsrj-41	133	36	and	and	CCONJ
gsrj-41	133	37	resources	resource	NOUN
gsrj-41	133	38	in	in	ADP
gsrj-41	133	39	unvaccinated	unvaccinated	ADJ
gsrj-41	133	40	communities	community	NOUN
gsrj-41	133	41	,	,	PUNCT
gsrj-41	133	42	specifically	specifically	ADV
gsrj-41	133	43	in	in	ADP
gsrj-41	133	44	the	the	DET
gsrj-41	133	45	health	health	NOUN
gsrj-41	133	46	field	field	NOUN
gsrj-41	133	47	.	.	PUNCT
gsrj-41	134	1	19	19	NUM
gsrj-41	134	2	georgetown	georgetown	PROPN
gsrj-41	134	3	scientific	scientific	PROPN
gsrj-41	134	4	research	research	PROPN
gsrj-41	134	5	journal	journal	NOUN
gsrj-41	134	6	figure	figure	VERB
gsrj-41	134	7	6	6	NUM
gsrj-41	134	8	:	:	PUNCT
gsrj-41	134	9	recommendations	recommendation	NOUN
gsrj-41	134	10	to	to	PART
gsrj-41	134	11	increase	increase	VERB
gsrj-41	134	12	covid-19	covid-19	PROPN
gsrj-41	134	13	vaccinations	vaccination	NOUN
gsrj-41	134	14	&	&	CCONJ
gsrj-41	134	15	vaccine	vaccine	NOUN
gsrj-41	134	16	confidence	confidence	NOUN
gsrj-41	134	17	in	in	ADP
gsrj-41	134	18	the	the	DET
gsrj-41	134	19	u.s	u.s	PROPN
gsrj-41	134	20	.	.	PROPN
gsrj-41	134	21	suggestions	suggestion	NOUN
gsrj-41	134	22	include	include	VERB
gsrj-41	134	23	specific	specific	ADJ
gsrj-41	134	24	communication	communication	NOUN
gsrj-41	134	25	efforts	effort	NOUN
gsrj-41	134	26	,	,	PUNCT
gsrj-41	134	27	system	system	NOUN
gsrj-41	134	28	reform	reform	NOUN
gsrj-41	134	29	,	,	PUNCT
gsrj-41	134	30	and	and	CCONJ
gsrj-41	134	31	community	community	NOUN
gsrj-41	134	32	-	-	PUNCT
gsrj-41	134	33	based	base	VERB
gsrj-41	134	34	initiatives	initiative	NOUN
gsrj-41	134	35	.	.	PUNCT
gsrj-41	135	1	4.4	4.4	NUM
gsrj-41	135	2	remaining	remain	VERB
gsrj-41	135	3	gaps	gap	NOUN
gsrj-41	135	4	in	in	ADP
gsrj-41	135	5	knowledge	knowledge	NOUN
gsrj-41	135	6	more	more	ADJ
gsrj-41	135	7	research	research	NOUN
gsrj-41	135	8	is	be	AUX
gsrj-41	135	9	needed	need	VERB
gsrj-41	135	10	about	about	ADP
gsrj-41	135	11	covid-19	covid-19	PROPN
gsrj-41	135	12	vaccine	vaccine	NOUN
gsrj-41	135	13	confidence	confidence	NOUN
gsrj-41	135	14	in	in	ADP
gsrj-41	135	15	general	general	ADJ
gsrj-41	135	16	,	,	PUNCT
gsrj-41	135	17	as	as	ADV
gsrj-41	135	18	well	well	ADV
gsrj-41	135	19	as	as	ADP
gsrj-41	135	20	specification	specification	NOUN
gsrj-41	135	21	between	between	ADP
gsrj-41	135	22	demographic	demographic	ADJ
gsrj-41	135	23	characteristics	characteristic	NOUN
gsrj-41	135	24	.	.	PUNCT
gsrj-41	136	1	because	because	SCONJ
gsrj-41	136	2	of	of	ADP
gsrj-41	136	3	the	the	DET
gsrj-41	136	4	novelty	novelty	NOUN
gsrj-41	136	5	of	of	ADP
gsrj-41	136	6	covid-19	covid-19	PROPN
gsrj-41	136	7	vaccines	vaccine	NOUN
gsrj-41	136	8	and	and	CCONJ
gsrj-41	136	9	the	the	DET
gsrj-41	136	10	virus	virus	NOUN
gsrj-41	136	11	,	,	PUNCT
gsrj-41	136	12	sustained	sustain	VERB
gsrj-41	136	13	research	research	NOUN
gsrj-41	136	14	and	and	CCONJ
gsrj-41	136	15	investigation	investigation	NOUN
gsrj-41	136	16	is	be	AUX
gsrj-41	136	17	necessary	necessary	ADJ
gsrj-41	136	18	.	.	PUNCT
gsrj-41	137	1	qualitative	qualitative	ADJ
gsrj-41	137	2	research	research	NOUN
gsrj-41	137	3	is	be	AUX
gsrj-41	137	4	essential	essential	ADJ
gsrj-41	137	5	to	to	PART
gsrj-41	137	6	better	well	ADV
gsrj-41	137	7	understand	understand	VERB
gsrj-41	137	8	the	the	DET
gsrj-41	137	9	nuances	nuance	NOUN
gsrj-41	137	10	in	in	ADP
gsrj-41	137	11	vaccine	vaccine	NOUN
gsrj-41	137	12	hesitancy	hesitancy	NOUN
gsrj-41	137	13	,	,	PUNCT
gsrj-41	137	14	including	include	VERB
gsrj-41	137	15	the	the	DET
gsrj-41	137	16	similarities	similarity	NOUN
gsrj-41	137	17	and	and	CCONJ
gsrj-41	137	18	differences	difference	NOUN
gsrj-41	137	19	between	between	ADP
gsrj-41	137	20	fear	fear	NOUN
gsrj-41	137	21	of	of	ADP
gsrj-41	137	22	side	side	NOUN
gsrj-41	137	23	effects	effect	NOUN
gsrj-41	137	24	and	and	CCONJ
gsrj-41	137	25	safety	safety	NOUN
gsrj-41	137	26	versus	versus	ADP
gsrj-41	137	27	distrust	distrust	NOUN
gsrj-41	137	28	.	.	PUNCT
gsrj-41	138	1	surveys	survey	NOUN
gsrj-41	138	2	must	must	AUX
gsrj-41	138	3	specify	specify	VERB
gsrj-41	138	4	which	which	DET
gsrj-41	138	5	side	side	NOUN
gsrj-41	138	6	effects	effect	NOUN
gsrj-41	138	7	populations	population	NOUN
gsrj-41	138	8	are	be	AUX
gsrj-41	138	9	most	most	ADV
gsrj-41	138	10	concerned	concerned	ADJ
gsrj-41	138	11	about	about	ADP
gsrj-41	138	12	.	.	PUNCT
gsrj-41	139	1	health	health	NOUN
gsrj-41	139	2	research	research	NOUN
gsrj-41	139	3	is	be	AUX
gsrj-41	139	4	needed	need	VERB
gsrj-41	139	5	on	on	ADP
gsrj-41	139	6	the	the	DET
gsrj-41	139	7	impact	impact	NOUN
gsrj-41	139	8	of	of	ADP
gsrj-41	139	9	social	social	ADJ
gsrj-41	139	10	media	medium	NOUN
gsrj-41	139	11	and	and	CCONJ
gsrj-41	139	12	social	social	ADJ
gsrj-41	139	13	networks	network	NOUN
gsrj-41	139	14	on	on	ADP
gsrj-41	139	15	covid-19	covid-19	PROPN
gsrj-41	139	16	vaccine	vaccine	NOUN
gsrj-41	139	17	uptake	uptake	VERB
gsrj-41	139	18	,	,	PUNCT
gsrj-41	139	19	as	as	ADV
gsrj-41	139	20	well	well	ADV
gsrj-41	139	21	as	as	ADP
gsrj-41	139	22	where	where	SCONJ
gsrj-41	139	23	these	these	DET
gsrj-41	139	24	fears	fear	NOUN
gsrj-41	139	25	and	and	CCONJ
gsrj-41	139	26	ideas	idea	NOUN
gsrj-41	139	27	stem	stem	VERB
gsrj-41	139	28	from	from	ADP
gsrj-41	139	29	.	.	PUNCT
gsrj-41	140	1	the	the	DET
gsrj-41	140	2	intersections	intersection	NOUN
gsrj-41	140	3	between	between	ADP
gsrj-41	140	4	social	social	ADJ
gsrj-41	140	5	sciences	science	NOUN
gsrj-41	140	6	and	and	CCONJ
gsrj-41	140	7	health	health	NOUN
gsrj-41	140	8	requires	require	VERB
gsrj-41	140	9	more	more	ADJ
gsrj-41	140	10	research	research	NOUN
gsrj-41	140	11	in	in	ADP
gsrj-41	140	12	the	the	DET
gsrj-41	140	13	covid-19	covid-19	PROPN
gsrj-41	140	14	context	context	NOUN
gsrj-41	140	15	.	.	PUNCT
gsrj-41	141	1	research	research	NOUN
gsrj-41	141	2	is	be	AUX
gsrj-41	141	3	also	also	ADV
gsrj-41	141	4	needed	need	VERB
gsrj-41	141	5	on	on	ADP
gsrj-41	141	6	correlations	correlation	NOUN
gsrj-41	141	7	between	between	ADP
gsrj-41	141	8	timing	timing	NOUN
gsrj-41	141	9	of	of	ADP
gsrj-41	141	10	fda	fda	PROPN
gsrj-41	141	11	approvals	approval	NOUN
gsrj-41	141	12	and	and	CCONJ
gsrj-41	141	13	reasons	reason	NOUN
gsrj-41	141	14	for	for	ADP
gsrj-41	141	15	vaccine	vaccine	NOUN
gsrj-41	141	16	refusal	refusal	NOUN
gsrj-41	141	17	.	.	PUNCT
gsrj-41	142	1	4.4	4.4	NUM
gsrj-41	142	2	limitations	limitation	NOUN
gsrj-41	142	3	there	there	PRON
gsrj-41	142	4	are	be	VERB
gsrj-41	142	5	several	several	ADJ
gsrj-41	142	6	limitations	limitation	NOUN
gsrj-41	142	7	to	to	ADP
gsrj-41	142	8	this	this	DET
gsrj-41	142	9	literature	literature	NOUN
gsrj-41	142	10	review	review	NOUN
gsrj-41	142	11	.	.	PUNCT
gsrj-41	143	1	the	the	DET
gsrj-41	143	2	surveys	survey	NOUN
gsrj-41	143	3	utilized	utilize	VERB
gsrj-41	143	4	did	do	AUX
gsrj-41	143	5	not	not	PART
gsrj-41	143	6	have	have	VERB
gsrj-41	143	7	a	a	DET
gsrj-41	143	8	consistent	consistent	ADJ
gsrj-41	143	9	wording	wording	NOUN
gsrj-41	143	10	of	of	ADP
gsrj-41	143	11	questions	question	NOUN
gsrj-41	143	12	or	or	CCONJ
gsrj-41	143	13	provide	provide	VERB
gsrj-41	143	14	the	the	DET
gsrj-41	143	15	same	same	ADJ
gsrj-41	143	16	questions	question	NOUN
gsrj-41	143	17	.	.	PUNCT
gsrj-41	144	1	some	some	DET
gsrj-41	144	2	articles	article	NOUN
gsrj-41	144	3	differentiated	differentiate	VERB
gsrj-41	144	4	between	between	ADP
gsrj-41	144	5	those	those	PRON
gsrj-41	144	6	who	who	PRON
gsrj-41	144	7	are	be	AUX
gsrj-41	144	8	unsure	unsure	ADJ
gsrj-41	144	9	and	and	CCONJ
gsrj-41	144	10	those	those	PRON
gsrj-41	144	11	who	who	PRON
gsrj-41	144	12	refuse	refuse	VERB
gsrj-41	144	13	,	,	PUNCT
gsrj-41	144	14	while	while	SCONJ
gsrj-41	144	15	some	some	PRON
gsrj-41	144	16	divided	divide	VERB
gsrj-41	144	17	this	this	PRON
gsrj-41	144	18	into	into	ADP
gsrj-41	144	19	a	a	DET
gsrj-41	144	20	broader	broader	ADV
gsrj-41	144	21	hesitant	hesitant	ADJ
gsrj-41	144	22	category	category	NOUN
gsrj-41	144	23	.	.	PUNCT
gsrj-41	145	1	5	5	X
gsrj-41	145	2	.	.	X
gsrj-41	145	3	conclusion	conclusion	NOUN
gsrj-41	145	4	this	this	DET
gsrj-41	145	5	literature	literature	NOUN
gsrj-41	145	6	review	review	NOUN
gsrj-41	145	7	found	find	VERB
gsrj-41	145	8	that	that	SCONJ
gsrj-41	145	9	concerns	concern	NOUN
gsrj-41	145	10	about	about	ADP
gsrj-41	145	11	side	side	NOUN
gsrj-41	145	12	effects	effect	NOUN
gsrj-41	145	13	is	be	AUX
gsrj-41	145	14	the	the	DET
gsrj-41	145	15	top	top	ADJ
gsrj-41	145	16	reason	reason	NOUN
gsrj-41	145	17	for	for	ADP
gsrj-41	145	18	covid19	covid19	NOUN
gsrj-41	145	19	vaccine	vaccine	NOUN
gsrj-41	145	20	hesitancy	hesitancy	NOUN
gsrj-41	145	21	in	in	ADP
gsrj-41	145	22	the	the	DET
gsrj-41	145	23	u.s	u.s	PROPN
gsrj-41	145	24	.	.	PROPN
gsrj-41	145	25	,	,	PUNCT
gsrj-41	145	26	followed	follow	VERB
gsrj-41	145	27	by	by	ADP
gsrj-41	145	28	need	need	NOUN
gsrj-41	145	29	for	for	ADP
gsrj-41	145	30	additional	additional	ADJ
gsrj-41	145	31	information	information	NOUN
gsrj-41	145	32	and	and	CCONJ
gsrj-41	145	33	distrust	distrust	NOUN
gsrj-41	145	34	.	.	PUNCT
gsrj-41	146	1	in	in	ADP
gsrj-41	146	2	order	order	NOUN
gsrj-41	146	3	to	to	PART
gsrj-41	146	4	gain	gain	VERB
gsrj-41	146	5	trust	trust	NOUN
gsrj-41	146	6	and	and	CCONJ
gsrj-41	146	7	therefore	therefore	ADV
gsrj-41	146	8	increase	increase	VERB
gsrj-41	146	9	uptake	uptake	ADJ
gsrj-41	146	10	address	address	NOUN
gsrj-41	146	11	all	all	DET
gsrj-41	146	12	side	side	ADJ
gsrj-41	146	13	effects	effect	NOUN
gsrj-41	146	14	in	in	ADP
gsrj-41	146	15	communication	communication	NOUN
gsrj-41	146	16	efforts	effort	NOUN
gsrj-41	146	17	:	:	PUNCT
gsrj-41	146	18	•	•	ADV
gsrj-41	146	19	from	from	ADP
gsrj-41	146	20	local	local	ADJ
gsrj-41	146	21	health	health	NOUN
gsrj-41	146	22	providers	provider	NOUN
gsrj-41	146	23	,	,	PUNCT
gsrj-41	146	24	institutions	institution	NOUN
gsrj-41	146	25	,	,	PUNCT
gsrj-41	146	26	&	&	CCONJ
gsrj-41	146	27	community	community	NOUN
gsrj-41	146	28	organizaters	organizater	NOUN
gsrj-41	146	29	•	•	ADV
gsrj-41	146	30	known	know	VERB
gsrj-41	146	31	flu	flu	NOUN
gsrj-41	146	32	-	-	PUNCT
gsrj-41	146	33	like	like	ADJ
gsrj-41	146	34	symptoms	symptom	NOUN
gsrj-41	146	35	•	•	ADV
gsrj-41	146	36	extremely	extremely	ADV
gsrj-41	146	37	rare	rare	ADJ
gsrj-41	146	38	allergic	allergic	ADJ
gsrj-41	146	39	reactions	reaction	NOUN
gsrj-41	146	40	•	•	ADV
gsrj-41	146	41	disprove	disprove	VERB
gsrj-41	146	42	long	long	ADJ
gsrj-41	146	43	-	-	PUNCT
gsrj-41	146	44	term	term	NOUN
gsrj-41	146	45	effects	effect	NOUN
gsrj-41	146	46	address	address	VERB
gsrj-41	146	47	misinformation	misinformation	NOUN
gsrj-41	146	48	&	&	CCONJ
gsrj-41	146	49	increase	increase	PROPN
gsrj-41	146	50	trust	trust	NOUN
gsrj-41	146	51	:	:	PUNCT
gsrj-41	146	52	•	•	NOUN
gsrj-41	146	53	communicate	communicate	VERB
gsrj-41	146	54	&	&	CCONJ
gsrj-41	146	55	teach	teach	VERB
gsrj-41	146	56	ways	way	NOUN
gsrj-41	146	57	to	to	PART
gsrj-41	146	58	point	point	VERB
gsrj-41	146	59	out	out	ADP
gsrj-41	146	60	misinformation	misinformation	NOUN
gsrj-41	146	61	healthcare	healthcare	NOUN
gsrj-41	146	62	system	system	NOUN
gsrj-41	146	63	reform	reform	NOUN
gsrj-41	146	64	:	:	PUNCT
gsrj-41	146	65	•	•	PUNCT
gsrj-41	146	66	ensure	ensure	VERB
gsrj-41	146	67	universal	universal	ADJ
gsrj-41	146	68	healthcare	healthcare	NOUN
gsrj-41	146	69	for	for	ADP
gsrj-41	146	70	all	all	DET
gsrj-41	146	71	•	•	NOUN
gsrj-41	146	72	increase	increase	NOUN
gsrj-41	146	73	representation	representation	NOUN
gsrj-41	146	74	of	of	ADP
gsrj-41	146	75	minority	minority	NOUN
gsrj-41	146	76	populations	population	NOUN
gsrj-41	146	77	in	in	ADP
gsrj-41	146	78	health	health	NOUN
gsrj-41	146	79	fields	field	NOUN
gsrj-41	146	80	•	•	ADV
gsrj-41	146	81	strengthen	strengthen	VERB
gsrj-41	146	82	doctor	doctor	NOUN
gsrj-41	146	83	-	-	PUNCT
gsrj-41	146	84	patient	patient	NOUN
gsrj-41	146	85	relationship	relationship	NOUN
gsrj-41	146	86	•	•	ADV
gsrj-41	146	87	follow	follow	NOUN
gsrj-41	146	88	-	-	PUNCT
gsrj-41	146	89	up	up	NOUN
gsrj-41	146	90	on	on	ADP
gsrj-41	146	91	vaccination	vaccination	NOUN
gsrj-41	146	92	status	status	NOUN
gsrj-41	146	93	•	•	NUM
gsrj-41	146	94	share	share	NOUN
gsrj-41	146	95	stories	story	NOUN
gsrj-41	146	96	&	&	CCONJ
gsrj-41	146	97	resources	resource	NOUN
gsrj-41	146	98	•	•	NOUN
gsrj-41	146	99	promote	promote	VERB
gsrj-41	146	100	community	community	NOUN
gsrj-41	146	101	efforts	effort	NOUN
gsrj-41	146	102	education	education	NOUN
gsrj-41	146	103	system	system	NOUN
gsrj-41	146	104	reform	reform	NOUN
gsrj-41	146	105	:	:	PUNCT
gsrj-41	146	106	•	•	NUM
gsrj-41	146	107	universal	universal	ADJ
gsrj-41	146	108	quality	quality	NOUN
gsrj-41	146	109	education	education	NOUN
gsrj-41	146	110	•	•	NOUN
gsrj-41	146	111	curricula	curricula	NOUN
gsrj-41	146	112	should	should	AUX
gsrj-41	146	113	include	include	VERB
gsrj-41	146	114	misinformation	misinformation	NOUN
gsrj-41	146	115	literacy	literacy	NOUN
gsrj-41	146	116	&	&	CCONJ
gsrj-41	146	117	vaccine	vaccine	NOUN
gsrj-41	146	118	mechanisms	mechanism	VERB
gsrj-41	146	119	authentic	authentic	ADJ
gsrj-41	146	120	community	community	NOUN
gsrj-41	146	121	investment	investment	NOUN
gsrj-41	146	122	&	&	CCONJ
gsrj-41	146	123	engagement	engagement	PROPN
gsrj-41	146	124	:	:	PUNCT
gsrj-41	146	125	•	•	ADP
gsrj-41	146	126	community	community	NOUN
gsrj-41	146	127	-	-	PUNCT
gsrj-41	146	128	based	base	VERB
gsrj-41	146	129	initiatives	initiative	NOUN
gsrj-41	146	130	in	in	ADP
gsrj-41	146	131	areas	area	NOUN
gsrj-41	146	132	with	with	ADP
gsrj-41	146	133	low	low	ADJ
gsrj-41	146	134	vaccination	vaccination	NOUN
gsrj-41	146	135	rates	rate	NOUN
gsrj-41	146	136	20	20	NUM
gsrj-41	146	137	georgetown	georgetown	PROPN
gsrj-41	146	138	scientific	scientific	ADJ
gsrj-41	146	139	research	research	NOUN
gsrj-41	146	140	journal	journal	NOUN
gsrj-41	146	141	among	among	ADP
gsrj-41	146	142	those	those	PRON
gsrj-41	146	143	who	who	PRON
gsrj-41	146	144	are	be	AUX
gsrj-41	146	145	still	still	ADV
gsrj-41	146	146	hesitant	hesitant	ADJ
gsrj-41	146	147	of	of	ADP
gsrj-41	146	148	the	the	DET
gsrj-41	146	149	available	available	ADJ
gsrj-41	146	150	covid-19	covid-19	PROPN
gsrj-41	146	151	vaccines	vaccine	NOUN
gsrj-41	146	152	,	,	PUNCT
gsrj-41	146	153	the	the	DET
gsrj-41	146	154	american	american	PROPN
gsrj-41	146	155	healthcare	healthcare	PROPN
gsrj-41	146	156	and	and	CCONJ
gsrj-41	146	157	education	education	NOUN
gsrj-41	146	158	system	system	NOUN
gsrj-41	146	159	must	must	AUX
gsrj-41	146	160	go	go	VERB
gsrj-41	146	161	through	through	ADP
gsrj-41	146	162	reform	reform	NOUN
gsrj-41	146	163	to	to	PART
gsrj-41	146	164	address	address	VERB
gsrj-41	146	165	systemic	systemic	ADJ
gsrj-41	146	166	racism	racism	NOUN
gsrj-41	146	167	.	.	PUNCT
gsrj-41	147	1	while	while	SCONJ
gsrj-41	147	2	increasing	increase	VERB
gsrj-41	147	3	representation	representation	NOUN
gsrj-41	147	4	in	in	ADP
gsrj-41	147	5	health	health	NOUN
gsrj-41	147	6	fields	field	NOUN
gsrj-41	147	7	,	,	PUNCT
gsrj-41	147	8	already	already	ADV
gsrj-41	147	9	working	work	VERB
gsrj-41	147	10	clinicians	clinician	NOUN
gsrj-41	147	11	can	can	AUX
gsrj-41	147	12	promote	promote	VERB
gsrj-41	147	13	vaccinations	vaccination	NOUN
gsrj-41	147	14	through	through	ADP
gsrj-41	147	15	strengthening	strengthen	VERB
gsrj-41	147	16	their	their	PRON
gsrj-41	147	17	patient	patient	ADJ
gsrj-41	147	18	relationships	relationship	NOUN
gsrj-41	147	19	,	,	PUNCT
gsrj-41	147	20	following	follow	VERB
gsrj-41	147	21	up	up	ADP
gsrj-41	147	22	on	on	ADP
gsrj-41	147	23	vaccination	vaccination	NOUN
gsrj-41	147	24	status	status	NOUN
gsrj-41	147	25	,	,	PUNCT
gsrj-41	147	26	sharing	share	VERB
gsrj-41	147	27	educational	educational	ADJ
gsrj-41	147	28	resources	resource	NOUN
gsrj-41	147	29	and	and	CCONJ
gsrj-41	147	30	personal	personal	ADJ
gsrj-41	147	31	stories	story	NOUN
gsrj-41	147	32	,	,	PUNCT
gsrj-41	147	33	and	and	CCONJ
gsrj-41	147	34	promoting	promote	VERB
gsrj-41	147	35	community	community	NOUN
gsrj-41	147	36	efforts	effort	NOUN
gsrj-41	147	37	.	.	PUNCT
gsrj-41	148	1	teachers	teacher	NOUN
gsrj-41	148	2	and	and	CCONJ
gsrj-41	148	3	schools	school	NOUN
gsrj-41	148	4	can	can	AUX
gsrj-41	148	5	implement	implement	VERB
gsrj-41	148	6	lessons	lesson	NOUN
gsrj-41	148	7	on	on	ADP
gsrj-41	148	8	immunizations	immunization	NOUN
gsrj-41	148	9	and	and	CCONJ
gsrj-41	148	10	disease	disease	NOUN
gsrj-41	148	11	.	.	PUNCT
gsrj-41	149	1	communication	communication	NOUN
gsrj-41	149	2	efforts	effort	NOUN
gsrj-41	149	3	from	from	ADP
gsrj-41	149	4	institutions	institution	NOUN
gsrj-41	149	5	and	and	CCONJ
gsrj-41	149	6	local	local	ADJ
gsrj-41	149	7	community	community	NOUN
gsrj-41	149	8	organizations	organization	NOUN
gsrj-41	149	9	must	must	AUX
gsrj-41	149	10	work	work	VERB
gsrj-41	149	11	to	to	PART
gsrj-41	149	12	increase	increase	VERB
gsrj-41	149	13	trust	trust	NOUN
gsrj-41	149	14	,	,	PUNCT
gsrj-41	149	15	address	address	VERB
gsrj-41	149	16	fear	fear	NOUN
gsrj-41	149	17	of	of	ADP
gsrj-41	149	18	side	side	NOUN
gsrj-41	149	19	effects	effect	NOUN
gsrj-41	149	20	,	,	PUNCT
gsrj-41	149	21	and	and	CCONJ
gsrj-41	149	22	combat	combat	NOUN
gsrj-41	149	23	misinformation	misinformation	NOUN
gsrj-41	149	24	,	,	PUNCT
gsrj-41	149	25	while	while	SCONJ
gsrj-41	149	26	also	also	ADV
gsrj-41	149	27	promoting	promote	VERB
gsrj-41	149	28	social	social	ADJ
gsrj-41	149	29	and	and	CCONJ
gsrj-41	149	30	self	self	NOUN
gsrj-41	149	31	-	-	PUNCT
gsrj-41	149	32	efficacy	efficacy	NOUN
gsrj-41	149	33	values	value	NOUN
gsrj-41	149	34	.	.	PUNCT
gsrj-41	150	1	promotion	promotion	NOUN
gsrj-41	150	2	of	of	ADP
gsrj-41	150	3	social	social	ADJ
gsrj-41	150	4	values	value	NOUN
gsrj-41	150	5	and	and	CCONJ
gsrj-41	150	6	authentic	authentic	ADJ
gsrj-41	150	7	community	community	NOUN
gsrj-41	150	8	investment	investment	NOUN
gsrj-41	150	9	and	and	CCONJ
gsrj-41	150	10	engagement	engagement	NOUN
gsrj-41	150	11	can	can	AUX
gsrj-41	150	12	increase	increase	VERB
gsrj-41	150	13	trust	trust	NOUN
gsrj-41	150	14	and	and	CCONJ
gsrj-41	150	15	vaccinations	vaccination	NOUN
gsrj-41	150	16	.	.	PUNCT
gsrj-41	151	1	vaccination	vaccination	NOUN
gsrj-41	151	2	of	of	ADP
gsrj-41	151	3	the	the	DET
gsrj-41	151	4	global	global	ADJ
gsrj-41	151	5	population	population	NOUN
gsrj-41	151	6	is	be	AUX
gsrj-41	151	7	necessary	necessary	ADJ
gsrj-41	151	8	to	to	PART
gsrj-41	151	9	combat	combat	VERB
gsrj-41	151	10	this	this	DET
gsrj-41	151	11	virus	virus	NOUN
gsrj-41	151	12	.	.	PUNCT
gsrj-41	152	1	addressing	address	VERB
gsrj-41	152	2	hesitancies	hesitancy	NOUN
gsrj-41	152	3	to	to	ADP
gsrj-41	152	4	covid-19	covid-19	PROPN
gsrj-41	152	5	vaccines	vaccine	NOUN
gsrj-41	152	6	can	can	AUX
gsrj-41	152	7	increase	increase	VERB
gsrj-41	152	8	uptake	uptake	ADJ
gsrj-41	152	9	in	in	ADP
gsrj-41	152	10	order	order	NOUN
gsrj-41	152	11	to	to	PART
gsrj-41	152	12	protect	protect	VERB
gsrj-41	152	13	all	all	PRON
gsrj-41	152	14	.	.	PUNCT
gsrj-41	153	1	acknowledgments	acknowledgment	NOUN
gsrj-41	153	2	i	i	PRON
gsrj-41	153	3	thank	thank	VERB
gsrj-41	153	4	chelsea	chelsea	PROPN
gsrj-41	153	5	toldeo	toldeo	PROPN
gsrj-41	153	6	,	,	PUNCT
gsrj-41	153	7	ma	ma	PROPN
gsrj-41	153	8	,	,	PUNCT
gsrj-41	153	9	mph	mph	PROPN
gsrj-41	153	10	,	,	PUNCT
gsrj-41	153	11	sr	sr	PROPN
gsrj-41	153	12	.	.	PUNCT
gsrj-41	154	1	health	health	PROPN
gsrj-41	154	2	communications	communications	PROPN
gsrj-41	154	3	advisor	advisor	NOUN
gsrj-41	154	4	–	–	PUNCT
gsrj-41	154	5	asrt	asrt	NOUN
gsrj-41	154	6	,	,	PUNCT
gsrj-41	154	7	contracting	contracting	NOUN
gsrj-41	154	8	for	for	ADP
gsrj-41	154	9	cdc	cdc	PROPN
gsrj-41	154	10	’s	’s	PART
gsrj-41	154	11	immunization	immunization	NOUN
gsrj-41	154	12	service	service	NOUN
gsrj-41	154	13	division	division	NOUN
gsrj-41	154	14	,	,	PUNCT
gsrj-41	154	15	atlanta	atlanta	PROPN
gsrj-41	154	16	,	,	PUNCT
gsrj-41	154	17	ga	ga	PROPN
gsrj-41	154	18	,	,	PUNCT
gsrj-41	154	19	for	for	ADP
gsrj-41	154	20	aiding	aid	VERB
gsrj-41	154	21	me	i	PRON
gsrj-41	154	22	in	in	ADP
gsrj-41	154	23	the	the	DET
gsrj-41	154	24	editing	editing	NOUN
gsrj-41	154	25	process	process	NOUN
gsrj-41	154	26	and	and	CCONJ
gsrj-41	154	27	providing	provide	VERB
gsrj-41	154	28	expertise	expertise	NOUN
gsrj-41	154	29	in	in	ADP
gsrj-41	154	30	the	the	DET
gsrj-41	154	31	matter	matter	NOUN
gsrj-41	154	32	.	.	PUNCT
gsrj-41	155	1	i	i	PRON
gsrj-41	155	2	thank	thank	VERB
gsrj-41	155	3	dr	dr	PROPN
gsrj-41	155	4	.	.	PROPN
gsrj-41	155	5	margaret	margaret	PROPN
gsrj-41	155	6	baker	baker	PROPN
gsrj-41	155	7	,	,	PUNCT
gsrj-41	155	8	associate	associate	ADJ
gsrj-41	155	9	professor	professor	NOUN
gsrj-41	155	10	at	at	ADP
gsrj-41	155	11	georgetown	georgetown	PROPN
gsrj-41	155	12	university	university	PROPN
gsrj-41	155	13	’s	’s	PART
gsrj-41	155	14	department	department	PROPN
gsrj-41	155	15	of	of	ADP
gsrj-41	155	16	international	international	ADJ
gsrj-41	155	17	health	health	NOUN
gsrj-41	155	18	,	,	PUNCT
gsrj-41	155	19	for	for	ADP
gsrj-41	155	20	being	be	AUX
gsrj-41	155	21	my	my	PRON
gsrj-41	155	22	advisor	advisor	NOUN
gsrj-41	155	23	during	during	ADP
gsrj-41	155	24	this	this	DET
gsrj-41	155	25	entire	entire	ADJ
gsrj-41	155	26	process	process	NOUN
gsrj-41	155	27	.	.	PUNCT
gsrj-41	156	1	references	reference	NOUN
gsrj-41	156	2	1	1	NUM
gsrj-41	156	3	.	.	PUNCT
gsrj-41	157	1	cdc	cdc	PROPN
gsrj-41	157	2	.	.	PUNCT
gsrj-41	157	3	(	(	PUNCT
gsrj-41	157	4	2022	2022	NUM
gsrj-41	157	5	)	)	PUNCT
gsrj-41	157	6	.	.	PUNCT
gsrj-41	158	1	covid	covid	PROPN
gsrj-41	158	2	data	data	PROPN
gsrj-41	158	3	tracker	tracker	PROPN
gsrj-41	158	4	.	.	PUNCT
gsrj-41	159	1	centers	center	NOUN
gsrj-41	159	2	for	for	ADP
gsrj-41	159	3	disease	disease	NOUN
gsrj-41	159	4	control	control	NOUN
gsrj-41	159	5	and	and	CCONJ
gsrj-41	159	6	prevention	prevention	NOUN
gsrj-41	159	7	.	.	PUNCT
gsrj-41	160	1	https://covid.cdc.gov/covid-data-tracker	https://covid.cdc.gov/covid-data-tracker	PRON
gsrj-41	160	2	2	2	NUM
gsrj-41	160	3	.	.	PUNCT
gsrj-41	160	4	commissioner	commissioner	NOUN
gsrj-41	160	5	,	,	PUNCT
gsrj-41	160	6	o.	o.	NOUN
gsrj-41	160	7	of	of	ADP
gsrj-41	160	8	the	the	PRON
gsrj-41	160	9	.	.	PUNCT
gsrj-41	161	1	(	(	PUNCT
gsrj-41	161	2	2021	2021	NUM
gsrj-41	161	3	,	,	PUNCT
gsrj-41	161	4	august	august	PROPN
gsrj-41	161	5	23	23	NUM
gsrj-41	161	6	)	)	PUNCT
gsrj-41	161	7	.	.	PUNCT
gsrj-41	162	1	fda	fda	PROPN
gsrj-41	162	2	approves	approve	VERB
gsrj-41	162	3	first	first	ADJ
gsrj-41	162	4	covid-19	covid-19	PROPN
gsrj-41	162	5	vaccine	vaccine	NOUN
gsrj-41	162	6	.	.	PUNCT
gsrj-41	163	1	fda	fda	PROPN
gsrj-41	163	2	;	;	PUNCT
gsrj-41	163	3	fda	fda	PROPN
gsrj-41	163	4	.	.	PUNCT
gsrj-41	163	5	https://www.fda.gov/news-events/pressannouncements/fda-approves-first-covid-19vaccine	https://www.fda.gov/news-events/pressannouncements/fda-approves-first-covid-19vaccine	PROPN
gsrj-41	164	1	3	3	X
gsrj-41	164	2	.	.	PUNCT
gsrj-41	164	3	assistant	assistant	PROPN
gsrj-41	164	4	secretary	secretary	NOUN
gsrj-41	164	5	for	for	ADP
gsrj-41	164	6	public	public	ADJ
gsrj-41	164	7	affairs	affair	NOUN
gsrj-41	164	8	(	(	PUNCT
gsrj-41	164	9	aspa	aspa	PROPN
gsrj-41	164	10	)	)	PUNCT
gsrj-41	164	11	.	.	PUNCT
gsrj-41	165	1	(	(	PUNCT
gsrj-41	165	2	2021	2021	NUM
gsrj-41	165	3	)	)	PUNCT
gsrj-41	165	4	.	.	PUNCT
gsrj-41	166	1	covid-19	covid-19	PROPN
gsrj-41	166	2	vaccine	vaccine	NOUN
gsrj-41	166	3	distribution	distribution	NOUN
gsrj-41	166	4	:	:	PUNCT
gsrj-41	166	5	the	the	DET
gsrj-41	166	6	process	process	NOUN
gsrj-41	166	7	[	[	X
gsrj-41	166	8	text	text	X
gsrj-41	166	9	]	]	PUNCT
gsrj-41	166	10	.	.	PUNCT
gsrj-41	167	1	hhs.gov	hhs.gov	PROPN
gsrj-41	167	2	.	.	PUNCT
gsrj-41	168	1	https://www.hhs.gov/coronavirus/covid-19vaccines/distribution/index.html	https://www.hhs.gov/coronavirus/covid-19vaccines/distribution/index.html	NUM
gsrj-41	168	2	4	4	NUM
gsrj-41	168	3	.	.	PUNCT
gsrj-41	168	4	science	science	NOUN
gsrj-41	168	5	brief	brief	NOUN
gsrj-41	168	6	:	:	PUNCT
gsrj-41	168	7	covid-19	covid-19	PROPN
gsrj-41	168	8	vaccines	vaccine	NOUN
gsrj-41	168	9	and	and	CCONJ
gsrj-41	168	10	vaccination	vaccination	NOUN
gsrj-41	168	11	.	.	PUNCT
gsrj-41	169	1	(	(	PUNCT
gsrj-41	169	2	2021	2021	NUM
gsrj-41	169	3	,	,	PUNCT
gsrj-41	169	4	september	september	PROPN
gsrj-41	169	5	15	15	NUM
gsrj-41	169	6	)	)	PUNCT
gsrj-41	169	7	.	.	PUNCT
gsrj-41	169	8	retrieved	retrieve	VERB
gsrj-41	169	9	february	february	PROPN
gsrj-41	169	10	15	15	NUM
gsrj-41	169	11	,	,	PUNCT
gsrj-41	169	12	2022	2022	NUM
gsrj-41	169	13	,	,	PUNCT
gsrj-41	169	14	from	from	ADP
gsrj-41	169	15	https://www.cdc.gov/coronavirus/2019ncov/science/science-briefs/fully-vaccinatedpeople.html	https://www.cdc.gov/coronavirus/2019ncov/science/science-briefs/fully-vaccinatedpeople.html	NUM
gsrj-41	169	16	5	5	NUM
gsrj-41	169	17	.	.	PUNCT
gsrj-41	169	18	naleway	naleway	PROPN
gsrj-41	169	19	,	,	PUNCT
gsrj-41	169	20	a.	a.	NOUN
gsrj-41	169	21	l.	l.	PROPN
gsrj-41	169	22	(	(	PUNCT
gsrj-41	169	23	2021	2021	NUM
gsrj-41	169	24	)	)	PUNCT
gsrj-41	169	25	.	.	PUNCT
gsrj-41	170	1	incidence	incidence	NOUN
gsrj-41	170	2	of	of	ADP
gsrj-41	170	3	sarscov-2	sarscov-2	NUM
gsrj-41	170	4	infection	infection	NOUN
gsrj-41	170	5	,	,	PUNCT
gsrj-41	170	6	emergency	emergency	NOUN
gsrj-41	170	7	department	department	NOUN
gsrj-41	170	8	visits	visit	NOUN
gsrj-41	170	9	,	,	PUNCT
gsrj-41	170	10	and	and	CCONJ
gsrj-41	170	11	hospitalizations	hospitalization	NOUN
gsrj-41	170	12	because	because	SCONJ
gsrj-41	170	13	of	of	ADP
gsrj-41	170	14	covid-19	covid-19	PROPN
gsrj-41	170	15	among	among	ADP
gsrj-41	170	16	persons	person	NOUN
gsrj-41	170	17	aged	age	VERB
gsrj-41	170	18	≥12	≥12	ADP
gsrj-41	170	19	years	year	NOUN
gsrj-41	170	20	,	,	PUNCT
gsrj-41	170	21	by	by	ADP
gsrj-41	170	22	covid-19	covid-19	PROPN
gsrj-41	170	23	vaccination	vaccination	NOUN
gsrj-41	170	24	status	status	NOUN
gsrj-41	170	25	—	—	PUNCT
gsrj-41	170	26	oregon	oregon	PROPN
gsrj-41	170	27	and	and	CCONJ
gsrj-41	170	28	washington	washington	PROPN
gsrj-41	170	29	,	,	PUNCT
gsrj-41	170	30	july	july	PROPN
gsrj-41	170	31	4	4	NUM
gsrj-41	170	32	–	–	PUNCT
gsrj-41	170	33	september	september	PROPN
gsrj-41	170	34	25	25	NUM
gsrj-41	170	35	,	,	PUNCT
gsrj-41	170	36	2021	2021	NUM
gsrj-41	170	37	.	.	PUNCT
gsrj-41	171	1	mmwr	mmwr	NOUN
gsrj-41	171	2	.	.	PUNCT
gsrj-41	172	1	morbidity	morbidity	NOUN
gsrj-41	172	2	and	and	CCONJ
gsrj-41	172	3	mortality	mortality	NOUN
gsrj-41	172	4	weekly	weekly	ADJ
gsrj-41	172	5	report	report	NOUN
gsrj-41	172	6	,	,	PUNCT
gsrj-41	172	7	70	70	NUM
gsrj-41	172	8	.	.	PUNCT
gsrj-41	173	1	https://doi.org/10.15585/mmwr.mm7046a4	https://doi.org/10.15585/mmwr.mm7046a4	NOUN
gsrj-41	173	2	6	6	NUM
gsrj-41	173	3	.	.	PUNCT
gsrj-41	174	1	cdc	cdc	PROPN
gsrj-41	174	2	.	.	PUNCT
gsrj-41	175	1	(	(	PUNCT
gsrj-41	175	2	2022	2022	NUM
gsrj-41	175	3	,	,	PUNCT
gsrj-41	175	4	february	february	PROPN
gsrj-41	175	5	15	15	NUM
gsrj-41	175	6	)	)	PUNCT
gsrj-41	175	7	.	.	PUNCT
gsrj-41	176	1	covid	covid	PROPN
gsrj-41	176	2	data	data	PROPN
gsrj-41	176	3	tracker	tracker	PROPN
gsrj-41	176	4	.	.	PUNCT
gsrj-41	177	1	centers	center	NOUN
gsrj-41	177	2	for	for	ADP
gsrj-41	177	3	disease	disease	NOUN
gsrj-41	177	4	control	control	NOUN
gsrj-41	177	5	and	and	CCONJ
gsrj-41	177	6	prevention	prevention	NOUN
gsrj-41	177	7	.	.	PUNCT
gsrj-41	178	1	https://covid.cdc.gov/covid-datatracker	https://covid.cdc.gov/covid-datatracker	ADP
gsrj-41	178	2	7	7	NUM
gsrj-41	178	3	.	.	PUNCT
gsrj-41	179	1	cdc	cdc	PROPN
gsrj-41	179	2	.	.	PUNCT
gsrj-41	180	1	(	(	PUNCT
gsrj-41	180	2	2019	2019	NUM
gsrj-41	180	3	,	,	PUNCT
gsrj-41	180	4	october	october	PROPN
gsrj-41	180	5	30	30	NUM
gsrj-41	180	6	)	)	PUNCT
gsrj-41	180	7	.	.	PUNCT
gsrj-41	181	1	vaccinate	vaccinate	VERB
gsrj-41	181	2	with	with	ADP
gsrj-41	181	3	confidence	confidence	NOUN
gsrj-41	181	4	.	.	PUNCT
gsrj-41	182	1	centers	center	NOUN
gsrj-41	182	2	for	for	ADP
gsrj-41	182	3	disease	disease	NOUN
gsrj-41	182	4	control	control	NOUN
gsrj-41	182	5	and	and	CCONJ
gsrj-41	182	6	prevention	prevention	NOUN
gsrj-41	182	7	.	.	PUNCT
gsrj-41	183	1	https://www.cdc.gov/vaccines/partners/vaccinatewith-confidence.html	https://www.cdc.gov/vaccines/partners/vaccinatewith-confidence.html	PROPN
gsrj-41	183	2	8	8	NUM
gsrj-41	183	3	.	.	PUNCT
gsrj-41	184	1	cdc	cdc	PROPN
gsrj-41	184	2	.	.	PUNCT
gsrj-41	185	1	(	(	PUNCT
gsrj-41	185	2	2022	2022	NUM
gsrj-41	185	3	,	,	PUNCT
gsrj-41	185	4	february	february	PROPN
gsrj-41	185	5	15	15	NUM
gsrj-41	185	6	)	)	PUNCT
gsrj-41	185	7	.	.	PUNCT
gsrj-41	186	1	demographic	demographic	ADJ
gsrj-41	186	2	trends	trend	NOUN
gsrj-41	186	3	of	of	ADP
gsrj-41	186	4	people	people	NOUN
gsrj-41	186	5	receiving	receive	VERB
gsrj-41	186	6	covid-19	covid-19	PROPN
gsrj-41	186	7	vaccinations	vaccination	NOUN
gsrj-41	186	8	in	in	ADP
gsrj-41	186	9	the	the	DET
gsrj-41	186	10	united	united	PROPN
gsrj-41	186	11	states	states	PROPN
gsrj-41	186	12	.	.	PUNCT
gsrj-41	187	1	centers	center	NOUN
gsrj-41	187	2	for	for	ADP
gsrj-41	187	3	disease	disease	NOUN
gsrj-41	187	4	control	control	NOUN
gsrj-41	187	5	and	and	CCONJ
gsrj-41	187	6	prevention	prevention	NOUN
gsrj-41	187	7	.	.	PUNCT
gsrj-41	188	1	https://covid.cdc.gov/covid-datatracker/#vaccination-demographics-trends	https://covid.cdc.gov/covid-datatracker/#vaccination-demographics-trends	PROPN
gsrj-41	189	1	9	9	NUM
gsrj-41	189	2	.	.	PUNCT
gsrj-41	190	1	cdc	cdc	PROPN
gsrj-41	190	2	.	.	PUNCT
gsrj-41	191	1	(	(	PUNCT
gsrj-41	191	2	2022	2022	NUM
gsrj-41	191	3	,	,	PUNCT
gsrj-41	191	4	february	february	PROPN
gsrj-41	191	5	15	15	NUM
gsrj-41	191	6	)	)	PUNCT
gsrj-41	191	7	.	.	PUNCT
gsrj-41	192	1	covid-19	covid-19	PROPN
gsrj-41	192	2	vaccination	vaccination	NOUN
gsrj-41	192	3	equity	equity	NOUN
gsrj-41	192	4	.	.	PUNCT
gsrj-41	193	1	centers	center	NOUN
gsrj-41	193	2	for	for	ADP
gsrj-41	193	3	disease	disease	NOUN
gsrj-41	193	4	control	control	NOUN
gsrj-41	193	5	and	and	CCONJ
gsrj-41	193	6	prevention	prevention	NOUN
gsrj-41	193	7	.	.	PUNCT
gsrj-41	194	1	https://covid.cdc.gov/covid-datatracker/#vaccination-equity	https://covid.cdc.gov/covid-datatracker/#vaccination-equity	NOUN
gsrj-41	194	2	10	10	NUM
gsrj-41	194	3	.	.	PUNCT
gsrj-41	195	1	cdc	cdc	PROPN
gsrj-41	195	2	.	.	PUNCT
gsrj-41	196	1	(	(	PUNCT
gsrj-41	196	2	2022	2022	NUM
gsrj-41	196	3	,	,	PUNCT
gsrj-41	196	4	february	february	PROPN
gsrj-41	196	5	15	15	NUM
gsrj-41	196	6	)	)	PUNCT
gsrj-41	196	7	.	.	PUNCT
gsrj-41	197	1	covid-19	covid-19	PROPN
gsrj-41	197	2	integrated	integrate	VERB
gsrj-41	197	3	county	county	NOUN
gsrj-41	197	4	view	view	NOUN
gsrj-41	197	5	.	.	PUNCT
gsrj-41	198	1	centers	center	NOUN
gsrj-41	198	2	for	for	ADP
gsrj-41	198	3	disease	disease	NOUN
gsrj-41	198	4	control	control	NOUN
gsrj-41	198	5	and	and	CCONJ
gsrj-41	198	6	prevention	prevention	NOUN
gsrj-41	198	7	.	.	PUNCT
gsrj-41	199	1	https://covid.cdc.gov/covid-datatracker/#countyview?list_select_state=all_states&list_select_coun	https://covid.cdc.gov/covid-datatracker/#countyview?list_select_state=all_states&list_select_coun	NOUN
gsrj-41	200	1	ty	ty	PRON
gsrj-41	200	2	=	=	NUM
gsrj-41	200	3	all_counties&data	all_counties&data	NOUN
gsrj-41	200	4	-	-	PUNCT
gsrj-41	200	5	type	type	NOUN
gsrj-41	200	6	=	=	NOUN
gsrj-41	200	7	vaccinations	vaccination	NOUN
gsrj-41	200	8	21	21	NUM
gsrj-41	200	9	georgetown	georgetown	PROPN
gsrj-41	200	10	scientific	scientific	ADJ
gsrj-41	200	11	research	research	NOUN
gsrj-41	200	12	journal	journal	NOUN
gsrj-41	200	13	11	11	NUM
gsrj-41	200	14	.	.	PUNCT
gsrj-41	201	1	covid-19	covid-19	PROPN
gsrj-41	201	2	vaccination	vaccination	NOUN
gsrj-41	201	3	coverage	coverage	NOUN
gsrj-41	201	4	and	and	CCONJ
gsrj-41	201	5	vaccine	vaccine	NOUN
gsrj-41	201	6	confidence	confidence	NOUN
gsrj-41	201	7	among	among	ADP
gsrj-41	201	8	adults	adult	NOUN
gsrj-41	201	9	|	|	ADV
gsrj-41	201	10	cdc	cdc	PROPN
gsrj-41	201	11	.	.	PUNCT
gsrj-41	202	1	(	(	PUNCT
gsrj-41	202	2	2021	2021	NUM
gsrj-41	202	3	,	,	PUNCT
gsrj-41	202	4	november	november	PROPN
gsrj-41	202	5	30	30	NUM
gsrj-41	202	6	)	)	PUNCT
gsrj-41	202	7	.	.	PUNCT
gsrj-41	203	1	https://www.cdc.gov/vaccines/imzmanagers/coverage/covidvaxview/interactive/adul	https://www.cdc.gov/vaccines/imzmanagers/coverage/covidvaxview/interactive/adul	NOUN
gsrj-41	203	2	ts.html	ts.html	PRON
gsrj-41	204	1	12	12	NUM
gsrj-41	204	2	.	.	PUNCT
gsrj-41	205	1	herd	herd	NOUN
gsrj-41	205	2	immunity	immunity	NOUN
gsrj-41	205	3	and	and	CCONJ
gsrj-41	205	4	covid-19	covid-19	PROPN
gsrj-41	205	5	(	(	PUNCT
gsrj-41	205	6	coronavirus	coronavirus	NOUN
gsrj-41	205	7	):	):	PUNCT
gsrj-41	205	8	what	what	PRON
gsrj-41	205	9	you	you	PRON
gsrj-41	205	10	need	need	VERB
gsrj-41	205	11	to	to	PART
gsrj-41	205	12	know	know	VERB
gsrj-41	205	13	.	.	PUNCT
gsrj-41	206	1	(	(	PUNCT
gsrj-41	206	2	2021	2021	NUM
gsrj-41	206	3	)	)	PUNCT
gsrj-41	206	4	.	.	PUNCT
gsrj-41	207	1	mayo	mayo	PROPN
gsrj-41	207	2	clinic	clinic	PROPN
gsrj-41	207	3	.	.	PUNCT
gsrj-41	208	1	retrieved	retrieve	VERB
gsrj-41	208	2	november	november	PROPN
gsrj-41	208	3	14	14	NUM
gsrj-41	208	4	,	,	PUNCT
gsrj-41	208	5	2021	2021	NUM
gsrj-41	208	6	,	,	PUNCT
gsrj-41	208	7	from	from	ADP
gsrj-41	208	8	https://www.mayoclinic.org/diseasesconditions/coronavirus/in-depth/herd-immunityand-coronavirus/art-20486808	https://www.mayoclinic.org/diseasesconditions/coronavirus/in-depth/herd-immunityand-coronavirus/art-20486808	PROPN
gsrj-41	208	9	13	13	NUM
gsrj-41	208	10	.	.	PUNCT
gsrj-41	209	1	d’souza	d’souza	PROPN
gsrj-41	209	2	,	,	PUNCT
gsrj-41	209	3	g.	g.	PROPN
gsrj-41	209	4	,	,	PUNCT
gsrj-41	209	5	&	&	CCONJ
gsrj-41	209	6	dowdy	dowdy	ADJ
gsrj-41	209	7	,	,	PUNCT
gsrj-41	209	8	d.	d.	PROPN
gsrj-41	209	9	(	(	PUNCT
gsrj-41	209	10	2021	2021	NUM
gsrj-41	209	11	,	,	PUNCT
gsrj-41	209	12	september	september	PROPN
gsrj-41	209	13	13	13	NUM
gsrj-41	209	14	)	)	PUNCT
gsrj-41	209	15	.	.	PUNCT
gsrj-41	210	1	rethinking	rethink	VERB
gsrj-41	210	2	herd	herd	NOUN
gsrj-41	210	3	immunity	immunity	NOUN
gsrj-41	210	4	and	and	CCONJ
gsrj-41	210	5	the	the	DET
gsrj-41	210	6	covid19	covid19	NOUN
gsrj-41	210	7	response	response	NOUN
gsrj-41	210	8	end	end	PROPN
gsrj-41	210	9	game	game	NOUN
gsrj-41	210	10	|	|	PROPN
gsrj-41	210	11	johns	johns	PROPN
gsrj-41	210	12	hopkins	hopkins	PROPN
gsrj-41	210	13	bloomberg	bloomberg	PROPN
gsrj-41	210	14	school	school	PROPN
gsrj-41	210	15	of	of	ADP
gsrj-41	210	16	public	public	ADJ
gsrj-41	210	17	health	health	NOUN
gsrj-41	210	18	.	.	PUNCT
gsrj-41	211	1	https://publichealth.jhu.edu/2021/what-is-herdimmunity-and-how-can-we-achieve-it-withcovid-19	https://publichealth.jhu.edu/2021/what-is-herdimmunity-and-how-can-we-achieve-it-withcovid-19	PROPN
gsrj-41	211	2	14	14	NUM
gsrj-41	211	3	.	.	PUNCT
gsrj-41	212	1	vaccine	vaccine	NOUN
gsrj-41	212	2	equity	equity	NOUN
gsrj-41	212	3	.	.	PUNCT
gsrj-41	213	1	(	(	PUNCT
gsrj-41	213	2	n.d	n.d	PROPN
gsrj-41	213	3	.	.	PROPN
gsrj-41	213	4	)	)	PUNCT
gsrj-41	213	5	.	.	PUNCT
gsrj-41	214	1	retrieved	retrieve	VERB
gsrj-41	214	2	february	february	PROPN
gsrj-41	214	3	15	15	NUM
gsrj-41	214	4	,	,	PUNCT
gsrj-41	214	5	2022	2022	NUM
gsrj-41	214	6	,	,	PUNCT
gsrj-41	214	7	from	from	ADP
gsrj-41	214	8	https://www.who.int/campaigns/vaccine-equity	https://www.who.int/campaigns/vaccine-equity	NOUN
gsrj-41	214	9	15	15	NUM
gsrj-41	214	10	.	.	PUNCT
gsrj-41	215	1	fisher	fisher	PROPN
gsrj-41	215	2	,	,	PUNCT
gsrj-41	215	3	k.	k.	PROPN
gsrj-41	215	4	a.	a.	PROPN
gsrj-41	215	5	,	,	PUNCT
gsrj-41	215	6	bloomstone	bloomstone	PROPN
gsrj-41	215	7	,	,	PUNCT
gsrj-41	215	8	s.	s.	PROPN
gsrj-41	215	9	j.	j.	PROPN
gsrj-41	215	10	,	,	PUNCT
gsrj-41	215	11	walder	walder	NOUN
gsrj-41	215	12	,	,	PUNCT
gsrj-41	215	13	j.	j.	PROPN
gsrj-41	215	14	,	,	PUNCT
gsrj-41	215	15	crawford	crawford	PROPN
gsrj-41	215	16	,	,	PUNCT
gsrj-41	215	17	s.	s.	PROPN
gsrj-41	215	18	,	,	PUNCT
gsrj-41	215	19	fouayzi	fouayzi	PROPN
gsrj-41	215	20	,	,	PUNCT
gsrj-41	215	21	h.	h.	PROPN
gsrj-41	215	22	,	,	PUNCT
gsrj-41	215	23	&	&	CCONJ
gsrj-41	215	24	mazor	mazor	PROPN
gsrj-41	215	25	,	,	PUNCT
gsrj-41	215	26	k.	k.	PROPN
gsrj-41	215	27	m.	m.	PROPN
gsrj-41	215	28	(	(	PUNCT
gsrj-41	215	29	2020	2020	NUM
gsrj-41	215	30	)	)	PUNCT
gsrj-41	215	31	.	.	PUNCT
gsrj-41	216	1	attitudes	attitude	NOUN
gsrj-41	216	2	toward	toward	ADP
gsrj-41	216	3	a	a	DET
gsrj-41	216	4	potential	potential	ADJ
gsrj-41	216	5	sarscov-2	sarscov-2	NUM
gsrj-41	216	6	vaccine	vaccine	NOUN
gsrj-41	216	7	:	:	PUNCT
gsrj-41	216	8	a	a	DET
gsrj-41	216	9	survey	survey	NOUN
gsrj-41	216	10	of	of	ADP
gsrj-41	216	11	u.s	u.s	PROPN
gsrj-41	216	12	.	.	PROPN
gsrj-41	216	13	adults	adult	NOUN
gsrj-41	216	14	.	.	PUNCT
gsrj-41	217	1	annals	annal	NOUN
gsrj-41	217	2	of	of	ADP
gsrj-41	217	3	internal	internal	ADJ
gsrj-41	217	4	medicine	medicine	NOUN
gsrj-41	217	5	,	,	PUNCT
gsrj-41	217	6	173(12	173(12	NUM
gsrj-41	217	7	)	)	PUNCT
gsrj-41	217	8	,	,	PUNCT
gsrj-41	217	9	964–973	964–973	NUM
gsrj-41	217	10	.	.	PUNCT
gsrj-41	218	1	https://doi.org/10.7326/m20-3569	https://doi.org/10.7326/m20-3569	PROPN
gsrj-41	218	2	16	16	NUM
gsrj-41	218	3	.	.	PUNCT
gsrj-41	219	1	unroe	unroe	PROPN
gsrj-41	219	2	,	,	PUNCT
gsrj-41	219	3	k.	k.	PROPN
gsrj-41	219	4	t.	t.	PROPN
gsrj-41	219	5	,	,	PUNCT
gsrj-41	219	6	evans	evans	PROPN
gsrj-41	219	7	,	,	PUNCT
gsrj-41	219	8	r.	r.	PROPN
gsrj-41	219	9	,	,	PUNCT
gsrj-41	219	10	weaver	weaver	PROPN
gsrj-41	219	11	,	,	PUNCT
gsrj-41	219	12	l.	l.	PROPN
gsrj-41	219	13	,	,	PUNCT
gsrj-41	219	14	rusyniak	rusyniak	PROPN
gsrj-41	219	15	,	,	PUNCT
gsrj-41	219	16	d.	d.	PROPN
gsrj-41	219	17	,	,	PUNCT
gsrj-41	219	18	&	&	CCONJ
gsrj-41	219	19	blackburn	blackburn	PROPN
gsrj-41	219	20	,	,	PUNCT
gsrj-41	219	21	j.	j.	PROPN
gsrj-41	219	22	(	(	PUNCT
gsrj-41	219	23	2021	2021	NUM
gsrj-41	219	24	)	)	PUNCT
gsrj-41	219	25	.	.	PUNCT
gsrj-41	220	1	willingness	willingness	NOUN
gsrj-41	220	2	of	of	ADP
gsrj-41	220	3	longterm	longterm	PROPN
gsrj-41	220	4	care	care	NOUN
gsrj-41	220	5	staff	staff	NOUN
gsrj-41	220	6	to	to	PART
gsrj-41	220	7	receive	receive	VERB
gsrj-41	220	8	a	a	DET
gsrj-41	220	9	covid-19	covid-19	PROPN
gsrj-41	220	10	vaccine	vaccine	NOUN
gsrj-41	220	11	:	:	PUNCT
gsrj-41	220	12	a	a	DET
gsrj-41	220	13	single	single	ADJ
gsrj-41	220	14	state	state	NOUN
gsrj-41	220	15	survey	survey	NOUN
gsrj-41	220	16	.	.	PUNCT
gsrj-41	221	1	journal	journal	NOUN
gsrj-41	221	2	of	of	ADP
gsrj-41	221	3	the	the	DET
gsrj-41	221	4	american	american	ADJ
gsrj-41	221	5	geriatrics	geriatrics	PROPN
gsrj-41	221	6	society	society	NOUN
gsrj-41	221	7	,	,	PUNCT
gsrj-41	221	8	69(3	69(3	NUM
gsrj-41	221	9	)	)	PUNCT
gsrj-41	221	10	,	,	PUNCT
gsrj-41	221	11	593–599	593–599	NUM
gsrj-41	221	12	.	.	PUNCT
gsrj-41	222	1	https://doi.org/10.1111/jgs.17022	https://doi.org/10.1111/jgs.17022	PROPN
gsrj-41	222	2	17	17	NUM
gsrj-41	222	3	.	.	PUNCT
gsrj-41	223	1	zhang	zhang	PROPN
gsrj-41	223	2	,	,	PUNCT
gsrj-41	223	3	m.	m.	NOUN
gsrj-41	223	4	,	,	PUNCT
gsrj-41	223	5	gurung	gurung	PROPN
gsrj-41	223	6	,	,	PUNCT
gsrj-41	223	7	a.	a.	PROPN
gsrj-41	223	8	,	,	PUNCT
gsrj-41	223	9	anglewicz	anglewicz	PROPN
gsrj-41	223	10	,	,	PUNCT
gsrj-41	223	11	p.	p.	PROPN
gsrj-41	223	12	,	,	PUNCT
gsrj-41	223	13	subedi	subedi	PROPN
gsrj-41	223	14	,	,	PUNCT
gsrj-41	223	15	p.	p.	PROPN
gsrj-41	223	16	,	,	PUNCT
gsrj-41	223	17	payton	payton	PROPN
gsrj-41	223	18	,	,	PUNCT
gsrj-41	223	19	c.	c.	PROPN
gsrj-41	223	20	,	,	PUNCT
gsrj-41	223	21	ali	ali	PROPN
gsrj-41	223	22	,	,	PUNCT
gsrj-41	223	23	a.	a.	PROPN
gsrj-41	223	24	,	,	PUNCT
gsrj-41	223	25	ibrahim	ibrahim	PROPN
gsrj-41	223	26	,	,	PUNCT
gsrj-41	223	27	a.	a.	PROPN
gsrj-41	223	28	,	,	PUNCT
gsrj-41	223	29	haider	haider	PROPN
gsrj-41	223	30	,	,	PUNCT
gsrj-41	223	31	m.	m.	NOUN
gsrj-41	223	32	,	,	PUNCT
gsrj-41	223	33	hamidi	hamidi	NOUN
gsrj-41	223	34	,	,	PUNCT
gsrj-41	223	35	n.	n.	NOUN
gsrj-41	223	36	,	,	PUNCT
gsrj-41	223	37	atem	atem	NOUN
gsrj-41	223	38	,	,	PUNCT
gsrj-41	223	39	j.	j.	PROPN
gsrj-41	223	40	,	,	PUNCT
gsrj-41	223	41	thang	thang	PROPN
gsrj-41	223	42	,	,	PUNCT
gsrj-41	223	43	j.	j.	PROPN
gsrj-41	223	44	,	,	PUNCT
gsrj-41	223	45	wang	wang	PROPN
gsrj-41	223	46	,	,	PUNCT
gsrj-41	223	47	s.	s.	PROPN
gsrj-41	223	48	,	,	PUNCT
gsrj-41	223	49	kim	kim	PROPN
gsrj-41	223	50	,	,	PUNCT
gsrj-41	223	51	c.	c.	PROPN
gsrj-41	223	52	,	,	PUNCT
gsrj-41	223	53	kimball	kimball	PROPN
gsrj-41	223	54	,	,	PUNCT
gsrj-41	223	55	s.	s.	PROPN
gsrj-41	223	56	l.	l.	PROPN
gsrj-41	223	57	,	,	PUNCT
gsrj-41	223	58	karaki	karaki	PROPN
gsrj-41	223	59	,	,	PUNCT
gsrj-41	223	60	f.	f.	PROPN
gsrj-41	223	61	,	,	PUNCT
gsrj-41	223	62	nazhat	nazhat	PROPN
gsrj-41	223	63	,	,	PUNCT
gsrj-41	223	64	n.	n.	NOUN
gsrj-41	223	65	,	,	PUNCT
gsrj-41	223	66	abouagila	abouagila	PROPN
gsrj-41	223	67	,	,	PUNCT
gsrj-41	223	68	m.	m.	NOUN
gsrj-41	223	69	,	,	PUNCT
gsrj-41	223	70	&	&	CCONJ
gsrj-41	223	71	yun	yun	PROPN
gsrj-41	223	72	,	,	PUNCT
gsrj-41	223	73	k.	k.	PROPN
gsrj-41	223	74	(	(	PUNCT
gsrj-41	223	75	2021	2021	NUM
gsrj-41	223	76	)	)	PUNCT
gsrj-41	223	77	.	.	PUNCT
gsrj-41	224	1	acceptance	acceptance	NOUN
gsrj-41	224	2	of	of	ADP
gsrj-41	224	3	covid-19	covid-19	PROPN
gsrj-41	224	4	vaccine	vaccine	NOUN
gsrj-41	224	5	among	among	ADP
gsrj-41	224	6	refugees	refugee	NOUN
gsrj-41	224	7	in	in	ADP
gsrj-41	224	8	the	the	DET
gsrj-41	224	9	united	united	PROPN
gsrj-41	224	10	states	states	PROPN
gsrj-41	224	11	.	.	PUNCT
gsrj-41	225	1	public	public	ADJ
gsrj-41	225	2	health	health	NOUN
gsrj-41	225	3	reports	report	NOUN
gsrj-41	225	4	(	(	PUNCT
gsrj-41	225	5	washington	washington	PROPN
gsrj-41	225	6	,	,	PUNCT
gsrj-41	225	7	d.c	d.c	PROPN
gsrj-41	225	8	.	.	PUNCT
gsrj-41	225	9	:	:	PUNCT
gsrj-41	225	10	1974	1974	NUM
gsrj-41	225	11	)	)	PUNCT
gsrj-41	225	12	,	,	PUNCT
gsrj-41	225	13	136(6	136(6	NUM
gsrj-41	225	14	)	)	PUNCT
gsrj-41	225	15	,	,	PUNCT
gsrj-41	225	16	774–781	774–781	NUM
gsrj-41	225	17	.	.	PUNCT
gsrj-41	225	18	https://doi.org/10.1177/00333549211045838	https://doi.org/10.1177/00333549211045838	VERB
gsrj-41	225	19	18	18	NUM
gsrj-41	225	20	.	.	PUNCT
gsrj-41	225	21	solís	solís	PROPN
gsrj-41	225	22	arce	arce	PROPN
gsrj-41	225	23	,	,	PUNCT
gsrj-41	225	24	j.	j.	PROPN
gsrj-41	225	25	s.	s.	PROPN
gsrj-41	225	26	,	,	PUNCT
gsrj-41	225	27	warren	warren	PROPN
gsrj-41	225	28	,	,	PUNCT
gsrj-41	225	29	s.	s.	PROPN
gsrj-41	225	30	s.	s.	PROPN
gsrj-41	225	31	,	,	PUNCT
gsrj-41	225	32	meriggi	meriggi	PROPN
gsrj-41	225	33	,	,	PUNCT
gsrj-41	225	34	n.	n.	PROPN
gsrj-41	225	35	f.	f.	PROPN
gsrj-41	225	36	,	,	PUNCT
gsrj-41	225	37	scacco	scacco	PROPN
gsrj-41	225	38	,	,	PUNCT
gsrj-41	225	39	a.	a.	PROPN
gsrj-41	225	40	,	,	PUNCT
gsrj-41	225	41	mcmurry	mcmurry	PROPN
gsrj-41	225	42	,	,	PUNCT
gsrj-41	225	43	n.	n.	NOUN
gsrj-41	225	44	,	,	PUNCT
gsrj-41	225	45	voors	voor	NOUN
gsrj-41	225	46	,	,	PUNCT
gsrj-41	225	47	m.	m.	NOUN
gsrj-41	225	48	,	,	PUNCT
gsrj-41	225	49	syunyaev	syunyaev	PROPN
gsrj-41	225	50	,	,	PUNCT
gsrj-41	225	51	g.	g.	PROPN
gsrj-41	225	52	,	,	PUNCT
gsrj-41	225	53	malik	malik	PROPN
gsrj-41	225	54	,	,	PUNCT
gsrj-41	225	55	a.	a.	NOUN
gsrj-41	225	56	a.	a.	PROPN
gsrj-41	225	57	,	,	PUNCT
gsrj-41	225	58	aboutajdine	aboutajdine	PROPN
gsrj-41	225	59	,	,	PUNCT
gsrj-41	225	60	s.	s.	PROPN
gsrj-41	225	61	,	,	PUNCT
gsrj-41	225	62	adeojo	adeojo	NOUN
gsrj-41	225	63	,	,	PUNCT
gsrj-41	225	64	o.	o.	NOUN
gsrj-41	225	65	,	,	PUNCT
gsrj-41	225	66	anigo	anigo	PROPN
gsrj-41	225	67	,	,	PUNCT
gsrj-41	225	68	d.	d.	PROPN
gsrj-41	225	69	,	,	PUNCT
gsrj-41	225	70	armand	armand	PROPN
gsrj-41	225	71	,	,	PUNCT
gsrj-41	225	72	a.	a.	NOUN
gsrj-41	225	73	,	,	PUNCT
gsrj-41	225	74	asad	asad	PROPN
gsrj-41	225	75	,	,	PUNCT
gsrj-41	225	76	s.	s.	PROPN
gsrj-41	225	77	,	,	PUNCT
gsrj-41	225	78	atyera	atyera	NOUN
gsrj-41	225	79	,	,	PUNCT
gsrj-41	225	80	m.	m.	NOUN
gsrj-41	225	81	,	,	PUNCT
gsrj-41	225	82	augsburg	augsburg	PROPN
gsrj-41	225	83	,	,	PUNCT
gsrj-41	225	84	b.	b.	PROPN
gsrj-41	225	85	,	,	PUNCT
gsrj-41	225	86	awasthi	awasthi	PROPN
gsrj-41	225	87	,	,	PUNCT
gsrj-41	225	88	m.	m.	NOUN
gsrj-41	225	89	,	,	PUNCT
gsrj-41	225	90	ayesiga	ayesiga	ADV
gsrj-41	225	91	,	,	PUNCT
gsrj-41	225	92	g.	g.	PROPN
gsrj-41	225	93	e.	e.	PROPN
gsrj-41	225	94	,	,	PUNCT
gsrj-41	225	95	bancalari	bancalari	PROPN
gsrj-41	225	96	,	,	PUNCT
gsrj-41	225	97	a.	a.	NOUN
gsrj-41	225	98	,	,	PUNCT
gsrj-41	225	99	björkman	björkman	NOUN
gsrj-41	225	100	nyqvist	nyqvist	NOUN
gsrj-41	225	101	,	,	PUNCT
gsrj-41	225	102	m.	m.	NOUN
gsrj-41	225	103	,	,	PUNCT
gsrj-41	225	104	borisova	borisova	PROPN
gsrj-41	225	105	,	,	PUNCT
gsrj-41	225	106	e.	e.	PROPN
gsrj-41	225	107	,	,	PUNCT
gsrj-41	225	108	…	…	PUNCT
gsrj-41	225	109	omer	omer	PROPN
gsrj-41	225	110	,	,	PUNCT
gsrj-41	225	111	s.	s.	PROPN
gsrj-41	225	112	b.	b.	PROPN
gsrj-41	225	113	(	(	PUNCT
gsrj-41	225	114	2021	2021	NUM
gsrj-41	225	115	)	)	PUNCT
gsrj-41	225	116	.	.	PUNCT
gsrj-41	226	1	covid-19	covid-19	PROPN
gsrj-41	226	2	vaccine	vaccine	NOUN
gsrj-41	226	3	acceptance	acceptance	NOUN
gsrj-41	226	4	and	and	CCONJ
gsrj-41	226	5	hesitancy	hesitancy	NOUN
gsrj-41	226	6	in	in	ADP
gsrj-41	226	7	lowand	lowand	PROPN
gsrj-41	226	8	middleincome	middleincome	PROPN
gsrj-41	226	9	countries	country	NOUN
gsrj-41	226	10	.	.	PUNCT
gsrj-41	227	1	nature	nature	NOUN
gsrj-41	227	2	medicine	medicine	NOUN
gsrj-41	227	3	,	,	PUNCT
gsrj-41	227	4	27(8	27(8	NUM
gsrj-41	227	5	)	)	PUNCT
gsrj-41	227	6	,	,	PUNCT
gsrj-41	227	7	1385	1385	NUM
gsrj-41	227	8	–	–	PUNCT
gsrj-41	227	9	1394	1394	NUM
gsrj-41	227	10	.	.	PUNCT
gsrj-41	228	1	https://doi.org/10.1038/s41591-02101454-y	https://doi.org/10.1038/s41591-02101454-y	PROPN
gsrj-41	228	2	19	19	NUM
gsrj-41	228	3	.	.	PUNCT
gsrj-41	228	4	ehde	ehde	PROPN
gsrj-41	228	5	,	,	PUNCT
gsrj-41	228	6	d.	d.	PROPN
gsrj-41	228	7	m.	m.	PROPN
gsrj-41	228	8	,	,	PUNCT
gsrj-41	228	9	roberts	roberts	PROPN
gsrj-41	228	10	,	,	PUNCT
gsrj-41	228	11	m.	m.	PROPN
gsrj-41	228	12	k.	k.	PROPN
gsrj-41	228	13	,	,	PUNCT
gsrj-41	228	14	humbert	humbert	PROPN
gsrj-41	228	15	,	,	PUNCT
gsrj-41	228	16	a.	a.	NOUN
gsrj-41	228	17	t.	t.	PROPN
gsrj-41	228	18	,	,	PUNCT
gsrj-41	228	19	herring	herring	NOUN
gsrj-41	228	20	,	,	PUNCT
gsrj-41	228	21	t.	t.	PROPN
gsrj-41	228	22	e.	e.	PROPN
gsrj-41	228	23	,	,	PUNCT
gsrj-41	228	24	&	&	CCONJ
gsrj-41	228	25	alschuler	alschuler	PROPN
gsrj-41	228	26	,	,	PUNCT
gsrj-41	228	27	k.	k.	PROPN
gsrj-41	228	28	n.	n.	PROPN
gsrj-41	228	29	(	(	PUNCT
gsrj-41	228	30	2021	2021	NUM
gsrj-41	228	31	)	)	PUNCT
gsrj-41	228	32	.	.	PUNCT
gsrj-41	229	1	covid-19	covid-19	PROPN
gsrj-41	229	2	vaccine	vaccine	NOUN
gsrj-41	229	3	hesitancy	hesitancy	NOUN
gsrj-41	229	4	in	in	ADP
gsrj-41	229	5	adults	adult	NOUN
gsrj-41	229	6	with	with	ADP
gsrj-41	229	7	multiple	multiple	ADJ
gsrj-41	229	8	sclerosis	sclerosis	NOUN
gsrj-41	229	9	in	in	ADP
gsrj-41	229	10	the	the	DET
gsrj-41	229	11	united	united	PROPN
gsrj-41	229	12	states	states	PROPN
gsrj-41	229	13	:	:	PUNCT
gsrj-41	229	14	a	a	DET
gsrj-41	229	15	follow	follow	VERB
gsrj-41	229	16	up	up	ADP
gsrj-41	229	17	survey	survey	NOUN
gsrj-41	229	18	during	during	ADP
gsrj-41	229	19	the	the	DET
gsrj-41	229	20	initial	initial	ADJ
gsrj-41	229	21	vaccine	vaccine	NOUN
gsrj-41	229	22	rollout	rollout	NOUN
gsrj-41	229	23	in	in	ADP
gsrj-41	229	24	2021	2021	NUM
gsrj-41	229	25	.	.	PUNCT
gsrj-41	230	1	multiple	multiple	ADJ
gsrj-41	230	2	sclerosis	sclerosis	NOUN
gsrj-41	230	3	and	and	CCONJ
gsrj-41	230	4	related	related	ADJ
gsrj-41	230	5	disorders	disorder	NOUN
gsrj-41	230	6	,	,	PUNCT
gsrj-41	230	7	54	54	NUM
gsrj-41	230	8	,	,	PUNCT
gsrj-41	230	9	103163	103163	NUM
gsrj-41	230	10	.	.	PUNCT
gsrj-41	231	1	https://doi.org/10.1016/j.msard.2021.103163	https://doi.org/10.1016/j.msard.2021.103163	ADJ
gsrj-41	231	2	20	20	NUM
gsrj-41	231	3	.	.	PUNCT
gsrj-41	231	4	tram	tram	PROPN
gsrj-41	231	5	,	,	PUNCT
gsrj-41	231	6	k.	k.	PROPN
gsrj-41	231	7	h.	h.	PROPN
gsrj-41	231	8	,	,	PUNCT
gsrj-41	231	9	saeed	saeed	PROPN
gsrj-41	231	10	,	,	PUNCT
gsrj-41	231	11	s.	s.	PROPN
gsrj-41	231	12	,	,	PUNCT
gsrj-41	231	13	bradley	bradley	PROPN
gsrj-41	231	14	,	,	PUNCT
gsrj-41	231	15	c.	c.	PROPN
gsrj-41	231	16	,	,	PUNCT
gsrj-41	231	17	fox	fox	PROPN
gsrj-41	231	18	,	,	PUNCT
gsrj-41	231	19	b.	b.	PROPN
gsrj-41	231	20	,	,	PUNCT
gsrj-41	231	21	eshun	eshun	PROPN
gsrj-41	231	22	-	-	PUNCT
gsrj-41	231	23	wilson	wilson	PROPN
gsrj-41	231	24	,	,	PUNCT
gsrj-41	231	25	i.	i.	PROPN
gsrj-41	231	26	,	,	PUNCT
gsrj-41	231	27	mody	mody	PROPN
gsrj-41	231	28	,	,	PUNCT
gsrj-41	231	29	a.	a.	PROPN
gsrj-41	231	30	,	,	PUNCT
gsrj-41	231	31	&	&	CCONJ
gsrj-41	231	32	geng	geng	PROPN
gsrj-41	231	33	,	,	PUNCT
gsrj-41	231	34	e.	e.	PROPN
gsrj-41	231	35	(	(	PUNCT
gsrj-41	231	36	2021	2021	NUM
gsrj-41	231	37	)	)	PUNCT
gsrj-41	231	38	.	.	PUNCT
gsrj-41	232	1	deliberation	deliberation	NOUN
gsrj-41	232	2	,	,	PUNCT
gsrj-41	232	3	dissent	dissent	NOUN
gsrj-41	232	4	,	,	PUNCT
gsrj-41	232	5	and	and	CCONJ
gsrj-41	232	6	distrust	distrust	NOUN
gsrj-41	232	7	:	:	PUNCT
gsrj-41	232	8	understanding	understand	VERB
gsrj-41	232	9	distinct	distinct	ADJ
gsrj-41	232	10	drivers	driver	NOUN
gsrj-41	232	11	of	of	ADP
gsrj-41	232	12	covid-19	covid-19	PROPN
gsrj-41	232	13	vaccine	vaccine	NOUN
gsrj-41	232	14	hesitancy	hesitancy	NOUN
gsrj-41	232	15	in	in	ADP
gsrj-41	232	16	the	the	DET
gsrj-41	232	17	united	united	PROPN
gsrj-41	232	18	states	states	PROPN
gsrj-41	232	19	.	.	PUNCT
gsrj-41	233	1	clinical	clinical	ADJ
gsrj-41	233	2	infectious	infectious	ADJ
gsrj-41	233	3	diseases	disease	NOUN
gsrj-41	233	4	:	:	PUNCT
gsrj-41	233	5	an	an	DET
gsrj-41	233	6	official	official	ADJ
gsrj-41	233	7	publication	publication	NOUN
gsrj-41	233	8	of	of	ADP
gsrj-41	233	9	the	the	DET
gsrj-41	233	10	infectious	infectious	ADJ
gsrj-41	233	11	diseases	disease	NOUN
gsrj-41	233	12	society	society	NOUN
gsrj-41	233	13	of	of	ADP
gsrj-41	233	14	america	america	PROPN
gsrj-41	233	15	,	,	PUNCT
gsrj-41	233	16	ciab633	ciab633	PROPN
gsrj-41	233	17	.	.	PUNCT
gsrj-41	233	18	advance	advance	VERB
gsrj-41	233	19	online	online	ADJ
gsrj-41	233	20	publication	publication	NOUN
gsrj-41	233	21	.	.	PUNCT
gsrj-41	234	1	https://doi.org/10.1093/cid/ciab633	https://doi.org/10.1093/cid/ciab633	PROPN
gsrj-41	235	1	21	21	NUM
gsrj-41	235	2	.	.	PUNCT
gsrj-41	236	1	trent	trent	NOUN
gsrj-41	236	2	,	,	PUNCT
gsrj-41	236	3	m.	m.	NOUN
gsrj-41	236	4	,	,	PUNCT
gsrj-41	236	5	seale	seale	PROPN
gsrj-41	236	6	,	,	PUNCT
gsrj-41	236	7	h.	h.	PROPN
gsrj-41	236	8	,	,	PUNCT
gsrj-41	236	9	chughtai	chughtai	PROPN
gsrj-41	236	10	,	,	PUNCT
gsrj-41	236	11	a.	a.	NOUN
gsrj-41	236	12	a.	a.	PROPN
gsrj-41	236	13	,	,	PUNCT
gsrj-41	236	14	salmon	salmon	NOUN
gsrj-41	236	15	,	,	PUNCT
gsrj-41	236	16	d.	d.	PROPN
gsrj-41	236	17	,	,	PUNCT
gsrj-41	236	18	&	&	CCONJ
gsrj-41	236	19	macintyre	macintyre	PROPN
gsrj-41	236	20	,	,	PUNCT
gsrj-41	236	21	c.	c.	PROPN
gsrj-41	236	22	r.	r.	PROPN
gsrj-41	236	23	(	(	PUNCT
gsrj-41	236	24	2021	2021	NUM
gsrj-41	236	25	)	)	PUNCT
gsrj-41	236	26	.	.	PUNCT
gsrj-41	237	1	trust	trust	NOUN
gsrj-41	237	2	in	in	ADP
gsrj-41	237	3	government	government	NOUN
gsrj-41	237	4	,	,	PUNCT
gsrj-41	237	5	intention	intention	NOUN
gsrj-41	237	6	to	to	PART
gsrj-41	237	7	vaccinate	vaccinate	VERB
gsrj-41	237	8	and	and	CCONJ
gsrj-41	237	9	covid19	covid19	NOUN
gsrj-41	237	10	vaccine	vaccine	NOUN
gsrj-41	237	11	hesitancy	hesitancy	NOUN
gsrj-41	237	12	:	:	PUNCT
gsrj-41	237	13	a	a	DET
gsrj-41	237	14	comparative	comparative	ADJ
gsrj-41	237	15	survey	survey	NOUN
gsrj-41	237	16	of	of	ADP
gsrj-41	237	17	five	five	NUM
gsrj-41	237	18	large	large	ADJ
gsrj-41	237	19	cities	city	NOUN
gsrj-41	237	20	in	in	ADP
gsrj-41	237	21	the	the	DET
gsrj-41	237	22	united	united	PROPN
gsrj-41	237	23	states	states	PROPN
gsrj-41	237	24	,	,	PUNCT
gsrj-41	237	25	united	united	ADJ
gsrj-41	237	26	kingdom	kingdom	PROPN
gsrj-41	237	27	,	,	PUNCT
gsrj-41	237	28	and	and	CCONJ
gsrj-41	237	29	australia	australia	PROPN
gsrj-41	237	30	.	.	PUNCT
gsrj-41	238	1	vaccine	vaccine	NOUN
gsrj-41	238	2	,	,	PUNCT
gsrj-41	238	3	s0264410x(21)00798	s0264410x(21)00798	PROPN
gsrj-41	238	4	-	-	PUNCT
gsrj-41	238	5	2	2	NUM
gsrj-41	238	6	.	.	PUNCT
gsrj-41	238	7	advance	advance	VERB
gsrj-41	238	8	online	online	ADJ
gsrj-41	238	9	publication	publication	NOUN
gsrj-41	238	10	.	.	PUNCT
gsrj-41	239	1	https://doi.org/10.1016/j.vaccine.2021.06.048	https://doi.org/10.1016/j.vaccine.2021.06.048	ADJ
gsrj-41	239	2	22	22	NUM
gsrj-41	239	3	.	.	PUNCT
gsrj-41	240	1	king	king	PROPN
gsrj-41	240	2	,	,	PUNCT
gsrj-41	240	3	w.	w.	PROPN
gsrj-41	240	4	c.	c.	PROPN
gsrj-41	240	5	,	,	PUNCT
gsrj-41	240	6	rubinstein	rubinstein	PROPN
gsrj-41	240	7	,	,	PUNCT
gsrj-41	240	8	m.	m.	NOUN
gsrj-41	240	9	,	,	PUNCT
gsrj-41	240	10	reinhart	reinhart	PROPN
gsrj-41	240	11	,	,	PUNCT
gsrj-41	240	12	a.	a.	PROPN
gsrj-41	240	13	,	,	PUNCT
gsrj-41	240	14	&	&	CCONJ
gsrj-41	240	15	mejia	mejia	PROPN
gsrj-41	240	16	,	,	PUNCT
gsrj-41	240	17	r.	r.	PROPN
gsrj-41	240	18	(	(	PUNCT
gsrj-41	240	19	2021	2021	NUM
gsrj-41	240	20	)	)	PUNCT
gsrj-41	240	21	.	.	PUNCT
gsrj-41	241	1	covid-19	covid-19	PROPN
gsrj-41	241	2	vaccine	vaccine	NOUN
gsrj-41	241	3	hesitancy	hesitancy	NOUN
gsrj-41	241	4	january	january	PROPN
gsrj-41	241	5	-	-	PUNCT
gsrj-41	241	6	may	may	AUX
gsrj-41	241	7	2021	2021	NUM
gsrj-41	241	8	among	among	ADP
gsrj-41	241	9	18	18	NUM
gsrj-41	241	10	-	-	SYM
gsrj-41	241	11	64	64	NUM
gsrj-41	241	12	year	year	NOUN
gsrj-41	241	13	old	old	ADJ
gsrj-41	241	14	us	us	PROPN
gsrj-41	241	15	adults	adult	NOUN
gsrj-41	241	16	by	by	ADP
gsrj-41	241	17	employment	employment	NOUN
gsrj-41	241	18	and	and	CCONJ
gsrj-41	241	19	occupation	occupation	NOUN
gsrj-41	241	20	.	.	PUNCT
gsrj-41	242	1	preventive	preventive	ADJ
gsrj-41	242	2	medicine	medicine	NOUN
gsrj-41	242	3	reports	report	NOUN
gsrj-41	242	4	,	,	PUNCT
gsrj-41	242	5	24	24	NUM
gsrj-41	242	6	,	,	PUNCT
gsrj-41	242	7	101569	101569	NUM
gsrj-41	242	8	.	.	PUNCT
gsrj-41	243	1	https://doi.org/10.1016/j.pmedr.2021.101569	https://doi.org/10.1016/j.pmedr.2021.101569	PROPN
gsrj-41	243	2	23	23	NUM
gsrj-41	243	3	.	.	PUNCT
gsrj-41	244	1	harrison	harrison	PROPN
gsrj-41	244	2	,	,	PUNCT
gsrj-41	244	3	j.	j.	PROPN
gsrj-41	244	4	,	,	PUNCT
gsrj-41	244	5	berry	berry	PROPN
gsrj-41	244	6	,	,	PUNCT
gsrj-41	244	7	s.	s.	PROPN
gsrj-41	244	8	,	,	PUNCT
gsrj-41	244	9	mor	mor	PROPN
gsrj-41	244	10	,	,	PUNCT
gsrj-41	244	11	v.	v.	ADJ
gsrj-41	244	12	,	,	PUNCT
gsrj-41	244	13	&	&	CCONJ
gsrj-41	244	14	gifford	gifford	PROPN
gsrj-41	244	15	,	,	PUNCT
gsrj-41	244	16	d.	d.	PROPN
gsrj-41	244	17	(	(	PUNCT
gsrj-41	244	18	2021	2021	NUM
gsrj-41	244	19	)	)	PUNCT
gsrj-41	244	20	.	.	PUNCT
gsrj-41	245	1	"	"	PUNCT
gsrj-41	245	2	somebody	somebody	PRON
gsrj-41	245	3	like	like	ADP
gsrj-41	245	4	me	i	PRON
gsrj-41	245	5	"	"	PUNCT
gsrj-41	245	6	:	:	PUNCT
gsrj-41	245	7	understanding	understand	VERB
gsrj-41	245	8	covid-19	covid-19	PROPN
gsrj-41	245	9	vaccine	vaccine	NOUN
gsrj-41	245	10	hesitancy	hesitancy	NOUN
gsrj-41	245	11	among	among	ADP
gsrj-41	245	12	staff	staff	NOUN
gsrj-41	245	13	in	in	ADP
gsrj-41	245	14	skilled	skilled	ADJ
gsrj-41	245	15	nursing	nursing	NOUN
gsrj-41	245	16	facilities	facility	NOUN
gsrj-41	245	17	.	.	PUNCT
gsrj-41	246	1	journal	journal	NOUN
gsrj-41	246	2	of	of	ADP
gsrj-41	246	3	the	the	DET
gsrj-41	246	4	american	american	PROPN
gsrj-41	246	5	medical	medical	PROPN
gsrj-41	246	6	directors	directors	PROPN
gsrj-41	246	7	association	association	PROPN
gsrj-41	246	8	,	,	PUNCT
gsrj-41	246	9	22(6	22(6	NUM
gsrj-41	246	10	)	)	PUNCT
gsrj-41	246	11	,	,	PUNCT
gsrj-41	246	12	1133–1137	1133–1137	NUM
gsrj-41	246	13	.	.	PUNCT
gsrj-41	247	1	https://doi.org/10.1016/j.jamda.2021.03.012	https://doi.org/10.1016/j.jamda.2021.03.012	PROPN
gsrj-41	247	2	24	24	NUM
gsrj-41	247	3	.	.	PUNCT
gsrj-41	247	4	momplaisir	momplaisir	PROPN
gsrj-41	247	5	,	,	PUNCT
gsrj-41	247	6	f.	f.	PROPN
gsrj-41	247	7	m.	m.	PROPN
gsrj-41	247	8	,	,	PUNCT
gsrj-41	247	9	kuter	kuter	PROPN
gsrj-41	247	10	,	,	PUNCT
gsrj-41	247	11	b.	b.	PROPN
gsrj-41	247	12	j.	j.	PROPN
gsrj-41	247	13	,	,	PUNCT
gsrj-41	247	14	ghadimi	ghadimi	PROPN
gsrj-41	247	15	,	,	PUNCT
gsrj-41	247	16	f.	f.	PROPN
gsrj-41	247	17	,	,	PUNCT
gsrj-41	247	18	browne	browne	PROPN
gsrj-41	247	19	,	,	PUNCT
gsrj-41	247	20	s.	s.	PROPN
gsrj-41	247	21	,	,	PUNCT
gsrj-41	247	22	nkwihoreze	nkwihoreze	VERB
gsrj-41	247	23	,	,	PUNCT
gsrj-41	247	24	h.	h.	PROPN
gsrj-41	247	25	,	,	PUNCT
gsrj-41	247	26	feemster	feemster	PROPN
gsrj-41	247	27	,	,	PUNCT
gsrj-41	247	28	k.	k.	PROPN
gsrj-41	247	29	a.	a.	PROPN
gsrj-41	247	30	,	,	PUNCT
gsrj-41	247	31	22	22	NUM
gsrj-41	247	32	georgetown	georgetown	PROPN
gsrj-41	247	33	scientific	scientific	PROPN
gsrj-41	247	34	research	research	PROPN
gsrj-41	247	35	journal	journal	PROPN
gsrj-41	247	36	frank	frank	PROPN
gsrj-41	247	37	,	,	PUNCT
gsrj-41	247	38	i.	i.	PROPN
gsrj-41	247	39	,	,	PUNCT
gsrj-41	247	40	faig	faig	PROPN
gsrj-41	247	41	,	,	PUNCT
gsrj-41	247	42	w.	w.	PROPN
gsrj-41	247	43	,	,	PUNCT
gsrj-41	247	44	shen	shen	PROPN
gsrj-41	247	45	,	,	PUNCT
gsrj-41	247	46	a.	a.	PROPN
gsrj-41	247	47	k.	k.	PROPN
gsrj-41	247	48	,	,	PUNCT
gsrj-41	247	49	offit	offit	ADJ
gsrj-41	247	50	,	,	PUNCT
gsrj-41	247	51	p.	p.	NOUN
gsrj-41	247	52	a.	a.	NOUN
gsrj-41	247	53	,	,	PUNCT
gsrj-41	247	54	&	&	CCONJ
gsrj-41	247	55	green	green	PROPN
gsrj-41	247	56	-	-	PUNCT
gsrj-41	247	57	mckenzie	mckenzie	NOUN
gsrj-41	247	58	,	,	PUNCT
gsrj-41	247	59	j.	j.	PROPN
gsrj-41	247	60	(	(	PUNCT
gsrj-41	247	61	2021	2021	NUM
gsrj-41	247	62	)	)	PUNCT
gsrj-41	247	63	.	.	PUNCT
gsrj-41	248	1	racial	racial	ADJ
gsrj-41	248	2	/	/	SYM
gsrj-41	248	3	ethnic	ethnic	ADJ
gsrj-41	248	4	differences	difference	NOUN
gsrj-41	248	5	in	in	ADP
gsrj-41	248	6	covid-19	covid-19	PROPN
gsrj-41	248	7	vaccine	vaccine	NOUN
gsrj-41	248	8	hesitancy	hesitancy	NOUN
gsrj-41	248	9	among	among	ADP
gsrj-41	248	10	health	health	NOUN
gsrj-41	248	11	care	care	NOUN
gsrj-41	248	12	workers	worker	NOUN
gsrj-41	248	13	in	in	ADP
gsrj-41	248	14	2	2	NUM
gsrj-41	248	15	large	large	ADJ
gsrj-41	248	16	academic	academic	ADJ
gsrj-41	248	17	hospitals	hospital	NOUN
gsrj-41	248	18	.	.	PUNCT
gsrj-41	249	1	jama	jama	PROPN
gsrj-41	249	2	network	network	PROPN
gsrj-41	249	3	open	open	VERB
gsrj-41	249	4	,	,	PUNCT
gsrj-41	249	5	4(8	4(8	NUM
gsrj-41	249	6	)	)	PUNCT
gsrj-41	249	7	,	,	PUNCT
gsrj-41	249	8	e2121931	e2121931	PROPN
gsrj-41	249	9	.	.	PUNCT
gsrj-41	250	1	https://doi.org/10.1001/jamanetworkopen.2021.2	https://doi.org/10.1001/jamanetworkopen.2021.2	NOUN
gsrj-41	250	2	1931	1931	NUM
gsrj-41	250	3	25	25	NUM
gsrj-41	250	4	.	.	PUNCT
gsrj-41	251	1	nguyen	nguyen	PROPN
gsrj-41	251	2	,	,	PUNCT
gsrj-41	251	3	k.	k.	PROPN
gsrj-41	251	4	h.	h.	PROPN
gsrj-41	251	5	,	,	PUNCT
gsrj-41	251	6	srivastav	srivastav	VERB
gsrj-41	251	7	,	,	PUNCT
gsrj-41	251	8	a.	a.	NOUN
gsrj-41	251	9	,	,	PUNCT
gsrj-41	251	10	razzaghi	razzaghi	PROPN
gsrj-41	251	11	,	,	PUNCT
gsrj-41	251	12	h.	h.	PROPN
gsrj-41	251	13	,	,	PUNCT
gsrj-41	251	14	williams	williams	PROPN
gsrj-41	251	15	,	,	PUNCT
gsrj-41	251	16	w.	w.	PROPN
gsrj-41	251	17	,	,	PUNCT
gsrj-41	251	18	lindley	lindley	PROPN
gsrj-41	251	19	,	,	PUNCT
gsrj-41	251	20	m.	m.	PROPN
gsrj-41	251	21	c.	c.	PROPN
gsrj-41	251	22	,	,	PUNCT
gsrj-41	251	23	jorgensen	jorgensen	PROPN
gsrj-41	251	24	,	,	PUNCT
gsrj-41	251	25	c.	c.	PROPN
gsrj-41	251	26	,	,	PUNCT
gsrj-41	251	27	abad	abad	PROPN
gsrj-41	251	28	,	,	PUNCT
gsrj-41	251	29	n.	n.	PROPN
gsrj-41	251	30	,	,	PUNCT
gsrj-41	251	31	&	&	CCONJ
gsrj-41	251	32	singleton	singleton	PROPN
gsrj-41	251	33	,	,	PUNCT
gsrj-41	251	34	j.	j.	PROPN
gsrj-41	251	35	a.	a.	PROPN
gsrj-41	251	36	(	(	PUNCT
gsrj-41	251	37	2021b	2021b	NUM
gsrj-41	251	38	)	)	PUNCT
gsrj-41	251	39	.	.	PUNCT
gsrj-41	252	1	covid19	covid19	NOUN
gsrj-41	252	2	vaccination	vaccination	NOUN
gsrj-41	252	3	intent	intent	NOUN
gsrj-41	252	4	,	,	PUNCT
gsrj-41	252	5	perceptions	perception	NOUN
gsrj-41	252	6	,	,	PUNCT
gsrj-41	252	7	and	and	CCONJ
gsrj-41	252	8	reasons	reason	NOUN
gsrj-41	252	9	for	for	ADP
gsrj-41	252	10	not	not	PART
gsrj-41	252	11	vaccinating	vaccinate	VERB
gsrj-41	252	12	among	among	ADP
gsrj-41	252	13	groups	group	NOUN
gsrj-41	252	14	prioritized	prioritize	VERB
gsrj-41	252	15	for	for	ADP
gsrj-41	252	16	early	early	ADJ
gsrj-41	252	17	vaccination	vaccination	NOUN
gsrj-41	252	18	united	united	PROPN
gsrj-41	252	19	states	states	PROPN
gsrj-41	252	20	,	,	PUNCT
gsrj-41	252	21	september	september	PROPN
gsrj-41	252	22	and	and	CCONJ
gsrj-41	252	23	december	december	PROPN
gsrj-41	252	24	2020	2020	NUM
gsrj-41	252	25	.	.	PUNCT
gsrj-41	253	1	american	american	ADJ
gsrj-41	253	2	journal	journal	PROPN
gsrj-41	253	3	of	of	ADP
gsrj-41	253	4	transplantation	transplantation	NOUN
gsrj-41	253	5	:	:	PUNCT
gsrj-41	253	6	official	official	ADJ
gsrj-41	253	7	journal	journal	NOUN
gsrj-41	253	8	of	of	ADP
gsrj-41	253	9	the	the	DET
gsrj-41	253	10	american	american	ADJ
gsrj-41	253	11	society	society	NOUN
gsrj-41	253	12	of	of	ADP
gsrj-41	253	13	transplantation	transplantation	NOUN
gsrj-41	253	14	and	and	CCONJ
gsrj-41	253	15	the	the	DET
gsrj-41	253	16	american	american	ADJ
gsrj-41	253	17	society	society	NOUN
gsrj-41	253	18	of	of	ADP
gsrj-41	253	19	transplant	transplant	NOUN
gsrj-41	253	20	surgeons	surgeon	NOUN
gsrj-41	253	21	,	,	PUNCT
gsrj-41	253	22	21(4	21(4	NUM
gsrj-41	253	23	)	)	PUNCT
gsrj-41	253	24	,	,	PUNCT
gsrj-41	253	25	1650	1650	NUM
gsrj-41	253	26	–	–	PUNCT
gsrj-41	253	27	1656	1656	NUM
gsrj-41	253	28	.	.	PUNCT
gsrj-41	254	1	https://doi.org/10.1111/ajt.16560	https://doi.org/10.1111/ajt.16560	PROPN
gsrj-41	254	2	26	26	NUM
gsrj-41	254	3	.	.	PUNCT
gsrj-41	255	1	mondal	mondal	PROPN
gsrj-41	255	2	,	,	PUNCT
gsrj-41	255	3	p.	p.	PROPN
gsrj-41	255	4	,	,	PUNCT
gsrj-41	255	5	sinharoy	sinharoy	NOUN
gsrj-41	255	6	,	,	PUNCT
gsrj-41	255	7	a.	a.	NOUN
gsrj-41	255	8	,	,	PUNCT
gsrj-41	255	9	&	&	CCONJ
gsrj-41	255	10	su	su	PROPN
gsrj-41	255	11	,	,	PUNCT
gsrj-41	255	12	l.	l.	PROPN
gsrj-41	255	13	(	(	PUNCT
gsrj-41	255	14	2021	2021	NUM
gsrj-41	255	15	)	)	PUNCT
gsrj-41	255	16	.	.	PUNCT
gsrj-41	256	1	sociodemographic	sociodemographic	ADJ
gsrj-41	256	2	predictors	predictor	NOUN
gsrj-41	256	3	of	of	ADP
gsrj-41	256	4	covid-19	covid-19	PROPN
gsrj-41	256	5	vaccine	vaccine	NOUN
gsrj-41	256	6	acceptance	acceptance	NOUN
gsrj-41	256	7	:	:	PUNCT
gsrj-41	256	8	a	a	DET
gsrj-41	256	9	nationwide	nationwide	ADJ
gsrj-41	256	10	us	us	PROPN
gsrj-41	256	11	-	-	PUNCT
gsrj-41	256	12	based	base	VERB
gsrj-41	256	13	survey	survey	NOUN
gsrj-41	256	14	study	study	NOUN
gsrj-41	256	15	.	.	PUNCT
gsrj-41	257	1	public	public	ADJ
gsrj-41	257	2	health	health	NOUN
gsrj-41	257	3	,	,	PUNCT
gsrj-41	257	4	198	198	NUM
gsrj-41	257	5	,	,	PUNCT
gsrj-41	257	6	252–259	252–259	NUM
gsrj-41	257	7	.	.	PUNCT
gsrj-41	258	1	https://doi.org/10.1016/j.puhe.2021.07.028	https://doi.org/10.1016/j.puhe.2021.07.028	ADJ
gsrj-41	258	2	27	27	NUM
gsrj-41	258	3	.	.	PUNCT
gsrj-41	258	4	nguyen	nguyen	PROPN
gsrj-41	258	5	,	,	PUNCT
gsrj-41	258	6	k.	k.	PROPN
gsrj-41	258	7	h.	h.	PROPN
gsrj-41	258	8	,	,	PUNCT
gsrj-41	258	9	nguyen	nguyen	PROPN
gsrj-41	258	10	,	,	PUNCT
gsrj-41	258	11	k.	k.	PROPN
gsrj-41	258	12	,	,	PUNCT
gsrj-41	258	13	corlin	corlin	PROPN
gsrj-41	258	14	,	,	PUNCT
gsrj-41	258	15	l.	l.	PROPN
gsrj-41	258	16	,	,	PUNCT
gsrj-41	258	17	allen	allen	PROPN
gsrj-41	258	18	,	,	PUNCT
gsrj-41	258	19	j.	j.	PROPN
gsrj-41	258	20	d.	d.	PROPN
gsrj-41	258	21	,	,	PUNCT
gsrj-41	258	22	&	&	CCONJ
gsrj-41	258	23	chung	chung	PROPN
gsrj-41	258	24	,	,	PUNCT
gsrj-41	258	25	m.	m.	NOUN
gsrj-41	258	26	(	(	PUNCT
gsrj-41	258	27	2021a	2021a	NUM
gsrj-41	258	28	)	)	PUNCT
gsrj-41	258	29	.	.	PUNCT
gsrj-41	259	1	changes	change	NOUN
gsrj-41	259	2	in	in	ADP
gsrj-41	259	3	covid19	covid19	NOUN
gsrj-41	259	4	vaccination	vaccination	NOUN
gsrj-41	259	5	receipt	receipt	NOUN
gsrj-41	259	6	and	and	CCONJ
gsrj-41	259	7	intention	intention	NOUN
gsrj-41	259	8	to	to	PART
gsrj-41	259	9	vaccinate	vaccinate	VERB
gsrj-41	259	10	by	by	ADP
gsrj-41	259	11	socioeconomic	socioeconomic	ADJ
gsrj-41	259	12	characteristics	characteristic	NOUN
gsrj-41	259	13	and	and	CCONJ
gsrj-41	259	14	geographic	geographic	ADJ
gsrj-41	259	15	area	area	NOUN
gsrj-41	259	16	,	,	PUNCT
gsrj-41	259	17	united	united	PROPN
gsrj-41	259	18	states	states	PROPN
gsrj-41	259	19	,	,	PUNCT
gsrj-41	259	20	january	january	PROPN
gsrj-41	259	21	6	6	NUM
gsrj-41	259	22	march	march	NOUN
gsrj-41	259	23	29	29	NUM
gsrj-41	259	24	,	,	PUNCT
gsrj-41	259	25	2021	2021	NUM
gsrj-41	259	26	.	.	PUNCT
gsrj-41	260	1	annals	annal	NOUN
gsrj-41	260	2	of	of	ADP
gsrj-41	260	3	medicine	medicine	NOUN
gsrj-41	260	4	,	,	PUNCT
gsrj-41	260	5	53(1	53(1	NOUN
gsrj-41	260	6	)	)	PUNCT
gsrj-41	260	7	,	,	PUNCT
gsrj-41	260	8	1419–1428	1419–1428	NUM
gsrj-41	260	9	.	.	PUNCT
gsrj-41	261	1	https://doi.org/10.1080/07853890.2021.1957998	https://doi.org/10.1080/07853890.2021.1957998	PROPN
gsrj-41	261	2	28	28	NUM
gsrj-41	261	3	.	.	PUNCT
gsrj-41	262	1	iadarola	iadarola	PROPN
gsrj-41	262	2	,	,	PUNCT
gsrj-41	262	3	s.	s.	PROPN
gsrj-41	262	4	,	,	PUNCT
gsrj-41	262	5	siegel	siegel	PROPN
gsrj-41	262	6	,	,	PUNCT
gsrj-41	262	7	j.	j.	PROPN
gsrj-41	262	8	f.	f.	PROPN
gsrj-41	262	9	,	,	PUNCT
gsrj-41	262	10	gao	gao	PROPN
gsrj-41	262	11	,	,	PUNCT
gsrj-41	262	12	q.	q.	PROPN
gsrj-41	262	13	,	,	PUNCT
gsrj-41	262	14	mcgrath	mcgrath	PROPN
gsrj-41	262	15	,	,	PUNCT
gsrj-41	262	16	k.	k.	PROPN
gsrj-41	262	17	,	,	PUNCT
gsrj-41	262	18	&	&	CCONJ
gsrj-41	262	19	bonuck	bonuck	PROPN
gsrj-41	262	20	,	,	PUNCT
gsrj-41	262	21	k.	k.	PROPN
gsrj-41	262	22	a.	a.	PROPN
gsrj-41	262	23	(	(	PUNCT
gsrj-41	262	24	2021	2021	NUM
gsrj-41	262	25	)	)	PUNCT
gsrj-41	262	26	.	.	PUNCT
gsrj-41	263	1	covid-19	covid-19	PROPN
gsrj-41	263	2	vaccine	vaccine	NOUN
gsrj-41	263	3	perceptions	perception	NOUN
gsrj-41	263	4	in	in	ADP
gsrj-41	263	5	new	new	PROPN
gsrj-41	263	6	york	york	PROPN
gsrj-41	263	7	state	state	PROPN
gsrj-41	263	8	's	's	PART
gsrj-41	263	9	intellectual	intellectual	ADJ
gsrj-41	263	10	and	and	CCONJ
gsrj-41	263	11	developmental	developmental	ADJ
gsrj-41	263	12	disabilities	disability	NOUN
gsrj-41	263	13	community	community	NOUN
gsrj-41	263	14	.	.	PUNCT
gsrj-41	264	1	disability	disability	NOUN
gsrj-41	264	2	and	and	CCONJ
gsrj-41	264	3	health	health	NOUN
gsrj-41	264	4	journal	journal	NOUN
gsrj-41	264	5	,	,	PUNCT
gsrj-41	264	6	101178	101178	NUM
gsrj-41	264	7	.	.	PUNCT
gsrj-41	265	1	advance	advance	VERB
gsrj-41	265	2	online	online	ADJ
gsrj-41	265	3	publication	publication	NOUN
gsrj-41	265	4	.	.	PUNCT
gsrj-41	266	1	https://doi.org/10.1016/j.dhjo.2021.101178	https://doi.org/10.1016/j.dhjo.2021.101178	ADV
gsrj-41	266	2	29	29	NUM
gsrj-41	266	3	.	.	PUNCT
gsrj-41	267	1	scott	scott	PROPN
gsrj-41	267	2	,	,	PUNCT
gsrj-41	267	3	e.	e.	PROPN
gsrj-41	267	4	m.	m.	PROPN
gsrj-41	267	5	,	,	PUNCT
gsrj-41	267	6	stein	stein	PROPN
gsrj-41	267	7	,	,	PUNCT
gsrj-41	267	8	r.	r.	PROPN
gsrj-41	267	9	,	,	PUNCT
gsrj-41	267	10	brown	brown	PROPN
gsrj-41	267	11	,	,	PUNCT
gsrj-41	267	12	m.	m.	PROPN
gsrj-41	267	13	f.	f.	PROPN
gsrj-41	267	14	,	,	PUNCT
gsrj-41	267	15	hershberger	hershberger	PROPN
gsrj-41	267	16	,	,	PUNCT
gsrj-41	267	17	j.	j.	PROPN
gsrj-41	267	18	,	,	PUNCT
gsrj-41	267	19	scott	scott	PROPN
gsrj-41	267	20	,	,	PUNCT
gsrj-41	267	21	e.	e.	PROPN
gsrj-41	267	22	m.	m.	PROPN
gsrj-41	267	23	,	,	PUNCT
gsrj-41	267	24	&	&	CCONJ
gsrj-41	267	25	wenger	wenger	PROPN
gsrj-41	267	26	,	,	PUNCT
gsrj-41	267	27	o.	o.	PROPN
gsrj-41	267	28	k.	k.	PROPN
gsrj-41	267	29	(	(	PUNCT
gsrj-41	267	30	2021	2021	NUM
gsrj-41	267	31	)	)	PUNCT
gsrj-41	267	32	.	.	PUNCT
gsrj-41	268	1	vaccination	vaccination	NOUN
gsrj-41	268	2	patterns	pattern	NOUN
gsrj-41	268	3	of	of	ADP
gsrj-41	268	4	the	the	DET
gsrj-41	268	5	northeast	northeast	ADJ
gsrj-41	268	6	ohio	ohio	PROPN
gsrj-41	268	7	amish	amish	PROPN
gsrj-41	268	8	revisited	revisit	VERB
gsrj-41	268	9	.	.	PUNCT
gsrj-41	269	1	vaccine	vaccine	NOUN
gsrj-41	269	2	,	,	PUNCT
gsrj-41	269	3	39(7	39(7	NUM
gsrj-41	269	4	)	)	PUNCT
gsrj-41	269	5	,	,	PUNCT
gsrj-41	269	6	1058	1058	NUM
gsrj-41	269	7	–	–	PUNCT
gsrj-41	269	8	1063	1063	NUM
gsrj-41	269	9	.	.	PUNCT
gsrj-41	270	1	https://doi.org/10.1016/j.vaccine.2021.01.022	https://doi.org/10.1016/j.vaccine.2021.01.022	NOUN
gsrj-41	270	2	30	30	NUM
gsrj-41	270	3	.	.	PUNCT
gsrj-41	271	1	meyer	meyer	PROPN
gsrj-41	271	2	,	,	PUNCT
gsrj-41	271	3	m.	m.	NOUN
gsrj-41	271	4	n.	n.	PROPN
gsrj-41	271	5	,	,	PUNCT
gsrj-41	271	6	gjorgjieva	gjorgjieva	PROPN
gsrj-41	271	7	,	,	PUNCT
gsrj-41	271	8	t.	t.	PROPN
gsrj-41	271	9	,	,	PUNCT
gsrj-41	271	10	&	&	CCONJ
gsrj-41	271	11	rosica	rosica	PROPN
gsrj-41	271	12	,	,	PUNCT
gsrj-41	271	13	d.	d.	PROPN
gsrj-41	271	14	(	(	PUNCT
gsrj-41	271	15	2021	2021	NUM
gsrj-41	271	16	)	)	PUNCT
gsrj-41	271	17	.	.	PUNCT
gsrj-41	272	1	trends	trend	NOUN
gsrj-41	272	2	in	in	ADP
gsrj-41	272	3	health	health	NOUN
gsrj-41	272	4	care	care	NOUN
gsrj-41	272	5	worker	worker	NOUN
gsrj-41	272	6	intentions	intention	NOUN
gsrj-41	272	7	to	to	PART
gsrj-41	272	8	receive	receive	VERB
gsrj-41	272	9	a	a	DET
gsrj-41	272	10	covid-19	covid-19	PROPN
gsrj-41	272	11	vaccine	vaccine	NOUN
gsrj-41	272	12	and	and	CCONJ
gsrj-41	272	13	reasons	reason	NOUN
gsrj-41	272	14	for	for	ADP
gsrj-41	272	15	hesitancy	hesitancy	NOUN
gsrj-41	272	16	.	.	PUNCT
gsrj-41	273	1	jama	jama	PROPN
gsrj-41	273	2	network	network	PROPN
gsrj-41	273	3	open	open	VERB
gsrj-41	273	4	,	,	PUNCT
gsrj-41	273	5	4(3	4(3	NUM
gsrj-41	273	6	)	)	PUNCT
gsrj-41	273	7	,	,	PUNCT
gsrj-41	273	8	e215344	e215344	PROPN
gsrj-41	273	9	.	.	PUNCT
gsrj-41	274	1	https://doi.org/10.1001/jamanetworkopen.2021.5	https://doi.org/10.1001/jamanetworkopen.2021.5	PROPN
gsrj-41	274	2	344	344	NUM
gsrj-41	274	3	31	31	NUM
gsrj-41	274	4	.	.	PUNCT
gsrj-41	275	1	bogart	bogart	PROPN
gsrj-41	275	2	,	,	PUNCT
gsrj-41	275	3	l.	l.	PROPN
gsrj-41	275	4	m.	m.	PROPN
gsrj-41	275	5	,	,	PUNCT
gsrj-41	275	6	dong	dong	PROPN
gsrj-41	275	7	,	,	PUNCT
gsrj-41	275	8	l.	l.	PROPN
gsrj-41	275	9	,	,	PUNCT
gsrj-41	275	10	gandhi	gandhi	PROPN
gsrj-41	275	11	,	,	PUNCT
gsrj-41	275	12	p.	p.	PROPN
gsrj-41	275	13	,	,	PUNCT
gsrj-41	275	14	klein	klein	PROPN
gsrj-41	275	15	,	,	PUNCT
gsrj-41	275	16	d.	d.	PROPN
gsrj-41	275	17	j.	j.	PROPN
gsrj-41	275	18	,	,	PUNCT
gsrj-41	275	19	smith	smith	PROPN
gsrj-41	275	20	,	,	PUNCT
gsrj-41	275	21	t.	t.	PROPN
gsrj-41	275	22	l.	l.	PROPN
gsrj-41	275	23	,	,	PUNCT
gsrj-41	275	24	ryan	ryan	PROPN
gsrj-41	275	25	,	,	PUNCT
gsrj-41	275	26	s.	s.	PROPN
gsrj-41	275	27	,	,	PUNCT
gsrj-41	275	28	&	&	CCONJ
gsrj-41	275	29	ojikutu	ojikutu	PROPN
gsrj-41	275	30	,	,	PUNCT
gsrj-41	275	31	b.	b.	PROPN
gsrj-41	275	32	o.	o.	PROPN
gsrj-41	275	33	(	(	PUNCT
gsrj-41	275	34	2021	2021	NUM
gsrj-41	275	35	)	)	PUNCT
gsrj-41	275	36	.	.	PUNCT
gsrj-41	276	1	covid-19	covid-19	PROPN
gsrj-41	276	2	vaccine	vaccine	NOUN
gsrj-41	276	3	intentions	intention	NOUN
gsrj-41	276	4	and	and	CCONJ
gsrj-41	276	5	mistrust	mistrust	NOUN
gsrj-41	276	6	in	in	ADP
gsrj-41	276	7	a	a	DET
gsrj-41	276	8	national	national	ADJ
gsrj-41	276	9	sample	sample	NOUN
gsrj-41	276	10	of	of	ADP
gsrj-41	276	11	black	black	ADJ
gsrj-41	276	12	americans	americans	PROPN
gsrj-41	276	13	.	.	PUNCT
gsrj-41	277	1	journal	journal	NOUN
gsrj-41	277	2	of	of	ADP
gsrj-41	277	3	the	the	DET
gsrj-41	277	4	national	national	PROPN
gsrj-41	277	5	medical	medical	PROPN
gsrj-41	277	6	association	association	PROPN
gsrj-41	277	7	,	,	PUNCT
gsrj-41	277	8	s0027	s0027	PROPN
gsrj-41	277	9	-	-	PUNCT
gsrj-41	277	10	9684(21)00082	9684(21)00082	NUM
gsrj-41	277	11	-	-	PUNCT
gsrj-41	277	12	1	1	NUM
gsrj-41	277	13	.	.	PUNCT
gsrj-41	278	1	advance	advance	VERB
gsrj-41	278	2	online	online	ADJ
gsrj-41	278	3	publication	publication	NOUN
gsrj-41	278	4	.	.	PUNCT
gsrj-41	279	1	https://doi.org/10.1016/j.jnma.2021.05.011	https://doi.org/10.1016/j.jnma.2021.05.011	PROPN
gsrj-41	279	2	32	32	NUM
gsrj-41	279	3	.	.	PUNCT
gsrj-41	280	1	latkin	latkin	PROPN
gsrj-41	280	2	,	,	PUNCT
gsrj-41	280	3	c.	c.	PROPN
gsrj-41	280	4	a.	a.	PROPN
gsrj-41	280	5	,	,	PUNCT
gsrj-41	280	6	dayton	dayton	PROPN
gsrj-41	280	7	,	,	PUNCT
gsrj-41	280	8	l.	l.	PROPN
gsrj-41	280	9	,	,	PUNCT
gsrj-41	280	10	yi	yi	PROPN
gsrj-41	280	11	,	,	PUNCT
gsrj-41	280	12	g.	g.	NOUN
gsrj-41	280	13	,	,	PUNCT
gsrj-41	280	14	colon	colon	NOUN
gsrj-41	280	15	,	,	PUNCT
gsrj-41	280	16	b.	b.	PROPN
gsrj-41	280	17	,	,	PUNCT
gsrj-41	280	18	&	&	CCONJ
gsrj-41	280	19	kong	kong	PROPN
gsrj-41	280	20	,	,	PUNCT
gsrj-41	280	21	x.	x.	NOUN
gsrj-41	280	22	(	(	PUNCT
gsrj-41	280	23	2021	2021	NUM
gsrj-41	280	24	)	)	PUNCT
gsrj-41	280	25	.	.	PUNCT
gsrj-41	281	1	mask	mask	NOUN
gsrj-41	281	2	usage	usage	NOUN
gsrj-41	281	3	,	,	PUNCT
gsrj-41	281	4	social	social	ADJ
gsrj-41	281	5	distancing	distancing	NOUN
gsrj-41	281	6	,	,	PUNCT
gsrj-41	281	7	racial	racial	ADJ
gsrj-41	281	8	,	,	PUNCT
gsrj-41	281	9	and	and	CCONJ
gsrj-41	281	10	gender	gender	NOUN
gsrj-41	281	11	correlates	correlate	VERB
gsrj-41	281	12	of	of	ADP
gsrj-41	281	13	covid-19	covid-19	PROPN
gsrj-41	281	14	vaccine	vaccine	NOUN
gsrj-41	281	15	intentions	intention	NOUN
gsrj-41	281	16	among	among	ADP
gsrj-41	281	17	adults	adult	NOUN
gsrj-41	281	18	in	in	ADP
gsrj-41	281	19	the	the	DET
gsrj-41	281	20	us	us	PROPN
gsrj-41	281	21	.	.	PUNCT
gsrj-41	282	1	plos	plos	PROPN
gsrj-41	282	2	one	one	NUM
gsrj-41	282	3	,	,	PUNCT
gsrj-41	282	4	16(2	16(2	NUM
gsrj-41	282	5	)	)	PUNCT
gsrj-41	282	6	,	,	PUNCT
gsrj-41	282	7	e0246970	e0246970	PROPN
gsrj-41	282	8	.	.	PUNCT
gsrj-41	283	1	https://doi.org/10.1371/journal.pone.0246970	https://doi.org/10.1371/journal.pone.0246970	PROPN
gsrj-41	283	2	33	33	NUM
gsrj-41	283	3	.	.	PUNCT
gsrj-41	284	1	gatwood	gatwood	PROPN
gsrj-41	284	2	,	,	PUNCT
gsrj-41	284	3	j.	j.	PROPN
gsrj-41	284	4	,	,	PUNCT
gsrj-41	284	5	mcknight	mcknight	PROPN
gsrj-41	284	6	,	,	PUNCT
gsrj-41	284	7	m.	m.	NOUN
gsrj-41	284	8	,	,	PUNCT
gsrj-41	284	9	fiscus	fiscus	NOUN
gsrj-41	284	10	,	,	PUNCT
gsrj-41	284	11	m.	m.	NOUN
gsrj-41	284	12	,	,	PUNCT
gsrj-41	284	13	hohmeier	hohmeier	NOUN
gsrj-41	284	14	,	,	PUNCT
gsrj-41	284	15	k.	k.	PROPN
gsrj-41	284	16	c.	c.	PROPN
gsrj-41	284	17	,	,	PUNCT
gsrj-41	284	18	&	&	CCONJ
gsrj-41	284	19	chisholm	chisholm	PROPN
gsrj-41	284	20	-	-	PUNCT
gsrj-41	284	21	burns	burn	NOUN
gsrj-41	284	22	,	,	PUNCT
gsrj-41	284	23	m.	m.	NOUN
gsrj-41	284	24	(	(	PUNCT
gsrj-41	284	25	2021	2021	NUM
gsrj-41	284	26	)	)	PUNCT
gsrj-41	284	27	.	.	PUNCT
gsrj-41	285	1	factors	factor	NOUN
gsrj-41	285	2	influencing	influence	VERB
gsrj-41	285	3	likelihood	likelihood	NOUN
gsrj-41	285	4	of	of	ADP
gsrj-41	285	5	covid-19	covid-19	PROPN
gsrj-41	285	6	vaccination	vaccination	NOUN
gsrj-41	285	7	:	:	PUNCT
gsrj-41	285	8	a	a	DET
gsrj-41	285	9	survey	survey	NOUN
gsrj-41	285	10	of	of	ADP
gsrj-41	285	11	tennessee	tennessee	PROPN
gsrj-41	285	12	adults	adult	NOUN
gsrj-41	285	13	.	.	PUNCT
gsrj-41	286	1	american	american	ADJ
gsrj-41	286	2	journal	journal	PROPN
gsrj-41	286	3	of	of	ADP
gsrj-41	286	4	health	health	NOUN
gsrj-41	286	5	-	-	PUNCT
gsrj-41	286	6	system	system	NOUN
gsrj-41	286	7	pharmacy	pharmacy	NOUN
gsrj-41	286	8	:	:	PUNCT
gsrj-41	286	9	ajhp	ajhp	NOUN
gsrj-41	286	10	:	:	PUNCT
gsrj-41	286	11	official	official	ADJ
gsrj-41	286	12	journal	journal	NOUN
gsrj-41	286	13	of	of	ADP
gsrj-41	286	14	the	the	DET
gsrj-41	286	15	american	american	ADJ
gsrj-41	286	16	society	society	NOUN
gsrj-41	286	17	of	of	ADP
gsrj-41	286	18	health	health	NOUN
gsrj-41	286	19	-	-	PUNCT
gsrj-41	286	20	system	system	NOUN
gsrj-41	286	21	pharmacists	pharmacist	NOUN
gsrj-41	286	22	,	,	PUNCT
gsrj-41	286	23	78(10	78(10	NUM
gsrj-41	286	24	)	)	PUNCT
gsrj-41	286	25	,	,	PUNCT
gsrj-41	286	26	879–889	879–889	NUM
gsrj-41	286	27	.	.	PUNCT
gsrj-41	286	28	https://doi.org/10.1093/ajhp/zxab099	https://doi.org/10.1093/ajhp/zxab099	PROPN
gsrj-41	287	1	34	34	NUM
gsrj-41	287	2	.	.	PUNCT
gsrj-41	287	3	rodriguez	rodriguez	PROPN
gsrj-41	287	4	,	,	PUNCT
gsrj-41	287	5	r.	r.	PROPN
gsrj-41	287	6	m.	m.	PROPN
gsrj-41	287	7	,	,	PUNCT
gsrj-41	287	8	torres	torre	NOUN
gsrj-41	287	9	,	,	PUNCT
gsrj-41	287	10	j.	j.	PROPN
gsrj-41	287	11	r.	r.	PROPN
gsrj-41	287	12	,	,	PUNCT
gsrj-41	287	13	chang	chang	PROPN
gsrj-41	287	14	,	,	PUNCT
gsrj-41	287	15	a.	a.	NOUN
gsrj-41	287	16	m.	m.	NOUN
gsrj-41	287	17	,	,	PUNCT
gsrj-41	287	18	haggins	haggin	NOUN
gsrj-41	287	19	,	,	PUNCT
gsrj-41	287	20	a.	a.	NOUN
gsrj-41	287	21	n.	n.	NOUN
gsrj-41	287	22	,	,	PUNCT
gsrj-41	287	23	eucker	eucker	NOUN
gsrj-41	287	24	,	,	PUNCT
gsrj-41	287	25	s.	s.	PROPN
gsrj-41	287	26	a.	a.	PROPN
gsrj-41	287	27	,	,	PUNCT
gsrj-41	287	28	o'laughlin	o'laughlin	PROPN
gsrj-41	287	29	,	,	PUNCT
gsrj-41	287	30	k.	k.	PROPN
gsrj-41	287	31	n.	n.	PROPN
gsrj-41	287	32	,	,	PUNCT
gsrj-41	287	33	anderson	anderson	PROPN
gsrj-41	287	34	,	,	PUNCT
gsrj-41	287	35	e.	e.	PROPN
gsrj-41	287	36	,	,	PUNCT
gsrj-41	287	37	miller	miller	PROPN
gsrj-41	287	38	,	,	PUNCT
gsrj-41	287	39	d.	d.	PROPN
gsrj-41	287	40	g.	g.	PROPN
gsrj-41	287	41	,	,	PUNCT
gsrj-41	287	42	wilkerson	wilkerson	PROPN
gsrj-41	287	43	,	,	PUNCT
gsrj-41	287	44	r.	r.	PROPN
gsrj-41	287	45	g.	g.	PROPN
gsrj-41	287	46	,	,	PUNCT
gsrj-41	287	47	caldwell	caldwell	PROPN
gsrj-41	287	48	,	,	PUNCT
gsrj-41	287	49	m.	m.	NOUN
gsrj-41	287	50	,	,	PUNCT
gsrj-41	287	51	lim	lim	PROPN
gsrj-41	287	52	,	,	PUNCT
gsrj-41	287	53	s.	s.	PROPN
gsrj-41	287	54	c.	c.	PROPN
gsrj-41	287	55	,	,	PUNCT
gsrj-41	287	56	raja	raja	PROPN
gsrj-41	287	57	,	,	PUNCT
gsrj-41	287	58	a.	a.	PROPN
gsrj-41	287	59	s.	s.	PROPN
gsrj-41	287	60	,	,	PUNCT
gsrj-41	287	61	baumann	baumann	PROPN
gsrj-41	287	62	,	,	PUNCT
gsrj-41	287	63	b.	b.	PROPN
gsrj-41	287	64	m.	m.	PROPN
gsrj-41	287	65	,	,	PUNCT
gsrj-41	287	66	graterol	graterol	PROPN
gsrj-41	287	67	,	,	PUNCT
gsrj-41	287	68	j.	j.	PROPN
gsrj-41	287	69	,	,	PUNCT
gsrj-41	287	70	eswaran	eswaran	ADJ
gsrj-41	287	71	,	,	PUNCT
gsrj-41	287	72	v.	v.	ADV
gsrj-41	287	73	,	,	PUNCT
gsrj-41	287	74	chinnock	chinnock	NOUN
gsrj-41	287	75	,	,	PUNCT
gsrj-41	287	76	b.	b.	PROPN
gsrj-41	287	77	,	,	PUNCT
gsrj-41	287	78	&	&	CCONJ
gsrj-41	287	79	revved	rev	VERB
gsrj-41	287	80	up	up	ADP
gsrj-41	287	81	investigators	investigator	NOUN
gsrj-41	287	82	(	(	PUNCT
gsrj-41	287	83	2021	2021	NUM
gsrj-41	287	84	)	)	PUNCT
gsrj-41	287	85	.	.	PUNCT
gsrj-41	288	1	the	the	DET
gsrj-41	288	2	rapid	rapid	ADJ
gsrj-41	288	3	evaluation	evaluation	NOUN
gsrj-41	288	4	of	of	ADP
gsrj-41	288	5	covid-19	covid-19	PROPN
gsrj-41	288	6	vaccination	vaccination	NOUN
gsrj-41	288	7	in	in	ADP
gsrj-41	288	8	emergency	emergency	NOUN
gsrj-41	288	9	departments	department	NOUN
gsrj-41	288	10	for	for	ADP
gsrj-41	288	11	underserved	underserved	ADJ
gsrj-41	288	12	patients	patient	NOUN
gsrj-41	288	13	study	study	VERB
gsrj-41	288	14	.	.	PUNCT
gsrj-41	289	1	annals	annal	NOUN
gsrj-41	289	2	of	of	ADP
gsrj-41	289	3	emergency	emergency	NOUN
gsrj-41	289	4	medicine	medicine	NOUN
gsrj-41	289	5	,	,	PUNCT
gsrj-41	289	6	78(4	78(4	NUM
gsrj-41	289	7	)	)	PUNCT
gsrj-41	289	8	,	,	PUNCT
gsrj-41	289	9	502–510	502–510	NUM
gsrj-41	289	10	.	.	PUNCT
gsrj-41	290	1	https://doi.org/10.1016/j.annemergmed.2021.05	https://doi.org/10.1016/j.annemergmed.2021.05	PROPN
gsrj-41	290	2	.	.	PUNCT
gsrj-41	291	1	026	026	NUM
gsrj-41	291	2	35	35	NUM
gsrj-41	291	3	.	.	PUNCT
gsrj-41	292	1	stern	stern	ADJ
gsrj-41	292	2	,	,	PUNCT
gsrj-41	292	3	m.	m.	NOUN
gsrj-41	292	4	f.	f.	PROPN
gsrj-41	292	5	,	,	PUNCT
gsrj-41	292	6	piasecki	piasecki	PROPN
gsrj-41	292	7	,	,	PUNCT
gsrj-41	292	8	a.	a.	NOUN
gsrj-41	292	9	m.	m.	NOUN
gsrj-41	292	10	,	,	PUNCT
gsrj-41	292	11	strick	strick	NOUN
gsrj-41	292	12	,	,	PUNCT
gsrj-41	292	13	l.	l.	PROPN
gsrj-41	292	14	b.	b.	PROPN
gsrj-41	292	15	,	,	PUNCT
gsrj-41	292	16	rajeshwar	rajeshwar	INTJ
gsrj-41	292	17	,	,	PUNCT
gsrj-41	292	18	p.	p.	PROPN
gsrj-41	292	19	,	,	PUNCT
gsrj-41	292	20	tyagi	tyagi	PROPN
gsrj-41	292	21	,	,	PUNCT
gsrj-41	292	22	e.	e.	PROPN
gsrj-41	292	23	,	,	PUNCT
gsrj-41	292	24	dolovich	dolovich	PROPN
gsrj-41	292	25	,	,	PUNCT
gsrj-41	292	26	s.	s.	PROPN
gsrj-41	292	27	,	,	PUNCT
gsrj-41	292	28	patel	patel	PROPN
gsrj-41	292	29	,	,	PUNCT
gsrj-41	292	30	p.	p.	PROPN
gsrj-41	292	31	r.	r.	PROPN
gsrj-41	292	32	,	,	PUNCT
gsrj-41	292	33	fukunaga	fukunaga	PROPN
gsrj-41	292	34	,	,	PUNCT
gsrj-41	292	35	r.	r.	PROPN
gsrj-41	292	36	,	,	PUNCT
gsrj-41	292	37	&	&	CCONJ
gsrj-41	292	38	furukawa	furukawa	PROPN
gsrj-41	292	39	,	,	PUNCT
gsrj-41	292	40	n.	n.	PROPN
gsrj-41	292	41	w.	w.	PROPN
gsrj-41	292	42	(	(	PUNCT
gsrj-41	292	43	2021	2021	NUM
gsrj-41	292	44	)	)	PUNCT
gsrj-41	292	45	.	.	PUNCT
gsrj-41	293	1	willingness	willingness	NOUN
gsrj-41	293	2	to	to	PART
gsrj-41	293	3	receive	receive	VERB
gsrj-41	293	4	a	a	DET
gsrj-41	293	5	covid-19	covid-19	PROPN
gsrj-41	293	6	vaccination	vaccination	NOUN
gsrj-41	293	7	among	among	ADP
gsrj-41	293	8	incarcerated	incarcerate	VERB
gsrj-41	293	9	or	or	CCONJ
gsrj-41	293	10	detained	detain	VERB
gsrj-41	293	11	persons	person	NOUN
gsrj-41	293	12	in	in	ADP
gsrj-41	293	13	correctional	correctional	ADJ
gsrj-41	293	14	and	and	CCONJ
gsrj-41	293	15	detention	detention	NOUN
gsrj-41	293	16	facilities	facility	NOUN
gsrj-41	293	17	four	four	NUM
gsrj-41	293	18	states	state	NOUN
gsrj-41	293	19	,	,	PUNCT
gsrj-41	293	20	september	september	PROPN
gsrj-41	293	21	-	-	PUNCT
gsrj-41	293	22	december	december	PROPN
gsrj-41	293	23	2020	2020	NUM
gsrj-41	293	24	.	.	PUNCT
gsrj-41	294	1	mmwr	mmwr	NOUN
gsrj-41	294	2	.	.	PUNCT
gsrj-41	295	1	morbidity	morbidity	NOUN
gsrj-41	295	2	and	and	CCONJ
gsrj-41	295	3	mortality	mortality	NOUN
gsrj-41	295	4	weekly	weekly	ADJ
gsrj-41	295	5	report	report	NOUN
gsrj-41	295	6	,	,	PUNCT
gsrj-41	295	7	23	23	NUM
gsrj-41	295	8	georgetown	georgetown	PROPN
gsrj-41	295	9	scientific	scientific	ADJ
gsrj-41	295	10	research	research	NOUN
gsrj-41	295	11	journal	journal	NOUN
gsrj-41	295	12	70(13	70(13	NUM
gsrj-41	295	13	)	)	PUNCT
gsrj-41	295	14	,	,	PUNCT
gsrj-41	295	15	473–477	473–477	NUM
gsrj-41	295	16	.	.	PUNCT
gsrj-41	296	1	https://doi.org/10.15585/mmwr.mm7013a3	https://doi.org/10.15585/mmwr.mm7013a3	PROPN
gsrj-41	296	2	36	36	NUM
gsrj-41	296	3	.	.	PUNCT
gsrj-41	297	1	dalal	dalal	PROPN
gsrj-41	297	2	,	,	PUNCT
gsrj-41	297	3	r.	r.	PROPN
gsrj-41	297	4	s.	s.	PROPN
gsrj-41	297	5	,	,	PUNCT
gsrj-41	297	6	mcclure	mcclure	PROPN
gsrj-41	297	7	,	,	PUNCT
gsrj-41	297	8	e.	e.	PROPN
gsrj-41	297	9	,	,	PUNCT
gsrj-41	297	10	marcus	marcus	PROPN
gsrj-41	297	11	,	,	PUNCT
gsrj-41	297	12	j.	j.	PROPN
gsrj-41	297	13	,	,	PUNCT
gsrj-41	297	14	winter	winter	PROPN
gsrj-41	297	15	,	,	PUNCT
gsrj-41	297	16	r.	r.	PROPN
gsrj-41	297	17	w.	w.	PROPN
gsrj-41	297	18	,	,	PUNCT
gsrj-41	297	19	hamilton	hamilton	PROPN
gsrj-41	297	20	,	,	PUNCT
gsrj-41	297	21	m.	m.	PROPN
gsrj-41	297	22	j.	j.	PROPN
gsrj-41	297	23	,	,	PUNCT
gsrj-41	297	24	&	&	CCONJ
gsrj-41	297	25	allegretti	allegretti	PROPN
gsrj-41	297	26	,	,	PUNCT
gsrj-41	297	27	j.	j.	PROPN
gsrj-41	297	28	r.	r.	PROPN
gsrj-41	297	29	(	(	PUNCT
gsrj-41	297	30	2021	2021	NUM
gsrj-41	297	31	)	)	PUNCT
gsrj-41	297	32	.	.	PUNCT
gsrj-41	298	1	covid-19	covid-19	PROPN
gsrj-41	298	2	vaccination	vaccination	NOUN
gsrj-41	298	3	intent	intent	NOUN
gsrj-41	298	4	and	and	CCONJ
gsrj-41	298	5	perceptions	perception	NOUN
gsrj-41	298	6	among	among	ADP
gsrj-41	298	7	patients	patient	NOUN
gsrj-41	298	8	with	with	ADP
gsrj-41	298	9	inflammatory	inflammatory	ADJ
gsrj-41	298	10	bowel	bowel	NOUN
gsrj-41	298	11	diseases	disease	NOUN
gsrj-41	298	12	.	.	PUNCT
gsrj-41	299	1	clinical	clinical	ADJ
gsrj-41	299	2	gastroenterology	gastroenterology	NOUN
gsrj-41	299	3	and	and	CCONJ
gsrj-41	299	4	hepatology	hepatology	NOUN
gsrj-41	299	5	:	:	PUNCT
gsrj-41	299	6	the	the	DET
gsrj-41	299	7	official	official	ADJ
gsrj-41	299	8	clinical	clinical	ADJ
gsrj-41	299	9	practice	practice	NOUN
gsrj-41	299	10	journal	journal	NOUN
gsrj-41	299	11	of	of	ADP
gsrj-41	299	12	the	the	DET
gsrj-41	299	13	american	american	ADJ
gsrj-41	299	14	gastroenterological	gastroenterological	PROPN
gsrj-41	299	15	association	association	NOUN
gsrj-41	299	16	,	,	PUNCT
gsrj-41	299	17	19(8	19(8	NUM
gsrj-41	299	18	)	)	PUNCT
gsrj-41	299	19	,	,	PUNCT
gsrj-41	299	20	1730–1732.e2	1730–1732.e2	NUM
gsrj-41	299	21	.	.	PUNCT
gsrj-41	300	1	https://doi.org/10.1016/j.cgh.2021.02.004	https://doi.org/10.1016/j.cgh.2021.02.004	VERB
gsrj-41	300	2	37	37	NUM
gsrj-41	300	3	.	.	PUNCT
gsrj-41	301	1	dorman	dorman	PROPN
gsrj-41	301	2	,	,	PUNCT
gsrj-41	301	3	c.	c.	PROPN
gsrj-41	301	4	,	,	PUNCT
gsrj-41	301	5	perera	perera	PROPN
gsrj-41	301	6	,	,	PUNCT
gsrj-41	301	7	a.	a.	PROPN
gsrj-41	301	8	,	,	PUNCT
gsrj-41	301	9	condon	condon	PROPN
gsrj-41	301	10	,	,	PUNCT
gsrj-41	301	11	c.	c.	PROPN
gsrj-41	301	12	,	,	PUNCT
gsrj-41	301	13	chau	chau	NOUN
gsrj-41	301	14	,	,	PUNCT
gsrj-41	301	15	c.	c.	PROPN
gsrj-41	301	16	,	,	PUNCT
gsrj-41	301	17	qian	qian	PROPN
gsrj-41	301	18	,	,	PUNCT
gsrj-41	301	19	j.	j.	PROPN
gsrj-41	301	20	,	,	PUNCT
gsrj-41	301	21	kalk	kalk	PROPN
gsrj-41	301	22	,	,	PUNCT
gsrj-41	301	23	k.	k.	PROPN
gsrj-41	301	24	,	,	PUNCT
gsrj-41	301	25	&	&	CCONJ
gsrj-41	301	26	diazdeleon	diazdeleon	NOUN
gsrj-41	301	27	,	,	PUNCT
gsrj-41	301	28	d.	d.	PROPN
gsrj-41	301	29	(	(	PUNCT
gsrj-41	301	30	2021	2021	NUM
gsrj-41	301	31	)	)	PUNCT
gsrj-41	301	32	.	.	PUNCT
gsrj-41	302	1	factors	factor	NOUN
gsrj-41	302	2	associated	associate	VERB
gsrj-41	302	3	with	with	ADP
gsrj-41	302	4	willingness	willingness	NOUN
gsrj-41	302	5	to	to	PART
gsrj-41	302	6	be	be	AUX
gsrj-41	302	7	vaccinated	vaccinate	VERB
gsrj-41	302	8	against	against	ADP
gsrj-41	302	9	covid-19	covid-19	PROPN
gsrj-41	302	10	in	in	ADP
gsrj-41	302	11	a	a	DET
gsrj-41	302	12	large	large	ADJ
gsrj-41	302	13	convenience	convenience	NOUN
gsrj-41	302	14	sample	sample	NOUN
gsrj-41	302	15	.	.	PUNCT
gsrj-41	303	1	journal	journal	NOUN
gsrj-41	303	2	of	of	ADP
gsrj-41	303	3	community	community	NOUN
gsrj-41	303	4	health	health	NOUN
gsrj-41	303	5	,	,	PUNCT
gsrj-41	303	6	46(5	46(5	NOUN
gsrj-41	303	7	)	)	PUNCT
gsrj-41	303	8	,	,	PUNCT
gsrj-41	303	9	1013–1019	1013–1019	NUM
gsrj-41	303	10	.	.	PUNCT
gsrj-41	304	1	https://doi.org/10.1007/s10900-021-00987-0	https://doi.org/10.1007/s10900-021-00987-0	VERB
gsrj-41	304	2	38	38	NUM
gsrj-41	304	3	.	.	PUNCT
gsrj-41	305	1	allen	allen	PROPN
gsrj-41	305	2	,	,	PUNCT
gsrj-41	305	3	j.	j.	PROPN
gsrj-41	305	4	d.	d.	PROPN
gsrj-41	305	5	,	,	PUNCT
gsrj-41	305	6	feng	feng	PROPN
gsrj-41	305	7	,	,	PUNCT
gsrj-41	305	8	w.	w.	PROPN
gsrj-41	305	9	,	,	PUNCT
gsrj-41	305	10	corlin	corlin	PROPN
gsrj-41	305	11	,	,	PUNCT
gsrj-41	305	12	l.	l.	PROPN
gsrj-41	305	13	,	,	PUNCT
gsrj-41	305	14	porteny	porteny	NOUN
gsrj-41	305	15	,	,	PUNCT
gsrj-41	305	16	t.	t.	PROPN
gsrj-41	305	17	,	,	PUNCT
gsrj-41	305	18	acevedo	acevedo	PROPN
gsrj-41	305	19	,	,	PUNCT
gsrj-41	305	20	a.	a.	PROPN
gsrj-41	305	21	,	,	PUNCT
gsrj-41	305	22	schildkraut	schildkraut	PROPN
gsrj-41	305	23	,	,	PUNCT
gsrj-41	305	24	d.	d.	PROPN
gsrj-41	305	25	,	,	PUNCT
gsrj-41	305	26	king	king	PROPN
gsrj-41	305	27	,	,	PUNCT
gsrj-41	305	28	e.	e.	PROPN
gsrj-41	305	29	,	,	PUNCT
gsrj-41	305	30	ladin	ladin	PROPN
gsrj-41	305	31	,	,	PUNCT
gsrj-41	305	32	k.	k.	PROPN
gsrj-41	305	33	,	,	PUNCT
gsrj-41	305	34	fu	fu	PROPN
gsrj-41	305	35	,	,	PUNCT
gsrj-41	305	36	q.	q.	PROPN
gsrj-41	305	37	,	,	PUNCT
gsrj-41	305	38	&	&	CCONJ
gsrj-41	305	39	stopka	stopka	PROPN
gsrj-41	305	40	,	,	PUNCT
gsrj-41	305	41	t.	t.	PROPN
gsrj-41	305	42	j.	j.	PROPN
gsrj-41	305	43	(	(	PUNCT
gsrj-41	305	44	2021	2021	NUM
gsrj-41	305	45	)	)	PUNCT
gsrj-41	305	46	.	.	PUNCT
gsrj-41	306	1	why	why	SCONJ
gsrj-41	306	2	are	be	AUX
gsrj-41	306	3	some	some	DET
gsrj-41	306	4	people	people	NOUN
gsrj-41	306	5	reluctant	reluctant	ADJ
gsrj-41	306	6	to	to	PART
gsrj-41	306	7	be	be	AUX
gsrj-41	306	8	vaccinated	vaccinate	VERB
gsrj-41	306	9	for	for	ADP
gsrj-41	306	10	covid-19	covid-19	PROPN
gsrj-41	306	11	?	?	PUNCT
gsrj-41	307	1	a	a	DET
gsrj-41	307	2	cross	cross	ADJ
gsrj-41	307	3	-	-	ADJ
gsrj-41	307	4	sectional	sectional	ADJ
gsrj-41	307	5	survey	survey	NOUN
gsrj-41	307	6	among	among	ADP
gsrj-41	307	7	u.s	u.s	PROPN
gsrj-41	307	8	.	.	PROPN
gsrj-41	307	9	adults	adult	NOUN
gsrj-41	307	10	in	in	ADP
gsrj-41	307	11	may	may	PROPN
gsrj-41	307	12	-	-	PUNCT
gsrj-41	307	13	june	june	PROPN
gsrj-41	307	14	2020	2020	NUM
gsrj-41	307	15	.	.	PUNCT
gsrj-41	308	1	preventive	preventive	ADJ
gsrj-41	308	2	medicine	medicine	NOUN
gsrj-41	308	3	reports	report	NOUN
gsrj-41	308	4	,	,	PUNCT
gsrj-41	308	5	24	24	NUM
gsrj-41	308	6	,	,	PUNCT
gsrj-41	308	7	101494	101494	NUM
gsrj-41	308	8	.	.	PUNCT
gsrj-41	309	1	https://doi.org/10.1016/j.pmedr.2021.101494	https://doi.org/10.1016/j.pmedr.2021.101494	NOUN
gsrj-41	309	2	39	39	NUM
gsrj-41	309	3	.	.	PUNCT
gsrj-41	310	1	teasdale	teasdale	PROPN
gsrj-41	310	2	,	,	PUNCT
gsrj-41	310	3	c.	c.	PROPN
gsrj-41	310	4	a.	a.	PROPN
gsrj-41	310	5	,	,	PUNCT
gsrj-41	310	6	borrell	borrell	INTJ
gsrj-41	310	7	,	,	PUNCT
gsrj-41	310	8	l.	l.	PROPN
gsrj-41	310	9	n.	n.	PROPN
gsrj-41	310	10	,	,	PUNCT
gsrj-41	310	11	shen	shen	PROPN
gsrj-41	310	12	,	,	PUNCT
gsrj-41	310	13	y.	y.	PROPN
gsrj-41	310	14	,	,	PUNCT
gsrj-41	310	15	kimball	kimball	PROPN
gsrj-41	310	16	,	,	PUNCT
gsrj-41	310	17	s.	s.	PROPN
gsrj-41	310	18	,	,	PUNCT
gsrj-41	310	19	rinke	rinke	NOUN
gsrj-41	310	20	,	,	PUNCT
gsrj-41	310	21	m.	m.	NOUN
gsrj-41	310	22	l.	l.	PROPN
gsrj-41	310	23	,	,	PUNCT
gsrj-41	310	24	fleary	fleary	PROPN
gsrj-41	310	25	,	,	PUNCT
gsrj-41	310	26	s.	s.	PROPN
gsrj-41	310	27	a.	a.	PROPN
gsrj-41	310	28	,	,	PUNCT
gsrj-41	310	29	&	&	CCONJ
gsrj-41	310	30	nash	nash	PROPN
gsrj-41	310	31	,	,	PUNCT
gsrj-41	310	32	d.	d.	PROPN
gsrj-41	310	33	(	(	PUNCT
gsrj-41	310	34	2021a	2021a	NUM
gsrj-41	310	35	)	)	PUNCT
gsrj-41	310	36	.	.	PUNCT
gsrj-41	311	1	parental	parental	ADJ
gsrj-41	311	2	plans	plan	NOUN
gsrj-41	311	3	to	to	PART
gsrj-41	311	4	vaccinate	vaccinate	VERB
gsrj-41	311	5	children	child	NOUN
gsrj-41	311	6	for	for	ADP
gsrj-41	311	7	covid-19	covid-19	PROPN
gsrj-41	311	8	in	in	ADP
gsrj-41	311	9	new	new	PROPN
gsrj-41	311	10	york	york	PROPN
gsrj-41	311	11	city	city	PROPN
gsrj-41	311	12	.	.	PUNCT
gsrj-41	312	1	vaccine	vaccine	NOUN
gsrj-41	312	2	,	,	PUNCT
gsrj-41	312	3	39(36	39(36	NUM
gsrj-41	312	4	)	)	PUNCT
gsrj-41	312	5	,	,	PUNCT
gsrj-41	312	6	5082–5086	5082–5086	NUM
gsrj-41	312	7	.	.	PUNCT
gsrj-41	313	1	https://doi.org/10.1016/j.vaccine.2021.07.058	https://doi.org/10.1016/j.vaccine.2021.07.058	NUM
gsrj-41	313	2	40	40	NUM
gsrj-41	313	3	.	.	PUNCT
gsrj-41	314	1	teasdale	teasdale	PROPN
gsrj-41	314	2	,	,	PUNCT
gsrj-41	314	3	c.	c.	PROPN
gsrj-41	314	4	a.	a.	PROPN
gsrj-41	314	5	,	,	PUNCT
gsrj-41	314	6	borrell	borrell	INTJ
gsrj-41	314	7	,	,	PUNCT
gsrj-41	314	8	l.	l.	PROPN
gsrj-41	314	9	n.	n.	PROPN
gsrj-41	314	10	,	,	PUNCT
gsrj-41	314	11	kimball	kimball	PROPN
gsrj-41	314	12	,	,	PUNCT
gsrj-41	314	13	s.	s.	PROPN
gsrj-41	314	14	,	,	PUNCT
gsrj-41	314	15	rinke	rinke	NOUN
gsrj-41	314	16	,	,	PUNCT
gsrj-41	314	17	m.	m.	NOUN
gsrj-41	314	18	l.	l.	PROPN
gsrj-41	314	19	,	,	PUNCT
gsrj-41	314	20	rane	rane	PROPN
gsrj-41	314	21	,	,	PUNCT
gsrj-41	314	22	m.	m.	NOUN
gsrj-41	314	23	,	,	PUNCT
gsrj-41	314	24	fleary	fleary	ADJ
gsrj-41	314	25	,	,	PUNCT
gsrj-41	314	26	s.	s.	PROPN
gsrj-41	314	27	a.	a.	PROPN
gsrj-41	314	28	,	,	PUNCT
gsrj-41	314	29	&	&	CCONJ
gsrj-41	314	30	nash	nash	PROPN
gsrj-41	314	31	,	,	PUNCT
gsrj-41	314	32	d.	d.	PROPN
gsrj-41	314	33	(	(	PUNCT
gsrj-41	314	34	2021b	2021b	NUM
gsrj-41	314	35	)	)	PUNCT
gsrj-41	314	36	.	.	PUNCT
gsrj-41	315	1	plans	plan	NOUN
gsrj-41	315	2	to	to	PART
gsrj-41	315	3	vaccinate	vaccinate	VERB
gsrj-41	315	4	children	child	NOUN
gsrj-41	315	5	for	for	ADP
gsrj-41	315	6	coronavirus	coronavirus	NOUN
gsrj-41	315	7	disease	disease	NOUN
gsrj-41	315	8	2019	2019	NUM
gsrj-41	315	9	:	:	PUNCT
gsrj-41	315	10	a	a	DET
gsrj-41	315	11	survey	survey	NOUN
gsrj-41	315	12	of	of	ADP
gsrj-41	315	13	united	united	PROPN
gsrj-41	315	14	states	states	PROPN
gsrj-41	315	15	parents	parent	NOUN
gsrj-41	315	16	.	.	PUNCT
gsrj-41	316	1	the	the	DET
gsrj-41	316	2	journal	journal	NOUN
gsrj-41	316	3	of	of	ADP
gsrj-41	316	4	pediatrics	pediatric	NOUN
gsrj-41	316	5	,	,	PUNCT
gsrj-41	316	6	237	237	NUM
gsrj-41	316	7	,	,	PUNCT
gsrj-41	316	8	292–297	292–297	NUM
gsrj-41	316	9	.	.	PUNCT
gsrj-41	317	1	https://doi.org/10.1016/j.jpeds.2021.07.021	https://doi.org/10.1016/j.jpeds.2021.07.021	NOUN
gsrj-41	317	2	41	41	NUM
gsrj-41	317	3	.	.	PUNCT
gsrj-41	318	1	teherani	teherani	NOUN
gsrj-41	318	2	,	,	PUNCT
gsrj-41	318	3	m.	m.	NOUN
gsrj-41	318	4	,	,	PUNCT
gsrj-41	318	5	banskota	banskota	NOUN
gsrj-41	318	6	,	,	PUNCT
gsrj-41	318	7	s.	s.	PROPN
gsrj-41	318	8	,	,	PUNCT
gsrj-41	318	9	camacho	camacho	PROPN
gsrj-41	318	10	-	-	PUNCT
gsrj-41	318	11	gonzalez	gonzalez	PROPN
gsrj-41	318	12	,	,	PUNCT
gsrj-41	318	13	a.	a.	PROPN
gsrj-41	318	14	,	,	PUNCT
gsrj-41	318	15	smith	smith	PROPN
gsrj-41	318	16	,	,	PUNCT
gsrj-41	318	17	a.	a.	PROPN
gsrj-41	318	18	,	,	PUNCT
gsrj-41	318	19	anderson	anderson	PROPN
gsrj-41	318	20	,	,	PUNCT
gsrj-41	318	21	e.	e.	PROPN
gsrj-41	318	22	j.	j.	PROPN
gsrj-41	318	23	,	,	PUNCT
gsrj-41	318	24	kao	kao	PROPN
gsrj-41	318	25	,	,	PUNCT
gsrj-41	318	26	c.	c.	PROPN
gsrj-41	318	27	m.	m.	NOUN
gsrj-41	318	28	,	,	PUNCT
gsrj-41	318	29	crepy	crepy	ADJ
gsrj-41	318	30	d'orleans	d'orleans	PROPN
gsrj-41	318	31	,	,	PUNCT
gsrj-41	318	32	c.	c.	PROPN
gsrj-41	318	33	,	,	PUNCT
gsrj-41	318	34	shane	shane	NOUN
gsrj-41	318	35	,	,	PUNCT
gsrj-41	318	36	a.	a.	PROPN
gsrj-41	318	37	l.	l.	PROPN
gsrj-41	318	38	,	,	PUNCT
gsrj-41	318	39	lu	lu	PROPN
gsrj-41	318	40	,	,	PUNCT
gsrj-41	318	41	a.	a.	PROPN
gsrj-41	318	42	,	,	PUNCT
gsrj-41	318	43	&	&	CCONJ
gsrj-41	318	44	jaggi	jaggi	PROPN
gsrj-41	318	45	,	,	PUNCT
gsrj-41	318	46	p.	p.	NOUN
gsrj-41	318	47	(	(	PUNCT
gsrj-41	318	48	2021	2021	NUM
gsrj-41	318	49	)	)	PUNCT
gsrj-41	318	50	.	.	PUNCT
gsrj-41	319	1	intent	intent	NOUN
gsrj-41	319	2	to	to	PART
gsrj-41	319	3	vaccinate	vaccinate	VERB
gsrj-41	319	4	sarscov-2	sarscov-2	NUM
gsrj-41	319	5	infected	infected	ADJ
gsrj-41	319	6	children	child	NOUN
gsrj-41	319	7	in	in	ADP
gsrj-41	319	8	us	us	PROPN
gsrj-41	319	9	households	household	NOUN
gsrj-41	319	10	:	:	PUNCT
gsrj-41	319	11	a	a	DET
gsrj-41	319	12	survey	survey	NOUN
gsrj-41	319	13	.	.	PUNCT
gsrj-41	320	1	vaccines	vaccine	NOUN
gsrj-41	320	2	,	,	PUNCT
gsrj-41	320	3	9(9	9(9	NUM
gsrj-41	320	4	)	)	PUNCT
gsrj-41	320	5	,	,	PUNCT
gsrj-41	320	6	1049	1049	NUM
gsrj-41	320	7	.	.	PUNCT
gsrj-41	321	1	https://doi.org/10.3390/vaccines9091049	https://doi.org/10.3390/vaccines9091049	PROPN
gsrj-41	321	2	42	42	NUM
gsrj-41	321	3	.	.	PUNCT
gsrj-41	322	1	commissioner	commissioner	NOUN
gsrj-41	322	2	,	,	PUNCT
gsrj-41	322	3	o.	o.	NOUN
gsrj-41	322	4	of	of	ADP
gsrj-41	322	5	the	the	PRON
gsrj-41	322	6	.	.	PUNCT
gsrj-41	323	1	(	(	PUNCT
gsrj-41	323	2	2019	2019	NUM
gsrj-41	323	3	,	,	PUNCT
gsrj-41	323	4	july	july	PROPN
gsrj-41	323	5	9	9	NUM
gsrj-41	323	6	)	)	PUNCT
gsrj-41	323	7	.	.	PUNCT
gsrj-41	324	1	emergency	emergency	NOUN
gsrj-41	324	2	use	use	VERB
gsrj-41	324	3	authorization	authorization	NOUN
gsrj-41	324	4	of	of	ADP
gsrj-41	324	5	medical	medical	ADJ
gsrj-41	324	6	products	product	NOUN
gsrj-41	324	7	and	and	CCONJ
gsrj-41	324	8	related	related	ADJ
gsrj-41	324	9	authorities	authority	NOUN
gsrj-41	324	10	.	.	PUNCT
gsrj-41	325	1	u.s	u.s	PROPN
gsrj-41	325	2	.	.	PROPN
gsrj-41	325	3	food	food	PROPN
gsrj-41	325	4	and	and	CCONJ
gsrj-41	325	5	drug	drug	NOUN
gsrj-41	325	6	administration	administration	NOUN
gsrj-41	325	7	;	;	PUNCT
gsrj-41	325	8	fda	fda	PROPN
gsrj-41	325	9	.	.	PUNCT
gsrj-41	326	1	https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments/emergency-use-authorizationmedical-products-and-related-authorities	https://www.fda.gov/regulatoryinformation/search-fda-guidancedocuments/emergency-use-authorizationmedical-products-and-related-authorities	PROPN
gsrj-41	326	2	43	43	NUM
gsrj-41	326	3	.	.	PUNCT
gsrj-41	326	4	piltch	piltch	PROPN
gsrj-41	326	5	-	-	PUNCT
gsrj-41	326	6	loeb	loeb	PROPN
gsrj-41	326	7	,	,	PUNCT
gsrj-41	326	8	r.	r.	PROPN
gsrj-41	326	9	,	,	PUNCT
gsrj-41	326	10	savoia	savoia	PROPN
gsrj-41	326	11	,	,	PUNCT
gsrj-41	326	12	e.	e.	PROPN
gsrj-41	326	13	,	,	PUNCT
gsrj-41	326	14	goldberg	goldberg	PROPN
gsrj-41	326	15	,	,	PUNCT
gsrj-41	326	16	b.	b.	PROPN
gsrj-41	326	17	,	,	PUNCT
gsrj-41	326	18	hughes	hughes	PROPN
gsrj-41	326	19	,	,	PUNCT
gsrj-41	326	20	b.	b.	PROPN
gsrj-41	326	21	,	,	PUNCT
gsrj-41	326	22	verhey	verhey	NOUN
gsrj-41	326	23	,	,	PUNCT
gsrj-41	326	24	t.	t.	PROPN
gsrj-41	326	25	,	,	PUNCT
gsrj-41	326	26	kayyem	kayyem	PROPN
gsrj-41	326	27	,	,	PUNCT
gsrj-41	326	28	j.	j.	PROPN
gsrj-41	326	29	,	,	PUNCT
gsrj-41	326	30	milleridriss	milleridriss	PROPN
gsrj-41	326	31	,	,	PUNCT
gsrj-41	326	32	c.	c.	PROPN
gsrj-41	326	33	,	,	PUNCT
gsrj-41	326	34	&	&	CCONJ
gsrj-41	326	35	testa	testa	PROPN
gsrj-41	326	36	,	,	PUNCT
gsrj-41	326	37	m.	m.	NOUN
gsrj-41	326	38	(	(	PUNCT
gsrj-41	326	39	2021	2021	NUM
gsrj-41	326	40	)	)	PUNCT
gsrj-41	326	41	.	.	PUNCT
gsrj-41	327	1	examining	examine	VERB
gsrj-41	327	2	the	the	DET
gsrj-41	327	3	effect	effect	NOUN
gsrj-41	327	4	of	of	ADP
gsrj-41	327	5	information	information	NOUN
gsrj-41	327	6	channel	channel	NOUN
gsrj-41	327	7	on	on	ADP
gsrj-41	327	8	covid-19	covid-19	PROPN
gsrj-41	327	9	vaccine	vaccine	NOUN
gsrj-41	327	10	acceptance	acceptance	NOUN
gsrj-41	327	11	.	.	PUNCT
gsrj-41	328	1	plos	plos	PROPN
gsrj-41	328	2	one	one	NUM
gsrj-41	328	3	,	,	PUNCT
gsrj-41	328	4	16(5	16(5	NUM
gsrj-41	328	5	)	)	PUNCT
gsrj-41	328	6	,	,	PUNCT
gsrj-41	328	7	e0251095	e0251095	NOUN
gsrj-41	328	8	.	.	PUNCT
gsrj-41	329	1	https://doi.org/10.1371/journal.pone.0251095	https://doi.org/10.1371/journal.pone.0251095	NOUN
gsrj-41	329	2	44	44	NUM
gsrj-41	329	3	.	.	PUNCT
gsrj-41	330	1	ojikutu	ojikutu	PROPN
gsrj-41	330	2	,	,	PUNCT
gsrj-41	330	3	b.	b.	PROPN
gsrj-41	330	4	o.	o.	PROPN
gsrj-41	330	5	,	,	PUNCT
gsrj-41	330	6	stephenson	stephenson	PROPN
gsrj-41	330	7	,	,	PUNCT
gsrj-41	330	8	k.	k.	PROPN
gsrj-41	330	9	e.	e.	PROPN
gsrj-41	330	10	,	,	PUNCT
gsrj-41	330	11	mayer	mayer	PROPN
gsrj-41	330	12	,	,	PUNCT
gsrj-41	330	13	k.	k.	PROPN
gsrj-41	330	14	h.	h.	PROPN
gsrj-41	330	15	,	,	PUNCT
gsrj-41	330	16	&	&	CCONJ
gsrj-41	330	17	emmons	emmons	PROPN
gsrj-41	330	18	,	,	PUNCT
gsrj-41	330	19	k.	k.	PROPN
gsrj-41	330	20	m.	m.	PROPN
gsrj-41	330	21	(	(	PUNCT
gsrj-41	330	22	2021	2021	NUM
gsrj-41	330	23	)	)	PUNCT
gsrj-41	330	24	.	.	PUNCT
gsrj-41	331	1	building	build	VERB
gsrj-41	331	2	trust	trust	NOUN
gsrj-41	331	3	in	in	ADP
gsrj-41	331	4	covid-19	covid-19	PROPN
gsrj-41	331	5	vaccines	vaccine	NOUN
gsrj-41	331	6	and	and	CCONJ
gsrj-41	331	7	beyond	beyond	ADP
gsrj-41	331	8	through	through	ADP
gsrj-41	331	9	authentic	authentic	ADJ
gsrj-41	331	10	community	community	NOUN
gsrj-41	331	11	investment	investment	NOUN
gsrj-41	331	12	.	.	PUNCT
gsrj-41	332	1	american	american	ADJ
gsrj-41	332	2	journal	journal	PROPN
gsrj-41	332	3	of	of	ADP
gsrj-41	332	4	public	public	ADJ
gsrj-41	332	5	health	health	NOUN
gsrj-41	332	6	,	,	PUNCT
gsrj-41	332	7	111(3	111(3	NUM
gsrj-41	332	8	)	)	PUNCT
gsrj-41	332	9	,	,	PUNCT
gsrj-41	332	10	366–368	366–368	NUM
gsrj-41	332	11	.	.	PUNCT
gsrj-41	333	1	https://doi.org/10.2105/ajph.2020.306087	https://doi.org/10.2105/ajph.2020.306087	PROPN
gsrj-41	333	2	45	45	NUM
gsrj-41	333	3	.	.	PUNCT
gsrj-41	334	1	cdc	cdc	PROPN
gsrj-41	334	2	.	.	PUNCT
gsrj-41	334	3	(	(	PUNCT
gsrj-41	334	4	2021	2021	NUM
gsrj-41	334	5	)	)	PUNCT
gsrj-41	334	6	.	.	PUNCT
gsrj-41	335	1	understanding	understand	VERB
gsrj-41	335	2	how	how	SCONJ
gsrj-41	335	3	covid-19	covid-19	PROPN
gsrj-41	335	4	vaccines	vaccine	NOUN
gsrj-41	335	5	work	work	VERB
gsrj-41	335	6	.	.	PUNCT
gsrj-41	336	1	centers	center	NOUN
gsrj-41	336	2	for	for	ADP
gsrj-41	336	3	disease	disease	NOUN
gsrj-41	336	4	control	control	NOUN
gsrj-41	336	5	and	and	CCONJ
gsrj-41	336	6	prevention	prevention	NOUN
gsrj-41	336	7	.	.	PUNCT
gsrj-41	337	1	https://www.cdc.gov/coronavirus/2019ncov/vaccines/different-vaccines/how-theywork.html	https://www.cdc.gov/coronavirus/2019ncov/vaccines/different-vaccines/how-theywork.html	INTJ
gsrj-41	337	2	46	46	NUM
gsrj-41	337	3	.	.	PUNCT
gsrj-41	338	1	cdc	cdc	PROPN
gsrj-41	338	2	.	.	PUNCT
gsrj-41	338	3	(	(	PUNCT
gsrj-41	338	4	2021	2021	NUM
gsrj-41	338	5	)	)	PUNCT
gsrj-41	338	6	.	.	PUNCT
gsrj-41	339	1	what	what	PRON
gsrj-41	339	2	to	to	PART
gsrj-41	339	3	expect	expect	VERB
gsrj-41	339	4	after	after	ADP
gsrj-41	339	5	getting	get	VERB
gsrj-41	339	6	a	a	DET
gsrj-41	339	7	covid-19	covid-19	PROPN
gsrj-41	339	8	vaccine	vaccine	NOUN
gsrj-41	339	9	.	.	PUNCT
gsrj-41	340	1	centers	center	NOUN
gsrj-41	340	2	for	for	ADP
gsrj-41	340	3	disease	disease	NOUN
gsrj-41	340	4	control	control	NOUN
gsrj-41	340	5	and	and	CCONJ
gsrj-41	340	6	prevention	prevention	NOUN
gsrj-41	340	7	.	.	PUNCT
gsrj-41	341	1	https://www.cdc.gov/coronavirus/2019ncov/vaccines/expect/after.html	https://www.cdc.gov/coronavirus/2019ncov/vaccines/expect/after.html	X
gsrj-41	341	2	47	47	NUM
gsrj-41	341	3	.	.	PUNCT
gsrj-41	342	1	cdc	cdc	PROPN
gsrj-41	342	2	.	.	PUNCT
gsrj-41	342	3	(	(	PUNCT
gsrj-41	342	4	2020	2020	NUM
gsrj-41	342	5	)	)	PUNCT
gsrj-41	342	6	.	.	PUNCT
gsrj-41	343	1	covid-19	covid-19	PROPN
gsrj-41	343	2	and	and	CCONJ
gsrj-41	343	3	your	your	PRON
gsrj-41	343	4	health	health	NOUN
gsrj-41	343	5	.	.	PUNCT
gsrj-41	344	1	centers	center	NOUN
gsrj-41	344	2	for	for	ADP
gsrj-41	344	3	disease	disease	NOUN
gsrj-41	344	4	control	control	NOUN
gsrj-41	344	5	and	and	CCONJ
gsrj-41	344	6	prevention	prevention	NOUN
gsrj-41	344	7	.	.	PUNCT
gsrj-41	345	1	https://www.cdc.gov/coronavirus/2019ncov/long-term-effects/index.html	https://www.cdc.gov/coronavirus/2019ncov/long-term-effects/index.html	PRON
gsrj-41	345	2	48	48	NUM
gsrj-41	345	3	.	.	PUNCT
gsrj-41	346	1	xie	xie	PROPN
gsrj-41	346	2	,	,	PUNCT
gsrj-41	346	3	y.	y.	PROPN
gsrj-41	346	4	,	,	PUNCT
gsrj-41	346	5	xu	xu	PROPN
gsrj-41	346	6	,	,	PUNCT
gsrj-41	346	7	e.	e.	PROPN
gsrj-41	346	8	,	,	PUNCT
gsrj-41	346	9	bowe	bowe	PROPN
gsrj-41	346	10	,	,	PUNCT
gsrj-41	346	11	b.	b.	PROPN
gsrj-41	346	12	,	,	PUNCT
gsrj-41	346	13	&	&	CCONJ
gsrj-41	346	14	al	al	PROPN
gsrj-41	346	15	-	-	PUNCT
gsrj-41	346	16	aly	aly	PROPN
gsrj-41	346	17	,	,	PUNCT
gsrj-41	346	18	z.	z.	PROPN
gsrj-41	346	19	(	(	PUNCT
gsrj-41	346	20	2022	2022	NUM
gsrj-41	346	21	)	)	PUNCT
gsrj-41	346	22	.	.	PUNCT
gsrj-41	347	1	long	long	ADJ
gsrj-41	347	2	-	-	PUNCT
gsrj-41	347	3	term	term	NOUN
gsrj-41	347	4	cardiovascular	cardiovascular	ADJ
gsrj-41	347	5	outcomes	outcome	NOUN
gsrj-41	347	6	of	of	ADP
gsrj-41	347	7	covid19	covid19	NOUN
gsrj-41	347	8	.	.	PUNCT
gsrj-41	348	1	nature	nature	NOUN
gsrj-41	348	2	medicine	medicine	NOUN
gsrj-41	348	3	,	,	PUNCT
gsrj-41	348	4	1–8	1–8	X
gsrj-41	348	5	.	.	PUNCT
gsrj-41	348	6	https://doi.org/10.1038/s41591-022-01689-3	https://doi.org/10.1038/s41591-022-01689-3	NUM
gsrj-41	348	7	49	49	NUM
gsrj-41	348	8	.	.	PUNCT
gsrj-41	349	1	chou	chou	NOUN
gsrj-41	349	2	,	,	PUNCT
gsrj-41	349	3	w.	w.	PROPN
gsrj-41	349	4	s.	s.	PROPN
gsrj-41	349	5	,	,	PUNCT
gsrj-41	349	6	&	&	CCONJ
gsrj-41	349	7	budenz	budenz	PROPN
gsrj-41	349	8	,	,	PUNCT
gsrj-41	349	9	a.	a.	NOUN
gsrj-41	349	10	(	(	PUNCT
gsrj-41	349	11	2020	2020	NUM
gsrj-41	349	12	)	)	PUNCT
gsrj-41	349	13	.	.	PUNCT
gsrj-41	350	1	considering	consider	VERB
gsrj-41	350	2	emotion	emotion	NOUN
gsrj-41	350	3	in	in	ADP
gsrj-41	350	4	covid-19	covid-19	PROPN
gsrj-41	350	5	vaccine	vaccine	NOUN
gsrj-41	350	6	communication	communication	NOUN
gsrj-41	350	7	:	:	PUNCT
gsrj-41	350	8	addressing	address	VERB
gsrj-41	350	9	vaccine	vaccine	NOUN
gsrj-41	350	10	hesitancy	hesitancy	NOUN
gsrj-41	350	11	and	and	CCONJ
gsrj-41	350	12	fostering	foster	VERB
gsrj-41	350	13	vaccine	vaccine	NOUN
gsrj-41	350	14	confidence	confidence	NOUN
gsrj-41	350	15	.	.	PUNCT
gsrj-41	351	1	health	health	NOUN
gsrj-41	351	2	communication	communication	NOUN
gsrj-41	351	3	,	,	PUNCT
gsrj-41	351	4	35(14	35(14	NUM
gsrj-41	351	5	)	)	PUNCT
gsrj-41	351	6	,	,	PUNCT
gsrj-41	351	7	1718–1722	1718–1722	NUM
gsrj-41	351	8	.	.	PUNCT
gsrj-41	352	1	https://doi.org/10.1080/10410236.2020.1838096	https://doi.org/10.1080/10410236.2020.1838096	ADJ
gsrj-41	352	2	50	50	NUM
gsrj-41	352	3	.	.	PUNCT
gsrj-41	353	1	tufekci	tufekci	ADJ
gsrj-41	353	2	,	,	PUNCT
gsrj-41	353	3	z.	z.	PROPN
gsrj-41	353	4	(	(	PUNCT
gsrj-41	353	5	2021	2021	NUM
gsrj-41	353	6	,	,	PUNCT
gsrj-41	353	7	october	october	PROPN
gsrj-41	353	8	15	15	NUM
gsrj-41	353	9	)	)	PUNCT
gsrj-41	353	10	.	.	PUNCT
gsrj-41	354	1	opinion	opinion	NOUN
gsrj-41	354	2	|	|	ADP
gsrj-41	354	3	the	the	DET
gsrj-41	354	4	unvaccinated	unvaccinated	ADJ
gsrj-41	354	5	may	may	AUX
gsrj-41	354	6	not	not	PART
gsrj-41	354	7	be	be	AUX
gsrj-41	354	8	who	who	PRON
gsrj-41	354	9	you	you	PRON
gsrj-41	354	10	think	think	VERB
gsrj-41	354	11	—	—	PUNCT
gsrj-41	354	12	24	24	NUM
gsrj-41	354	13	georgetown	georgetown	PROPN
gsrj-41	354	14	scientific	scientific	PROPN
gsrj-41	354	15	research	research	PROPN
gsrj-41	354	16	journal	journal	NOUN
gsrj-41	354	17	the	the	DET
gsrj-41	354	18	new	new	PROPN
gsrj-41	354	19	york	york	PROPN
gsrj-41	354	20	times	times	PROPN
gsrj-41	354	21	.	.	PUNCT
gsrj-41	355	1	https://www.nytimes.com/2021/10/15/opinion/c	https://www.nytimes.com/2021/10/15/opinion/c	PROPN
gsrj-41	355	2	ovid-vaccines-unvaccinated.html	ovid-vaccines-unvaccinated.html	PROPN
gsrj-41	355	3	51	51	NUM
gsrj-41	355	4	.	.	PUNCT
gsrj-41	356	1	kff	kff	PROPN
gsrj-41	356	2	covid-19	covid-19	PROPN
gsrj-41	356	3	vaccine	vaccine	NOUN
gsrj-41	356	4	monitor	monitor	VERB
gsrj-41	356	5	dashboard	dashboard	NOUN
gsrj-41	356	6	|	|	PROPN
gsrj-41	356	7	kff	kff	PROPN
gsrj-41	356	8	.	.	PUNCT
gsrj-41	357	1	(	(	PUNCT
gsrj-41	357	2	2021	2021	NUM
gsrj-41	357	3	)	)	PUNCT
gsrj-41	357	4	.	.	PUNCT
gsrj-41	358	1	retrieved	retrieve	VERB
gsrj-41	358	2	november	november	PROPN
gsrj-41	358	3	10	10	NUM
gsrj-41	358	4	,	,	PUNCT
gsrj-41	358	5	2021	2021	NUM
gsrj-41	358	6	,	,	PUNCT
gsrj-41	358	7	from	from	ADP
gsrj-41	358	8	https://www.kff.org/coronavirus-covid19/dashboard/kff-covid-19-vaccine-monitordashboard/	https://www.kff.org/coronavirus-covid19/dashboard/kff-covid-19-vaccine-monitordashboard/	PROPN
gsrj-41	358	9	52	52	NUM
gsrj-41	358	10	.	.	PUNCT
gsrj-41	358	11	standards	standard	NOUN
gsrj-41	358	12	for	for	ADP
gsrj-41	358	13	adult	adult	NOUN
gsrj-41	358	14	immunization	immunization	NOUN
gsrj-41	358	15	practices	practice	NOUN
gsrj-41	359	1	|	|	ADV
gsrj-41	359	2	cdc	cdc	PROPN
gsrj-41	359	3	.	.	PUNCT
gsrj-41	360	1	(	(	PUNCT
gsrj-41	360	2	2019	2019	NUM
gsrj-41	360	3	,	,	PUNCT
gsrj-41	360	4	march	march	PROPN
gsrj-41	360	5	11	11	NUM
gsrj-41	360	6	)	)	PUNCT
gsrj-41	360	7	.	.	PUNCT
gsrj-41	361	1	https://www.cdc.gov/vaccines/hcp/adults/forpractice/standards/index.html	https://www.cdc.gov/vaccines/hcp/adults/forpractice/standards/index.html	PROPN
gsrj-41	361	2	53	53	NUM
gsrj-41	361	3	.	.	PUNCT
gsrj-41	361	4	zulman	zulman	PROPN
gsrj-41	362	1	dm	dm	PROPN
gsrj-41	362	2	,	,	PUNCT
gsrj-41	362	3	haverfield	haverfield	PROPN
gsrj-41	362	4	mc	mc	PROPN
gsrj-41	362	5	,	,	PUNCT
gsrj-41	362	6	shaw	shaw	PROPN
gsrj-41	362	7	jg	jg	PROPN
gsrj-41	362	8	,	,	PUNCT
gsrj-41	362	9	et	et	PROPN
gsrj-41	362	10	al	al	PROPN
gsrj-41	362	11	.	.	PROPN
gsrj-41	362	12	practices	practice	NOUN
gsrj-41	362	13	to	to	PART
gsrj-41	362	14	foster	foster	VERB
gsrj-41	362	15	physician	physician	NOUN
gsrj-41	362	16	presence	presence	NOUN
gsrj-41	362	17	and	and	CCONJ
gsrj-41	362	18	connection	connection	NOUN
gsrj-41	362	19	with	with	ADP
gsrj-41	362	20	patients	patient	NOUN
gsrj-41	362	21	in	in	ADP
gsrj-41	362	22	the	the	DET
gsrj-41	362	23	clinical	clinical	ADJ
gsrj-41	362	24	encounter	encounter	NOUN
gsrj-41	362	25	.	.	PUNCT
gsrj-41	363	1	jama	jama	PROPN
gsrj-41	363	2	.	.	PUNCT
gsrj-41	364	1	2020;323(1):70–81	2020;323(1):70–81	NUM
gsrj-41	364	2	.	.	PUNCT
gsrj-41	365	1	doi:10.1001	doi:10.1001	PROPN
gsrj-41	365	2	/	/	SYM
gsrj-41	365	3	jama.2019.19003	jama.2019.19003	PROPN
gsrj-41	365	4	54	54	NUM
gsrj-41	365	5	.	.	PUNCT
gsrj-41	365	6	philadelphia	philadelphia	PROPN
gsrj-41	365	7	,	,	PUNCT
gsrj-41	365	8	t.	t.	PROPN
gsrj-41	365	9	c.	c.	PROPN
gsrj-41	365	10	h.	h.	PROPN
gsrj-41	365	11	of	of	ADP
gsrj-41	365	12	.	.	PUNCT
gsrj-41	366	1	(	(	PUNCT
gsrj-41	366	2	2015	2015	NUM
gsrj-41	366	3	,	,	PUNCT
gsrj-41	366	4	march	march	PROPN
gsrj-41	366	5	17	17	NUM
gsrj-41	366	6	)	)	PUNCT
gsrj-41	366	7	.	.	PUNCT
gsrj-41	367	1	educating	educate	VERB
gsrj-41	367	2	students	student	NOUN
gsrj-41	367	3	about	about	ADP
gsrj-41	367	4	the	the	DET
gsrj-41	367	5	immune	immune	ADJ
gsrj-41	367	6	system	system	NOUN
gsrj-41	367	7	,	,	PUNCT
gsrj-41	367	8	diseases	disease	NOUN
gsrj-41	367	9	and	and	CCONJ
gsrj-41	367	10	vaccines	vaccine	NOUN
gsrj-41	367	11	[	[	X
gsrj-41	367	12	text	text	NOUN
gsrj-41	367	13	]	]	PUNCT
gsrj-41	367	14	.	.	PUNCT
gsrj-41	368	1	the	the	DET
gsrj-41	368	2	children	child	NOUN
gsrj-41	368	3	’s	’s	PART
gsrj-41	368	4	hospital	hospital	NOUN
gsrj-41	368	5	of	of	ADP
gsrj-41	368	6	philadelphia	philadelphia	PROPN
gsrj-41	368	7	.	.	PUNCT
gsrj-41	369	1	https://www.chop.edu/centers-programs/vaccineeducation-center/resources/vaccine-powerpointpresentations-and-learning-modules	https://www.chop.edu/centers-programs/vaccineeducation-center/resources/vaccine-powerpointpresentations-and-learning-modules	PROPN
gsrj-41	369	2	25	25	NUM
gsrj-41	369	3	georgetown	georgetown	PROPN
gsrj-41	369	4	scientific	scientific	ADJ
gsrj-41	369	5	research	research	NOUN
gsrj-41	369	6	journal	journal	NOUN
gsrj-41	369	7	appendix	appendix	NOUN
gsrj-41	369	8	table	table	NOUN
gsrj-41	369	9	a1	a1	NOUN
gsrj-41	369	10	.	.	PUNCT
gsrj-41	369	11	pubmed	pubmed	PROPN
gsrj-41	369	12	search	search	NOUN
gsrj-41	369	13	results	result	NOUN
gsrj-41	369	14	:	:	PUNCT
gsrj-41	370	1	“	"	PUNCT
gsrj-41	370	2	covid-19	covid-19	PROPN
gsrj-41	370	3	united	united	PROPN
gsrj-41	370	4	states	states	PROPN
gsrj-41	370	5	vaccine	vaccine	NOUN
gsrj-41	370	6	hesitancy	hesitancy	NOUN
gsrj-41	370	7	reasons	reason	NOUN
gsrj-41	370	8	”	"	PUNCT
gsrj-41	370	9	authors	author	NOUN
gsrj-41	370	10	,	,	PUNCT
gsrj-41	370	11	year	year	NOUN
gsrj-41	370	12	,	,	PUNCT
gsrj-41	370	13	title	title	NOUN
gsrj-41	370	14	purpose	purpose	NOUN
gsrj-41	370	15	of	of	ADP
gsrj-41	370	16	study	study	NOUN
gsrj-41	370	17	method	method	NOUN
gsrj-41	370	18	before	before	ADV
gsrj-41	370	19	,	,	PUNCT
gsrj-41	370	20	after	after	ADP
gsrj-41	370	21	,	,	PUNCT
gsrj-41	370	22	or	or	CCONJ
gsrj-41	370	23	both	both	DET
gsrj-41	370	24	fda	fda	PROPN
gsrj-41	370	25	eua	eua	PROPN
gsrj-41	370	26	of	of	ADP
gsrj-41	370	27	pfizer	pfizer	PROPN
gsrj-41	370	28	(	(	PUNCT
gsrj-41	370	29	dec	dec	PROPN
gsrj-41	370	30	11	11	NUM
gsrj-41	370	31	,	,	PUNCT
gsrj-41	370	32	2020	2020	NUM
gsrj-41	370	33	)	)	PUNCT
gsrj-41	371	1	population	population	NOUN
gsrj-41	371	2	studied	study	VERB
gsrj-41	371	3	(	(	PUNCT
gsrj-41	371	4	sample	sample	NOUN
gsrj-41	371	5	size	size	NOUN
gsrj-41	371	6	,	,	PUNCT
gsrj-41	371	7	can	can	AUX
gsrj-41	371	8	it	it	PRON
gsrj-41	371	9	be	be	AUX
gsrj-41	371	10	generalized	generalize	VERB
gsrj-41	371	11	,	,	PUNCT
gsrj-41	371	12	specific	specific	ADJ
gsrj-41	371	13	location	location	NOUN
gsrj-41	371	14	within	within	ADP
gsrj-41	371	15	us	we	PRON
gsrj-41	371	16	)	)	PUNCT
gsrj-41	371	17	reason(s	reason(s	PROPN
gsrj-41	371	18	)	)	PUNCT
gsrj-41	371	19	for	for	ADP
gsrj-41	371	20	hesitancy	hesitancy	NOUN
gsrj-41	371	21	(	(	PUNCT
gsrj-41	371	22	with	with	ADP
gsrj-41	371	23	percentages	percentage	NOUN
gsrj-41	371	24	)	)	PUNCT
gsrj-41	371	25	fisher	fisher	PROPN
gsrj-41	371	26	,	,	PUNCT
gsrj-41	371	27	et	et	PROPN
gsrj-41	371	28	al	al	PROPN
gsrj-41	371	29	.	.	PROPN
gsrj-41	371	30	(	(	PUNCT
gsrj-41	371	31	2020	2020	NUM
gsrj-41	371	32	)	)	PUNCT
gsrj-41	371	33	.	.	PUNCT
gsrj-41	372	1	attitudes	attitude	NOUN
gsrj-41	372	2	toward	toward	ADP
gsrj-41	372	3	a	a	DET
gsrj-41	372	4	potential	potential	ADJ
gsrj-41	372	5	sars	sar	NOUN
gsrj-41	372	6	-	-	PUNCT
gsrj-41	372	7	cov-2	cov-2	PART
gsrj-41	372	8	vaccine	vaccine	NOUN
gsrj-41	372	9	:	:	PUNCT
gsrj-41	372	10	a	a	DET
gsrj-41	372	11	survey	survey	NOUN
gsrj-41	372	12	of	of	ADP
gsrj-41	372	13	u.s	u.s	PROPN
gsrj-41	372	14	.	.	PROPN
gsrj-41	372	15	adults15	adults15	PROPN
gsrj-41	372	16	to	to	PART
gsrj-41	372	17	assess	assess	VERB
gsrj-41	372	18	intent	intent	NOUN
gsrj-41	372	19	to	to	PART
gsrj-41	372	20	be	be	AUX
gsrj-41	372	21	vaccinated	vaccinate	VERB
gsrj-41	372	22	against	against	ADP
gsrj-41	372	23	covid-19	covid-19	PROPN
gsrj-41	372	24	among	among	ADP
gsrj-41	372	25	a	a	DET
gsrj-41	372	26	representative	representative	ADJ
gsrj-41	372	27	sample	sample	NOUN
gsrj-41	372	28	of	of	ADP
gsrj-41	372	29	adults	adult	NOUN
gsrj-41	372	30	in	in	ADP
gsrj-41	372	31	the	the	DET
gsrj-41	372	32	united	united	PROPN
gsrj-41	372	33	states	states	PROPN
gsrj-41	372	34	and	and	CCONJ
gsrj-41	372	35	identify	identify	VERB
gsrj-41	372	36	predictors	predictor	NOUN
gsrj-41	372	37	of	of	ADP
gsrj-41	372	38	and	and	CCONJ
gsrj-41	372	39	reasons	reason	NOUN
gsrj-41	372	40	for	for	ADP
gsrj-41	372	41	vaccine	vaccine	NOUN
gsrj-41	372	42	hesitancy	hesitancy	NOUN
gsrj-41	372	43	.	.	PUNCT
gsrj-41	373	1	online	online	ADJ
gsrj-41	373	2	or	or	CCONJ
gsrj-41	373	3	telephone	telephone	NOUN
gsrj-41	373	4	crosssectional	crosssectional	ADJ
gsrj-41	373	5	survey	survey	NOUN
gsrj-41	373	6	,	,	PUNCT
gsrj-41	373	7	fielded	field	VERB
gsrj-41	373	8	from	from	ADP
gsrj-41	373	9	16	16	NUM
gsrj-41	373	10	through	through	ADP
gsrj-41	373	11	20	20	NUM
gsrj-41	373	12	april	april	PROPN
gsrj-41	373	13	2020	2020	NUM
gsrj-41	373	14	.	.	PUNCT
gsrj-41	374	1	before	before	SCONJ
gsrj-41	374	2	991	991	NUM
gsrj-41	374	3	amerispeak	amerispeak	ADJ
gsrj-41	374	4	panel	panel	NOUN
gsrj-41	374	5	members	member	NOUN
gsrj-41	374	6	responded	respond	VERB
gsrj-41	374	7	approximately	approximately	ADV
gsrj-41	374	8	1000	1000	NUM
gsrj-41	374	9	adults	adult	NOUN
gsrj-41	374	10	drawn	draw	VERB
gsrj-41	374	11	from	from	ADP
gsrj-41	374	12	the	the	DET
gsrj-41	374	13	amerispeak	amerispeak	ADJ
gsrj-41	374	14	probability	probability	NOUN
gsrj-41	374	15	-	-	PUNCT
gsrj-41	374	16	based	base	VERB
gsrj-41	374	17	research	research	NOUN
gsrj-41	374	18	panel	panel	NOUN
gsrj-41	374	19	,	,	PUNCT
gsrj-41	374	20	covering	cover	VERB
gsrj-41	374	21	approximately	approximately	ADV
gsrj-41	374	22	97	97	NUM
gsrj-41	374	23	%	%	NOUN
gsrj-41	374	24	of	of	ADP
gsrj-41	374	25	the	the	DET
gsrj-41	374	26	u.s	u.s	PROPN
gsrj-41	374	27	.	.	PROPN
gsrj-41	374	28	household	household	NOUN
gsrj-41	374	29	population	population	NOUN
gsrj-41	374	30	.	.	PUNCT
gsrj-41	375	1	16.1	16.1	NUM
gsrj-41	375	2	%	%	NOUN
gsrj-41	375	3	response	response	NOUN
gsrj-41	375	4	rate	rate	NOUN
gsrj-41	375	5	of	of	ADP
gsrj-41	375	6	the	the	DET
gsrj-41	375	7	31.6	31.6	NUM
gsrj-41	375	8	%	%	NOUN
gsrj-41	375	9	who	who	PRON
gsrj-41	375	10	were	be	AUX
gsrj-41	375	11	not	not	PART
gsrj-41	375	12	sure	sure	ADJ
gsrj-41	375	13	about	about	ADP
gsrj-41	375	14	being	be	AUX
gsrj-41	375	15	vaccinated	vaccinate	VERB
gsrj-41	375	16	&	&	CCONJ
gsrj-41	375	17	the	the	DET
gsrj-41	375	18	10.8	10.8	NUM
gsrj-41	375	19	%	%	NOUN
gsrj-41	375	20	who	who	PRON
gsrj-41	375	21	did	do	AUX
gsrj-41	375	22	not	not	PART
gsrj-41	375	23	intend	intend	VERB
gsrj-41	375	24	to	to	PART
gsrj-41	375	25	be	be	AUX
gsrj-41	375	26	vaccinated	vaccinate	VERB
gsrj-41	375	27	,	,	PUNCT
gsrj-41	375	28	72.1	72.1	NUM
gsrj-41	375	29	%	%	NOUN
gsrj-41	375	30	(	(	PUNCT
gsrj-41	375	31	n=220	n=220	ADP
gsrj-41	375	32	not	not	PART
gsrj-41	375	33	sure	sure	ADJ
gsrj-41	375	34	&	&	CCONJ
gsrj-41	375	35	n=83	n=83	PROPN
gsrj-41	375	36	no	no	PRON
gsrj-41	375	37	)	)	PUNCT
gsrj-41	375	38	responded	respond	VERB
gsrj-41	375	39	with	with	ADP
gsrj-41	375	40	reasons	reason	NOUN
gsrj-41	375	41	.	.	PUNCT
gsrj-41	376	1	the	the	DET
gsrj-41	376	2	most	most	ADV
gsrj-41	376	3	common	common	ADJ
gsrj-41	376	4	reasons	reason	NOUN
gsrj-41	376	5	cited	cite	VERB
gsrj-41	376	6	by	by	ADP
gsrj-41	376	7	participants	participant	NOUN
gsrj-41	376	8	who	who	PRON
gsrj-41	376	9	were	be	AUX
gsrj-41	376	10	not	not	PART
gsrj-41	376	11	sure	sure	ADJ
gsrj-41	376	12	whether	whether	SCONJ
gsrj-41	376	13	they	they	PRON
gsrj-41	376	14	will	will	AUX
gsrj-41	376	15	be	be	AUX
gsrj-41	376	16	vaccinated	vaccinate	VERB
gsrj-41	376	17	included	include	VERB
gsrj-41	376	18	specific	specific	ADJ
gsrj-41	376	19	concerns	concern	NOUN
gsrj-41	376	20	about	about	ADP
gsrj-41	376	21	the	the	DET
gsrj-41	376	22	vaccine	vaccine	NOUN
gsrj-41	376	23	(	(	PUNCT
gsrj-41	376	24	such	such	ADJ
gsrj-41	376	25	as	as	ADP
gsrj-41	376	26	safety	safety	NOUN
gsrj-41	376	27	or	or	CCONJ
gsrj-41	376	28	effectiveness	effectiveness	NOUN
gsrj-41	376	29	)	)	PUNCT
gsrj-41	376	30	(	(	PUNCT
gsrj-41	376	31	57.3	57.3	NUM
gsrj-41	376	32	%	%	NOUN
gsrj-41	376	33	of	of	ADP
gsrj-41	376	34	not	not	PART
gsrj-41	376	35	sure	sure	ADJ
gsrj-41	376	36	)	)	PUNCT
gsrj-41	376	37	or	or	CCONJ
gsrj-41	376	38	a	a	DET
gsrj-41	376	39	need	need	NOUN
gsrj-41	376	40	for	for	ADP
gsrj-41	376	41	more	more	ADJ
gsrj-41	376	42	information	information	NOUN
gsrj-41	376	43	(	(	PUNCT
gsrj-41	376	44	22.3	22.3	NUM
gsrj-41	376	45	%	%	NOUN
gsrj-41	376	46	of	of	ADP
gsrj-41	376	47	not	not	PART
gsrj-41	376	48	sure	sure	ADJ
gsrj-41	376	49	)	)	PUNCT
gsrj-41	376	50	in	in	ADP
gsrj-41	376	51	contrast	contrast	NOUN
gsrj-41	376	52	,	,	PUNCT
gsrj-41	376	53	the	the	DET
gsrj-41	376	54	most	most	ADV
gsrj-41	376	55	common	common	ADJ
gsrj-41	376	56	reasons	reason	NOUN
gsrj-41	376	57	provided	provide	VERB
gsrj-41	376	58	by	by	ADP
gsrj-41	376	59	participants	participant	NOUN
gsrj-41	376	60	who	who	PRON
gsrj-41	376	61	did	do	AUX
gsrj-41	376	62	not	not	PART
gsrj-41	376	63	intend	intend	VERB
gsrj-41	376	64	to	to	PART
gsrj-41	376	65	be	be	AUX
gsrj-41	376	66	vaccinated	vaccinate	VERB
gsrj-41	376	67	included	include	VERB
gsrj-41	376	68	antivaccine	antivaccine	NOUN
gsrj-41	376	69	attitudes	attitude	NOUN
gsrj-41	376	70	,	,	PUNCT
gsrj-41	376	71	beliefs	belief	NOUN
gsrj-41	376	72	,	,	PUNCT
gsrj-41	376	73	or	or	CCONJ
gsrj-41	376	74	emotions	emotion	NOUN
gsrj-41	376	75	(	(	PUNCT
gsrj-41	376	76	56.6	56.6	NUM
gsrj-41	376	77	%	%	NOUN
gsrj-41	376	78	of	of	ADP
gsrj-41	376	79	no	no	NOUN
gsrj-41	376	80	)	)	PUNCT
gsrj-41	376	81	,	,	PUNCT
gsrj-41	376	82	and	and	CCONJ
gsrj-41	376	83	lack	lack	NOUN
gsrj-41	376	84	of	of	ADP
gsrj-41	376	85	trust	trust	NOUN
gsrj-41	376	86	(	(	PUNCT
gsrj-41	376	87	32.5	32.5	NUM
gsrj-41	376	88	%	%	NOUN
gsrj-41	376	89	of	of	ADP
gsrj-41	376	90	no	no	NOUN
gsrj-41	376	91	)	)	PUNCT
gsrj-41	376	92	more	more	ADV
gsrj-41	376	93	specific	specific	ADJ
gsrj-41	376	94	top	top	ADJ
gsrj-41	376	95	reasons	reason	NOUN
gsrj-41	376	96	:	:	PUNCT
gsrj-41	376	97	34.1	34.1	NUM
gsrj-41	376	98	%	%	NOUN
gsrj-41	376	99	of	of	ADP
gsrj-41	376	100	not	not	PART
gsrj-41	376	101	sure	sure	ADJ
gsrj-41	376	102	:	:	PUNCT
gsrj-41	376	103	side	side	ADJ
gsrj-41	376	104	effects	effect	NOUN
gsrj-41	376	105	,	,	PUNCT
gsrj-41	376	106	safety	safety	NOUN
gsrj-41	376	107	&	&	CCONJ
gsrj-41	376	108	21.7	21.7	NUM
gsrj-41	376	109	%	%	NOUN
gsrj-41	376	110	of	of	ADP
gsrj-41	376	111	no	no	NOUN
gsrj-41	376	112	:	:	PUNCT
gsrj-41	376	113	do	do	AUX
gsrj-41	376	114	n’t	not	PART
gsrj-41	376	115	believe	believe	VERB
gsrj-41	376	116	in	in	ADP
gsrj-41	376	117	,	,	PUNCT
gsrj-41	376	118	want	want	VERB
gsrj-41	376	119	,	,	PUNCT
gsrj-41	376	120	or	or	CCONJ
gsrj-41	376	121	feel	feel	VERB
gsrj-41	376	122	26	26	NUM
gsrj-41	376	123	georgetown	georgetown	PROPN
gsrj-41	376	124	scientific	scientific	PROPN
gsrj-41	376	125	research	research	NOUN
gsrj-41	376	126	journal	journal	NOUN
gsrj-41	376	127	comfortable	comfortable	ADJ
gsrj-41	376	128	with	with	ADP
gsrj-41	376	129	vaccines	vaccine	NOUN
gsrj-41	376	130	unroe	unroe	PROPN
gsrj-41	376	131	,	,	PUNCT
gsrj-41	376	132	et	et	PROPN
gsrj-41	376	133	al	al	PROPN
gsrj-41	376	134	.	.	PROPN
gsrj-41	377	1	(	(	PUNCT
gsrj-41	377	2	2021	2021	NUM
gsrj-41	377	3	)	)	PUNCT
gsrj-41	377	4	.	.	PUNCT
gsrj-41	378	1	willingness	willingness	NOUN
gsrj-41	378	2	of	of	ADP
gsrj-41	378	3	long	long	ADJ
gsrj-41	378	4	-	-	PUNCT
gsrj-41	378	5	term	term	NOUN
gsrj-41	378	6	care	care	NOUN
gsrj-41	378	7	staff	staff	NOUN
gsrj-41	378	8	to	to	PART
gsrj-41	378	9	receive	receive	VERB
gsrj-41	378	10	a	a	DET
gsrj-41	378	11	covid-19	covid-19	PROPN
gsrj-41	378	12	vaccine	vaccine	NOUN
gsrj-41	378	13	:	:	PUNCT
gsrj-41	378	14	a	a	DET
gsrj-41	378	15	single	single	ADJ
gsrj-41	378	16	state	state	NOUN
gsrj-41	378	17	survey16	survey16	NOUN
gsrj-41	378	18	to	to	PART
gsrj-41	378	19	plan	plan	VERB
gsrj-41	378	20	for	for	ADP
gsrj-41	378	21	coronavirus	coronavirus	NOUN
gsrj-41	378	22	infectious	infectious	ADJ
gsrj-41	378	23	disease	disease	NOUN
gsrj-41	378	24	2019	2019	NUM
gsrj-41	378	25	(	(	PUNCT
gsrj-41	378	26	covid-19	covid-19	PROPN
gsrj-41	378	27	)	)	PUNCT
gsrj-41	378	28	vaccine	vaccine	NOUN
gsrj-41	378	29	distribution	distribution	NOUN
gsrj-41	378	30	,	,	PUNCT
gsrj-41	378	31	the	the	DET
gsrj-41	378	32	indiana	indiana	PROPN
gsrj-41	378	33	department	department	PROPN
gsrj-41	378	34	of	of	ADP
gsrj-41	378	35	health	health	PROPN
gsrj-41	378	36	surveyed	survey	VERB
gsrj-41	378	37	nursing	nursing	NOUN
gsrj-41	378	38	home	home	NOUN
gsrj-41	378	39	and	and	CCONJ
gsrj-41	378	40	assisted	assist	VERB
gsrj-41	378	41	living	living	NOUN
gsrj-41	378	42	facility	facility	NOUN
gsrj-41	378	43	staff	staff	NOUN
gsrj-41	378	44	.	.	PUNCT
gsrj-41	379	1	crosssectional	crosssectional	ADJ
gsrj-41	379	2	analysis	analysis	NOUN
gsrj-41	379	3	of	of	ADP
gsrj-41	379	4	an	an	DET
gsrj-41	379	5	anonymous	anonymous	ADJ
gsrj-41	379	6	survey	survey	NOUN
gsrj-41	379	7	sent	send	VERB
gsrj-41	379	8	via	via	ADP
gsrj-41	379	9	text	text	NOUN
gsrj-41	379	10	message	message	NOUN
gsrj-41	379	11	link	link	NOUN
gsrj-41	379	12	to	to	ADP
gsrj-41	379	13	personal	personal	ADJ
gsrj-41	379	14	cell	cell	NOUN
gsrj-41	379	15	phones	phone	NOUN
gsrj-41	379	16	and	and	CCONJ
gsrj-41	379	17	emails	email	NOUN
gsrj-41	379	18	in	in	ADP
gsrj-41	379	19	november	november	PROPN
gsrj-41	379	20	of	of	ADP
gsrj-41	379	21	2020	2020	NUM
gsrj-41	379	22	before	before	ADP
gsrj-41	379	23	nursing	nursing	NOUN
gsrj-41	379	24	home	home	NOUN
gsrj-41	379	25	and	and	CCONJ
gsrj-41	379	26	assisted	assist	VERB
gsrj-41	379	27	living	living	NOUN
gsrj-41	379	28	facility	facility	NOUN
gsrj-41	379	29	staff	staff	NOUN
gsrj-41	379	30	in	in	ADP
gsrj-41	379	31	indiana	indiana	PROPN
gsrj-41	379	32	8,243	8,243	NUM
gsrj-41	379	33	responses	response	NOUN
gsrj-41	379	34	–	–	PUNCT
gsrj-41	379	35	sent	send	VERB
gsrj-41	379	36	to	to	ADP
gsrj-41	379	37	23,232	23,232	NUM
gsrj-41	379	38	november	november	PROPN
gsrj-41	379	39	2020	2020	NUM
gsrj-41	379	40	of	of	ADP
gsrj-41	379	41	those	those	PRON
gsrj-41	379	42	unwilling	unwilling	ADJ
gsrj-41	379	43	to	to	PART
gsrj-41	379	44	take	take	VERB
gsrj-41	379	45	the	the	DET
gsrj-41	379	46	vaccine	vaccine	NOUN
gsrj-41	379	47	when	when	SCONJ
gsrj-41	379	48	first	first	ADV
gsrj-41	379	49	available	available	ADJ
gsrj-41	379	50	(	(	PUNCT
gsrj-41	379	51	55	55	NUM
gsrj-41	379	52	%	%	NOUN
gsrj-41	379	53	of	of	ADP
gsrj-41	379	54	participants	participant	NOUN
gsrj-41	379	55	)	)	PUNCT
gsrj-41	379	56	,	,	PUNCT
gsrj-41	379	57	44	44	NUM
gsrj-41	379	58	%	%	NOUN
gsrj-41	379	59	would	would	AUX
gsrj-41	379	60	consider	consider	VERB
gsrj-41	379	61	in	in	ADP
gsrj-41	379	62	the	the	DET
gsrj-41	379	63	future	future	NOUN
gsrj-41	379	64	.	.	PUNCT
gsrj-41	380	1	concerns	concern	NOUN
gsrj-41	380	2	about	about	ADP
gsrj-41	380	3	side	side	NOUN
gsrj-41	380	4	effects	effect	NOUN
gsrj-41	380	5	was	be	AUX
gsrj-41	380	6	the	the	DET
gsrj-41	380	7	primary	primary	ADJ
gsrj-41	380	8	reason	reason	NOUN
gsrj-41	380	9	for	for	ADP
gsrj-41	380	10	vaccine	vaccine	NOUN
gsrj-41	380	11	hesitancy	hesitancy	NOUN
gsrj-41	380	12	(	(	PUNCT
gsrj-41	380	13	70	70	NUM
gsrj-41	380	14	%	%	NOUN
gsrj-41	380	15	of	of	ADP
gsrj-41	380	16	those	those	PRON
gsrj-41	380	17	unwilling	unwilling	ADJ
gsrj-41	380	18	)	)	PUNCT
gsrj-41	380	19	.	.	PUNCT
gsrj-41	381	1	health	health	NOUN
gsrj-41	381	2	concerns	concern	NOUN
gsrj-41	381	3	(	(	PUNCT
gsrj-41	381	4	34	34	NUM
gsrj-41	381	5	%	%	NOUN
gsrj-41	381	6	)	)	PUNCT
gsrj-41	381	7	questioning	question	VERB
gsrj-41	381	8	effectiveness	effectiveness	NOUN
gsrj-41	381	9	(	(	PUNCT
gsrj-41	381	10	20	20	NUM
gsrj-41	381	11	%	%	NOUN
gsrj-41	381	12	)	)	PUNCT
gsrj-41	381	13	religious	religious	ADJ
gsrj-41	381	14	reasons	reason	NOUN
gsrj-41	381	15	(	(	PUNCT
gsrj-41	381	16	12	12	NUM
gsrj-41	381	17	%	%	NOUN
gsrj-41	381	18	)	)	PUNCT
gsrj-41	381	19	characteristics	characteristic	NOUN
gsrj-41	381	20	associated	associate	VERB
gsrj-41	381	21	with	with	ADP
gsrj-41	381	22	increased	increase	VERB
gsrj-41	381	23	willingness	willingness	NOUN
gsrj-41	381	24	were	be	AUX
gsrj-41	381	25	age	age	NOUN
gsrj-41	381	26	over	over	ADP
gsrj-41	381	27	60	60	NUM
gsrj-41	381	28	,	,	PUNCT
gsrj-41	381	29	male	male	NOUN
gsrj-41	381	30	,	,	PUNCT
gsrj-41	381	31	and	and	CCONJ
gsrj-41	381	32	white	white	ADJ
gsrj-41	381	33	race	race	NOUN
gsrj-41	381	34	(	(	PUNCT
gsrj-41	381	35	p	p	X
gsrj-41	381	36	<	<	X
gsrj-41	381	37	.0001	.0001	NOUN
gsrj-41	381	38	)	)	PUNCT
gsrj-41	381	39	.	.	PUNCT
gsrj-41	382	1	zhang	zhang	PROPN
gsrj-41	382	2	,	,	PUNCT
gsrj-41	382	3	et	et	PROPN
gsrj-41	382	4	al	al	PROPN
gsrj-41	382	5	.	.	PROPN
gsrj-41	382	6	(	(	PUNCT
gsrj-41	382	7	2021	2021	NUM
gsrj-41	382	8	)	)	PUNCT
gsrj-41	382	9	.	.	PUNCT
gsrj-41	383	1	acceptance	acceptance	NOUN
gsrj-41	383	2	of	of	ADP
gsrj-41	383	3	covid-19	covid-19	PROPN
gsrj-41	383	4	vaccine	vaccine	NOUN
gsrj-41	383	5	among	among	ADP
gsrj-41	383	6	refugees	refugee	NOUN
gsrj-41	383	7	in	in	ADP
gsrj-41	383	8	the	the	DET
gsrj-41	383	9	united	united	PROPN
gsrj-41	383	10	states17	states17	PROPN
gsrj-41	383	11	little	little	PROPN
gsrj-41	383	12	is	be	AUX
gsrj-41	383	13	known	know	VERB
gsrj-41	383	14	about	about	ADP
gsrj-41	383	15	covid-19	covid-19	PROPN
gsrj-41	383	16	vaccination	vaccination	NOUN
gsrj-41	383	17	intentions	intention	NOUN
gsrj-41	383	18	among	among	ADP
gsrj-41	383	19	refugee	refugee	NOUN
gsrj-41	383	20	communities	community	NOUN
gsrj-41	383	21	in	in	ADP
gsrj-41	383	22	the	the	DET
gsrj-41	383	23	united	united	PROPN
gsrj-41	383	24	states	states	PROPN
gsrj-41	383	25	.	.	PUNCT
gsrj-41	384	1	the	the	DET
gsrj-41	384	2	objective	objective	NOUN
gsrj-41	384	3	of	of	ADP
gsrj-41	384	4	this	this	DET
gsrj-41	384	5	study	study	NOUN
gsrj-41	384	6	was	be	AUX
gsrj-41	384	7	to	to	PART
gsrj-41	384	8	measure	measure	VERB
gsrj-41	384	9	covid-19	covid-19	PROPN
gsrj-41	384	10	vaccination	vaccination	NOUN
gsrj-41	384	11	intentions	intention	NOUN
gsrj-41	384	12	among	among	ADP
gsrj-41	384	13	a	a	DET
gsrj-41	384	14	sample	sample	NOUN
gsrj-41	384	15	of	of	ADP
gsrj-41	384	16	refugees	refugee	NOUN
gsrj-41	384	17	in	in	ADP
gsrj-41	384	18	the	the	DET
gsrj-41	384	19	united	united	PROPN
gsrj-41	384	20	states	states	PROPN
gsrj-41	384	21	and	and	CCONJ
gsrj-41	384	22	the	the	DET
gsrj-41	384	23	reasons	reason	NOUN
gsrj-41	384	24	for	for	ADP
gsrj-41	384	25	their	their	PRON
gsrj-41	384	26	vaccine	vaccine	NOUN
gsrj-41	384	27	acceptance	acceptance	NOUN
gsrj-41	384	28	or	or	CCONJ
gsrj-41	384	29	hesitancy	hesitancy	NOUN
gsrj-41	384	30	.	.	PUNCT
gsrj-41	385	1	email	email	NOUN
gsrj-41	385	2	and	and	CCONJ
gsrj-41	385	3	text	text	NOUN
gsrj-41	385	4	message	message	NOUN
gsrj-41	385	5	anonymous	anonymous	ADJ
gsrj-41	385	6	online	online	ADJ
gsrj-41	385	7	surveys	survey	NOUN
gsrj-41	385	8	to	to	ADP
gsrj-41	385	9	refugee	refugee	NOUN
gsrj-41	385	10	populations	population	NOUN
gsrj-41	385	11	in	in	ADP
gsrj-41	385	12	us	we	PRON
gsrj-41	385	13	from	from	ADP
gsrj-41	385	14	december	december	PROPN
gsrj-41	385	15	2020	2020	NUM
gsrj-41	385	16	through	through	ADP
gsrj-41	385	17	january	january	PROPN
gsrj-41	385	18	2021	2021	NUM
gsrj-41	385	19	(	(	PUNCT
gsrj-41	385	20	very	very	ADV
gsrj-41	385	21	beginning	beginning	NOUN
gsrj-41	385	22	of	of	ADP
gsrj-41	385	23	roll	roll	NOUN
gsrj-41	385	24	-	-	PUNCT
gsrj-41	385	25	out	out	NOUN
gsrj-41	385	26	,	,	PUNCT
gsrj-41	385	27	approved	approve	VERB
gsrj-41	385	28	vaccines	vaccine	NOUN
gsrj-41	385	29	)	)	PUNCT
gsrj-41	385	30	after	after	ADP
gsrj-41	385	31	435	435	NUM
gsrj-41	385	32	respondents	respondent	NOUN
gsrj-41	385	33	,	,	PUNCT
gsrj-41	385	34	refugees	refugee	NOUN
gsrj-41	385	35	in	in	ADP
gsrj-41	385	36	the	the	DET
gsrj-41	385	37	us	we	PRON
gsrj-41	385	38	70.3	70.3	NUM
gsrj-41	385	39	%	%	NOUN
gsrj-41	385	40	intended	intend	VERB
gsrj-41	385	41	to	to	PART
gsrj-41	385	42	get	get	VERB
gsrj-41	385	43	vaccine	vaccine	NOUN
gsrj-41	385	44	,	,	PUNCT
gsrj-41	385	45	7.6	7.6	NUM
gsrj-41	385	46	%	%	NOUN
gsrj-41	385	47	no	no	NOUN
gsrj-41	385	48	,	,	PUNCT
gsrj-41	385	49	22.1	22.1	NUM
gsrj-41	385	50	%	%	NOUN
gsrj-41	385	51	unsure	unsure	ADJ
gsrj-41	385	52	reasons	reason	NOUN
gsrj-41	385	53	:	:	PUNCT
gsrj-41	385	54	among	among	ADP
gsrj-41	385	55	respondents	respondent	NOUN
gsrj-41	385	56	who	who	PRON
gsrj-41	385	57	were	be	AUX
gsrj-41	385	58	unsure	unsure	ADJ
gsrj-41	385	59	about	about	ADP
gsrj-41	385	60	receiving	receive	VERB
gsrj-41	385	61	the	the	DET
gsrj-41	385	62	covid-19	covid-19	PROPN
gsrj-41	385	63	vaccine	vaccine	NOUN
gsrj-41	385	64	or	or	CCONJ
gsrj-41	385	65	who	who	PRON
gsrj-41	385	66	did	do	AUX
gsrj-41	385	67	not	not	PART
gsrj-41	385	68	intend	intend	VERB
gsrj-41	385	69	to	to	PART
gsrj-41	385	70	receive	receive	VERB
gsrj-41	385	71	the	the	DET
gsrj-41	385	72	vaccine	vaccine	NOUN
gsrj-41	385	73	,	,	PUNCT
gsrj-41	385	74	most	most	ADJ
gsrj-41	385	75	were	be	AUX
gsrj-41	385	76	worried	worried	ADJ
gsrj-41	385	77	about	about	ADP
gsrj-41	385	78	side	side	NOUN
gsrj-41	385	79	effects	effect	NOUN
gsrj-41	385	80	(	(	PUNCT
gsrj-41	385	81	71.3	71.3	NUM
gsrj-41	385	82	%	%	NOUN
gsrj-41	385	83	)	)	PUNCT
gsrj-41	385	84	,	,	PUNCT
gsrj-41	385	85	followed	follow	VERB
gsrj-41	385	86	by	by	ADP
gsrj-41	385	87	concerns	concern	NOUN
gsrj-41	385	88	about	about	ADP
gsrj-41	385	89	the	the	DET
gsrj-41	385	90	effectiveness	effectiveness	NOUN
gsrj-41	385	91	of	of	ADP
gsrj-41	385	92	a	a	DET
gsrj-41	385	93	covid-19	covid-19	PROPN
gsrj-41	385	94	vaccine	vaccine	NOUN
gsrj-41	385	95	(	(	PUNCT
gsrj-41	385	96	12.4	12.4	NUM
gsrj-41	385	97	%	%	NOUN
gsrj-41	385	98	)	)	PUNCT
gsrj-41	385	99	and	and	CCONJ
gsrj-41	385	100	a	a	DET
gsrj-41	385	101	fear	fear	NOUN
gsrj-41	385	102	of	of	ADP
gsrj-41	385	103	needles	needle	NOUN
gsrj-41	385	104	(	(	PUNCT
gsrj-41	385	105	8.5	8.5	NUM
gsrj-41	385	106	%	%	NOUN
gsrj-41	385	107	)	)	PUNCT
gsrj-41	385	108	.	.	PUNCT
gsrj-41	386	1	27	27	NUM
gsrj-41	386	2	georgetown	georgetown	PROPN
gsrj-41	386	3	scientific	scientific	PROPN
gsrj-41	386	4	research	research	PROPN
gsrj-41	386	5	journal	journal	PROPN
gsrj-41	386	6	solís	solís	PROPN
gsrj-41	386	7	arce	arce	PROPN
gsrj-41	386	8	,	,	PUNCT
gsrj-41	386	9	et	et	PROPN
gsrj-41	386	10	al	al	PROPN
gsrj-41	386	11	.	.	PROPN
gsrj-41	386	12	(	(	PUNCT
gsrj-41	386	13	2021	2021	NUM
gsrj-41	386	14	)	)	PUNCT
gsrj-41	386	15	.	.	PUNCT
gsrj-41	387	1	covid-19	covid-19	PROPN
gsrj-41	387	2	vaccine	vaccine	NOUN
gsrj-41	387	3	acceptance	acceptance	NOUN
gsrj-41	387	4	and	and	CCONJ
gsrj-41	387	5	hesitancy	hesitancy	NOUN
gsrj-41	387	6	in	in	ADP
gsrj-41	387	7	lowand	lowand	ADJ
gsrj-41	387	8	middle	middle	ADJ
gsrj-41	387	9	-	-	PUNCT
gsrj-41	387	10	income	income	NOUN
gsrj-41	387	11	countries18	countries18	PROPN
gsrj-41	387	12	comparison	comparison	NOUN
gsrj-41	387	13	of	of	ADP
gsrj-41	387	14	vaccination	vaccination	NOUN
gsrj-41	387	15	between	between	ADP
gsrj-41	387	16	lmics	lmic	NOUN
gsrj-41	387	17	and	and	CCONJ
gsrj-41	387	18	us	we	PRON
gsrj-41	387	19	and	and	CCONJ
gsrj-41	387	20	russia	russia	PROPN
gsrj-41	387	21	online	online	PROPN
gsrj-41	387	22	,	,	PUNCT
gsrj-41	387	23	crosssectional	crosssectional	ADJ
gsrj-41	387	24	survey	survey	NOUN
gsrj-41	387	25	conducted	conduct	VERB
gsrj-41	387	26	dec	dec	PROPN
gsrj-41	387	27	4	4	NUM
gsrj-41	387	28	-	-	SYM
gsrj-41	387	29	5	5	NUM
gsrj-41	387	30	,	,	PUNCT
gsrj-41	387	31	2020	2020	NUM
gsrj-41	387	32	before	before	ADP
gsrj-41	387	33	462	462	NUM
gsrj-41	387	34	of	of	ADP
gsrj-41	387	35	u.s	u.s	PROPN
gsrj-41	387	36	.	.	PROPN
gsrj-41	387	37	participants	participant	NOUN
gsrj-41	387	38	replied	reply	VERB
gsrj-41	387	39	with	with	ADP
gsrj-41	387	40	reasons	reason	NOUN
gsrj-41	387	41	for	for	ADP
gsrj-41	387	42	vaccine	vaccine	NOUN
gsrj-41	387	43	hesitancy	hesitancy	NOUN
gsrj-41	387	44	,	,	PUNCT
gsrj-41	387	45	1313	1313	NUM
gsrj-41	387	46	replied	reply	VERB
gsrj-41	387	47	with	with	ADP
gsrj-41	387	48	reasons	reason	NOUN
gsrj-41	387	49	for	for	ADP
gsrj-41	387	50	getting	get	VERB
gsrj-41	387	51	vaccine	vaccine	NOUN
gsrj-41	387	52	nationally	nationally	ADV
gsrj-41	387	53	representative	representative	ADJ
gsrj-41	387	54	sample	sample	NOUN
gsrj-41	387	55	of	of	ADP
gsrj-41	387	56	adult	adult	NOUN
gsrj-41	387	57	internet	internet	NOUN
gsrj-41	387	58	users	user	NOUN
gsrj-41	387	59	recruited	recruit	VERB
gsrj-41	387	60	through	through	ADP
gsrj-41	387	61	the	the	DET
gsrj-41	387	62	market	market	NOUN
gsrj-41	387	63	research	research	NOUN
gsrj-41	387	64	firm	firm	NOUN
gsrj-41	387	65	lucid	lucid	ADJ
gsrj-41	387	66	acceptance	acceptance	NOUN
gsrj-41	387	67	rate	rate	NOUN
gsrj-41	387	68	in	in	ADP
gsrj-41	387	69	us	we	PRON
gsrj-41	387	70	is	be	AUX
gsrj-41	387	71	64.6	64.6	NUM
gsrj-41	387	72	%	%	NOUN
gsrj-41	387	73	vaccine	vaccine	NOUN
gsrj-41	387	74	hesitancy	hesitancy	NOUN
gsrj-41	387	75	reasons	reason	NOUN
gsrj-41	387	76	:	:	PUNCT
gsrj-41	387	77	concern	concern	NOUN
gsrj-41	387	78	about	about	ADP
gsrj-41	387	79	side	side	NOUN
gsrj-41	387	80	effects	effect	NOUN
gsrj-41	387	81	(	(	PUNCT
gsrj-41	387	82	79.3	79.3	NUM
gsrj-41	387	83	%	%	NOUN
gsrj-41	387	84	of	of	ADP
gsrj-41	387	85	hesitant	hesitant	ADJ
gsrj-41	387	86	)	)	PUNCT
gsrj-41	387	87	,	,	PUNCT
gsrj-41	387	88	skepticism	skepticism	NOUN
gsrj-41	387	89	about	about	ADP
gsrj-41	387	90	effectiveness	effectiveness	NOUN
gsrj-41	387	91	(	(	PUNCT
gsrj-41	387	92	46.8	46.8	NUM
gsrj-41	387	93	%	%	NOUN
gsrj-41	387	94	)	)	PUNCT
gsrj-41	387	95	,	,	PUNCT
gsrj-41	387	96	lack	lack	NOUN
gsrj-41	387	97	of	of	ADP
gsrj-41	387	98	concern	concern	NOUN
gsrj-41	387	99	about	about	ADP
gsrj-41	387	100	covid-19	covid-19	PROPN
gsrj-41	387	101	infection	infection	NOUN
gsrj-41	387	102	(	(	PUNCT
gsrj-41	387	103	39.3	39.3	NUM
gsrj-41	387	104	%	%	NOUN
gsrj-41	387	105	)	)	PUNCT
gsrj-41	387	106	ehde	ehde	PROPN
gsrj-41	387	107	,	,	PUNCT
gsrj-41	387	108	et	et	PROPN
gsrj-41	387	109	al	al	PROPN
gsrj-41	387	110	.	.	PROPN
gsrj-41	388	1	(	(	PUNCT
gsrj-41	388	2	2021	2021	NUM
gsrj-41	388	3	)	)	PUNCT
gsrj-41	388	4	.	.	PUNCT
gsrj-41	389	1	covid-19	covid-19	PROPN
gsrj-41	389	2	vaccine	vaccine	NOUN
gsrj-41	389	3	hesitancy	hesitancy	NOUN
gsrj-41	389	4	in	in	ADP
gsrj-41	389	5	adults	adult	NOUN
gsrj-41	389	6	with	with	ADP
gsrj-41	389	7	multiple	multiple	ADJ
gsrj-41	389	8	sclerosis	sclerosis	NOUN
gsrj-41	389	9	in	in	ADP
gsrj-41	389	10	the	the	DET
gsrj-41	389	11	united	united	PROPN
gsrj-41	389	12	states	states	PROPN
gsrj-41	389	13	:	:	PUNCT
gsrj-41	389	14	a	a	DET
gsrj-41	389	15	follow	follow	VERB
gsrj-41	389	16	up	up	ADP
gsrj-41	389	17	survey	survey	NOUN
gsrj-41	389	18	during	during	ADP
gsrj-41	389	19	the	the	DET
gsrj-41	389	20	initial	initial	ADJ
gsrj-41	389	21	vaccine	vaccine	NOUN
gsrj-41	389	22	rollout	rollout	NOUN
gsrj-41	389	23	in	in	ADP
gsrj-41	389	24	202119	202119	NUM
gsrj-41	389	25	to	to	PART
gsrj-41	389	26	assess	assess	VERB
gsrj-41	389	27	covid-19	covid-19	PROPN
gsrj-41	389	28	vaccine	vaccine	NOUN
gsrj-41	389	29	hesitancy	hesitancy	NOUN
gsrj-41	389	30	before	before	ADP
gsrj-41	389	31	and	and	CCONJ
gsrj-41	389	32	after	after	ADP
gsrj-41	389	33	roll	roll	NOUN
gsrj-41	389	34	-	-	PUNCT
gsrj-41	389	35	out	out	NOUN
gsrj-41	389	36	among	among	ADP
gsrj-41	389	37	adults	adult	NOUN
gsrj-41	389	38	with	with	ADP
gsrj-41	389	39	ms	ms	PROPN
gsrj-41	389	40	in	in	ADP
gsrj-41	389	41	the	the	DET
gsrj-41	389	42	u.s	u.s	PROPN
gsrj-41	389	43	.	.	PROPN
gsrj-41	389	44	2	2	NUM
gsrj-41	389	45	online	online	ADJ
gsrj-41	389	46	surveys	survey	NOUN
gsrj-41	389	47	in	in	ADP
gsrj-41	389	48	april	april	PROPN
gsrj-41	389	49	/	/	SYM
gsrj-41	389	50	may	may	PROPN
gsrj-41	389	51	2020	2020	NUM
gsrj-41	389	52	and	and	CCONJ
gsrj-41	389	53	jan	jan	PROPN
gsrj-41	389	54	/	/	SYM
gsrj-41	389	55	feb	feb	NOUN
gsrj-41	389	56	2021	2021	NUM
gsrj-41	389	57	1	1	NUM
gsrj-41	389	58	before	before	ADP
gsrj-41	389	59	1	1	NUM
gsrj-41	389	60	after	after	ADP
gsrj-41	389	61	adults	adult	NOUN
gsrj-41	389	62	with	with	ADP
gsrj-41	389	63	ms	ms	NOUN
gsrj-41	389	64	living	live	VERB
gsrj-41	389	65	in	in	ADP
gsrj-41	389	66	the	the	DET
gsrj-41	389	67	us	us	PROPN
gsrj-41	389	68	(	(	PUNCT
gsrj-41	389	69	n	n	NOUN
gsrj-41	389	70	=	=	SYM
gsrj-41	389	71	359	359	NUM
gsrj-41	389	72	)	)	PUNCT
gsrj-41	389	73	participants	participant	NOUN
gsrj-41	389	74	who	who	PRON
gsrj-41	389	75	were	be	AUX
gsrj-41	389	76	vaccine	vaccine	NOUN
gsrj-41	389	77	hesitant	hesitant	ADJ
gsrj-41	389	78	(	(	PUNCT
gsrj-41	389	79	20.3	20.3	NUM
gsrj-41	389	80	%	%	NOUN
gsrj-41	389	81	)	)	PUNCT
gsrj-41	389	82	reported	report	VERB
gsrj-41	389	83	concerns	concern	NOUN
gsrj-41	389	84	about	about	ADP
gsrj-41	389	85	the	the	DET
gsrj-41	389	86	long	long	ADJ
gsrj-41	389	87	-	-	PUNCT
gsrj-41	389	88	term	term	NOUN
gsrj-41	389	89	effects	effect	NOUN
gsrj-41	389	90	of	of	ADP
gsrj-41	389	91	the	the	DET
gsrj-41	389	92	vaccine	vaccine	NOUN
gsrj-41	389	93	,	,	PUNCT
gsrj-41	389	94	the	the	DET
gsrj-41	389	95	vaccine	vaccine	NOUN
gsrj-41	389	96	approval	approval	NOUN
gsrj-41	389	97	process	process	NOUN
gsrj-41	389	98	,	,	PUNCT
gsrj-41	389	99	and	and	CCONJ
gsrj-41	389	100	the	the	DET
gsrj-41	389	101	potential	potential	ADJ
gsrj-41	389	102	impact	impact	NOUN
gsrj-41	389	103	of	of	ADP
gsrj-41	389	104	the	the	DET
gsrj-41	389	105	vaccine	vaccine	NOUN
gsrj-41	389	106	given	give	VERB
gsrj-41	389	107	their	their	PRON
gsrj-41	389	108	own	own	ADJ
gsrj-41	389	109	health	health	NOUN
gsrj-41	389	110	conditions	condition	NOUN
gsrj-41	389	111	/	/	SYM
gsrj-41	389	112	history	history	NOUN
gsrj-41	389	113	.	.	PUNCT
gsrj-41	390	1	90	90	NUM
gsrj-41	390	2	%	%	NOUN
gsrj-41	390	3	of	of	ADP
gsrj-41	390	4	hesitant	hesitant	PROPN
gsrj-41	390	5	wanted	want	VERB
gsrj-41	390	6	additional	additional	ADJ
gsrj-41	390	7	information	information	NOUN
gsrj-41	390	8	about	about	ADP
gsrj-41	390	9	the	the	DET
gsrj-41	390	10	vaccine	vaccine	NOUN
gsrj-41	390	11	before	before	ADP
gsrj-41	390	12	deciding	decide	VERB
gsrj-41	390	13	vaccine	vaccine	NOUN
gsrj-41	390	14	willingness	willingness	NOUN
gsrj-41	390	15	among	among	ADP
gsrj-41	390	16	this	this	DET
gsrj-41	390	17	group	group	NOUN
gsrj-41	390	18	increased	increase	VERB
gsrj-41	390	19	over	over	ADP
gsrj-41	390	20	time	time	NOUN
gsrj-41	390	21	tram	tram	PROPN
gsrj-41	390	22	,	,	PUNCT
gsrj-41	390	23	et	et	PROPN
gsrj-41	390	24	al	al	PROPN
gsrj-41	390	25	.	.	PROPN
gsrj-41	391	1	(	(	PUNCT
gsrj-41	391	2	2021	2021	NUM
gsrj-41	391	3	)	)	PUNCT
gsrj-41	391	4	.	.	PUNCT
gsrj-41	392	1	deliberation	deliberation	NOUN
gsrj-41	392	2	,	,	PUNCT
gsrj-41	392	3	dissent	dissent	NOUN
gsrj-41	392	4	,	,	PUNCT
gsrj-41	392	5	and	and	CCONJ
gsrj-41	392	6	distrust	distrust	NOUN
gsrj-41	392	7	:	:	PUNCT
gsrj-41	392	8	understanding	understand	VERB
gsrj-41	392	9	distinct	distinct	ADJ
gsrj-41	392	10	drivers	driver	NOUN
gsrj-41	392	11	of	of	ADP
gsrj-41	392	12	covid-19	covid-19	PROPN
gsrj-41	392	13	vaccine	vaccine	NOUN
gsrj-41	392	14	hesitancy	hesitancy	NOUN
gsrj-41	392	15	in	in	ADP
gsrj-41	392	16	the	the	DET
gsrj-41	392	17	united	united	PROPN
gsrj-41	392	18	states20	states20	PROPN
gsrj-41	392	19	to	to	PART
gsrj-41	392	20	assess	assess	VERB
gsrj-41	392	21	reasons	reason	NOUN
gsrj-41	392	22	for	for	ADP
gsrj-41	392	23	covid-19	covid-19	PROPN
gsrj-41	392	24	vaccine	vaccine	NOUN
gsrj-41	392	25	hesitancy	hesitancy	NOUN
gsrj-41	392	26	and	and	CCONJ
gsrj-41	392	27	refusal	refusal	NOUN
gsrj-41	392	28	in	in	ADP
gsrj-41	392	29	the	the	DET
gsrj-41	392	30	u.s	u.s	PROPN
gsrj-41	392	31	.	.	PROPN
gsrj-41	392	32	data	datum	NOUN
gsrj-41	392	33	analysis	analysis	NOUN
gsrj-41	392	34	of	of	ADP
gsrj-41	392	35	the	the	DET
gsrj-41	392	36	us	us	PROPN
gsrj-41	392	37	census	census	PROPN
gsrj-41	392	38	bureau	bureau	PROPN
gsrj-41	392	39	’s	’s	PART
gsrj-41	392	40	household	household	PROPN
gsrj-41	392	41	pulse	pulse	NOUN
gsrj-41	392	42	survey	survey	NOUN
gsrj-41	392	43	(	(	PUNCT
gsrj-41	392	44	biweekly	biweekly	ADJ
gsrj-41	392	45	crosssectional	crosssectional	ADJ
gsrj-41	392	46	survey	survey	NOUN
gsrj-41	392	47	of	of	ADP
gsrj-41	392	48	us	us	PROPN
gsrj-41	392	49	households	household	NOUN
gsrj-41	392	50	)	)	PUNCT
gsrj-41	392	51	in	in	ADP
gsrj-41	392	52	jan	jan	PROPN
gsrj-41	392	53	-	-	PUNCT
gsrj-41	392	54	march	march	PROPN
gsrj-41	392	55	2021	2021	NUM
gsrj-41	392	56	after	after	ADP
gsrj-41	392	57	459,235	459,235	NUM
gsrj-41	392	58	participants	participant	NOUN
gsrj-41	392	59	in	in	ADP
gsrj-41	392	60	janmarch	janmarch	NOUN
gsrj-41	392	61	2021	2021	NUM
gsrj-41	392	62	representative	representative	NOUN
gsrj-41	392	63	because	because	SCONJ
gsrj-41	392	64	weighted	weight	VERB
gsrj-41	392	65	140	140	NUM
gsrj-41	392	66	million	million	NUM
gsrj-41	392	67	housing	housing	NOUN
gsrj-41	392	68	units	unit	NOUN
gsrj-41	392	69	contacted	contact	VERB
gsrj-41	392	70	10.2	10.2	NUM
gsrj-41	392	71	%	%	NOUN
gsrj-41	392	72	reported	report	VERB
gsrj-41	392	73	that	that	SCONJ
gsrj-41	392	74	they	they	PRON
gsrj-41	392	75	would	would	AUX
gsrj-41	392	76	probably	probably	ADV
gsrj-41	392	77	not	not	PART
gsrj-41	392	78	get	get	VERB
gsrj-41	392	79	the	the	DET
gsrj-41	392	80	vaccine	vaccine	NOUN
gsrj-41	392	81	&	&	CCONJ
gsrj-41	392	82	8.2	8.2	NUM
gsrj-41	392	83	%	%	NOUN
gsrj-41	392	84	that	that	SCONJ
gsrj-41	392	85	they	they	PRON
gsrj-41	392	86	would	would	AUX
gsrj-41	392	87	definitely	definitely	ADV
gsrj-41	392	88	not	not	PART
gsrj-41	392	89	get	get	VERB
gsrj-41	392	90	a	a	DET
gsrj-41	392	91	vaccine	vaccine	NOUN
gsrj-41	392	92	those	those	PRON
gsrj-41	392	93	who	who	PRON
gsrj-41	392	94	expressed	express	VERB
gsrj-41	392	95	reluctance	reluctance	NOUN
gsrj-41	392	96	invoked	invoke	VERB
gsrj-41	392	97	mostly	mostly	ADV
gsrj-41	392	98	“	"	PUNCT
gsrj-41	392	99	deliberative	deliberative	ADJ
gsrj-41	392	100	”	"	PUNCT
gsrj-41	392	101	reasons	reason	NOUN
gsrj-41	392	102	,	,	PUNCT
gsrj-41	392	103	while	while	SCONJ
gsrj-41	392	104	those	those	PRON
gsrj-41	392	105	who	who	PRON
gsrj-41	392	106	rejected	reject	VERB
gsrj-41	392	107	the	the	DET
gsrj-41	392	108	vaccine	vaccine	NOUN
gsrj-41	392	109	were	be	AUX
gsrj-41	392	110	also	also	ADV
gsrj-41	392	111	likely	likely	ADJ
gsrj-41	392	112	to	to	PART
gsrj-41	392	113	invoke	invoke	VERB
gsrj-41	392	114	reasons	reason	NOUN
gsrj-41	392	115	of	of	ADP
gsrj-41	392	116	“	"	PUNCT
gsrj-41	392	117	dissent	dissent	NOUN
gsrj-41	392	118	”	"	PUNCT
gsrj-41	392	119	or	or	CCONJ
gsrj-41	392	120	“	"	PUNCT
gsrj-41	392	121	distrust	distrust	NOUN
gsrj-41	392	122	28	28	NUM
gsrj-41	392	123	georgetown	georgetown	PROPN
gsrj-41	392	124	scientific	scientific	PROPN
gsrj-41	392	125	research	research	NOUN
gsrj-41	392	126	journal	journal	NOUN
gsrj-41	392	127	“	"	PUNCT
gsrj-41	392	128	probably	probably	ADV
gsrj-41	392	129	not	not	PART
gsrj-41	392	130	”	"	PUNCT
gsrj-41	392	131	:	:	PUNCT
gsrj-41	392	132	deliberative	deliberative	ADJ
gsrj-41	392	133	reasons	reason	NOUN
gsrj-41	392	134	–	–	PUNCT
gsrj-41	392	135	“	"	PUNCT
gsrj-41	392	136	plan	plan	NOUN
gsrj-41	392	137	to	to	PART
gsrj-41	392	138	wait	wait	VERB
gsrj-41	392	139	and	and	CCONJ
gsrj-41	392	140	see	see	VERB
gsrj-41	392	141	if	if	SCONJ
gsrj-41	392	142	it	it	PRON
gsrj-41	392	143	is	be	AUX
gsrj-41	392	144	safe	safe	ADJ
gsrj-41	392	145	and	and	CCONJ
gsrj-41	392	146	may	may	AUX
gsrj-41	392	147	get	get	VERB
gsrj-41	392	148	it	it	PRON
gsrj-41	392	149	later	later	ADV
gsrj-41	392	150	”	"	PUNCT
gsrj-41	392	151	(	(	PUNCT
gsrj-41	392	152	57.0	57.0	NUM
gsrj-41	392	153	%	%	NOUN
gsrj-41	392	154	)	)	PUNCT
gsrj-41	392	155	,	,	PUNCT
gsrj-41	392	156	“	"	PUNCT
gsrj-41	392	157	concern	concern	NOUN
gsrj-41	392	158	about	about	ADP
gsrj-41	392	159	possible	possible	ADJ
gsrj-41	392	160	side	side	NOUN
gsrj-41	392	161	effects	effect	NOUN
gsrj-41	392	162	”	"	PUNCT
gsrj-41	392	163	(	(	PUNCT
gsrj-41	392	164	52.1	52.1	NUM
gsrj-41	392	165	%	%	NOUN
gsrj-41	392	166	)	)	PUNCT
gsrj-41	392	167	,	,	PUNCT
gsrj-41	392	168	“	"	PUNCT
gsrj-41	392	169	other	other	ADJ
gsrj-41	392	170	people	people	NOUN
gsrj-41	392	171	need	need	VERB
gsrj-41	392	172	it	it	PRON
gsrj-41	392	173	more	more	ADJ
gsrj-41	392	174	than	than	SCONJ
gsrj-41	392	175	i	i	PRON
gsrj-41	392	176	do	do	VERB
gsrj-41	392	177	right	right	ADV
gsrj-41	392	178	now	now	ADV
gsrj-41	392	179	”	"	PUNCT
gsrj-41	392	180	(	(	PUNCT
gsrj-41	392	181	26.7	26.7	NUM
gsrj-41	392	182	%	%	NOUN
gsrj-41	392	183	)	)	PUNCT
gsrj-41	392	184	“	"	PUNCT
gsrj-41	392	185	definitely	definitely	ADV
gsrj-41	392	186	not	not	PART
gsrj-41	392	187	”	"	PUNCT
gsrj-41	392	188	:	:	PUNCT
gsrj-41	392	189	distrust	distrust	NOUN
gsrj-41	392	190	–	–	PUNCT
gsrj-41	392	191	do	do	AUX
gsrj-41	392	192	not	not	PART
gsrj-41	392	193	trust	trust	VERB
gsrj-41	392	194	the	the	DET
gsrj-41	392	195	covid-19	covid-19	PROPN
gsrj-41	392	196	vaccine	vaccine	NOUN
gsrj-41	392	197	(	(	PUNCT
gsrj-41	392	198	49.0	49.0	NUM
gsrj-41	392	199	%	%	NOUN
gsrj-41	392	200	)	)	PUNCT
gsrj-41	392	201	&	&	CCONJ
gsrj-41	392	202	do	do	AUX
gsrj-41	392	203	not	not	PART
gsrj-41	392	204	trust	trust	VERB
gsrj-41	392	205	the	the	DET
gsrj-41	392	206	government	government	NOUN
gsrj-41	392	207	(	(	PUNCT
gsrj-41	392	208	40	40	NUM
gsrj-41	392	209	%	%	NOUN
gsrj-41	392	210	)	)	PUNCT
gsrj-41	392	211	trent	trent	NOUN
gsrj-41	392	212	,	,	PUNCT
gsrj-41	392	213	et	et	PROPN
gsrj-41	392	214	al	al	PROPN
gsrj-41	392	215	.	.	PROPN
gsrj-41	393	1	(	(	PUNCT
gsrj-41	393	2	2021	2021	NUM
gsrj-41	393	3	)	)	PUNCT
gsrj-41	393	4	.	.	PUNCT
gsrj-41	394	1	trust	trust	NOUN
gsrj-41	394	2	in	in	ADP
gsrj-41	394	3	government	government	NOUN
gsrj-41	394	4	,	,	PUNCT
gsrj-41	394	5	intention	intention	NOUN
gsrj-41	394	6	to	to	PART
gsrj-41	394	7	vaccinate	vaccinate	VERB
gsrj-41	394	8	and	and	CCONJ
gsrj-41	394	9	covid-19	covid-19	PROPN
gsrj-41	394	10	vaccine	vaccine	NOUN
gsrj-41	394	11	hesitancy	hesitancy	NOUN
gsrj-41	394	12	:	:	PUNCT
gsrj-41	394	13	a	a	DET
gsrj-41	394	14	comparative	comparative	ADJ
gsrj-41	394	15	survey	survey	NOUN
gsrj-41	394	16	of	of	ADP
gsrj-41	394	17	five	five	NUM
gsrj-41	394	18	large	large	ADJ
gsrj-41	394	19	cities	city	NOUN
gsrj-41	394	20	in	in	ADP
gsrj-41	394	21	the	the	DET
gsrj-41	394	22	us	us	PROPN
gsrj-41	394	23	,	,	PUNCT
gsrj-41	394	24	uk	uk	PROPN
gsrj-41	394	25	,	,	PUNCT
gsrj-41	394	26	and	and	CCONJ
gsrj-41	394	27	australia21	australia21	VERB
gsrj-41	394	28	to	to	PART
gsrj-41	394	29	identify	identify	VERB
gsrj-41	394	30	predictors	predictor	NOUN
gsrj-41	394	31	of	of	ADP
gsrj-41	394	32	willingness	willingness	NOUN
gsrj-41	394	33	to	to	PART
gsrj-41	394	34	vaccinate	vaccinate	VERB
gsrj-41	394	35	against	against	ADP
gsrj-41	394	36	covid-19	covid-19	PROPN
gsrj-41	394	37	in	in	ADP
gsrj-41	394	38	five	five	NUM
gsrj-41	394	39	cities	city	NOUN
gsrj-41	394	40	with	with	ADP
gsrj-41	394	41	varying	vary	VERB
gsrj-41	394	42	covid-19	covid-19	PROPN
gsrj-41	394	43	incidence	incidence	NOUN
gsrj-41	394	44	in	in	ADP
gsrj-41	394	45	the	the	DET
gsrj-41	394	46	us	us	PROPN
gsrj-41	394	47	,	,	PUNCT
gsrj-41	394	48	uk	uk	PROPN
gsrj-41	394	49	,	,	PUNCT
gsrj-41	394	50	and	and	CCONJ
gsrj-41	394	51	australia	australia	PROPN
gsrj-41	394	52	.	.	PUNCT
gsrj-41	395	1	online	online	PROPN
gsrj-41	395	2	,	,	PUNCT
gsrj-41	395	3	crosssectional	crosssectional	ADJ
gsrj-41	395	4	survey	survey	NOUN
gsrj-41	395	5	of	of	ADP
gsrj-41	395	6	adults	adult	NOUN
gsrj-41	395	7	from	from	ADP
gsrj-41	395	8	dynata	dynata	PROPN
gsrj-41	395	9	’s	’s	PART
gsrj-41	395	10	research	research	NOUN
gsrj-41	395	11	panel	panel	NOUN
gsrj-41	395	12	in	in	ADP
gsrj-41	395	13	julyseptember	julyseptember	PROPN
gsrj-41	395	14	2020	2020	NUM
gsrj-41	395	15	.	.	PUNCT
gsrj-41	396	1	before	before	ADP
gsrj-41	396	2	adults	adult	NOUN
gsrj-41	396	3	aged	aged	ADJ
gsrj-41	396	4	18	18	NUM
gsrj-41	396	5	and	and	CCONJ
gsrj-41	396	6	over	over	ADV
gsrj-41	396	7	in	in	ADP
gsrj-41	396	8	sydney	sydney	PROPN
gsrj-41	396	9	,	,	PUNCT
gsrj-41	396	10	melbourne	melbourne	PROPN
gsrj-41	396	11	,	,	PUNCT
gsrj-41	396	12	london	london	PROPN
gsrj-41	396	13	,	,	PUNCT
gsrj-41	396	14	new	new	PROPN
gsrj-41	396	15	york	york	PROPN
gsrj-41	396	16	city	city	PROPN
gsrj-41	396	17	,	,	PUNCT
gsrj-41	396	18	or	or	CCONJ
gsrj-41	396	19	phoenix	phoenix	PROPN
gsrj-41	396	20	.	.	PUNCT
gsrj-41	397	1	1204	1204	NUM
gsrj-41	397	2	adults	adult	NOUN
gsrj-41	397	3	in	in	ADP
gsrj-41	397	4	nyc	nyc	PROPN
gsrj-41	397	5	500	500	NUM
gsrj-41	397	6	adults	adult	NOUN
gsrj-41	397	7	in	in	ADP
gsrj-41	397	8	phoenix	phoenix	PROPN
gsrj-41	397	9	may	may	AUX
gsrj-41	397	10	not	not	PART
gsrj-41	397	11	be	be	AUX
gsrj-41	397	12	representative	representative	ADJ
gsrj-41	397	13	of	of	ADP
gsrj-41	397	14	entire	entire	ADJ
gsrj-41	397	15	population	population	NOUN
gsrj-41	397	16	participants	participant	NOUN
gsrj-41	397	17	with	with	ADP
gsrj-41	397	18	high	high	ADJ
gsrj-41	397	19	or	or	CCONJ
gsrj-41	397	20	very	very	ADV
gsrj-41	397	21	high	high	ADJ
gsrj-41	397	22	confidence	confidence	NOUN
gsrj-41	397	23	in	in	ADP
gsrj-41	397	24	their	their	PRON
gsrj-41	397	25	current	current	ADJ
gsrj-41	397	26	government	government	NOUN
gsrj-41	397	27	were	be	AUX
gsrj-41	397	28	less	less	ADV
gsrj-41	397	29	likely	likely	ADJ
gsrj-41	397	30	to	to	PART
gsrj-41	397	31	be	be	AUX
gsrj-41	397	32	willing	willing	ADJ
gsrj-41	397	33	to	to	PART
gsrj-41	397	34	receive	receive	VERB
gsrj-41	397	35	the	the	DET
gsrj-41	397	36	vaccine	vaccine	NOUN
gsrj-41	397	37	highest	high	ADJ
gsrj-41	397	38	reason	reason	NOUN
gsrj-41	397	39	in	in	ADP
gsrj-41	397	40	nyc	nyc	PROPN
gsrj-41	397	41	for	for	ADP
gsrj-41	397	42	not	not	PART
gsrj-41	397	43	vaccinating	vaccinating	NOUN
gsrj-41	397	44	is	be	AUX
gsrj-41	397	45	no	no	DET
gsrj-41	397	46	reason	reason	NOUN
gsrj-41	397	47	/	/	SYM
gsrj-41	397	48	don’t	don’t	NUM
gsrj-41	397	49	know	know	NOUN
gsrj-41	397	50	(	(	PUNCT
gsrj-41	397	51	42	42	NUM
gsrj-41	397	52	%	%	NOUN
gsrj-41	397	53	of	of	ADP
gsrj-41	397	54	hesitant	hesitant	ADJ
gsrj-41	397	55	in	in	ADP
gsrj-41	397	56	nyc	nyc	PROPN
gsrj-41	397	57	)	)	PUNCT
gsrj-41	397	58	highest	high	ADJ
gsrj-41	397	59	reason	reason	NOUN
gsrj-41	397	60	in	in	ADP
gsrj-41	397	61	phoenix	phoenix	PROPN
gsrj-41	397	62	is	be	AUX
gsrj-41	397	63	not	not	PART
gsrj-41	397	64	sure	sure	ADJ
gsrj-41	397	65	or	or	CCONJ
gsrj-41	397	66	waiting	wait	VERB
gsrj-41	397	67	for	for	ADP
gsrj-41	397	68	more	more	ADJ
gsrj-41	397	69	information	information	NOUN
gsrj-41	397	70	(	(	PUNCT
gsrj-41	397	71	30	30	NUM
gsrj-41	397	72	%	%	NOUN
gsrj-41	397	73	)	)	PUNCT
gsrj-41	397	74	king	king	NOUN
gsrj-41	397	75	,	,	PUNCT
gsrj-41	397	76	et	et	PROPN
gsrj-41	397	77	al	al	PROPN
gsrj-41	397	78	.	.	PROPN
gsrj-41	398	1	(	(	PUNCT
gsrj-41	398	2	2021	2021	NUM
gsrj-41	398	3	)	)	PUNCT
gsrj-41	398	4	.	.	PUNCT
gsrj-41	399	1	covid-19	covid-19	PROPN
gsrj-41	399	2	vaccine	vaccine	NOUN
gsrj-41	399	3	hesitancy	hesitancy	NOUN
gsrj-41	399	4	january	january	PROPN
gsrj-41	399	5	-	-	PUNCT
gsrj-41	399	6	may	may	AUX
gsrj-41	399	7	2021	2021	NUM
gsrj-41	399	8	among	among	ADP
gsrj-41	399	9	18	18	NUM
gsrj-41	399	10	-	-	SYM
gsrj-41	399	11	64	64	NUM
gsrj-41	399	12	year	year	NOUN
gsrj-41	399	13	old	old	ADJ
gsrj-41	399	14	us	us	PROPN
gsrj-41	399	15	adults	adult	NOUN
gsrj-41	399	16	by	by	ADP
gsrj-41	399	17	employment	employment	NOUN
gsrj-41	399	18	and	and	CCONJ
gsrj-41	399	19	occupation22	occupation22	ADJ
gsrj-41	399	20	vaccine	vaccine	NOUN
gsrj-41	399	21	hesitancy	hesitancy	NOUN
gsrj-41	399	22	in	in	ADP
gsrj-41	399	23	us	we	PRON
gsrj-41	399	24	by	by	ADP
gsrj-41	399	25	employment	employment	NOUN
gsrj-41	399	26	status	status	NOUN
gsrj-41	399	27	and	and	CCONJ
gsrj-41	399	28	occupation	occupation	NOUN
gsrj-41	399	29	category	category	NOUN
gsrj-41	399	30	online	online	ADV
gsrj-41	399	31	,	,	PUNCT
gsrj-41	399	32	crosssectional	crosssectional	ADJ
gsrj-41	399	33	survey	survey	NOUN
gsrj-41	399	34	on	on	ADP
gsrj-41	399	35	facebook	facebook	PROPN
gsrj-41	399	36	from	from	ADP
gsrj-41	399	37	jan	jan	PROPN
gsrj-41	399	38	to	to	PART
gsrj-41	399	39	may	may	AUX
gsrj-41	399	40	2021	2021	NUM
gsrj-41	399	41	after	after	ADP
gsrj-41	399	42	us	we	PRON
gsrj-41	399	43	adults	adult	VERB
gsrj-41	399	44	18	18	NUM
gsrj-41	399	45	-	-	SYM
gsrj-41	399	46	64	64	NUM
gsrj-41	399	47	years	year	NOUN
gsrj-41	399	48	completed	complete	VERB
gsrj-41	399	49	an	an	DET
gsrj-41	399	50	online	online	ADJ
gsrj-41	399	51	covid-19	covid-19	PROPN
gsrj-41	399	52	survey	survey	NOUN
gsrj-41	399	53	3,179,174	3,179,174	NUM
gsrj-41	399	54	times	time	NOUN
gsrj-41	399	55	from	from	ADP
gsrj-41	399	56	january	january	PROPN
gsrj-41	399	57	6	6	NUM
gsrj-41	399	58	-	-	PUNCT
gsrj-41	399	59	may	may	PROPN
gsrj-41	399	60	19	19	NUM
gsrj-41	399	61	,	,	PUNCT
gsrj-41	399	62	2021	2021	NUM
gsrj-41	399	63	.	.	PUNCT
gsrj-41	400	1	employed	employ	VERB
gsrj-41	400	2	participants	participant	NOUN
gsrj-41	400	3	that	that	PRON
gsrj-41	400	4	responded	respond	VERB
gsrj-41	400	5	with	with	ADP
gsrj-41	400	6	reasons	reason	NOUN
gsrj-41	400	7	:	:	PUNCT
gsrj-41	400	8	55375	55375	NUM
gsrj-41	400	9	data	datum	NOUN
gsrj-41	400	10	on	on	ADP
gsrj-41	400	11	employed	employ	VERB
gsrj-41	400	12	participants	participant	NOUN
gsrj-41	400	13	over	over	ADP
gsrj-41	400	14	half	half	NOUN
gsrj-41	400	15	of	of	ADP
gsrj-41	400	16	employed	employ	VERB
gsrj-41	400	17	hesitant	hesitant	ADJ
gsrj-41	400	18	participants	participant	NOUN
gsrj-41	400	19	reported	report	VERB
gsrj-41	400	20	concerns	concern	NOUN
gsrj-41	400	21	about	about	ADP
gsrj-41	400	22	side	side	NOUN
gsrj-41	400	23	effects	effect	NOUN
gsrj-41	400	24	(	(	PUNCT
gsrj-41	400	25	51.7	51.7	NUM
gsrj-41	400	26	%	%	NOUN
gsrj-41	400	27	)	)	PUNCT
gsrj-41	400	28	,	,	PUNCT
gsrj-41	400	29	not	not	PART
gsrj-41	400	30	trusting	trust	VERB
gsrj-41	400	31	covid-19	covid-19	PROPN
gsrj-41	400	32	vaccines	vaccine	NOUN
gsrj-41	400	33	(	(	PUNCT
gsrj-41	400	34	51.3	51.3	NUM
gsrj-41	400	35	%	%	NOUN
gsrj-41	400	36	)	)	PUNCT
gsrj-41	400	37	,	,	PUNCT
gsrj-41	400	38	and	and	CCONJ
gsrj-41	400	39	not	not	PART
gsrj-41	400	40	liking	like	VERB
gsrj-41	400	41	vaccines	vaccine	NOUN
gsrj-41	400	42	in	in	ADP
gsrj-41	400	43	general	general	ADJ
gsrj-41	400	44	(	(	PUNCT
gsrj-41	400	45	15	15	NUM
gsrj-41	400	46	%	%	NOUN
gsrj-41	400	47	)	)	PUNCT
gsrj-41	400	48	over	over	ADP
gsrj-41	400	49	a	a	DET
gsrj-41	400	50	third	third	ADJ
gsrj-41	400	51	did	do	AUX
gsrj-41	400	52	n’t	not	PART
gsrj-41	400	53	believe	believe	VERB
gsrj-41	400	54	they	they	PRON
gsrj-41	400	55	needed	need	VERB
gsrj-41	400	56	the	the	DET
gsrj-41	400	57	vaccine	vaccine	NOUN
gsrj-41	400	58	(	(	PUNCT
gsrj-41	400	59	45.1	45.1	NUM
gsrj-41	400	60	%	%	NOUN
gsrj-41	400	61	)	)	PUNCT
gsrj-41	400	62	,	,	PUNCT
gsrj-41	400	63	did	do	AUX
gsrj-41	400	64	n’t	not	PART
gsrj-41	400	65	trust	trust	VERB
gsrj-41	400	66	the	the	DET
gsrj-41	400	67	government	government	NOUN
gsrj-41	400	68	(	(	PUNCT
gsrj-41	400	69	44.6	44.6	NUM
gsrj-41	400	70	%	%	NOUN
gsrj-41	400	71	)	)	PUNCT
gsrj-41	400	72	,	,	PUNCT
gsrj-41	400	73	and/or	and/or	CCONJ
gsrj-41	400	74	were	be	AUX
gsrj-41	400	75	29	29	NUM
gsrj-41	400	76	georgetown	georgetown	PROPN
gsrj-41	400	77	scientific	scientific	ADJ
gsrj-41	400	78	research	research	NOUN
gsrj-41	400	79	journal	journal	PROPN
gsrj-41	400	80	waiting	wait	VERB
gsrj-41	400	81	to	to	PART
gsrj-41	400	82	see	see	VERB
gsrj-41	400	83	if	if	SCONJ
gsrj-41	400	84	it	it	PRON
gsrj-41	400	85	was	be	AUX
gsrj-41	400	86	safe	safe	ADJ
gsrj-41	400	87	(	(	PUNCT
gsrj-41	400	88	35.2	35.2	NUM
gsrj-41	400	89	%	%	NOUN
gsrj-41	400	90	)	)	PUNCT
gsrj-41	400	91	harrison	harrison	PROPN
gsrj-41	400	92	,	,	PUNCT
gsrj-41	400	93	et	et	PROPN
gsrj-41	400	94	al	al	PROPN
gsrj-41	400	95	.	.	PROPN
gsrj-41	401	1	(	(	PUNCT
gsrj-41	401	2	2021	2021	NUM
gsrj-41	401	3	)	)	PUNCT
gsrj-41	401	4	.	.	PUNCT
gsrj-41	402	1	“	"	PUNCT
gsrj-41	402	2	somebody	somebody	PRON
gsrj-41	402	3	like	like	ADP
gsrj-41	402	4	me	i	PRON
gsrj-41	402	5	:	:	PUNCT
gsrj-41	402	6	understanding	understand	VERB
gsrj-41	402	7	covid-19	covid-19	PROPN
gsrj-41	402	8	vaccine	vaccine	NOUN
gsrj-41	402	9	hesitancy	hesitancy	NOUN
gsrj-41	402	10	among	among	ADP
gsrj-41	402	11	staff	staff	NOUN
gsrj-41	402	12	in	in	ADP
gsrj-41	402	13	skilled	skilled	ADJ
gsrj-41	402	14	nursing	nursing	NOUN
gsrj-41	402	15	facilities23	facilities23	NOUN
gsrj-41	402	16	to	to	PART
gsrj-41	402	17	describe	describe	VERB
gsrj-41	402	18	reasons	reason	NOUN
gsrj-41	402	19	for	for	ADP
gsrj-41	402	20	covid-19	covid-19	PROPN
gsrj-41	402	21	vaccine	vaccine	NOUN
gsrj-41	402	22	hesitancy	hesitancy	NOUN
gsrj-41	402	23	reported	report	VERB
gsrj-41	402	24	by	by	ADP
gsrj-41	402	25	staff	staff	NOUN
gsrj-41	402	26	of	of	ADP
gsrj-41	402	27	skilled	skilled	ADJ
gsrj-41	402	28	nursing	nursing	NOUN
gsrj-41	402	29	facilities	facility	NOUN
gsrj-41	402	30	and	and	CCONJ
gsrj-41	402	31	understand	understand	VERB
gsrj-41	402	32	factors	factor	NOUN
gsrj-41	402	33	that	that	PRON
gsrj-41	402	34	could	could	AUX
gsrj-41	402	35	potentially	potentially	ADV
gsrj-41	402	36	reduce	reduce	VERB
gsrj-41	402	37	hesitancy	hesitancy	NOUN
gsrj-41	402	38	focus	focus	NOUN
gsrj-41	402	39	groups	group	NOUN
gsrj-41	402	40	(	(	PUNCT
gsrj-41	402	41	qualitative	qualitative	ADJ
gsrj-41	402	42	interviews	interview	NOUN
gsrj-41	402	43	)	)	PUNCT
gsrj-41	402	44	with	with	SCONJ
gsrj-41	402	45	58	58	NUM
gsrj-41	402	46	staff	staff	NOUN
gsrj-41	402	47	members	member	NOUN
gsrj-41	402	48	were	be	AUX
gsrj-41	402	49	conducted	conduct	VERB
gsrj-41	402	50	virtually	virtually	ADV
gsrj-41	402	51	over	over	ADP
gsrj-41	402	52	zoom	zoom	NOUN
gsrj-41	402	53	in	in	ADP
gsrj-41	402	54	dec	dec	PROPN
gsrj-41	402	55	2020	2020	NUM
gsrj-41	402	56	after	after	ADP
gsrj-41	402	57	58	58	NUM
gsrj-41	402	58	skilled	skilled	ADJ
gsrj-41	402	59	nursing	nursing	NOUN
gsrj-41	402	60	facility	facility	NOUN
gsrj-41	402	61	staff	staff	NOUN
gsrj-41	402	62	in	in	ADP
gsrj-41	402	63	u.s	u.s	PROPN
gsrj-41	402	64	.	.	PROPN
gsrj-41	402	65	small	small	ADJ
gsrj-41	402	66	sample	sample	NOUN
gsrj-41	402	67	size	size	NOUN
gsrj-41	402	68	reasons	reason	NOUN
gsrj-41	402	69	for	for	ADP
gsrj-41	402	70	hesitancy	hesitancy	NOUN
gsrj-41	402	71	:	:	PUNCT
gsrj-41	402	72	beliefs	belief	NOUN
gsrj-41	402	73	that	that	SCONJ
gsrj-41	402	74	the	the	DET
gsrj-41	402	75	vaccine	vaccine	NOUN
gsrj-41	402	76	has	have	AUX
gsrj-41	402	77	been	be	AUX
gsrj-41	402	78	developed	develop	VERB
gsrj-41	402	79	too	too	ADV
gsrj-41	402	80	fast	fast	ADJ
gsrj-41	402	81	and	and	CCONJ
gsrj-41	402	82	without	without	ADP
gsrj-41	402	83	sufficient	sufficient	ADJ
gsrj-41	402	84	testing	testing	NOUN
gsrj-41	402	85	;	;	PUNCT
gsrj-41	402	86	personal	personal	ADJ
gsrj-41	402	87	fear	fear	NOUN
gsrj-41	402	88	about	about	ADP
gsrj-41	402	89	preexisting	preexist	VERB
gsrj-41	402	90	medical	medical	ADJ
gsrj-41	402	91	conditions	condition	NOUN
gsrj-41	402	92	,	,	PUNCT
gsrj-41	402	93	and	and	CCONJ
gsrj-41	402	94	more	more	ADV
gsrj-41	402	95	general	general	ADJ
gsrj-41	402	96	distrust	distrust	NOUN
gsrj-41	402	97	of	of	ADP
gsrj-41	402	98	the	the	DET
gsrj-41	402	99	government	government	NOUN
gsrj-41	402	100	vaccine	vaccine	NOUN
gsrj-41	402	101	uptake	uptake	ADJ
gsrj-41	402	102	is	be	AUX
gsrj-41	402	103	a	a	DET
gsrj-41	402	104	social	social	ADJ
gsrj-41	402	105	enterprise	enterprise	NOUN
gsrj-41	402	106	.	.	PUNCT
gsrj-41	403	1	momplaisir	momplaisir	NOUN
gsrj-41	403	2	,	,	PUNCT
gsrj-41	403	3	et	et	PROPN
gsrj-41	403	4	al	al	PROPN
gsrj-41	403	5	.	.	PUNCT
gsrj-41	403	6	(	(	PUNCT
gsrj-41	403	7	2021	2021	NUM
gsrj-41	403	8	)	)	PUNCT
gsrj-41	403	9	.	.	PUNCT
gsrj-41	404	1	racial	racial	ADJ
gsrj-41	404	2	/	/	SYM
gsrj-41	404	3	ethnic	ethnic	ADJ
gsrj-41	404	4	differences	difference	NOUN
gsrj-41	404	5	in	in	ADP
gsrj-41	404	6	covid-19	covid-19	PROPN
gsrj-41	404	7	vaccine	vaccine	NOUN
gsrj-41	404	8	hesitancy	hesitancy	NOUN
gsrj-41	404	9	among	among	ADP
gsrj-41	404	10	hcws	hcw	NOUN
gsrj-41	404	11	in	in	ADP
gsrj-41	404	12	2	2	NUM
gsrj-41	404	13	large	large	ADJ
gsrj-41	404	14	academic	academic	ADJ
gsrj-41	404	15	hospitals24	hospitals24	NOUN
gsrj-41	404	16	to	to	PART
gsrj-41	404	17	assess	assess	VERB
gsrj-41	404	18	hesitancy	hesitancy	NOUN
gsrj-41	404	19	to	to	ADP
gsrj-41	404	20	covid-19	covid-19	PROPN
gsrj-41	404	21	vaccination	vaccination	NOUN
gsrj-41	404	22	among	among	ADP
gsrj-41	404	23	hcws	hcw	NOUN
gsrj-41	404	24	across	across	ADP
gsrj-41	404	25	different	different	ADJ
gsrj-41	404	26	racial	racial	ADJ
gsrj-41	404	27	/	/	SYM
gsrj-41	404	28	ethnic	ethnic	ADJ
gsrj-41	404	29	groups	group	NOUN
gsrj-41	404	30	and	and	CCONJ
gsrj-41	404	31	assess	assess	NOUN
gsrj-41	404	32	factors	factor	NOUN
gsrj-41	404	33	associated	associate	VERB
gsrj-41	404	34	with	with	ADP
gsrj-41	404	35	vaccine	vaccine	NOUN
gsrj-41	404	36	hesitancy	hesitancy	NOUN
gsrj-41	404	37	.	.	PUNCT
gsrj-41	405	1	online	online	ADJ
gsrj-41	405	2	,	,	PUNCT
gsrj-41	405	3	crosssectional	crosssectional	ADJ
gsrj-41	405	4	survey	survey	NOUN
gsrj-41	405	5	study	study	NOUN
gsrj-41	405	6	was	be	AUX
gsrj-41	405	7	conducted	conduct	VERB
gsrj-41	405	8	among	among	ADP
gsrj-41	405	9	hcws	hcw	NOUN
gsrj-41	405	10	from	from	ADP
gsrj-41	405	11	2	2	NUM
gsrj-41	405	12	large	large	ADJ
gsrj-41	405	13	academic	academic	ADJ
gsrj-41	405	14	hospitals	hospital	NOUN
gsrj-41	405	15	(	(	PUNCT
gsrj-41	405	16	ie	ie	X
gsrj-41	405	17	,	,	PUNCT
gsrj-41	405	18	a	a	DET
gsrj-41	405	19	children	child	NOUN
gsrj-41	405	20	’s	’s	PART
gsrj-41	405	21	hospital	hospital	NOUN
gsrj-41	405	22	and	and	CCONJ
gsrj-41	405	23	an	an	DET
gsrj-41	405	24	adult	adult	NOUN
gsrj-41	405	25	hospital	hospital	NOUN
gsrj-41	405	26	)	)	PUNCT
gsrj-41	405	27	over	over	ADP
gsrj-41	405	28	a	a	DET
gsrj-41	405	29	3	3	NUM
gsrj-41	405	30	-	-	PUNCT
gsrj-41	405	31	week	week	NOUN
gsrj-41	405	32	period	period	NOUN
gsrj-41	405	33	in	in	ADP
gsrj-41	405	34	november	november	PROPN
gsrj-41	405	35	and	and	CCONJ
gsrj-41	405	36	december	december	PROPN
gsrj-41	405	37	2020	2020	NUM
gsrj-41	405	38	.	.	PUNCT
gsrj-41	406	1	before	before	ADP
gsrj-41	406	2	12,034	12,034	NUM
gsrj-41	406	3	hcws	hcw	NOUN
gsrj-41	406	4	at	at	ADP
gsrj-41	406	5	2	2	NUM
gsrj-41	406	6	hospitals	hospital	NOUN
gsrj-41	406	7	in	in	ADP
gsrj-41	406	8	philadelphia	philadelphia	PROPN
gsrj-41	406	9	who	who	PRON
gsrj-41	406	10	responded	respond	VERB
gsrj-41	406	11	to	to	ADP
gsrj-41	406	12	the	the	DET
gsrj-41	406	13	survey	survey	NOUN
gsrj-41	406	14	(	(	PUNCT
gsrj-41	406	15	34.5	34.5	NUM
gsrj-41	406	16	%	%	NOUN
gsrj-41	406	17	response	response	NOUN
gsrj-41	406	18	rate	rate	NOUN
gsrj-41	406	19	)	)	PUNCT
gsrj-41	406	20	among	among	ADP
gsrj-41	406	21	5440	5440	NUM
gsrj-41	406	22	hcws	hcw	NOUN
gsrj-41	406	23	with	with	ADP
gsrj-41	406	24	vaccine	vaccine	NOUN
gsrj-41	406	25	hesitancy	hesitancy	NOUN
gsrj-41	406	26	,	,	PUNCT
gsrj-41	406	27	reasons	reason	NOUN
gsrj-41	406	28	given	give	VERB
gsrj-41	406	29	for	for	ADP
gsrj-41	406	30	hesitancy	hesitancy	NOUN
gsrj-41	406	31	included	include	VERB
gsrj-41	406	32	concerns	concern	NOUN
gsrj-41	406	33	about	about	ADP
gsrj-41	406	34	side	side	NOUN
gsrj-41	406	35	effects	effect	NOUN
gsrj-41	406	36	(	(	PUNCT
gsrj-41	406	37	4737	4737	NUM
gsrj-41	406	38	individuals	individual	NOUN
gsrj-41	406	39	[	[	X
gsrj-41	406	40	87.1	87.1	NUM
gsrj-41	406	41	%	%	NOUN
gsrj-41	406	42	]	]	PUNCT
gsrj-41	406	43	)	)	PUNCT
gsrj-41	406	44	,	,	PUNCT
gsrj-41	406	45	newness	newness	NOUN
gsrj-41	406	46	of	of	ADP
gsrj-41	406	47	the	the	DET
gsrj-41	406	48	vaccine	vaccine	NOUN
gsrj-41	406	49	(	(	PUNCT
gsrj-41	406	50	4306	4306	NUM
gsrj-41	406	51	individuals	individual	NOUN
gsrj-41	406	52	[	[	X
gsrj-41	406	53	79.2	79.2	NUM
gsrj-41	406	54	%	%	NOUN
gsrj-41	406	55	]	]	PUNCT
gsrj-41	406	56	)	)	PUNCT
gsrj-41	406	57	,	,	PUNCT
gsrj-41	406	58	and	and	CCONJ
gsrj-41	406	59	lack	lack	NOUN
gsrj-41	406	60	of	of	ADP
gsrj-41	406	61	vaccine	vaccine	NOUN
gsrj-41	406	62	knowledge	knowledge	NOUN
gsrj-41	406	63	(	(	PUNCT
gsrj-41	406	64	4091	4091	NUM
gsrj-41	406	65	individuals	individual	NOUN
gsrj-41	406	66	[	[	X
gsrj-41	406	67	75.2	75.2	NUM
gsrj-41	406	68	%	%	NOUN
gsrj-41	406	69	]	]	PUNCT
gsrj-41	406	70	)	)	PUNCT
gsrj-41	406	71	.	.	PUNCT
gsrj-41	407	1	nguyen	nguyen	NOUN
gsrj-41	407	2	,	,	PUNCT
gsrj-41	407	3	et	et	PROPN
gsrj-41	407	4	al	al	PROPN
gsrj-41	407	5	.	.	PROPN
gsrj-41	407	6	(	(	PUNCT
gsrj-41	407	7	2021	2021	NUM
gsrj-41	407	8	)	)	PUNCT
gsrj-41	407	9	.	.	PUNCT
gsrj-41	408	1	covid-19	covid-19	PROPN
gsrj-41	408	2	vaccination	vaccination	NOUN
gsrj-41	408	3	intent	intent	NOUN
gsrj-41	408	4	,	,	PUNCT
gsrj-41	408	5	perceptions	perception	NOUN
gsrj-41	408	6	,	,	PUNCT
gsrj-41	408	7	and	and	CCONJ
gsrj-41	408	8	reasons	reason	NOUN
gsrj-41	408	9	for	for	ADP
gsrj-41	408	10	not	not	PART
gsrj-41	408	11	vaccinating	vaccinate	VERB
gsrj-41	408	12	among	among	ADP
gsrj-41	408	13	groups	group	NOUN
gsrj-41	408	14	to	to	PART
gsrj-41	408	15	assess	assess	VERB
gsrj-41	408	16	vaccine	vaccine	NOUN
gsrj-41	408	17	intent	intent	NOUN
gsrj-41	408	18	,	,	PUNCT
gsrj-41	408	19	perceptions	perception	NOUN
gsrj-41	408	20	,	,	PUNCT
gsrj-41	408	21	and	and	CCONJ
gsrj-41	408	22	reasons	reason	NOUN
gsrj-41	408	23	among	among	ADP
gsrj-41	408	24	prioritized	prioritized	ADJ
gsrj-41	408	25	groups	group	NOUN
gsrj-41	408	26	in	in	ADP
gsrj-41	408	27	the	the	DET
gsrj-41	408	28	us	us	PROPN
gsrj-41	408	29	as	as	ADP
gsrj-41	408	30	of	of	ADP
gsrj-41	408	31	sept	sept	PROPN
gsrj-41	408	32	and	and	CCONJ
gsrj-41	408	33	dec	dec	PROPN
gsrj-41	408	34	2020	2020	NUM
gsrj-41	408	35	online	online	ADJ
gsrj-41	408	36	cdc	cdc	PROPN
gsrj-41	408	37	surveys	survey	NOUN
gsrj-41	408	38	in	in	ADP
gsrj-41	408	39	sept	sept	PROPN
gsrj-41	408	40	and	and	CCONJ
gsrj-41	408	41	dec	dec	PROPN
gsrj-41	408	42	2020	2020	NUM
gsrj-41	408	43	before	before	ADP
gsrj-41	408	44	representative	representative	ADJ
gsrj-41	408	45	sample	sample	NOUN
gsrj-41	408	46	of	of	ADP
gsrj-41	408	47	prioritized	prioritize	VERB
gsrj-41	408	48	us	us	PROPN
gsrj-41	408	49	adults	adult	NOUN
gsrj-41	408	50	(	(	PUNCT
gsrj-41	408	51	3541	3541	NUM
gsrj-41	408	52	in	in	ADP
gsrj-41	408	53	oct	oct	PROPN
gsrj-41	408	54	and	and	CCONJ
gsrj-41	408	55	2033	2033	NUM
gsrj-41	408	56	in	in	ADP
gsrj-41	408	57	dec	dec	PROPN
gsrj-41	408	58	)	)	PUNCT
gsrj-41	408	59	groups	group	NOUN
gsrj-41	408	60	for	for	ADP
gsrj-41	408	61	prioritization	prioritization	NOUN
gsrj-41	408	62	(	(	PUNCT
gsrj-41	408	63	essential	essential	ADJ
gsrj-41	408	64	workers	worker	NOUN
gsrj-41	408	65	,	,	PUNCT
gsrj-41	408	66	underlying	underlying	ADJ
gsrj-41	408	67	medical	medical	ADJ
gsrj-41	408	68	conditions	condition	NOUN
gsrj-41	408	69	,	,	PUNCT
gsrj-41	408	70	aged	aged	ADJ
gsrj-41	408	71	65	65	NUM
gsrj-41	408	72	and	and	CCONJ
gsrj-41	408	73	over	over	ADV
gsrj-41	408	74	)	)	PUNCT
gsrj-41	408	75	among	among	ADP
gsrj-41	408	76	adults	adult	NOUN
gsrj-41	408	77	in	in	ADP
gsrj-41	408	78	the	the	DET
gsrj-41	408	79	december	december	PROPN
gsrj-41	408	80	surveys	survey	NOUN
gsrj-41	408	81	who	who	PRON
gsrj-41	408	82	did	do	AUX
gsrj-41	408	83	not	not	PART
gsrj-41	408	84	intend	intend	VERB
gsrj-41	408	85	to	to	PART
gsrj-41	408	86	get	get	VERB
gsrj-41	408	87	vaccinated	vaccinate	VERB
gsrj-41	408	88	(	(	PUNCT
gsrj-41	408	89	32.1	32.1	NUM
gsrj-41	408	90	%	%	NOUN
gsrj-41	408	91	of	of	ADP
gsrj-41	408	92	participants	participant	NOUN
gsrj-41	408	93	)	)	PUNCT
gsrj-41	408	94	,	,	PUNCT
gsrj-41	408	95	the	the	DET
gsrj-41	408	96	main	main	ADJ
gsrj-41	408	97	reasons	reason	NOUN
gsrj-41	408	98	most	most	ADV
gsrj-41	408	99	frequently	frequently	ADV
gsrj-41	408	100	cited	cite	VERB
gsrj-41	408	101	were	be	AUX
gsrj-41	408	102	concerns	concern	NOUN
gsrj-41	408	103	about	about	ADP
gsrj-41	408	104	side	side	NOUN
gsrj-41	408	105	effects	effect	NOUN
gsrj-41	408	106	and	and	CCONJ
gsrj-41	408	107	safety	safety	NOUN
gsrj-41	408	108	of	of	ADP
gsrj-41	408	109	the	the	DET
gsrj-41	408	110	covid19	covid19	NOUN
gsrj-41	408	111	vaccine	vaccine	NOUN
gsrj-41	408	112	(	(	PUNCT
gsrj-41	408	113	29.8	29.8	NUM
gsrj-41	408	114	%	%	NOUN
gsrj-41	408	115	)	)	PUNCT
gsrj-41	408	116	,	,	PUNCT
gsrj-41	408	117	planning	plan	VERB
gsrj-41	408	118	to	to	PART
gsrj-41	408	119	wait	wait	VERB
gsrj-41	408	120	to	to	PART
gsrj-41	408	121	see	see	VERB
gsrj-41	408	122	if	if	SCONJ
gsrj-41	408	123	the	the	DET
gsrj-41	408	124	vaccine	vaccine	NOUN
gsrj-41	408	125	is	be	AUX
gsrj-41	408	126	safe	safe	ADJ
gsrj-41	408	127	30	30	NUM
gsrj-41	408	128	georgetown	georgetown	PROPN
gsrj-41	408	129	scientific	scientific	ADJ
gsrj-41	408	130	research	research	NOUN
gsrj-41	408	131	journal	journal	NOUN
gsrj-41	408	132	prioritized	prioritize	VERB
gsrj-41	408	133	for	for	ADP
gsrj-41	408	134	early	early	ADJ
gsrj-41	408	135	vaccination	vaccination	NOUN
gsrj-41	408	136	–	–	PUNCT
gsrj-41	408	137	united	united	ADJ
gsrj-41	408	138	states	states	PROPN
gsrj-41	408	139	,	,	PUNCT
gsrj-41	408	140	september	september	PROPN
gsrj-41	408	141	and	and	CCONJ
gsrj-41	408	142	december	december	PROPN
gsrj-41	408	143	202025	202025	NUM
gsrj-41	408	144	and	and	CCONJ
gsrj-41	408	145	consider	consider	VERB
gsrj-41	408	146	receiving	receive	VERB
gsrj-41	408	147	it	it	PRON
gsrj-41	408	148	later	later	ADV
gsrj-41	408	149	(	(	PUNCT
gsrj-41	408	150	14.5	14.5	NUM
gsrj-41	408	151	%	%	NOUN
gsrj-41	408	152	)	)	PUNCT
gsrj-41	408	153	,	,	PUNCT
gsrj-41	408	154	lack	lack	NOUN
gsrj-41	408	155	of	of	ADP
gsrj-41	408	156	trust	trust	NOUN
gsrj-41	408	157	in	in	ADP
gsrj-41	408	158	the	the	DET
gsrj-41	408	159	government	government	NOUN
gsrj-41	408	160	(	(	PUNCT
gsrj-41	408	161	12.5	12.5	NUM
gsrj-41	408	162	%	%	NOUN
gsrj-41	408	163	)	)	PUNCT
gsrj-41	408	164	,	,	PUNCT
gsrj-41	408	165	and	and	CCONJ
gsrj-41	408	166	concern	concern	NOUN
gsrj-41	408	167	that	that	PRON
gsrj-41	408	168	covid-19	covid-19	PROPN
gsrj-41	408	169	vaccines	vaccine	NOUN
gsrj-41	408	170	were	be	AUX
gsrj-41	408	171	developed	develop	VERB
gsrj-41	408	172	too	too	ADV
gsrj-41	408	173	quickly	quickly	ADV
gsrj-41	408	174	(	(	PUNCT
gsrj-41	408	175	10.4	10.4	NUM
gsrj-41	408	176	%	%	NOUN
gsrj-41	408	177	)	)	PUNCT
gsrj-41	408	178	mondal	mondal	PROPN
gsrj-41	408	179	,	,	PUNCT
gsrj-41	408	180	et	et	PROPN
gsrj-41	408	181	al	al	PROPN
gsrj-41	408	182	.	.	PROPN
gsrj-41	409	1	(	(	PUNCT
gsrj-41	409	2	2021	2021	NUM
gsrj-41	409	3	)	)	PUNCT
gsrj-41	409	4	.	.	PUNCT
gsrj-41	410	1	sociodemogra	sociodemogra	PROPN
gsrj-41	410	2	phic	phic	ADJ
gsrj-41	410	3	predictors	predictor	NOUN
gsrj-41	410	4	of	of	ADP
gsrj-41	410	5	covid-19	covid-19	PROPN
gsrj-41	410	6	vaccine	vaccine	NOUN
gsrj-41	410	7	acceptance	acceptance	NOUN
gsrj-41	410	8	:	:	PUNCT
gsrj-41	410	9	a	a	DET
gsrj-41	410	10	nationwide	nationwide	ADJ
gsrj-41	410	11	us	us	PROPN
gsrj-41	410	12	-	-	PUNCT
gsrj-41	410	13	based	base	VERB
gsrj-41	410	14	survey	survey	NOUN
gsrj-41	410	15	study26	study26	VERB
gsrj-41	410	16	our	our	PRON
gsrj-41	410	17	primary	primary	ADJ
gsrj-41	410	18	objective	objective	NOUN
gsrj-41	410	19	was	be	AUX
gsrj-41	410	20	to	to	PART
gsrj-41	410	21	determine	determine	VERB
gsrj-41	410	22	the	the	DET
gsrj-41	410	23	relative	relative	ADJ
gsrj-41	410	24	influence	influence	NOUN
gsrj-41	410	25	of	of	ADP
gsrj-41	410	26	sociodemogra	sociodemogra	PROPN
gsrj-41	410	27	phic	phic	ADJ
gsrj-41	410	28	predictors	predictor	NOUN
gsrj-41	410	29	on	on	ADP
gsrj-41	410	30	covid-19	covid-19	PROPN
gsrj-41	410	31	vaccine	vaccine	NOUN
gsrj-41	410	32	acceptance	acceptance	NOUN
gsrj-41	410	33	.	.	PUNCT
gsrj-41	411	1	the	the	DET
gsrj-41	411	2	secondary	secondary	ADJ
gsrj-41	411	3	objectives	objective	NOUN
gsrj-41	411	4	were	be	AUX
gsrj-41	411	5	to	to	PART
gsrj-41	411	6	understand	understand	VERB
gsrj-41	411	7	the	the	DET
gsrj-41	411	8	reasons	reason	NOUN
gsrj-41	411	9	behind	behind	ADP
gsrj-41	411	10	vaccine	vaccine	NOUN
gsrj-41	411	11	refusal	refusal	NOUN
gsrj-41	411	12	and	and	CCONJ
gsrj-41	411	13	compare	compare	VERB
gsrj-41	411	14	covid-19	covid-19	PROPN
gsrj-41	411	15	vaccine	vaccine	NOUN
gsrj-41	411	16	acceptance	acceptance	NOUN
gsrj-41	411	17	with	with	ADP
gsrj-41	411	18	influenza	influenza	ADJ
gsrj-41	411	19	vaccine	vaccine	NOUN
gsrj-41	411	20	uptake	uptake	ADJ
gsrj-41	411	21	.	.	PUNCT
gsrj-41	412	1	online	online	PROPN
gsrj-41	412	2	crosssectional	crosssectional	ADJ
gsrj-41	412	3	survey	survey	NOUN
gsrj-41	412	4	conducted	conduct	VERB
gsrj-41	412	5	between	between	ADP
gsrj-41	412	6	may	may	PROPN
gsrj-41	412	7	2020	2020	NUM
gsrj-41	412	8	and	and	CCONJ
gsrj-41	412	9	jan	jan	PROPN
gsrj-41	412	10	2021	2021	NUM
gsrj-41	412	11	both	both	PRON
gsrj-41	412	12	(	(	PUNCT
gsrj-41	412	13	mostly	mostly	ADV
gsrj-41	412	14	before	before	ADP
gsrj-41	412	15	)	)	PUNCT
gsrj-41	412	16	2978	2978	NUM
gsrj-41	412	17	participants	participant	NOUN
gsrj-41	412	18	in	in	ADP
gsrj-41	412	19	us	we	PRON
gsrj-41	412	20	nationally	nationally	ADV
gsrj-41	412	21	representative	representative	ADJ
gsrj-41	412	22	information	information	NOUN
gsrj-41	412	23	channels	channel	NOUN
gsrj-41	412	24	:	:	PUNCT
gsrj-41	412	25	both	both	DET
gsrj-41	412	26	vaccine	vaccine	NOUN
gsrj-41	412	27	-	-	PUNCT
gsrj-41	412	28	compliant	compliant	ADJ
gsrj-41	412	29	and	and	CCONJ
gsrj-41	412	30	vaccine	vaccine	NOUN
gsrj-41	412	31	-	-	PUNCT
gsrj-41	412	32	hesitant	hesitant	ADJ
gsrj-41	412	33	groups	group	NOUN
gsrj-41	412	34	had	have	VERB
gsrj-41	412	35	equivalent	equivalent	ADJ
gsrj-41	412	36	reliance	reliance	NOUN
gsrj-41	412	37	on	on	ADP
gsrj-41	412	38	television	television	NOUN
gsrj-41	412	39	,	,	PUNCT
gsrj-41	412	40	social	social	ADJ
gsrj-41	412	41	interaction	interaction	NOUN
gsrj-41	412	42	and	and	CCONJ
gsrj-41	412	43	social	social	ADJ
gsrj-41	412	44	media	medium	NOUN
gsrj-41	412	45	(	(	PUNCT
gsrj-41	412	46	e.g.	e.g.	ADV
gsrj-41	412	47	facebook	facebook	NOUN
gsrj-41	412	48	)	)	PUNCT
gsrj-41	412	49	to	to	PART
gsrj-41	412	50	acquire	acquire	VERB
gsrj-41	412	51	covid-19	covid-19	PROPN
gsrj-41	412	52	-	-	PUNCT
gsrj-41	412	53	related	relate	VERB
gsrj-41	412	54	information	information	NOUN
gsrj-41	412	55	.	.	PUNCT
gsrj-41	413	1	however	however	ADV
gsrj-41	413	2	,	,	PUNCT
gsrj-41	413	3	a	a	DET
gsrj-41	413	4	significantly	significantly	ADV
gsrj-41	413	5	higher	high	ADJ
gsrj-41	413	6	number	number	NOUN
gsrj-41	413	7	of	of	ADP
gsrj-41	413	8	vaccinecompliant	vaccinecompliant	NOUN
gsrj-41	413	9	participants	participant	NOUN
gsrj-41	413	10	gained	gain	VERB
gsrj-41	413	11	covid-19	covid-19	PROPN
gsrj-41	413	12	information	information	NOUN
gsrj-41	413	13	from	from	ADP
gsrj-41	413	14	the	the	DET
gsrj-41	413	15	cdc	cdc	PROPN
gsrj-41	413	16	and	and	CCONJ
gsrj-41	413	17	other	other	ADJ
gsrj-41	413	18	official	official	ADJ
gsrj-41	413	19	health	health	NOUN
gsrj-41	413	20	websites	website	NOUN
gsrj-41	413	21	.	.	PUNCT
gsrj-41	414	1	18.9	18.9	NUM
gsrj-41	414	2	%	%	NOUN
gsrj-41	414	3	not	not	PART
gsrj-41	414	4	accepting	accept	VERB
gsrj-41	414	5	of	of	ADP
gsrj-41	414	6	vaccine	vaccine	NOUN
gsrj-41	414	7	potential	potential	ADJ
gsrj-41	414	8	adverse	adverse	ADJ
gsrj-41	414	9	effects	effect	NOUN
gsrj-41	414	10	(	(	PUNCT
gsrj-41	414	11	84.2	84.2	NUM
gsrj-41	414	12	%	%	NOUN
gsrj-41	414	13	)	)	PUNCT
gsrj-41	414	14	,	,	PUNCT
gsrj-41	414	15	followed	follow	VERB
gsrj-41	414	16	by	by	ADP
gsrj-41	414	17	doubt	doubt	NOUN
gsrj-41	414	18	about	about	ADP
gsrj-41	414	19	vaccine	vaccine	NOUN
gsrj-41	414	20	efficacy	efficacy	NOUN
gsrj-41	414	21	(	(	PUNCT
gsrj-41	414	22	44.4	44.4	NUM
gsrj-41	414	23	%	%	NOUN
gsrj-41	414	24	)	)	PUNCT
gsrj-41	414	25	,	,	PUNCT
gsrj-41	414	26	were	be	AUX
gsrj-41	414	27	the	the	DET
gsrj-41	414	28	primary	primary	ADJ
gsrj-41	414	29	reasons	reason	NOUN
gsrj-41	414	30	reported	report	VERB
gsrj-41	414	31	by	by	ADP
gsrj-41	414	32	the	the	DET
gsrj-41	414	33	vaccine	vaccine	NOUN
gsrj-41	414	34	-	-	PUNCT
gsrj-41	414	35	hesitant	hesitant	ADJ
gsrj-41	414	36	group	group	NOUN
gsrj-41	414	37	.	.	PUNCT
gsrj-41	415	1	even	even	ADV
gsrj-41	415	2	51.0	51.0	NUM
gsrj-41	415	3	%	%	NOUN
gsrj-41	415	4	of	of	ADP
gsrj-41	415	5	the	the	DET
gsrj-41	415	6	vaccine	vaccine	NOUN
gsrj-41	415	7	-	-	PUNCT
gsrj-41	415	8	compliant	compliant	ADJ
gsrj-41	415	9	participants	participant	NOUN
gsrj-41	415	10	were	be	AUX
gsrj-41	415	11	concerned	concern	VERB
gsrj-41	415	12	about	about	ADP
gsrj-41	415	13	adverse	adverse	ADJ
gsrj-41	415	14	effects	effect	NOUN
gsrj-41	415	15	;	;	PUNCT
gsrj-41	415	16	however	however	ADV
gsrj-41	415	17	,	,	PUNCT
gsrj-41	415	18	only	only	ADV
gsrj-41	415	19	5.4	5.4	NUM
gsrj-41	415	20	%	%	NOUN
gsrj-41	415	21	doubted	doubt	VERB
gsrj-41	415	22	the	the	DET
gsrj-41	415	23	efficacy	efficacy	NOUN
gsrj-41	415	24	of	of	ADP
gsrj-41	415	25	the	the	DET
gsrj-41	415	26	vaccine	vaccine	NOUN
gsrj-41	415	27	.	.	PUNCT
gsrj-41	416	1	also	also	ADV
gsrj-41	416	2	have	have	VERB
gsrj-41	416	3	racial	racial	ADJ
gsrj-41	416	4	/	/	SYM
gsrj-41	416	5	ethnic	ethnic	ADJ
gsrj-41	416	6	breakdown	breakdown	NOUN
gsrj-41	416	7	of	of	ADP
gsrj-41	416	8	reasons	reason	NOUN
gsrj-41	416	9	31	31	NUM
gsrj-41	416	10	georgetown	georgetown	PROPN
gsrj-41	416	11	scientific	scientific	PROPN
gsrj-41	416	12	research	research	PROPN
gsrj-41	416	13	journal	journal	PROPN
gsrj-41	416	14	nguyen	nguyen	PROPN
gsrj-41	416	15	,	,	PUNCT
gsrj-41	416	16	et	et	PROPN
gsrj-41	416	17	al	al	PROPN
gsrj-41	416	18	.	.	PROPN
gsrj-41	417	1	(	(	PUNCT
gsrj-41	417	2	2021	2021	NUM
gsrj-41	417	3	)	)	PUNCT
gsrj-41	417	4	.	.	PUNCT
gsrj-41	418	1	changes	change	NOUN
gsrj-41	418	2	in	in	ADP
gsrj-41	418	3	covid-19	covid-19	PROPN
gsrj-41	418	4	vaccination	vaccination	NOUN
gsrj-41	418	5	receipt	receipt	NOUN
gsrj-41	418	6	and	and	CCONJ
gsrj-41	418	7	intention	intention	NOUN
gsrj-41	418	8	to	to	PART
gsrj-41	418	9	vaccinate	vaccinate	VERB
gsrj-41	418	10	by	by	ADP
gsrj-41	418	11	socioeconomic	socioeconomic	ADJ
gsrj-41	418	12	characteristics	characteristic	NOUN
gsrj-41	418	13	and	and	CCONJ
gsrj-41	418	14	geographic	geographic	ADJ
gsrj-41	418	15	area	area	NOUN
gsrj-41	418	16	,	,	PUNCT
gsrj-41	418	17	united	united	PROPN
gsrj-41	418	18	states	states	PROPN
gsrj-41	418	19	,	,	PUNCT
gsrj-41	418	20	january	january	PROPN
gsrj-41	418	21	6	6	NUM
gsrj-41	418	22	–	–	PUNCT
gsrj-41	418	23	march	march	PROPN
gsrj-41	418	24	29	29	NUM
gsrj-41	418	25	,	,	PUNCT
gsrj-41	418	26	202127	202127	NUM
gsrj-41	418	27	the	the	DET
gsrj-41	418	28	purpose	purpose	NOUN
gsrj-41	418	29	of	of	ADP
gsrj-41	418	30	this	this	DET
gsrj-41	418	31	study	study	NOUN
gsrj-41	418	32	was	be	AUX
gsrj-41	418	33	to	to	PART
gsrj-41	418	34	examine	examine	VERB
gsrj-41	418	35	changes	change	NOUN
gsrj-41	418	36	in	in	ADP
gsrj-41	418	37	vaccine	vaccine	NOUN
gsrj-41	418	38	intentions	intention	NOUN
gsrj-41	418	39	and	and	CCONJ
gsrj-41	418	40	attitudes	attitude	NOUN
gsrj-41	418	41	by	by	ADP
gsrj-41	418	42	sociodemogra	sociodemogra	PROPN
gsrj-41	418	43	phic	phic	PROPN
gsrj-41	418	44	characteristics	characteristic	NOUN
gsrj-41	418	45	and	and	CCONJ
gsrj-41	418	46	geographic	geographic	ADJ
gsrj-41	418	47	areas	area	NOUN
gsrj-41	418	48	,	,	PUNCT
gsrj-41	418	49	factors	factor	NOUN
gsrj-41	418	50	associated	associate	VERB
gsrj-41	418	51	with	with	ADP
gsrj-41	418	52	vaccination	vaccination	NOUN
gsrj-41	418	53	intent	intent	NOUN
gsrj-41	418	54	,	,	PUNCT
gsrj-41	418	55	and	and	CCONJ
gsrj-41	418	56	reasons	reason	NOUN
gsrj-41	418	57	for	for	ADP
gsrj-41	418	58	nonvaccination	nonvaccination	NOUN
gsrj-41	418	59	among	among	ADP
gsrj-41	418	60	a	a	DET
gsrj-41	418	61	nationally	nationally	ADV
gsrj-41	418	62	representative	representative	ADJ
gsrj-41	418	63	sample	sample	NOUN
gsrj-41	418	64	of	of	ADP
gsrj-41	418	65	u.s	u.s	PROPN
gsrj-41	418	66	.	.	PROPN
gsrj-41	418	67	adults	adult	NOUN
gsrj-41	418	68	.	.	PUNCT
gsrj-41	419	1	household	household	NOUN
gsrj-41	419	2	pulse	pulse	NOUN
gsrj-41	419	3	survey	survey	NOUN
gsrj-41	419	4	from	from	ADP
gsrj-41	419	5	jan	jan	PROPN
gsrj-41	419	6	to	to	ADP
gsrj-41	419	7	march	march	PROPN
gsrj-41	419	8	2021	2021	NUM
gsrj-41	419	9	online	online	NOUN
gsrj-41	419	10	&	&	CCONJ
gsrj-41	419	11	phone	phone	PROPN
gsrj-41	419	12	crosssectional	crosssectional	PROPN
gsrj-41	419	13	survey	survey	NOUN
gsrj-41	419	14	after	after	ADP
gsrj-41	419	15	approx	approx	PROPN
gsrj-41	419	16	.	.	PUNCT
gsrj-41	420	1	75,000	75,000	NUM
gsrj-41	420	2	respondents	respondent	NOUN
gsrj-41	420	3	,	,	PUNCT
gsrj-41	420	4	u.s	u.s	PROPN
gsrj-41	420	5	.	.	PROPN
gsrj-41	420	6	adults	adult	NOUN
gsrj-41	420	7	response	response	NOUN
gsrj-41	420	8	rates	rate	NOUN
gsrj-41	420	9	of	of	ADP
gsrj-41	420	10	6.4	6.4	NUM
gsrj-41	420	11	-	-	SYM
gsrj-41	420	12	7.5	7.5	NUM
gsrj-41	420	13	%	%	NOUN
gsrj-41	420	14	reasons	reason	NOUN
gsrj-41	420	15	for	for	ADP
gsrj-41	420	16	not	not	PART
gsrj-41	420	17	getting	getting	AUX
gsrj-41	420	18	vaccinated	vaccinate	VERB
gsrj-41	420	19	changed	change	VERB
gsrj-41	420	20	slightly	slightly	ADV
gsrj-41	420	21	from	from	ADP
gsrj-41	420	22	january	january	PROPN
gsrj-41	420	23	to	to	ADP
gsrj-41	420	24	march	march	PROPN
gsrj-41	420	25	(	(	PUNCT
gsrj-41	420	26	the	the	DET
gsrj-41	420	27	belief	belief	NOUN
gsrj-41	420	28	that	that	SCONJ
gsrj-41	420	29	a	a	DET
gsrj-41	420	30	vaccine	vaccine	NOUN
gsrj-41	420	31	is	be	AUX
gsrj-41	420	32	not	not	PART
gsrj-41	420	33	needed	need	VERB
gsrj-41	420	34	increased	increase	VERB
gsrj-41	420	35	by	by	ADP
gsrj-41	420	36	more	more	ADJ
gsrj-41	420	37	than	than	ADP
gsrj-41	420	38	five	five	NUM
gsrj-41	420	39	percentage	percentage	NOUN
gsrj-41	420	40	points	point	NOUN
gsrj-41	420	41	from	from	ADP
gsrj-41	420	42	early	early	ADJ
gsrj-41	420	43	january	january	PROPN
gsrj-41	420	44	to	to	ADP
gsrj-41	420	45	late	late	ADJ
gsrj-41	420	46	march	march	PROPN
gsrj-41	420	47	.	.	PUNCT
gsrj-41	420	48	)	)	PUNCT
gsrj-41	421	1	in	in	ADP
gsrj-41	421	2	late	late	ADJ
gsrj-41	421	3	march	march	NOUN
gsrj-41	421	4	,	,	PUNCT
gsrj-41	421	5	among	among	ADP
gsrj-41	421	6	“	"	PUNCT
gsrj-41	421	7	probably	probably	ADV
gsrj-41	421	8	will	will	AUX
gsrj-41	421	9	”	"	PUNCT
gsrj-41	421	10	:	:	PUNCT
gsrj-41	421	11	plan	plan	VERB
gsrj-41	421	12	to	to	PART
gsrj-41	421	13	wait	wait	VERB
gsrj-41	421	14	and	and	CCONJ
gsrj-41	421	15	see	see	VERB
gsrj-41	421	16	if	if	SCONJ
gsrj-41	421	17	it	it	PRON
gsrj-41	421	18	’s	’	VERB
gsrj-41	421	19	safe	safe	ADJ
gsrj-41	421	20	(	(	PUNCT
gsrj-41	421	21	54.5	54.5	NUM
gsrj-41	421	22	%	%	NOUN
gsrj-41	421	23	)	)	PUNCT
gsrj-41	421	24	,	,	PUNCT
gsrj-41	421	25	concern	concern	NOUN
gsrj-41	421	26	about	about	ADP
gsrj-41	421	27	possible	possible	ADJ
gsrj-41	421	28	side	side	NOUN
gsrj-41	421	29	effects	effect	NOUN
gsrj-41	421	30	(	(	PUNCT
gsrj-41	421	31	50.9	50.9	NUM
gsrj-41	421	32	%	%	NOUN
gsrj-41	421	33	)	)	PUNCT
gsrj-41	421	34	,	,	PUNCT
gsrj-41	421	35	other	other	ADJ
gsrj-41	421	36	people	people	NOUN
gsrj-41	421	37	need	need	VERB
gsrj-41	421	38	it	it	PRON
gsrj-41	421	39	more	more	ADV
gsrj-41	421	40	right	right	ADV
gsrj-41	421	41	now	now	ADV
gsrj-41	421	42	(	(	PUNCT
gsrj-41	421	43	35.5	35.5	NUM
gsrj-41	421	44	%	%	NOUN
gsrj-41	421	45	)	)	PUNCT
gsrj-41	421	46	among	among	ADP
gsrj-41	421	47	probably	probably	ADV
gsrj-41	421	48	will	will	AUX
gsrj-41	421	49	not	not	PART
gsrj-41	421	50	:	:	PUNCT
gsrj-41	421	51	plan	plan	VERB
gsrj-41	421	52	to	to	PART
gsrj-41	421	53	wait	wait	VERB
gsrj-41	421	54	(	(	PUNCT
gsrj-41	421	55	56	56	NUM
gsrj-41	421	56	%	%	NOUN
gsrj-41	421	57	)	)	PUNCT
gsrj-41	421	58	,	,	PUNCT
gsrj-41	421	59	side	side	NOUN
gsrj-41	421	60	effects	effect	NOUN
gsrj-41	421	61	(	(	PUNCT
gsrj-41	421	62	51.1	51.1	NUM
gsrj-41	421	63	%	%	NOUN
gsrj-41	421	64	)	)	PUNCT
gsrj-41	421	65	,	,	PUNCT
gsrj-41	421	66	other	other	ADJ
gsrj-41	421	67	people	people	NOUN
gsrj-41	421	68	need	need	VERB
gsrj-41	421	69	it	it	PRON
gsrj-41	421	70	more	more	ADV
gsrj-41	421	71	right	right	ADV
gsrj-41	421	72	now	now	ADV
gsrj-41	421	73	(	(	PUNCT
gsrj-41	421	74	25.4	25.4	NUM
gsrj-41	421	75	)	)	PUNCT
gsrj-41	421	76	,	,	PUNCT
gsrj-41	421	77	do	do	AUX
gsrj-41	421	78	n’t	not	PART
gsrj-41	421	79	trust	trust	VERB
gsrj-41	421	80	covid	covid	ADJ
gsrj-41	421	81	vaccines	vaccine	NOUN
gsrj-41	421	82	(	(	PUNCT
gsrj-41	421	83	25	25	NUM
gsrj-41	421	84	)	)	PUNCT
gsrj-41	421	85	definitely	definitely	ADV
gsrj-41	421	86	not	not	PART
gsrj-41	421	87	:	:	PUNCT
gsrj-41	421	88	concern	concern	NOUN
gsrj-41	421	89	about	about	ADP
gsrj-41	421	90	side	side	NOUN
gsrj-41	421	91	effects	effect	NOUN
gsrj-41	421	92	(	(	PUNCT
gsrj-41	421	93	46.5	46.5	NUM
gsrj-41	421	94	%	%	NOUN
gsrj-41	421	95	)	)	PUNCT
gsrj-41	421	96	,	,	PUNCT
gsrj-41	421	97	do	do	AUX
gsrj-41	421	98	n’t	not	PART
gsrj-41	421	99	trust	trust	VERB
gsrj-41	421	100	covid-19	covid-19	PROPN
gsrj-41	421	101	vaccines	vaccine	NOUN
gsrj-41	421	102	(	(	PUNCT
gsrj-41	421	103	47.9	47.9	NUM
gsrj-41	421	104	)	)	PUNCT
gsrj-41	421	105	,	,	PUNCT
gsrj-41	421	106	do	do	AUX
gsrj-41	421	107	n’t	not	PART
gsrj-41	421	108	trust	trust	VERB
gsrj-41	421	109	government	government	NOUN
gsrj-41	421	110	(	(	PUNCT
gsrj-41	421	111	40.1	40.1	NUM
gsrj-41	421	112	)	)	PUNCT
gsrj-41	421	113	7.6	7.6	NUM
gsrj-41	421	114	%	%	NOUN
gsrj-41	421	115	in	in	ADP
gsrj-41	421	116	late	late	ADJ
gsrj-41	421	117	march	march	NOUN
gsrj-41	421	118	do	do	AUX
gsrj-41	421	119	not	not	PART
gsrj-41	421	120	plan	plan	VERB
gsrj-41	421	121	to	to	PART
gsrj-41	421	122	be	be	AUX
gsrj-41	421	123	vaccinated	vaccinate	VERB
gsrj-41	421	124	–	–	PUNCT
gsrj-41	421	125	reasons	reason	NOUN
gsrj-41	421	126	above	above	ADP
gsrj-41	421	127	iadarola	iadarola	NOUN
gsrj-41	421	128	,	,	PUNCT
gsrj-41	421	129	et	et	PROPN
gsrj-41	421	130	al	al	PROPN
gsrj-41	421	131	.	.	PROPN
gsrj-41	422	1	(	(	PUNCT
gsrj-41	422	2	2021	2021	NUM
gsrj-41	422	3	)	)	PUNCT
gsrj-41	422	4	.	.	PUNCT
gsrj-41	423	1	covid-19	covid-19	PROPN
gsrj-41	423	2	vaccine	vaccine	NOUN
gsrj-41	423	3	perceptions	perception	NOUN
gsrj-41	423	4	in	in	ADP
gsrj-41	423	5	new	new	PROPN
gsrj-41	423	6	york	york	PROPN
gsrj-41	423	7	state	state	PROPN
gsrj-41	423	8	’s	’s	PART
gsrj-41	423	9	intellectual	intellectual	ADJ
gsrj-41	423	10	and	and	CCONJ
gsrj-41	423	11	developmental	developmental	NOUN
gsrj-41	423	12	to	to	PART
gsrj-41	423	13	explore	explore	VERB
gsrj-41	423	14	covid-19	covid-19	PROPN
gsrj-41	423	15	vaccine	vaccine	NOUN
gsrj-41	423	16	perceptions	perception	NOUN
gsrj-41	423	17	in	in	ADP
gsrj-41	423	18	individuals	individual	NOUN
gsrj-41	423	19	with	with	ADP
gsrj-41	423	20	idd	idd	PROPN
gsrj-41	423	21	,	,	PUNCT
gsrj-41	423	22	their	their	PRON
gsrj-41	423	23	family	family	NOUN
gsrj-41	423	24	members	member	NOUN
gsrj-41	423	25	,	,	PUNCT
gsrj-41	423	26	and	and	CCONJ
gsrj-41	423	27	those	those	PRON
gsrj-41	423	28	who	who	PRON
gsrj-41	423	29	work	work	VERB
gsrj-41	423	30	with	with	ADP
gsrj-41	423	31	online	online	ADJ
gsrj-41	423	32	survey	survey	NOUN
gsrj-41	423	33	distributed	distribute	VERB
gsrj-41	423	34	to	to	ADP
gsrj-41	423	35	a	a	DET
gsrj-41	423	36	convenience	convenience	NOUN
gsrj-41	423	37	sample	sample	NOUN
gsrj-41	423	38	of	of	ADP
gsrj-41	423	39	idd	idd	PROPN
gsrj-41	423	40	organization	organization	NOUN
gsrj-41	423	41	s	s	PART
gsrj-41	423	42	throughout	throughout	ADP
gsrj-41	423	43	ny	ny	PROPN
gsrj-41	423	44	state	state	NOUN
gsrj-41	423	45	after	after	SCONJ
gsrj-41	423	46	new	new	PROPN
gsrj-41	423	47	york	york	PROPN
gsrj-41	423	48	’s	’s	PART
gsrj-41	423	49	intellectual	intellectual	ADJ
gsrj-41	423	50	and	and	CCONJ
gsrj-41	423	51	development	development	NOUN
gsrj-41	423	52	disabilities	disability	NOUN
gsrj-41	423	53	community	community	NOUN
gsrj-41	423	54	825	825	NUM
gsrj-41	423	55	respondents	respondent	NOUN
gsrj-41	423	56	25	25	NUM
gsrj-41	423	57	%	%	NOUN
gsrj-41	423	58	hesitant	hesitant	ADJ
gsrj-41	423	59	concerns	concern	NOUN
gsrj-41	423	60	about	about	ADP
gsrj-41	423	61	side	side	NOUN
gsrj-41	423	62	effects	effect	NOUN
gsrj-41	423	63	(	(	PUNCT
gsrj-41	423	64	16	16	NUM
gsrj-41	423	65	%	%	NOUN
gsrj-41	423	66	)	)	PUNCT
gsrj-41	423	67	and	and	CCONJ
gsrj-41	423	68	swiftness	swiftness	NOUN
gsrj-41	423	69	of	of	ADP
gsrj-41	423	70	vaccine	vaccine	NOUN
gsrj-41	423	71	(	(	PUNCT
gsrj-41	423	72	15	15	NUM
gsrj-41	423	73	%	%	NOUN
gsrj-41	423	74	)	)	PUNCT
gsrj-41	423	75	development	development	NOUN
gsrj-41	423	76	,	,	PUNCT
gsrj-41	423	77	being	be	AUX
gsrj-41	423	78	an	an	DET
gsrj-41	423	79	“	"	PUNCT
gsrj-41	423	80	experiment	experiment	NOUN
gsrj-41	423	81	”	"	PUNCT
gsrj-41	423	82	for	for	ADP
gsrj-41	423	83	the	the	DET
gsrj-41	423	84	vaccine	vaccine	NOUN
gsrj-41	423	85	(	(	PUNCT
gsrj-41	423	86	14	14	NUM
gsrj-41	423	87	%	%	NOUN
gsrj-41	423	88	)	)	PUNCT
gsrj-41	423	89	and	and	CCONJ
gsrj-41	423	90	not	not	PART
gsrj-41	423	91	trusting	trust	VERB
gsrj-41	423	92	government	government	NOUN
gsrj-41	423	93	(	(	PUNCT
gsrj-41	423	94	14	14	NUM
gsrj-41	423	95	%	%	NOUN
gsrj-41	423	96	)	)	PUNCT
gsrj-41	423	97	32	32	NUM
gsrj-41	423	98	georgetown	georgetown	PROPN
gsrj-41	423	99	scientific	scientific	PROPN
gsrj-41	423	100	research	research	PROPN
gsrj-41	423	101	journal	journal	PROPN
gsrj-41	423	102	disabilities	disability	NOUN
gsrj-41	423	103	community28	community28	VERB
gsrj-41	423	104	them	they	PRON
gsrj-41	423	105	,	,	PUNCT
gsrj-41	423	106	to	to	PART
gsrj-41	423	107	inform	inform	VERB
gsrj-41	423	108	a	a	DET
gsrj-41	423	109	statewide	statewide	ADJ
gsrj-41	423	110	vaccine	vaccine	NOUN
gsrj-41	423	111	information	information	NOUN
gsrj-41	423	112	and	and	CCONJ
gsrj-41	423	113	messaging	messaging	NOUN
gsrj-41	423	114	project	project	NOUN
gsrj-41	423	115	.	.	PUNCT
gsrj-41	424	1	jan	jan	PROPN
gsrj-41	424	2	-	-	PROPN
gsrj-41	424	3	feb	feb	PROPN
gsrj-41	424	4	2021	2021	NUM
gsrj-41	424	5	regarding	regard	VERB
gsrj-41	424	6	trusted	trusted	ADJ
gsrj-41	424	7	sources	source	NOUN
gsrj-41	424	8	of	of	ADP
gsrj-41	424	9	vaccine	vaccine	NOUN
gsrj-41	424	10	information	information	NOUN
gsrj-41	424	11	,	,	PUNCT
gsrj-41	424	12	health	health	NOUN
gsrj-41	424	13	professionals	professional	NOUN
gsrj-41	424	14	ranked	rank	VERB
gsrj-41	424	15	highest	highest	ADV
gsrj-41	424	16	(	(	PUNCT
gsrj-41	424	17	92	92	NUM
gsrj-41	424	18	%	%	NOUN
gsrj-41	424	19	)	)	PUNCT
gsrj-41	424	20	,	,	PUNCT
gsrj-41	424	21	followed	follow	VERB
gsrj-41	424	22	by	by	ADP
gsrj-41	424	23	friends	friend	NOUN
gsrj-41	424	24	and	and	CCONJ
gsrj-41	424	25	family	family	NOUN
gsrj-41	424	26	(	(	PUNCT
gsrj-41	424	27	74	74	NUM
gsrj-41	424	28	%	%	NOUN
gsrj-41	424	29	)	)	PUNCT
gsrj-41	424	30	.	.	PUNCT
gsrj-41	425	1	newspapers	newspaper	NOUN
gsrj-41	425	2	and	and	CCONJ
gsrj-41	425	3	television	television	NOUN
gsrj-41	425	4	were	be	AUX
gsrj-41	425	5	trusted	trust	VERB
gsrj-41	425	6	by	by	ADP
gsrj-41	425	7	twice	twice	DET
gsrj-41	425	8	as	as	ADV
gsrj-41	425	9	many	many	ADJ
gsrj-41	425	10	people	people	NOUN
gsrj-41	425	11	as	as	ADP
gsrj-41	425	12	social	social	ADJ
gsrj-41	425	13	media	medium	NOUN
gsrj-41	425	14	.	.	PUNCT
gsrj-41	426	1	scott	scott	PROPN
gsrj-41	426	2	,	,	PUNCT
gsrj-41	426	3	et	et	PROPN
gsrj-41	426	4	al	al	PROPN
gsrj-41	426	5	.	.	PROPN
gsrj-41	426	6	(	(	PUNCT
gsrj-41	426	7	2021	2021	NUM
gsrj-41	426	8	)	)	PUNCT
gsrj-41	426	9	.	.	PUNCT
gsrj-41	427	1	vaccination	vaccination	NOUN
gsrj-41	427	2	patterns	pattern	NOUN
gsrj-41	427	3	of	of	ADP
gsrj-41	427	4	the	the	DET
gsrj-41	427	5	northeast	northeast	ADJ
gsrj-41	427	6	ohio	ohio	PROPN
gsrj-41	427	7	amish	amish	PROPN
gsrj-41	427	8	revisited29	revisited29	PROPN
gsrj-41	427	9	to	to	PART
gsrj-41	427	10	evaluate	evaluate	VERB
gsrj-41	427	11	;	;	PUNCT
gsrj-41	427	12	the	the	DET
gsrj-41	427	13	rate	rate	NOUN
gsrj-41	427	14	and	and	CCONJ
gsrj-41	427	15	influences	influence	NOUN
gsrj-41	427	16	of	of	ADP
gsrj-41	427	17	vaccine	vaccine	NOUN
gsrj-41	427	18	hesitancy	hesitancy	NOUN
gsrj-41	427	19	compared	compare	VERB
gsrj-41	427	20	to	to	ADP
gsrj-41	427	21	a	a	DET
gsrj-41	427	22	decade	decade	NOUN
gsrj-41	427	23	ago	ago	ADV
gsrj-41	427	24	,	,	PUNCT
gsrj-41	427	25	vaccination	vaccination	NOUN
gsrj-41	427	26	patterns	pattern	NOUN
gsrj-41	427	27	between	between	ADP
gsrj-41	427	28	amish	amish	ADJ
gsrj-41	427	29	affiliations	affiliation	NOUN
gsrj-41	427	30	,	,	PUNCT
gsrj-41	427	31	vaccine	vaccine	NOUN
gsrj-41	427	32	practices	practice	NOUN
gsrj-41	427	33	of	of	ADP
gsrj-41	427	34	amish	amish	ADJ
gsrj-41	427	35	special	special	ADJ
gsrj-41	427	36	needs	need	NOUN
gsrj-41	427	37	children	child	NOUN
gsrj-41	427	38	,	,	PUNCT
gsrj-41	427	39	and	and	CCONJ
gsrj-41	427	40	the	the	DET
gsrj-41	427	41	amish	amish	NOUN
gsrj-41	427	42	's	's	PART
gsrj-41	427	43	acceptance	acceptance	NOUN
gsrj-41	427	44	of	of	ADP
gsrj-41	427	45	a	a	DET
gsrj-41	427	46	covid-19	covid-19	PROPN
gsrj-41	427	47	vaccine	vaccine	NOUN
gsrj-41	427	48	.	.	PUNCT
gsrj-41	428	1	april	april	PROPN
gsrj-41	428	2	2020	2020	NUM
gsrj-41	428	3	,	,	PUNCT
gsrj-41	428	4	survey	survey	NOUN
gsrj-41	428	5	mailed	mail	VERB
gsrj-41	428	6	to	to	ADP
gsrj-41	428	7	1000	1000	NUM
gsrj-41	428	8	amish	amish	ADJ
gsrj-41	428	9	families	family	NOUN
gsrj-41	428	10	before	before	ADP
gsrj-41	428	11	391	391	NUM
gsrj-41	428	12	respondents	respondent	NOUN
gsrj-41	428	13	of	of	ADP
gsrj-41	428	14	ohio	ohio	PROPN
gsrj-41	428	15	amish	amish	PROPN
gsrj-41	428	16	75	75	NUM
gsrj-41	428	17	%	%	NOUN
gsrj-41	428	18	would	would	AUX
gsrj-41	428	19	reject	reject	VERB
gsrj-41	428	20	a	a	DET
gsrj-41	428	21	covid	covid	PROPN
gsrj-41	428	22	vaccine	vaccine	NOUN
gsrj-41	428	23	fear	fear	NOUN
gsrj-41	428	24	of	of	ADP
gsrj-41	428	25	adverse	adverse	ADJ
gsrj-41	428	26	effects	effect	NOUN
gsrj-41	428	27	was	be	AUX
gsrj-41	428	28	the	the	DET
gsrj-41	428	29	most	most	ADV
gsrj-41	428	30	common	common	ADJ
gsrj-41	428	31	reason	reason	NOUN
gsrj-41	428	32	to	to	PART
gsrj-41	428	33	reject	reject	VERB
gsrj-41	428	34	vaccines	vaccine	NOUN
gsrj-41	428	35	(	(	PUNCT
gsrj-41	428	36	83.9	83.9	NUM
gsrj-41	428	37	%	%	NOUN
gsrj-41	428	38	of	of	ADP
gsrj-41	428	39	refusers	refuser	NOUN
gsrj-41	428	40	)	)	PUNCT
gsrj-41	428	41	&	&	CCONJ
gsrj-41	428	42	46	46	NUM
gsrj-41	428	43	%	%	NOUN
gsrj-41	428	44	believed	believe	VERB
gsrj-41	428	45	that	that	SCONJ
gsrj-41	428	46	shots	shot	NOUN
gsrj-41	428	47	could	could	AUX
gsrj-41	428	48	have	have	VERB
gsrj-41	428	49	dangerous	dangerous	ADJ
gsrj-41	428	50	preservatives	preservative	NOUN
gsrj-41	428	51	or	or	CCONJ
gsrj-41	428	52	chemicals	chemical	NOUN
gsrj-41	428	53	in	in	ADP
gsrj-41	428	54	them	they	PRON
gsrj-41	428	55	.	.	PUNCT
gsrj-41	429	1	families	family	NOUN
gsrj-41	429	2	that	that	PRON
gsrj-41	429	3	accepted	accept	VERB
gsrj-41	429	4	vaccines	vaccine	NOUN
gsrj-41	429	5	were	be	AUX
gsrj-41	429	6	more	more	ADV
gsrj-41	429	7	likely	likely	ADJ
gsrj-41	429	8	to	to	PART
gsrj-41	429	9	cite	cite	VERB
gsrj-41	429	10	a	a	DET
gsrj-41	429	11	healthcare	healthcare	NOUN
gsrj-41	429	12	worker	worker	NOUN
gsrj-41	429	13	as	as	ADP
gsrj-41	429	14	the	the	DET
gsrj-41	429	15	primary	primary	ADJ
gsrj-41	429	16	influence	influence	NOUN
gsrj-41	429	17	to	to	PART
gsrj-41	429	18	vaccinate	vaccinate	VERB
gsrj-41	429	19	.	.	PUNCT
gsrj-41	430	1	wives	wife	NOUN
gsrj-41	430	2	were	be	AUX
gsrj-41	430	3	more	more	ADV
gsrj-41	430	4	likely	likely	ADJ
gsrj-41	430	5	to	to	PART
gsrj-41	430	6	cite	cite	VERB
gsrj-41	430	7	their	their	PRON
gsrj-41	430	8	spouse	spouse	NOUN
gsrj-41	430	9	as	as	ADP
gsrj-41	430	10	the	the	DET
gsrj-41	430	11	primary	primary	ADJ
gsrj-41	430	12	influence	influence	NOUN
gsrj-41	430	13	to	to	PART
gsrj-41	430	14	vaccinate	vaccinate	VERB
gsrj-41	430	15	.	.	PUNCT
gsrj-41	431	1	families	family	NOUN
gsrj-41	431	2	that	that	PRON
gsrj-41	431	3	rejected	reject	VERB
gsrj-41	431	4	vaccines	vaccine	NOUN
gsrj-41	431	5	were	be	AUX
gsrj-41	431	6	more	more	ADV
gsrj-41	431	7	likely	likely	ADJ
gsrj-41	431	8	to	to	PART
gsrj-41	431	9	state	state	VERB
gsrj-41	431	10	their	their	PRON
gsrj-41	431	11	bishop	bishop	NOUN
gsrj-41	431	12	was	be	AUX
gsrj-41	431	13	the	the	DET
gsrj-41	431	14	most	most	ADV
gsrj-41	431	15	influential	influential	ADJ
gsrj-41	431	16	person	person	NOUN
gsrj-41	431	17	on	on	ADP
gsrj-41	431	18	vaccination	vaccination	NOUN
gsrj-41	431	19	.	.	PUNCT
gsrj-41	432	1	meyer	meyer	PROPN
gsrj-41	432	2	,	,	PUNCT
gsrj-41	432	3	et	et	PROPN
gsrj-41	432	4	al	al	PROPN
gsrj-41	432	5	.	.	PROPN
gsrj-41	432	6	(	(	PUNCT
gsrj-41	432	7	2021	2021	NUM
gsrj-41	432	8	)	)	PUNCT
gsrj-41	432	9	.	.	PUNCT
gsrj-41	433	1	trends	trend	NOUN
gsrj-41	433	2	in	in	ADP
gsrj-41	433	3	health	health	NOUN
gsrj-41	433	4	care	care	NOUN
gsrj-41	433	5	worker	worker	NOUN
gsrj-41	433	6	intentions	intention	NOUN
gsrj-41	433	7	to	to	PART
gsrj-41	433	8	receive	receive	VERB
gsrj-41	433	9	covid-19	covid-19	PROPN
gsrj-41	433	10	vaccine	vaccine	NOUN
gsrj-41	433	11	and	and	CCONJ
gsrj-41	433	12	reasons	reason	NOUN
gsrj-41	433	13	for	for	ADP
gsrj-41	433	14	hesitancy30	hesitancy30	NOUN
gsrj-41	433	15	to	to	PART
gsrj-41	433	16	assess	assess	VERB
gsrj-41	433	17	intentions	intention	NOUN
gsrj-41	433	18	of	of	ADP
gsrj-41	433	19	employees	employee	NOUN
gsrj-41	433	20	of	of	ADP
gsrj-41	433	21	a	a	DET
gsrj-41	433	22	health	health	NOUN
gsrj-41	433	23	care	care	NOUN
gsrj-41	433	24	system	system	NOUN
gsrj-41	433	25	before	before	SCONJ
gsrj-41	433	26	covid-19	covid-19	PROPN
gsrj-41	433	27	vaccine	vaccine	NOUN
gsrj-41	433	28	distribution	distribution	NOUN
gsrj-41	433	29	to	to	PART
gsrj-41	433	30	receive	receive	VERB
gsrj-41	433	31	a	a	DET
gsrj-41	433	32	vaccine	vaccine	NOUN
gsrj-41	433	33	and	and	CCONJ
gsrj-41	433	34	to	to	PART
gsrj-41	433	35	understand	understand	VERB
gsrj-41	433	36	their	their	PRON
gsrj-41	433	37	reasons	reason	NOUN
gsrj-41	433	38	online	online	ADV
gsrj-41	433	39	nonidentifia	nonidentifia	NOUN
gsrj-41	433	40	ble	ble	ADJ
gsrj-41	433	41	administrativ	administrativ	PROPN
gsrj-41	433	42	e	e	PROPN
gsrj-41	433	43	survey	survey	NOUN
gsrj-41	433	44	data	datum	NOUN
gsrj-41	433	45	sent	send	VERB
gsrj-41	433	46	in	in	ADP
gsrj-41	433	47	dec	dec	PROPN
gsrj-41	433	48	2020	2020	NUM
gsrj-41	433	49	before	before	ADP
gsrj-41	433	50	16292	16292	NUM
gsrj-41	433	51	employees	employee	NOUN
gsrj-41	433	52	–	–	PUNCT
gsrj-41	433	53	hcws	hcw	NOUN
gsrj-41	433	54	across	across	ADP
gsrj-41	433	55	u.s	u.s	PROPN
gsrj-41	433	56	.	.	PROPN
gsrj-41	433	57	68.5	68.5	NUM
gsrj-41	433	58	%	%	NOUN
gsrj-41	433	59	response	response	NOUN
gsrj-41	433	60	rate	rate	NOUN
gsrj-41	433	61	28.4	28.4	NUM
gsrj-41	433	62	%	%	NOUN
gsrj-41	433	63	undecided	undecided	ADJ
gsrj-41	433	64	on	on	ADP
gsrj-41	433	65	vaccine	vaccine	NOUN
gsrj-41	433	66	,	,	PUNCT
gsrj-41	433	67	16.3	16.3	NUM
gsrj-41	433	68	%	%	NOUN
gsrj-41	433	69	said	say	VERB
gsrj-41	433	70	no	no	INTJ
gsrj-41	433	71	most	most	ADV
gsrj-41	433	72	(	(	PUNCT
gsrj-41	433	73	90.3	90.3	NUM
gsrj-41	433	74	%	%	NOUN
gsrj-41	433	75	[	[	X
gsrj-41	433	76	6569	6569	NUM
gsrj-41	433	77	employees	employee	NOUN
gsrj-41	433	78	]	]	PUNCT
gsrj-41	433	79	)	)	PUNCT
gsrj-41	433	80	of	of	ADP
gsrj-41	433	81	those	those	PRON
gsrj-41	433	82	who	who	PRON
gsrj-41	433	83	responded	respond	VERB
gsrj-41	433	84	no	no	DET
gsrj-41	433	85	or	or	CCONJ
gsrj-41	433	86	undecided	undecided	ADJ
gsrj-41	433	87	reported	report	VERB
gsrj-41	433	88	concerns	concern	NOUN
gsrj-41	433	89	about	about	ADP
gsrj-41	433	90	unknown	unknown	ADJ
gsrj-41	433	91	risks	risk	NOUN
gsrj-41	433	92	of	of	ADP
gsrj-41	433	93	the	the	DET
gsrj-41	433	94	vaccines	vaccine	NOUN
gsrj-41	433	95	,	,	PUNCT
gsrj-41	433	96	44.3	44.3	NUM
gsrj-41	433	97	%	%	NOUN
gsrj-41	433	98	(	(	PUNCT
gsrj-41	433	99	3226	3226	NUM
gsrj-41	433	100	employees	employee	NOUN
gsrj-41	433	101	)	)	PUNCT
gsrj-41	433	102	reported	report	VERB
gsrj-41	433	103	they	they	PRON
gsrj-41	433	104	wanted	want	VERB
gsrj-41	433	105	to	to	PART
gsrj-41	433	106	wait	wait	VERB
gsrj-41	433	107	until	until	SCONJ
gsrj-41	433	108	others	other	NOUN
gsrj-41	433	109	’	’	PART
gsrj-41	433	110	vaccine	vaccine	NOUN
gsrj-41	433	111	33	33	NUM
gsrj-41	433	112	georgetown	georgetown	PROPN
gsrj-41	433	113	scientific	scientific	PROPN
gsrj-41	433	114	research	research	NOUN
gsrj-41	433	115	journal	journal	NOUN
gsrj-41	433	116	for	for	ADP
gsrj-41	433	117	hesitancy	hesitancy	NOUN
gsrj-41	433	118	to	to	PART
gsrj-41	433	119	do	do	VERB
gsrj-41	433	120	so	so	ADV
gsrj-41	433	121	.	.	PUNCT
gsrj-41	434	1	experiences	experience	NOUN
gsrj-41	434	2	are	be	AUX
gsrj-41	434	3	known	know	VERB
gsrj-41	434	4	,	,	PUNCT
gsrj-41	434	5	and	and	CCONJ
gsrj-41	434	6	21.1	21.1	NUM
gsrj-41	434	7	%	%	NOUN
gsrj-41	434	8	(	(	PUNCT
gsrj-41	434	9	1539	1539	NUM
gsrj-41	434	10	employees	employee	NOUN
gsrj-41	434	11	)	)	PUNCT
gsrj-41	434	12	reported	report	VERB
gsrj-41	434	13	that	that	SCONJ
gsrj-41	434	14	they	they	PRON
gsrj-41	434	15	do	do	AUX
gsrj-41	434	16	not	not	PART
gsrj-41	434	17	trust	trust	VERB
gsrj-41	434	18	the	the	DET
gsrj-41	434	19	rushed	rush	VERB
gsrj-41	434	20	fda	fda	PROPN
gsrj-41	434	21	process	process	NOUN
gsrj-41	434	22	.	.	PUNCT
gsrj-41	435	1	more	more	ADJ
gsrj-41	435	2	than	than	ADP
gsrj-41	435	3	one	one	NUM
gsrj-41	435	4	-	-	PUNCT
gsrj-41	435	5	half	half	NOUN
gsrj-41	435	6	(	(	PUNCT
gsrj-41	435	7	57.4	57.4	NUM
gsrj-41	435	8	%	%	NOUN
gsrj-41	435	9	[	[	X
gsrj-41	435	10	4187	4187	NUM
gsrj-41	435	11	employees	employee	NOUN
gsrj-41	435	12	]	]	PUNCT
gsrj-41	435	13	)	)	PUNCT
gsrj-41	435	14	cited	cite	VERB
gsrj-41	435	15	concerns	concern	NOUN
gsrj-41	435	16	about	about	ADP
gsrj-41	435	17	known	know	VERB
gsrj-41	435	18	adverse	adverse	ADJ
gsrj-41	435	19	effects	effect	NOUN
gsrj-41	435	20	,	,	PUNCT
gsrj-41	435	21	such	such	ADJ
gsrj-41	435	22	as	as	ADP
gsrj-41	435	23	headache	headache	NOUN
gsrj-41	435	24	and	and	CCONJ
gsrj-41	435	25	fatigue	fatigue	NOUN
gsrj-41	435	26	.	.	PUNCT
gsrj-41	436	1	bogart	bogart	PROPN
gsrj-41	436	2	,	,	PUNCT
gsrj-41	436	3	et	et	PROPN
gsrj-41	436	4	al	al	PROPN
gsrj-41	436	5	.	.	PROPN
gsrj-41	436	6	(	(	PUNCT
gsrj-41	436	7	2021	2021	NUM
gsrj-41	436	8	)	)	PUNCT
gsrj-41	436	9	.	.	PUNCT
gsrj-41	437	1	covid-19	covid-19	PROPN
gsrj-41	437	2	vaccine	vaccine	NOUN
gsrj-41	437	3	intentions	intention	NOUN
gsrj-41	437	4	and	and	CCONJ
gsrj-41	437	5	mistrust	mistrust	NOUN
gsrj-41	437	6	in	in	ADP
gsrj-41	437	7	a	a	DET
gsrj-41	437	8	national	national	ADJ
gsrj-41	437	9	sample	sample	NOUN
gsrj-41	437	10	of	of	ADP
gsrj-41	437	11	black	black	ADJ
gsrj-41	437	12	americans31	americans31	NOUN
gsrj-41	437	13	to	to	PART
gsrj-41	437	14	assess	assess	VERB
gsrj-41	437	15	vaccine	vaccine	NOUN
gsrj-41	437	16	intentions	intention	NOUN
gsrj-41	437	17	and	and	CCONJ
gsrj-41	437	18	reasons	reason	NOUN
gsrj-41	437	19	for	for	ADP
gsrj-41	437	20	hesitancy	hesitancy	NOUN
gsrj-41	437	21	among	among	ADP
gsrj-41	437	22	the	the	DET
gsrj-41	437	23	black	black	ADJ
gsrj-41	437	24	american	american	ADJ
gsrj-41	437	25	population	population	NOUN
gsrj-41	437	26	web	web	NOUN
gsrj-41	437	27	-	-	PUNCT
gsrj-41	437	28	based	base	VERB
gsrj-41	437	29	survey	survey	NOUN
gsrj-41	437	30	in	in	ADP
gsrj-41	437	31	nov	nov	PROPN
gsrj-41	437	32	-	-	PUNCT
gsrj-41	437	33	dec	dec	PROPN
gsrj-41	437	34	2020	2020	NUM
gsrj-41	437	35	before	before	SCONJ
gsrj-41	437	36	207	207	NUM
gsrj-41	437	37	black	black	ADJ
gsrj-41	437	38	american	american	ADJ
gsrj-41	437	39	participants	participant	NOUN
gsrj-41	437	40	in	in	ADP
gsrj-41	437	41	rand	rand	NOUN
gsrj-41	437	42	american	american	PROPN
gsrj-41	437	43	life	life	PROPN
gsrj-41	437	44	panel	panel	NOUN
gsrj-41	437	45	nationally	nationally	ADV
gsrj-41	437	46	representative	representative	VERB
gsrj-41	437	47	overall	overall	ADV
gsrj-41	437	48	,	,	PUNCT
gsrj-41	437	49	35	35	NUM
gsrj-41	437	50	%	%	NOUN
gsrj-41	437	51	agreed	agree	VERB
gsrj-41	437	52	or	or	CCONJ
gsrj-41	437	53	strongly	strongly	ADV
gsrj-41	437	54	agreed	agree	VERB
gsrj-41	437	55	that	that	SCONJ
gsrj-41	437	56	they	they	PRON
gsrj-41	437	57	would	would	AUX
gsrj-41	437	58	not	not	PART
gsrj-41	437	59	get	get	VERB
gsrj-41	437	60	a	a	DET
gsrj-41	437	61	covid-19	covid-19	PROPN
gsrj-41	437	62	vaccine	vaccine	NOUN
gsrj-41	437	63	,	,	PUNCT
gsrj-41	437	64	40	40	NUM
gsrj-41	437	65	%	%	NOUN
gsrj-41	437	66	agreed	agree	VERB
gsrj-41	437	67	or	or	CCONJ
gsrj-41	437	68	strongly	strongly	ADV
gsrj-41	437	69	agreed	agree	VERB
gsrj-41	437	70	that	that	SCONJ
gsrj-41	437	71	they	they	PRON
gsrj-41	437	72	would	would	AUX
gsrj-41	437	73	get	get	AUX
gsrj-41	437	74	vaccinated	vaccinate	VERB
gsrj-41	437	75	,	,	PUNCT
gsrj-41	437	76	and	and	CCONJ
gsrj-41	437	77	25	25	NUM
gsrj-41	437	78	%	%	NOUN
gsrj-41	437	79	reported	report	VERB
gsrj-41	437	80	"	"	PUNCT
gsrj-41	437	81	do	do	AUX
gsrj-41	437	82	n't	not	PART
gsrj-41	437	83	know	know	VERB
gsrj-41	437	84	.	.	PUNCT
gsrj-41	437	85	"	"	PUNCT
gsrj-41	438	1	significant	significant	ADJ
gsrj-41	438	2	multivariable	multivariable	ADJ
gsrj-41	438	3	predictors	predictor	NOUN
gsrj-41	438	4	of	of	ADP
gsrj-41	438	5	not	not	PART
gsrj-41	438	6	wanting	want	VERB
gsrj-41	438	7	to	to	PART
gsrj-41	438	8	get	get	VERB
gsrj-41	438	9	vaccinated	vaccinate	VERB
gsrj-41	438	10	included	include	VERB
gsrj-41	438	11	high	high	ADJ
gsrj-41	438	12	mistrust	mistrust	NOUN
gsrj-41	438	13	of	of	ADP
gsrj-41	438	14	the	the	DET
gsrj-41	438	15	vaccine	vaccine	NOUN
gsrj-41	438	16	itself	itself	PRON
gsrj-41	438	17	(	(	PUNCT
gsrj-41	438	18	e.g.	e.g.	ADV
gsrj-41	438	19	,	,	PUNCT
gsrj-41	438	20	concerns	concern	NOUN
gsrj-41	438	21	about	about	ADP
gsrj-41	438	22	harm	harm	NOUN
gsrj-41	438	23	and	and	CCONJ
gsrj-41	438	24	side	side	NOUN
gsrj-41	438	25	effects	effect	NOUN
gsrj-41	438	26	)	)	PUNCT
gsrj-41	438	27	,	,	PUNCT
gsrj-41	438	28	or	or	CCONJ
gsrj-41	438	29	(	(	PUNCT
gsrj-41	438	30	95	95	NUM
gsrj-41	438	31	%	%	NOUN
gsrj-41	438	32	ci	ci	NOUN
gsrj-41	438	33	)	)	PUNCT
gsrj-41	438	34	=	=	SYM
gsrj-41	438	35	2.2	2.2	NUM
gsrj-41	438	36	(	(	PUNCT
gsrj-41	438	37	1.23.9	1.23.9	NUM
gsrj-41	438	38	)	)	PUNCT
gsrj-41	438	39	,	,	PUNCT
gsrj-41	438	40	p	p	X
gsrj-41	438	41	=	=	NOUN
gsrj-41	438	42	.007	.007	NUM
gsrj-41	438	43	,	,	PUNCT
gsrj-41	438	44	and	and	CCONJ
gsrj-41	438	45	weak	weak	ADJ
gsrj-41	438	46	subjective	subjective	ADJ
gsrj-41	438	47	norms	norm	NOUN
gsrj-41	438	48	for	for	ADP
gsrj-41	438	49	vaccination	vaccination	NOUN
gsrj-41	438	50	in	in	ADP
gsrj-41	438	51	one	one	NUM
gsrj-41	438	52	's	's	PART
gsrj-41	438	53	close	close	ADJ
gsrj-41	438	54	social	social	ADJ
gsrj-41	438	55	network	network	NOUN
gsrj-41	438	56	,	,	PUNCT
gsrj-41	438	57	or	or	CCONJ
gsrj-41	438	58	(	(	PUNCT
gsrj-41	438	59	95	95	NUM
gsrj-41	438	60	%	%	NOUN
gsrj-41	438	61	ci	ci	NOUN
gsrj-41	438	62	)	)	PUNCT
gsrj-41	438	63	=	=	SYM
gsrj-41	438	64	0.6	0.6	NUM
gsrj-41	438	65	(	(	PUNCT
gsrj-41	438	66	0.4	0.4	NUM
gsrj-41	438	67	-	-	SYM
gsrj-41	438	68	0.7	0.7	NUM
gsrj-41	438	69	)	)	PUNCT
gsrj-41	438	70	,	,	PUNCT
gsrj-41	438	71	p	p	X
gsrj-41	438	72	<	<	X
gsrj-41	438	73	.001	.001	NUM
gsrj-41	438	74	.	.	PUNCT
gsrj-41	439	1	latkin	latkin	PROPN
gsrj-41	439	2	,	,	PUNCT
gsrj-41	439	3	et	et	PROPN
gsrj-41	439	4	al	al	PROPN
gsrj-41	439	5	.	.	PROPN
gsrj-41	439	6	(	(	PUNCT
gsrj-41	439	7	2021	2021	NUM
gsrj-41	439	8	)	)	PUNCT
gsrj-41	439	9	.	.	PUNCT
gsrj-41	440	1	mask	mask	NOUN
gsrj-41	440	2	usage	usage	NOUN
gsrj-41	440	3	,	,	PUNCT
gsrj-41	440	4	social	social	ADJ
gsrj-41	440	5	distancing	distancing	NOUN
gsrj-41	440	6	,	,	PUNCT
gsrj-41	440	7	racial	racial	ADJ
gsrj-41	440	8	,	,	PUNCT
gsrj-41	440	9	and	and	CCONJ
gsrj-41	440	10	gender	gender	NOUN
gsrj-41	440	11	correlates	correlate	VERB
gsrj-41	440	12	of	of	ADP
gsrj-41	440	13	covid-19	covid-19	PROPN
gsrj-41	440	14	vaccine	vaccine	NOUN
gsrj-41	440	15	intentions	intention	NOUN
gsrj-41	440	16	among	among	ADP
gsrj-41	440	17	adults	adult	NOUN
gsrj-41	440	18	in	in	ADP
gsrj-41	440	19	the	the	DET
gsrj-41	440	20	us32	us32	PROPN
gsrj-41	440	21	assess	assess	NOUN
gsrj-41	440	22	vaccine	vaccine	NOUN
gsrj-41	440	23	intentions	intention	NOUN
gsrj-41	440	24	and	and	CCONJ
gsrj-41	440	25	hesitancy	hesitancy	NOUN
gsrj-41	440	26	among	among	ADP
gsrj-41	440	27	american	american	ADJ
gsrj-41	440	28	adults	adult	NOUN
gsrj-41	440	29	national	national	ADJ
gsrj-41	440	30	panel	panel	NOUN
gsrj-41	440	31	survey	survey	NOUN
gsrj-41	440	32	,	,	PUNCT
gsrj-41	440	33	online	online	PROPN
gsrj-41	440	34	&	&	CCONJ
gsrj-41	440	35	telephone	telephone	NOUN
gsrj-41	440	36	in	in	ADP
gsrj-41	440	37	may	may	PROPN
gsrj-41	440	38	2020	2020	NUM
gsrj-41	440	39	before	before	ADP
gsrj-41	440	40	1,056	1,056	NUM
gsrj-41	440	41	respondents	respondent	NOUN
gsrj-41	440	42	,	,	PUNCT
gsrj-41	440	43	nationally	nationally	ADV
gsrj-41	440	44	representative	representative	VERB
gsrj-41	440	45	53.6	53.6	NUM
gsrj-41	440	46	%	%	NOUN
gsrj-41	440	47	yes	yes	INTJ
gsrj-41	440	48	,	,	PUNCT
gsrj-41	440	49	16.7	16.7	NUM
gsrj-41	440	50	%	%	NOUN
gsrj-41	440	51	no	no	INTJ
gsrj-41	440	52	,	,	PUNCT
gsrj-41	440	53	29.7	29.7	NUM
gsrj-41	440	54	%	%	NOUN
gsrj-41	440	55	unsure	unsure	ADJ
gsrj-41	440	56	a	a	DET
gsrj-41	440	57	sub	sub	NOUN
gsrj-41	440	58	-	-	NOUN
gsrj-41	440	59	analysis	analysis	NOUN
gsrj-41	440	60	among	among	ADP
gsrj-41	440	61	respondents	respondent	NOUN
gsrj-41	440	62	who	who	PRON
gsrj-41	440	63	did	do	AUX
gsrj-41	440	64	not	not	PART
gsrj-41	440	65	plan	plan	VERB
gsrj-41	440	66	to	to	PART
gsrj-41	440	67	obtain	obtain	VERB
gsrj-41	440	68	a	a	DET
gsrj-41	440	69	covid-19	covid-19	PROPN
gsrj-41	440	70	vaccine	vaccine	NOUN
gsrj-41	440	71	(	(	PUNCT
gsrj-41	440	72	16.7	16.7	NUM
gsrj-41	440	73	%	%	NOUN
gsrj-41	440	74	)	)	PUNCT
gsrj-41	440	75	indicated	indicate	VERB
gsrj-41	440	76	that	that	SCONJ
gsrj-41	440	77	the	the	DET
gsrj-41	440	78	black	black	ADJ
gsrj-41	440	79	population	population	NOUN
gsrj-41	440	80	,	,	PUNCT
gsrj-41	440	81	compared	compare	VERB
gsrj-41	440	82	to	to	ADP
gsrj-41	440	83	white	white	ADJ
gsrj-41	440	84	,	,	PUNCT
gsrj-41	440	85	were	be	AUX
gsrj-41	440	86	almost	almost	ADV
gsrj-41	440	87	twice	twice	ADV
gsrj-41	440	88	as	as	ADV
gsrj-41	440	89	likely	likely	ADJ
gsrj-41	440	90	to	to	PART
gsrj-41	440	91	report	report	VERB
gsrj-41	440	92	concerns	concern	NOUN
gsrj-41	440	93	about	about	ADP
gsrj-41	440	94	becoming	becoming	AUX
gsrj-41	440	95	infected	infect	VERB
gsrj-41	440	96	from	from	ADP
gsrj-41	440	97	the	the	DET
gsrj-41	440	98	vaccine	vaccine	NOUN
gsrj-41	440	99	.	.	PUNCT
gsrj-41	441	1	in	in	ADP
gsrj-41	441	2	contrast	contrast	NOUN
gsrj-41	441	3	,	,	PUNCT
gsrj-41	441	4	whites	white	NOUN
gsrj-41	441	5	,	,	PUNCT
gsrj-41	441	6	compared	compare	VERB
gsrj-41	441	7	to	to	ADP
gsrj-41	441	8	34	34	NUM
gsrj-41	441	9	georgetown	georgetown	PROPN
gsrj-41	441	10	scientific	scientific	PROPN
gsrj-41	441	11	research	research	PROPN
gsrj-41	441	12	journal	journal	NOUN
gsrj-41	441	13	other	other	ADJ
gsrj-41	441	14	racial	racial	ADJ
gsrj-41	441	15	/	/	SYM
gsrj-41	441	16	ethnic	ethnic	ADJ
gsrj-41	441	17	groups	group	NOUN
gsrj-41	441	18	,	,	PUNCT
gsrj-41	441	19	were	be	AUX
gsrj-41	441	20	more	more	ADJ
gsrj-41	441	21	than	than	ADP
gsrj-41	441	22	twice	twice	ADV
gsrj-41	441	23	as	as	ADV
gsrj-41	441	24	likely	likely	ADJ
gsrj-41	441	25	to	to	PART
gsrj-41	441	26	report	report	VERB
gsrj-41	441	27	that	that	SCONJ
gsrj-41	441	28	one	one	NUM
gsrj-41	441	29	of	of	ADP
gsrj-41	441	30	the	the	DET
gsrj-41	441	31	reasons	reason	NOUN
gsrj-41	441	32	for	for	ADP
gsrj-41	441	33	not	not	PART
gsrj-41	441	34	intending	intend	VERB
gsrj-41	441	35	to	to	PART
gsrj-41	441	36	get	get	VERB
gsrj-41	441	37	a	a	DET
gsrj-41	441	38	vaccine	vaccine	NOUN
gsrj-41	441	39	was	be	AUX
gsrj-41	441	40	that	that	SCONJ
gsrj-41	441	41	“	"	PUNCT
gsrj-41	441	42	the	the	DET
gsrj-41	441	43	coronavirus	coronavirus	NOUN
gsrj-41	441	44	outbreak	outbreak	NOUN
gsrj-41	441	45	is	be	AUX
gsrj-41	441	46	not	not	PART
gsrj-41	441	47	as	as	ADV
gsrj-41	441	48	serious	serious	ADJ
gsrj-41	441	49	as	as	SCONJ
gsrj-41	441	50	some	some	DET
gsrj-41	441	51	people	people	NOUN
gsrj-41	441	52	say	say	VERB
gsrj-41	441	53	it	it	PRON
gsrj-41	441	54	is	be	AUX
gsrj-41	441	55	.	.	PUNCT
gsrj-41	441	56	”	"	PUNCT
gsrj-41	442	1	these	these	DET
gsrj-41	442	2	findings	finding	NOUN
gsrj-41	442	3	are	be	AUX
gsrj-41	442	4	from	from	ADP
gsrj-41	442	5	a	a	DET
gsrj-41	442	6	subsample	subsample	NOUN
gsrj-41	442	7	and	and	CCONJ
gsrj-41	442	8	highlight	highlight	VERB
gsrj-41	442	9	the	the	DET
gsrj-41	442	10	importance	importance	NOUN
gsrj-41	442	11	of	of	ADP
gsrj-41	442	12	studies	study	NOUN
gsrj-41	442	13	examining	examine	VERB
gsrj-41	442	14	racial	racial	ADJ
gsrj-41	442	15	/	/	SYM
gsrj-41	442	16	ethnic	ethnic	ADJ
gsrj-41	442	17	differences	difference	NOUN
gsrj-41	442	18	in	in	ADP
gsrj-41	442	19	vaccine	vaccine	NOUN
gsrj-41	442	20	intentions	intention	NOUN
gsrj-41	442	21	.	.	PUNCT
gsrj-41	443	1	gatwood	gatwood	NOUN
gsrj-41	443	2	,	,	PUNCT
gsrj-41	443	3	et	et	PROPN
gsrj-41	443	4	al	al	PROPN
gsrj-41	443	5	.	.	PROPN
gsrj-41	443	6	(	(	PUNCT
gsrj-41	443	7	2021	2021	NUM
gsrj-41	443	8	)	)	PUNCT
gsrj-41	443	9	.	.	PUNCT
gsrj-41	444	1	factors	factor	NOUN
gsrj-41	444	2	influencing	influence	VERB
gsrj-41	444	3	likelihood	likelihood	NOUN
gsrj-41	444	4	of	of	ADP
gsrj-41	444	5	covid-19	covid-19	PROPN
gsrj-41	444	6	vaccination	vaccination	NOUN
gsrj-41	444	7	:	:	PUNCT
gsrj-41	444	8	a	a	DET
gsrj-41	444	9	survey	survey	NOUN
gsrj-41	444	10	of	of	ADP
gsrj-41	444	11	tennessee	tennessee	PROPN
gsrj-41	444	12	adults33	adults33	PROPN
gsrj-41	444	13	to	to	PART
gsrj-41	444	14	examine	examine	VERB
gsrj-41	444	15	the	the	DET
gsrj-41	444	16	vaccinerelated	vaccinerelate	VERB
gsrj-41	444	17	beliefs	belief	NOUN
gsrj-41	444	18	and	and	CCONJ
gsrj-41	444	19	behaviors	behavior	NOUN
gsrj-41	444	20	associated	associate	VERB
gsrj-41	444	21	with	with	ADP
gsrj-41	444	22	likely	likely	ADJ
gsrj-41	444	23	hesitancy	hesitancy	NOUN
gsrj-41	444	24	toward	toward	ADP
gsrj-41	444	25	vaccination	vaccination	NOUN
gsrj-41	444	26	against	against	ADP
gsrj-41	444	27	coronavirus	coronavirus	NOUN
gsrj-41	444	28	disease	disease	NOUN
gsrj-41	444	29	2019	2019	NUM
gsrj-41	444	30	(	(	PUNCT
gsrj-41	444	31	covid-19	covid-19	PROPN
gsrj-41	444	32	)	)	PUNCT
gsrj-41	444	33	among	among	ADP
gsrj-41	444	34	nonelderly	nonelderly	ADJ
gsrj-41	444	35	adults	adult	NOUN
gsrj-41	444	36	.	.	PUNCT
gsrj-41	445	1	online	online	ADJ
gsrj-41	445	2	crosssectional	crosssectional	ADJ
gsrj-41	445	3	survey	survey	NOUN
gsrj-41	445	4	in	in	ADP
gsrj-41	445	5	june	june	PROPN
gsrj-41	445	6	2020	2020	NUM
gsrj-41	445	7	before	before	ADP
gsrj-41	445	8	tn	tn	NOUN
gsrj-41	445	9	adults	adult	NOUN
gsrj-41	445	10	18	18	NUM
gsrj-41	445	11	-	-	SYM
gsrj-41	445	12	64	64	NUM
gsrj-41	445	13	who	who	PRON
gsrj-41	445	14	were	be	AUX
gsrj-41	445	15	not	not	PART
gsrj-41	445	16	healthcare	healthcare	NOUN
gsrj-41	445	17	providers	provider	NOUN
gsrj-41	445	18	1,000	1,000	NUM
gsrj-41	445	19	completed	complete	VERB
gsrj-41	445	20	responses	response	NOUN
gsrj-41	445	21	(	(	PUNCT
gsrj-41	445	22	62.9	62.9	NUM
gsrj-41	445	23	%	%	NOUN
gsrj-41	445	24	response	response	NOUN
gsrj-41	445	25	rate	rate	NOUN
gsrj-41	445	26	)	)	PUNCT
gsrj-41	445	27	54.1	54.1	NUM
gsrj-41	445	28	%	%	NOUN
gsrj-41	445	29	had	have	VERB
gsrj-41	445	30	some	some	DET
gsrj-41	445	31	hesitancy	hesitancy	NOUN
gsrj-41	445	32	three	three	NUM
gsrj-41	445	33	leading	lead	VERB
gsrj-41	445	34	reasons	reason	NOUN
gsrj-41	445	35	for	for	ADP
gsrj-41	445	36	being	be	AUX
gsrj-41	445	37	hesitant	hesitant	ADJ
gsrj-41	445	38	toward	toward	ADP
gsrj-41	445	39	covid-19	covid-19	PROPN
gsrj-41	445	40	vaccination	vaccination	NOUN
gsrj-41	445	41	emerged	emerge	VERB
gsrj-41	445	42	:	:	PUNCT
gsrj-41	446	1	lack	lack	NOUN
gsrj-41	446	2	of	of	ADP
gsrj-41	446	3	sufficient	sufficient	ADJ
gsrj-41	446	4	effectiveness	effectiveness	NOUN
gsrj-41	446	5	evidence	evidence	NOUN
gsrj-41	446	6	(	(	PUNCT
gsrj-41	446	7	32.1	32.1	NUM
gsrj-41	446	8	%	%	NOUN
gsrj-41	446	9	)	)	PUNCT
gsrj-41	446	10	,	,	PUNCT
gsrj-41	446	11	perceived	perceive	VERB
gsrj-41	446	12	lack	lack	NOUN
gsrj-41	446	13	of	of	ADP
gsrj-41	446	14	disease	disease	NOUN
gsrj-41	446	15	risk	risk	NOUN
gsrj-41	446	16	(	(	PUNCT
gsrj-41	446	17	24.6	24.6	NUM
gsrj-41	446	18	%	%	NOUN
gsrj-41	446	19	)	)	PUNCT
gsrj-41	446	20	,	,	PUNCT
gsrj-41	446	21	and	and	CCONJ
gsrj-41	446	22	vaccine	vaccine	NOUN
gsrj-41	446	23	safety	safety	NOUN
gsrj-41	446	24	concerns	concern	NOUN
gsrj-41	446	25	(	(	PUNCT
gsrj-41	446	26	23.2	23.2	NUM
gsrj-41	446	27	%	%	NOUN
gsrj-41	446	28	)	)	PUNCT
gsrj-41	446	29	.	.	PUNCT
gsrj-41	447	1	approximately	approximately	ADV
gsrj-41	447	2	onethird	onethird	PROPN
gsrj-41	447	3	(	(	PUNCT
gsrj-41	447	4	34.4	34.4	NUM
gsrj-41	447	5	%	%	NOUN
gsrj-41	447	6	)	)	PUNCT
gsrj-41	447	7	of	of	ADP
gsrj-41	447	8	respondents	respondent	NOUN
gsrj-41	447	9	indicated	indicate	VERB
gsrj-41	447	10	some	some	DET
gsrj-41	447	11	historical	historical	ADJ
gsrj-41	447	12	vaccine	vaccine	NOUN
gsrj-41	447	13	hesitancy	hesitancy	NOUN
gsrj-41	447	14	,	,	PUNCT
gsrj-41	447	15	and	and	CCONJ
gsrj-41	447	16	only	only	ADV
gsrj-41	447	17	21.4	21.4	NUM
gsrj-41	447	18	%	%	NOUN
gsrj-41	447	19	indicated	indicate	VERB
gsrj-41	447	20	always	always	ADV
gsrj-41	447	21	getting	get	VERB
gsrj-41	447	22	a	a	DET
gsrj-41	447	23	seasonal	seasonal	ADJ
gsrj-41	447	24	influenza	influenza	NOUN
gsrj-41	447	25	vaccination	vaccination	NOUN
gsrj-41	447	26	.	.	PUNCT
gsrj-41	448	1	rodriguez	rodriguez	NOUN
gsrj-41	448	2	,	,	PUNCT
gsrj-41	448	3	et	et	PROPN
gsrj-41	448	4	al	al	PROPN
gsrj-41	448	5	.	.	PROPN
gsrj-41	448	6	(	(	PUNCT
gsrj-41	448	7	2021	2021	NUM
gsrj-41	448	8	)	)	PUNCT
gsrj-41	448	9	.	.	PUNCT
gsrj-41	449	1	the	the	DET
gsrj-41	449	2	rapid	rapid	ADJ
gsrj-41	449	3	evaluation	evaluation	NOUN
gsrj-41	449	4	of	of	ADP
gsrj-41	449	5	covid-19	covid-19	PROPN
gsrj-41	449	6	vaccination	vaccination	NOUN
gsrj-41	449	7	in	in	ADP
gsrj-41	449	8	emergency	emergency	NOUN
gsrj-41	449	9	departments	department	NOUN
gsrj-41	449	10	for	for	ADP
gsrj-41	449	11	underserved	underserved	ADJ
gsrj-41	449	12	patients	patient	NOUN
gsrj-41	449	13	study34	study34	VERB
gsrj-41	449	14	emergency	emergency	NOUN
gsrj-41	449	15	departments	department	NOUN
gsrj-41	449	16	(	(	PUNCT
gsrj-41	449	17	eds	ed	NOUN
gsrj-41	449	18	)	)	PUNCT
gsrj-41	449	19	often	often	ADV
gsrj-41	449	20	serve	serve	VERB
gsrj-41	449	21	vulnerable	vulnerable	ADJ
gsrj-41	449	22	populations	population	NOUN
gsrj-41	449	23	who	who	PRON
gsrj-41	449	24	may	may	AUX
gsrj-41	449	25	lack	lack	VERB
gsrj-41	449	26	primary	primary	ADJ
gsrj-41	449	27	care	care	NOUN
gsrj-41	449	28	and	and	CCONJ
gsrj-41	449	29	have	have	AUX
gsrj-41	449	30	suffered	suffer	VERB
gsrj-41	449	31	disproportiona	disproportiona	PROPN
gsrj-41	449	32	te	te	ADP
gsrj-41	449	33	covid-19	covid-19	PROPN
gsrj-41	449	34	in	in	ADP
gsrj-41	449	35	-	-	PUNCT
gsrj-41	449	36	person	person	NOUN
gsrj-41	449	37	crosssectional	crosssectional	ADJ
gsrj-41	449	38	survey	survey	NOUN
gsrj-41	449	39	dec	dec	PROPN
gsrj-41	449	40	2020	2020	NUM
gsrj-41	449	41	to	to	PART
gsrj-41	449	42	march	march	PROPN
gsrj-41	449	43	2021	2021	NUM
gsrj-41	449	44	after	after	ADP
gsrj-41	449	45	ed	ed	NOUN
gsrj-41	449	46	patients	patient	NOUN
gsrj-41	449	47	during	during	ADP
gsrj-41	449	48	their	their	PRON
gsrj-41	449	49	visits	visit	NOUN
gsrj-41	449	50	to	to	ADP
gsrj-41	449	51	15	15	NUM
gsrj-41	449	52	safety	safety	NOUN
gsrj-41	449	53	net	net	ADJ
gsrj-41	449	54	eds	ed	NOUN
gsrj-41	449	55	in	in	ADP
gsrj-41	449	56	14	14	NUM
gsrj-41	449	57	us	us	PROPN
gsrj-41	449	58	cities	city	NOUN
gsrj-41	449	59	2,301	2,301	NUM
gsrj-41	449	60	participants	participant	NOUN
gsrj-41	449	61	(	(	PUNCT
gsrj-41	449	62	89.4	89.4	NUM
gsrj-41	449	63	%	%	NOUN
gsrj-41	449	64	response	response	NOUN
gsrj-41	449	65	rate	rate	NOUN
gsrj-41	449	66	)	)	PUNCT
gsrj-41	449	67	61	61	NUM
gsrj-41	449	68	%	%	NOUN
gsrj-41	449	69	stated	state	VERB
gsrj-41	449	70	they	they	PRON
gsrj-41	449	71	would	would	AUX
gsrj-41	449	72	accept	accept	VERB
gsrj-41	449	73	vaccine	vaccine	NOUN
gsrj-41	449	74	,	,	PUNCT
gsrj-41	449	75	rest	rest	NOUN
gsrj-41	449	76	are	be	AUX
gsrj-41	449	77	hesitant	hesitant	ADJ
gsrj-41	449	78	3	3	NUM
gsrj-41	449	79	primary	primary	ADJ
gsrj-41	449	80	reasons	reason	NOUN
gsrj-41	449	81	for	for	ADP
gsrj-41	449	82	vaccine	vaccine	NOUN
gsrj-41	449	83	hesitancy	hesitancy	NOUN
gsrj-41	449	84	were	be	AUX
gsrj-41	449	85	similar	similar	ADJ
gsrj-41	449	86	for	for	ADP
gsrj-41	449	87	those	those	PRON
gsrj-41	449	88	with	with	ADP
gsrj-41	449	89	and	and	CCONJ
gsrj-41	449	90	without	without	ADP
gsrj-41	449	91	a	a	DET
gsrj-41	449	92	source	source	NOUN
gsrj-41	449	93	of	of	ADP
gsrj-41	449	94	regular	regular	ADJ
gsrj-41	449	95	medical	medical	ADJ
gsrj-41	449	96	care	care	NOUN
gsrj-41	449	97	:	:	PUNCT
gsrj-41	449	98	concerns	concern	NOUN
gsrj-41	449	99	about	about	ADP
gsrj-41	449	100	side	side	NOUN
gsrj-41	449	101	effects	effect	NOUN
gsrj-41	449	102	and	and	CCONJ
gsrj-41	449	103	safety	safety	NOUN
gsrj-41	449	104	(	(	PUNCT
gsrj-41	449	105	65	65	NUM
gsrj-41	449	106	%	%	NOUN
gsrj-41	449	107	)	)	PUNCT
gsrj-41	449	108	,	,	PUNCT
gsrj-41	449	109	need	need	VERB
gsrj-41	449	110	for	for	ADP
gsrj-41	449	111	more	more	ADJ
gsrj-41	449	112	35	35	NUM
gsrj-41	449	113	georgetown	georgetown	PROPN
gsrj-41	449	114	scientific	scientific	ADJ
gsrj-41	449	115	research	research	NOUN
gsrj-41	449	116	journal	journal	NOUN
gsrj-41	449	117	pandemic	pandemic	ADJ
gsrj-41	449	118	effects	effect	NOUN
gsrj-41	449	119	.	.	PUNCT
gsrj-41	450	1	comparing	compare	VERB
gsrj-41	450	2	patients	patient	NOUN
gsrj-41	450	3	having	have	VERB
gsrj-41	450	4	and	and	CCONJ
gsrj-41	450	5	lacking	lack	VERB
gsrj-41	450	6	a	a	DET
gsrj-41	450	7	regular	regular	ADJ
gsrj-41	450	8	source	source	NOUN
gsrj-41	450	9	of	of	ADP
gsrj-41	450	10	medical	medical	ADJ
gsrj-41	450	11	care	care	NOUN
gsrj-41	450	12	and	and	CCONJ
gsrj-41	450	13	other	other	ADJ
gsrj-41	450	14	ed	ed	PROPN
gsrj-41	450	15	patient	patient	ADJ
gsrj-41	450	16	characteristics	characteristic	NOUN
gsrj-41	450	17	,	,	PUNCT
gsrj-41	450	18	we	we	PRON
gsrj-41	450	19	assessed	assess	VERB
gsrj-41	450	20	covid-19	covid-19	PROPN
gsrj-41	450	21	vaccine	vaccine	NOUN
gsrj-41	450	22	hesitancy	hesitancy	NOUN
gsrj-41	450	23	,	,	PUNCT
gsrj-41	450	24	reasons	reason	NOUN
gsrj-41	450	25	for	for	ADP
gsrj-41	450	26	not	not	PART
gsrj-41	450	27	wanting	want	VERB
gsrj-41	450	28	the	the	DET
gsrj-41	450	29	vaccine	vaccine	NOUN
gsrj-41	450	30	,	,	PUNCT
gsrj-41	450	31	perceived	perceive	VERB
gsrj-41	450	32	access	access	NOUN
gsrj-41	450	33	to	to	ADP
gsrj-41	450	34	vaccine	vaccine	NOUN
gsrj-41	450	35	sites	site	NOUN
gsrj-41	450	36	,	,	PUNCT
gsrj-41	450	37	and	and	CCONJ
gsrj-41	450	38	willingness	willingness	NOUN
gsrj-41	450	39	to	to	PART
gsrj-41	450	40	get	get	VERB
gsrj-41	450	41	the	the	DET
gsrj-41	450	42	vaccine	vaccine	NOUN
gsrj-41	450	43	as	as	ADP
gsrj-41	450	44	part	part	NOUN
gsrj-41	450	45	of	of	ADP
gsrj-41	450	46	ed	ed	PROPN
gsrj-41	450	47	care	care	NOUN
gsrj-41	450	48	.	.	PUNCT
gsrj-41	451	1	information	information	NOUN
gsrj-41	451	2	(	(	PUNCT
gsrj-41	451	3	47	47	NUM
gsrj-41	451	4	%	%	NOUN
gsrj-41	451	5	)	)	PUNCT
gsrj-41	451	6	,	,	PUNCT
gsrj-41	451	7	and	and	CCONJ
gsrj-41	451	8	having	having	AUX
gsrj-41	451	9	heard	hear	VERB
gsrj-41	451	10	stories	story	NOUN
gsrj-41	451	11	in	in	ADP
gsrj-41	451	12	the	the	DET
gsrj-41	451	13	media	medium	NOUN
gsrj-41	451	14	or	or	CCONJ
gsrj-41	451	15	online	online	ADJ
gsrj-41	451	16	(	(	PUNCT
gsrj-41	451	17	24	24	NUM
gsrj-41	451	18	%	%	NOUN
gsrj-41	451	19	)	)	PUNCT
gsrj-41	451	20	.	.	PUNCT
gsrj-41	452	1	the	the	DET
gsrj-41	452	2	fourth	fourth	ADJ
gsrj-41	452	3	most	most	ADV
gsrj-41	452	4	common	common	ADJ
gsrj-41	452	5	reason	reason	NOUN
gsrj-41	452	6	for	for	ADP
gsrj-41	452	7	respondents	respondent	NOUN
gsrj-41	452	8	who	who	PRON
gsrj-41	452	9	had	have	VERB
gsrj-41	452	10	primary	primary	ADJ
gsrj-41	452	11	care	care	NOUN
gsrj-41	452	12	was	be	AUX
gsrj-41	452	13	“	"	PUNCT
gsrj-41	452	14	do	do	AUX
gsrj-41	452	15	n’t	not	PART
gsrj-41	452	16	believe	believe	VERB
gsrj-41	452	17	the	the	DET
gsrj-41	452	18	vaccine	vaccine	NOUN
gsrj-41	452	19	will	will	AUX
gsrj-41	452	20	work	work	VERB
gsrj-41	452	21	”	"	PUNCT
gsrj-41	452	22	;	;	PUNCT
gsrj-41	452	23	in	in	ADP
gsrj-41	452	24	respondents	respondent	NOUN
gsrj-41	452	25	who	who	PRON
gsrj-41	452	26	lacked	lack	VERB
gsrj-41	452	27	primary	primary	ADJ
gsrj-41	452	28	care	care	NOUN
gsrj-41	452	29	,	,	PUNCT
gsrj-41	452	30	the	the	DET
gsrj-41	452	31	fourth	fourth	ADJ
gsrj-41	452	32	most	most	ADV
gsrj-41	452	33	common	common	ADJ
gsrj-41	452	34	reason	reason	NOUN
gsrj-41	452	35	was	be	AUX
gsrj-41	452	36	“	"	PUNCT
gsrj-41	452	37	not	not	PART
gsrj-41	452	38	worried	worried	ADJ
gsrj-41	452	39	about	about	ADP
gsrj-41	452	40	getting	get	VERB
gsrj-41	452	41	covid-19	covid-19	PROPN
gsrj-41	452	42	infection	infection	NOUN
gsrj-41	452	43	”	"	PUNCT
gsrj-41	452	44	differences	difference	NOUN
gsrj-41	452	45	between	between	ADP
gsrj-41	452	46	those	those	PRON
gsrj-41	452	47	who	who	PRON
gsrj-41	452	48	had	have	VERB
gsrj-41	452	49	primary	primary	ADJ
gsrj-41	452	50	care	care	NOUN
gsrj-41	452	51	and	and	CCONJ
gsrj-41	452	52	those	those	PRON
gsrj-41	452	53	who	who	PRON
gsrj-41	452	54	did	do	AUX
gsrj-41	452	55	not	not	PART
gsrj-41	452	56	stern	stern	ADJ
gsrj-41	452	57	,	,	PUNCT
gsrj-41	452	58	et	et	PROPN
gsrj-41	452	59	al	al	PROPN
gsrj-41	452	60	.	.	PROPN
gsrj-41	453	1	(	(	PUNCT
gsrj-41	453	2	2021	2021	NUM
gsrj-41	453	3	)	)	PUNCT
gsrj-41	453	4	.	.	PUNCT
gsrj-41	454	1	willingness	willingness	NOUN
gsrj-41	454	2	to	to	PART
gsrj-41	454	3	receive	receive	VERB
gsrj-41	454	4	a	a	DET
gsrj-41	454	5	covid-19	covid-19	PROPN
gsrj-41	454	6	vaccination	vaccination	NOUN
gsrj-41	454	7	among	among	ADP
gsrj-41	454	8	incarcerated	incarcerate	VERB
gsrj-41	454	9	or	or	CCONJ
gsrj-41	454	10	detained	detain	VERB
gsrj-41	454	11	persons	person	NOUN
gsrj-41	454	12	in	in	ADP
gsrj-41	454	13	correctional	correctional	ADJ
gsrj-41	454	14	and	and	CCONJ
gsrj-41	454	15	detention	detention	NOUN
gsrj-41	454	16	facilities35	facilities35	NOUN
gsrj-41	454	17	to	to	PART
gsrj-41	454	18	assess	assess	VERB
gsrj-41	454	19	vaccination	vaccination	NOUN
gsrj-41	454	20	willingness	willingness	NOUN
gsrj-41	454	21	and	and	CCONJ
gsrj-41	454	22	intent	intent	NOUN
gsrj-41	454	23	among	among	ADP
gsrj-41	454	24	incarcerated	incarcerated	ADJ
gsrj-41	454	25	populations	population	NOUN
gsrj-41	454	26	in	in	ADP
gsrj-41	454	27	the	the	DET
gsrj-41	454	28	us	us	PROPN
gsrj-41	454	29	sept	sept	PROPN
gsrj-41	454	30	to	to	ADP
gsrj-41	454	31	dec	dec	PROPN
gsrj-41	454	32	2020	2020	NUM
gsrj-41	454	33	interviews	interview	NOUN
gsrj-41	454	34	before	before	ADP
gsrj-41	454	35	3	3	NUM
gsrj-41	454	36	prisons	prison	NOUN
gsrj-41	454	37	and	and	CCONJ
gsrj-41	454	38	13	13	NUM
gsrj-41	454	39	jails	jail	NOUN
gsrj-41	454	40	in	in	ADP
gsrj-41	454	41	4	4	NUM
gsrj-41	454	42	states	state	NOUN
gsrj-41	454	43	(	(	PUNCT
gsrj-41	454	44	washington	washington	PROPN
gsrj-41	454	45	,	,	PUNCT
gsrj-41	454	46	florida	florida	PROPN
gsrj-41	454	47	,	,	PUNCT
gsrj-41	454	48	california	california	PROPN
gsrj-41	454	49	,	,	PUNCT
gsrj-41	454	50	texas	texas	PROPN
gsrj-41	454	51	)	)	PUNCT
gsrj-41	454	52	5,110	5,110	NUM
gsrj-41	454	53	participants	participant	NOUN
gsrj-41	454	54	(	(	PUNCT
gsrj-41	454	55	64.2	64.2	NUM
gsrj-41	454	56	%	%	NOUN
gsrj-41	454	57	response	response	NOUN
gsrj-41	454	58	rate	rate	NOUN
gsrj-41	454	59	)	)	PUNCT
gsrj-41	454	60	45.4	45.4	NUM
gsrj-41	454	61	%	%	NOUN
gsrj-41	454	62	would	would	AUX
gsrj-41	454	63	refuse	refuse	VERB
gsrj-41	454	64	,	,	PUNCT
gsrj-41	454	65	9.8	9.8	NUM
gsrj-41	454	66	%	%	NOUN
gsrj-41	454	67	would	would	AUX
gsrj-41	454	68	hesitate	hesitate	VERB
gsrj-41	454	69	common	common	ADJ
gsrj-41	454	70	reasons	reason	NOUN
gsrj-41	454	71	reported	report	VERB
gsrj-41	454	72	for	for	ADP
gsrj-41	454	73	covid19	covid19	NOUN
gsrj-41	454	74	vaccine	vaccine	NOUN
gsrj-41	454	75	hesitancy	hesitancy	NOUN
gsrj-41	454	76	were	be	AUX
gsrj-41	454	77	waiting	wait	VERB
gsrj-41	454	78	for	for	ADP
gsrj-41	454	79	more	more	ADJ
gsrj-41	454	80	information	information	NOUN
gsrj-41	454	81	(	(	PUNCT
gsrj-41	454	82	54.8	54.8	NUM
gsrj-41	454	83	%	%	NOUN
gsrj-41	454	84	)	)	PUNCT
gsrj-41	454	85	and	and	CCONJ
gsrj-41	454	86	efficacy	efficacy	NOUN
gsrj-41	454	87	or	or	CCONJ
gsrj-41	454	88	safety	safety	NOUN
gsrj-41	454	89	concerns	concern	NOUN
gsrj-41	454	90	(	(	PUNCT
gsrj-41	454	91	31.0	31.0	NUM
gsrj-41	454	92	%	%	NOUN
gsrj-41	454	93	)	)	PUNCT
gsrj-41	454	94	.	.	PUNCT
gsrj-41	455	1	the	the	DET
gsrj-41	455	2	most	most	ADV
gsrj-41	455	3	common	common	ADJ
gsrj-41	455	4	reason	reason	NOUN
gsrj-41	455	5	for	for	ADP
gsrj-41	455	6	covid-19	covid-19	PROPN
gsrj-41	455	7	vaccination	vaccination	NOUN
gsrj-41	455	8	refusal	refusal	NOUN
gsrj-41	455	9	was	be	AUX
gsrj-41	455	10	distrust	distrust	NOUN
gsrj-41	455	11	of	of	ADP
gsrj-41	455	12	health	health	NOUN
gsrj-41	455	13	care	care	NOUN
gsrj-41	455	14	,	,	PUNCT
gsrj-41	455	15	correctional	correctional	ADJ
gsrj-41	455	16	,	,	PUNCT
gsrj-41	455	17	or	or	CCONJ
gsrj-41	455	18	government	government	NOUN
gsrj-41	455	19	personnel	personnel	NOUN
gsrj-41	455	20	or	or	CCONJ
gsrj-41	455	21	institutions	institution	NOUN
gsrj-41	455	22	(	(	PUNCT
gsrj-41	455	23	20.1	20.1	NUM
gsrj-41	455	24	%	%	NOUN
gsrj-41	455	25	)	)	PUNCT
gsrj-41	455	26	.	.	PUNCT
gsrj-41	456	1	dalal	dalal	PROPN
gsrj-41	456	2	,	,	PUNCT
gsrj-41	456	3	et	et	PROPN
gsrj-41	456	4	al	al	PROPN
gsrj-41	456	5	.	.	PROPN
gsrj-41	456	6	(	(	PUNCT
gsrj-41	456	7	2021	2021	NUM
gsrj-41	456	8	)	)	PUNCT
gsrj-41	456	9	.	.	PUNCT
gsrj-41	457	1	covid-19	covid-19	PROPN
gsrj-41	457	2	vaccination	vaccination	NOUN
gsrj-41	457	3	intent	intent	NOUN
gsrj-41	457	4	and	and	CCONJ
gsrj-41	457	5	perceptions	perception	NOUN
gsrj-41	457	6	to	to	PART
gsrj-41	457	7	assess	assess	VERB
gsrj-41	457	8	vaccine	vaccine	NOUN
gsrj-41	457	9	uptake	uptake	ADJ
gsrj-41	457	10	and	and	CCONJ
gsrj-41	457	11	hesitancy	hesitancy	NOUN
gsrj-41	457	12	among	among	ADP
gsrj-41	457	13	ibd	ibd	PROPN
gsrj-41	457	14	population	population	NOUN
gsrj-41	457	15	dec	dec	PROPN
gsrj-41	457	16	to	to	ADP
gsrj-41	457	17	jan	jan	PROPN
gsrj-41	457	18	2021	2021	NUM
gsrj-41	457	19	anonymous	anonymous	ADJ
gsrj-41	457	20	survey	survey	NOUN
gsrj-41	457	21	online	online	ADV
gsrj-41	457	22	after	after	ADP
gsrj-41	457	23	906	906	NUM
gsrj-41	457	24	participants	participant	NOUN
gsrj-41	457	25	with	with	ADP
gsrj-41	457	26	ibs	ibs	PROPN
gsrj-41	457	27	in	in	ADP
gsrj-41	457	28	boston	boston	PROPN
gsrj-41	457	29	,	,	PUNCT
gsrj-41	457	30	ma	ma	PROPN
gsrj-41	457	31	&	&	CCONJ
gsrj-41	457	32	from	from	ADP
gsrj-41	457	33	social	social	ADJ
gsrj-41	457	34	media	medium	NOUN
gsrj-41	457	35	8.1	8.1	NUM
gsrj-41	457	36	%	%	NOUN
gsrj-41	457	37	response	response	NOUN
gsrj-41	457	38	rate	rate	NOUN
gsrj-41	457	39	rates	rate	NOUN
gsrj-41	457	40	of	of	ADP
gsrj-41	457	41	covid-19	covid-19	PROPN
gsrj-41	457	42	vaccination	vaccination	NOUN
gsrj-41	457	43	intent	intent	NOUN
gsrj-41	457	44	were	be	AUX
gsrj-41	457	45	80.9	80.9	NUM
gsrj-41	457	46	%	%	NOUN
gsrj-41	457	47	for	for	ADP
gsrj-41	457	48	local	local	ADJ
gsrj-41	457	49	and	and	CCONJ
gsrj-41	457	50	60.0	60.0	NUM
gsrj-41	457	51	%	%	NOUN
gsrj-41	457	52	for	for	ADP
gsrj-41	457	53	sm	sm	PROPN
gsrj-41	457	54	participants	participant	NOUN
gsrj-41	457	55	.	.	PUNCT
gsrj-41	458	1	36	36	NUM
gsrj-41	458	2	georgetown	georgetown	PROPN
gsrj-41	458	3	scientific	scientific	PROPN
gsrj-41	458	4	research	research	PROPN
gsrj-41	458	5	journal	journal	NOUN
gsrj-41	458	6	among	among	ADP
gsrj-41	458	7	patients	patient	NOUN
gsrj-41	458	8	with	with	ADP
gsrj-41	458	9	inflammatory	inflammatory	ADJ
gsrj-41	458	10	bowel	bowel	NOUN
gsrj-41	458	11	disease36	disease36	NOUN
gsrj-41	458	12	not	not	PART
gsrj-41	458	13	representative	representative	NOUN
gsrj-41	458	14	of	of	ADP
gsrj-41	458	15	national	national	ADJ
gsrj-41	458	16	ibd	ibd	PROPN
gsrj-41	458	17	population	population	NOUN
gsrj-41	458	18	the	the	DET
gsrj-41	458	19	hesitant	hesitant	ADJ
gsrj-41	458	20	participants	participant	NOUN
gsrj-41	458	21	most	most	ADV
gsrj-41	458	22	commonly	commonly	ADV
gsrj-41	458	23	selected	select	VERB
gsrj-41	458	24	“	"	PUNCT
gsrj-41	458	25	concern	concern	NOUN
gsrj-41	458	26	that	that	PRON
gsrj-41	458	27	longterm	longterm	VERB
gsrj-41	458	28	safety	safety	NOUN
gsrj-41	458	29	of	of	ADP
gsrj-41	458	30	vaccines	vaccine	NOUN
gsrj-41	458	31	is	be	AUX
gsrj-41	458	32	unknown	unknown	ADJ
gsrj-41	458	33	”	"	PUNCT
gsrj-41	458	34	(	(	PUNCT
gsrj-41	458	35	64.4	64.4	NUM
gsrj-41	458	36	%	%	NOUN
gsrj-41	458	37	local	local	ADJ
gsrj-41	458	38	,	,	PUNCT
gsrj-41	458	39	70.1	70.1	NUM
gsrj-41	458	40	%	%	NOUN
gsrj-41	458	41	sm	sm	NOUN
gsrj-41	458	42	)	)	PUNCT
gsrj-41	458	43	and	and	CCONJ
gsrj-41	458	44	“	"	PUNCT
gsrj-41	458	45	prefer	prefer	VERB
gsrj-41	458	46	to	to	PART
gsrj-41	458	47	see	see	VERB
gsrj-41	458	48	how	how	SCONJ
gsrj-41	458	49	others	other	NOUN
gsrj-41	458	50	tolerate	tolerate	VERB
gsrj-41	458	51	vaccine	vaccine	NOUN
gsrj-41	458	52	first	first	ADV
gsrj-41	458	53	”	"	PUNCT
gsrj-41	458	54	(	(	PUNCT
gsrj-41	458	55	62.2	62.2	NUM
gsrj-41	458	56	%	%	NOUN
gsrj-41	458	57	local	local	ADJ
gsrj-41	458	58	,	,	PUNCT
gsrj-41	458	59	55.6	55.6	NUM
gsrj-41	458	60	%	%	NOUN
gsrj-41	458	61	sm	sm	NOUN
gsrj-41	458	62	)	)	PUNCT
gsrj-41	458	63	.	.	PUNCT
gsrj-41	459	1	approximately	approximately	ADV
gsrj-41	459	2	70	70	NUM
gsrj-41	459	3	%	%	NOUN
gsrj-41	459	4	desire	desire	NOUN
gsrj-41	459	5	data	datum	NOUN
gsrj-41	459	6	regarding	regard	VERB
gsrj-41	459	7	vaccine	vaccine	NOUN
gsrj-41	459	8	safety	safety	NOUN
gsrj-41	459	9	/	/	SYM
gsrj-41	459	10	efficacy	efficacy	NOUN
gsrj-41	459	11	among	among	ADP
gsrj-41	459	12	patients	patient	NOUN
gsrj-41	459	13	with	with	ADP
gsrj-41	459	14	ibd	ibd	PROPN
gsrj-41	459	15	dorman	dorman	PROPN
gsrj-41	459	16	,	,	PUNCT
gsrj-41	459	17	et	et	PROPN
gsrj-41	459	18	al	al	PROPN
gsrj-41	459	19	.	.	PROPN
gsrj-41	460	1	(	(	PUNCT
gsrj-41	460	2	2021	2021	NUM
gsrj-41	460	3	)	)	PUNCT
gsrj-41	460	4	.	.	PUNCT
gsrj-41	461	1	factors	factor	NOUN
gsrj-41	461	2	associated	associate	VERB
gsrj-41	461	3	with	with	ADP
gsrj-41	461	4	willingness	willingness	NOUN
gsrj-41	461	5	to	to	PART
gsrj-41	461	6	be	be	AUX
gsrj-41	461	7	vaccinated	vaccinate	VERB
gsrj-41	461	8	against	against	ADP
gsrj-41	461	9	covid-19	covid-19	PROPN
gsrj-41	461	10	in	in	ADP
gsrj-41	461	11	a	a	DET
gsrj-41	461	12	large	large	ADJ
gsrj-41	461	13	convenience	convenience	NOUN
gsrj-41	461	14	sample37	sample37	NOUN
gsrj-41	461	15	to	to	PART
gsrj-41	461	16	assess	assess	VERB
gsrj-41	461	17	factors	factor	NOUN
gsrj-41	461	18	of	of	ADP
gsrj-41	461	19	hesitancy	hesitancy	NOUN
gsrj-41	461	20	and	and	CCONJ
gsrj-41	461	21	receipt	receipt	NOUN
gsrj-41	461	22	of	of	ADP
gsrj-41	461	23	vaccination	vaccination	NOUN
gsrj-41	461	24	among	among	ADP
gsrj-41	461	25	californian	californian	ADJ
gsrj-41	461	26	adults	adult	NOUN
gsrj-41	461	27	internet	internet	NOUN
gsrj-41	461	28	survey	survey	NOUN
gsrj-41	461	29	,	,	PUNCT
gsrj-41	461	30	face	face	VERB
gsrj-41	461	31	to	to	ADP
gsrj-41	461	32	face	face	NOUN
gsrj-41	461	33	and	and	CCONJ
gsrj-41	461	34	telephone	telephone	NOUN
gsrj-41	461	35	interviews	interview	NOUN
gsrj-41	461	36	oct	oct	PROPN
gsrj-41	461	37	and	and	CCONJ
gsrj-41	461	38	nov	nov	PROPN
gsrj-41	461	39	2020	2020	NUM
gsrj-41	461	40	before	before	ADP
gsrj-41	461	41	26,324	26,324	NUM
gsrj-41	461	42	respondents	respondent	NOUN
gsrj-41	461	43	large	large	ADJ
gsrj-41	461	44	convenience	convenience	NOUN
gsrj-41	461	45	sample	sample	NOUN
gsrj-41	461	46	in	in	ADP
gsrj-41	461	47	california	california	PROPN
gsrj-41	461	48	response	response	NOUN
gsrj-41	461	49	rate	rate	NOUN
gsrj-41	461	50	unknown	unknown	ADJ
gsrj-41	461	51	measures	measure	NOUN
gsrj-41	461	52	from	from	ADP
gsrj-41	461	53	5c	5c	NUM
gsrj-41	461	54	scale	scale	NOUN
gsrj-41	461	55	:	:	PUNCT
gsrj-41	461	56	confidence	confidence	NOUN
gsrj-41	461	57	,	,	PUNCT
gsrj-41	461	58	complacency	complacency	NOUN
gsrj-41	461	59	,	,	PUNCT
gsrj-41	461	60	convenience	convenience	NOUN
gsrj-41	461	61	,	,	PUNCT
gsrj-41	461	62	calculates	calculate	VERB
gsrj-41	461	63	risks	risk	NOUN
gsrj-41	461	64	and	and	CCONJ
gsrj-41	461	65	benefits	benefit	NOUN
gsrj-41	461	66	,	,	PUNCT
gsrj-41	461	67	concern	concern	NOUN
gsrj-41	461	68	for	for	ADP
gsrj-41	461	69	others	other	NOUN
gsrj-41	461	70	for	for	ADP
gsrj-41	461	71	the	the	DET
gsrj-41	461	72	sample	sample	NOUN
gsrj-41	461	73	as	as	ADP
gsrj-41	461	74	a	a	DET
gsrj-41	461	75	whole	whole	NOUN
gsrj-41	461	76	,	,	PUNCT
gsrj-41	461	77	confidence	confidence	NOUN
gsrj-41	461	78	in	in	ADP
gsrj-41	461	79	the	the	DET
gsrj-41	461	80	safety	safety	NOUN
gsrj-41	461	81	of	of	ADP
gsrj-41	461	82	the	the	DET
gsrj-41	461	83	vaccine	vaccine	NOUN
gsrj-41	461	84	was	be	AUX
gsrj-41	461	85	the	the	DET
gsrj-41	461	86	strongest	strong	ADJ
gsrj-41	461	87	predictor	predictor	NOUN
gsrj-41	461	88	of	of	ADP
gsrj-41	461	89	willingness	willingness	NOUN
gsrj-41	461	90	to	to	PART
gsrj-41	461	91	be	be	AUX
gsrj-41	461	92	vaccinated	vaccinate	VERB
gsrj-41	461	93	,	,	PUNCT
gsrj-41	461	94	followed	follow	VERB
gsrj-41	461	95	by	by	ADP
gsrj-41	461	96	concern	concern	NOUN
gsrj-41	461	97	for	for	ADP
gsrj-41	461	98	protecting	protect	VERB
gsrj-41	461	99	others	other	NOUN
gsrj-41	461	100	and	and	CCONJ
gsrj-41	461	101	whether	whether	SCONJ
gsrj-41	461	102	or	or	CCONJ
gsrj-41	461	103	not	not	PART
gsrj-41	461	104	one	one	NUM
gsrj-41	461	105	believed	believe	VERB
gsrj-41	461	106	that	that	SCONJ
gsrj-41	461	107	covid19	covid19	NOUN
gsrj-41	461	108	was	be	AUX
gsrj-41	461	109	serious	serious	ADJ
gsrj-41	461	110	enough	enough	ADV
gsrj-41	461	111	to	to	PART
gsrj-41	461	112	warrant	warrant	VERB
gsrj-41	461	113	vaccination	vaccination	NOUN
gsrj-41	461	114	not	not	PART
gsrj-41	461	115	sure	sure	ADV
gsrj-41	461	116	exact	exact	ADJ
gsrj-41	461	117	percentages	percentage	NOUN
gsrj-41	461	118	allen	allen	PROPN
gsrj-41	461	119	,	,	PUNCT
gsrj-41	461	120	et	et	PROPN
gsrj-41	461	121	al	al	PROPN
gsrj-41	461	122	.	.	PROPN
gsrj-41	462	1	(	(	PUNCT
gsrj-41	462	2	2021	2021	NUM
gsrj-41	462	3	)	)	PUNCT
gsrj-41	462	4	.	.	PUNCT
gsrj-41	463	1	why	why	SCONJ
gsrj-41	463	2	are	be	AUX
gsrj-41	463	3	some	some	DET
gsrj-41	463	4	people	people	NOUN
gsrj-41	463	5	reluctant	reluctant	ADJ
gsrj-41	463	6	to	to	PART
gsrj-41	463	7	be	be	AUX
gsrj-41	463	8	vaccinated	vaccinate	VERB
gsrj-41	463	9	for	for	ADP
gsrj-41	463	10	covid-19	covid-19	PROPN
gsrj-41	463	11	?	?	PUNCT
gsrj-41	464	1	a	a	DET
gsrj-41	464	2	crosssectional	crosssectional	ADJ
gsrj-41	464	3	survey	survey	NOUN
gsrj-41	464	4	among	among	ADP
gsrj-41	464	5	u.s	u.s	PROPN
gsrj-41	464	6	.	.	PROPN
gsrj-41	464	7	adults	adult	NOUN
gsrj-41	464	8	in	in	ADP
gsrj-41	464	9	to	to	PART
gsrj-41	464	10	assess	assess	VERB
gsrj-41	464	11	cognitive	cognitive	ADJ
gsrj-41	464	12	,	,	PUNCT
gsrj-41	464	13	attitudinal	attitudinal	ADJ
gsrj-41	464	14	and	and	CCONJ
gsrj-41	464	15	normative	normative	ADJ
gsrj-41	464	16	beliefs	belief	NOUN
gsrj-41	464	17	associated	associate	VERB
gsrj-41	464	18	with	with	ADP
gsrj-41	464	19	not	not	PART
gsrj-41	464	20	intending	intend	VERB
gsrj-41	464	21	to	to	PART
gsrj-41	464	22	get	get	VERB
gsrj-41	464	23	a	a	DET
gsrj-41	464	24	covid-19	covid-19	PROPN
gsrj-41	464	25	vaccine	vaccine	NOUN
gsrj-41	464	26	among	among	ADP
gsrj-41	464	27	online	online	ADJ
gsrj-41	464	28	crosssectional	crosssectional	ADJ
gsrj-41	464	29	survey	survey	NOUN
gsrj-41	464	30	of	of	ADP
gsrj-41	464	31	us	us	PROPN
gsrj-41	464	32	adults	adult	NOUN
gsrj-41	464	33	may	may	PROPN
gsrj-41	464	34	-	-	PUNCT
gsrj-41	464	35	june	june	PROPN
gsrj-41	464	36	2020	2020	NUM
gsrj-41	464	37	before	before	ADP
gsrj-41	464	38	1219	1219	NUM
gsrj-41	464	39	respondents	respondent	NOUN
gsrj-41	464	40	nationally	nationally	ADV
gsrj-41	464	41	representative	representative	ADJ
gsrj-41	464	42	sample	sample	NOUN
gsrj-41	464	43	of	of	ADP
gsrj-41	464	44	us	us	PROPN
gsrj-41	464	45	adults	adult	NOUN
gsrj-41	464	46	64	64	NUM
gsrj-41	464	47	%	%	NOUN
gsrj-41	464	48	response	response	NOUN
gsrj-41	464	49	rate	rate	NOUN
gsrj-41	464	50	17.7	17.7	NUM
gsrj-41	464	51	%	%	NOUN
gsrj-41	464	52	no	no	NOUN
gsrj-41	464	53	&	&	CCONJ
gsrj-41	464	54	24.2	24.2	NUM
gsrj-41	464	55	%	%	NOUN
gsrj-41	464	56	unsure	unsure	NOUN
gsrj-41	464	57	those	those	PRON
gsrj-41	464	58	who	who	PRON
gsrj-41	464	59	strongly	strongly	ADV
gsrj-41	464	60	disagreed	disagree	VERB
gsrj-41	464	61	with	with	ADP
gsrj-41	464	62	statements	statement	NOUN
gsrj-41	464	63	that	that	SCONJ
gsrj-41	464	64	most	most	ADJ
gsrj-41	464	65	vaccines	vaccine	NOUN
gsrj-41	464	66	are	be	AUX
gsrj-41	464	67	very	very	ADV
gsrj-41	464	68	safe	safe	ADJ
gsrj-41	464	69	and/or	and/or	CCONJ
gsrj-41	464	70	effective	effective	ADJ
gsrj-41	464	71	were	be	AUX
gsrj-41	464	72	more	more	ADV
gsrj-41	464	73	likely	likely	ADJ
gsrj-41	464	74	to	to	PART
gsrj-41	464	75	say	say	VERB
gsrj-41	464	76	they	they	PRON
gsrj-41	464	77	would	would	AUX
gsrj-41	464	78	not	not	PART
gsrj-41	464	79	get	get	VERB
gsrj-41	464	80	the	the	DET
gsrj-41	464	81	vaccine	vaccine	NOUN
gsrj-41	464	82	,	,	PUNCT
gsrj-41	464	83	compared	compare	VERB
gsrj-41	464	84	with	with	ADP
gsrj-41	464	85	those	those	PRON
gsrj-41	464	86	who	who	PRON
gsrj-41	464	87	strongly	strongly	ADV
gsrj-41	464	88	37	37	NUM
gsrj-41	464	89	georgetown	georgetown	PROPN
gsrj-41	464	90	scientific	scientific	PROPN
gsrj-41	464	91	research	research	NOUN
gsrj-41	464	92	journal	journal	NOUN
gsrj-41	464	93	may	may	PROPN
gsrj-41	464	94	-	-	PUNCT
gsrj-41	464	95	june	june	PROPN
gsrj-41	464	96	202038	202038	NUM
gsrj-41	464	97	american	american	ADJ
gsrj-41	464	98	adults	adult	NOUN
gsrj-41	464	99	believed	believe	VERB
gsrj-41	464	100	most	most	ADJ
gsrj-41	464	101	vaccines	vaccine	NOUN
gsrj-41	464	102	are	be	AUX
gsrj-41	464	103	very	very	ADV
gsrj-41	464	104	safe	safe	ADJ
gsrj-41	464	105	/	/	SYM
gsrj-41	464	106	effective	effective	ADJ
gsrj-41	464	107	(	(	PUNCT
gsrj-41	464	108	78.1	78.1	NUM
gsrj-41	464	109	%	%	NOUN
gsrj-41	464	110	vs.	vs.	ADP
gsrj-41	464	111	5.0	5.0	NUM
gsrj-41	464	112	%	%	NOUN
gsrj-41	464	113	)	)	PUNCT
gsrj-41	464	114	those	those	PRON
gsrj-41	464	115	who	who	PRON
gsrj-41	464	116	strongly	strongly	ADV
gsrj-41	464	117	disagreed	disagree	VERB
gsrj-41	464	118	with	with	ADP
gsrj-41	464	119	statements	statement	NOUN
gsrj-41	464	120	that	that	SCONJ
gsrj-41	464	121	they	they	PRON
gsrj-41	464	122	themselves	themselves	PRON
gsrj-41	464	123	and	and	CCONJ
gsrj-41	464	124	everyone	everyone	PRON
gsrj-41	464	125	else	else	ADV
gsrj-41	464	126	in	in	ADP
gsrj-41	464	127	society	society	NOUN
gsrj-41	464	128	has	have	AUX
gsrj-41	464	129	a	a	DET
gsrj-41	464	130	responsibility	responsibility	NOUN
gsrj-41	464	131	to	to	PART
gsrj-41	464	132	be	be	AUX
gsrj-41	464	133	vaccinated	vaccinate	VERB
gsrj-41	464	134	were	be	AUX
gsrj-41	464	135	more	more	ADV
gsrj-41	464	136	likely	likely	ADJ
gsrj-41	464	137	to	to	PART
gsrj-41	464	138	indicate	indicate	VERB
gsrj-41	464	139	they	they	PRON
gsrj-41	464	140	would	would	AUX
gsrj-41	464	141	not	not	PART
gsrj-41	464	142	get	get	VERB
gsrj-41	464	143	a	a	DET
gsrj-41	464	144	covid-19	covid-19	PROPN
gsrj-41	464	145	vaccine	vaccine	NOUN
gsrj-41	464	146	,	,	PUNCT
gsrj-41	464	147	compared	compare	VERB
gsrj-41	464	148	with	with	ADP
gsrj-41	464	149	those	those	PRON
gsrj-41	464	150	who	who	PRON
gsrj-41	464	151	strongly	strongly	ADV
gsrj-41	464	152	agreed	agree	VERB
gsrj-41	464	153	with	with	ADP
gsrj-41	464	154	these	these	DET
gsrj-41	464	155	statements	statement	NOUN
gsrj-41	464	156	(	(	PUNCT
gsrj-41	464	157	77.2	77.2	NUM
gsrj-41	464	158	%	%	NOUN
gsrj-41	464	159	vs	vs	ADP
gsrj-41	464	160	4.8	4.8	NUM
gsrj-41	464	161	%	%	NOUN
gsrj-41	464	162	)	)	PUNCT
gsrj-41	464	163	when	when	SCONJ
gsrj-41	464	164	asked	ask	VERB
gsrj-41	464	165	about	about	ADP
gsrj-41	464	166	not	not	PART
gsrj-41	464	167	needing	need	VERB
gsrj-41	464	168	to	to	PART
gsrj-41	464	169	be	be	AUX
gsrj-41	464	170	vaccinated	vaccinate	VERB
gsrj-41	464	171	if	if	SCONJ
gsrj-41	464	172	everyone	everyone	PRON
gsrj-41	464	173	else	else	ADV
gsrj-41	464	174	were	be	AUX
gsrj-41	464	175	vaccinated	vaccinate	VERB
gsrj-41	464	176	,	,	PUNCT
gsrj-41	464	177	results	result	NOUN
gsrj-41	464	178	were	be	AUX
gsrj-41	464	179	mixed	mixed	ADJ
gsrj-41	464	180	.	.	PUNCT
gsrj-41	465	1	those	those	PRON
gsrj-41	465	2	who	who	PRON
gsrj-41	465	3	strongly	strongly	ADV
gsrj-41	465	4	opposed	oppose	VERB
gsrj-41	465	5	this	this	DET
gsrj-41	465	6	statement	statement	NOUN
gsrj-41	465	7	were	be	AUX
gsrj-41	465	8	most	most	ADV
gsrj-41	465	9	likely	likely	ADJ
gsrj-41	465	10	to	to	PART
gsrj-41	465	11	report	report	VERB
gsrj-41	465	12	an	an	DET
gsrj-41	465	13	intention	intention	NOUN
gsrj-41	465	14	to	to	PART
gsrj-41	465	15	vaccinate	vaccinate	VERB
gsrj-41	465	16	(	(	PUNCT
gsrj-41	465	17	74	74	NUM
gsrj-41	465	18	%	%	NOUN
gsrj-41	465	19	)	)	PUNCT
gsrj-41	465	20	,	,	PUNCT
gsrj-41	465	21	while	while	SCONJ
gsrj-41	465	22	those	those	PRON
gsrj-41	465	23	who	who	PRON
gsrj-41	465	24	strongly	strongly	ADV
gsrj-41	465	25	agreed	agree	VERB
gsrj-41	465	26	were	be	AUX
gsrj-41	465	27	most	most	ADV
gsrj-41	465	28	likely	likely	ADJ
gsrj-41	465	29	to	to	PART
gsrj-41	465	30	indicate	indicate	VERB
gsrj-41	465	31	they	they	PRON
gsrj-41	465	32	would	would	AUX
gsrj-41	465	33	not	not	PART
gsrj-41	465	34	get	get	VERB
gsrj-41	465	35	the	the	DET
gsrj-41	465	36	vaccine	vaccine	NOUN
gsrj-41	465	37	(	(	PUNCT
gsrj-41	465	38	45.3	45.3	NUM
gsrj-41	465	39	%	%	NOUN
gsrj-41	465	40	)	)	PUNCT
gsrj-41	465	41	.	.	PUNCT
gsrj-41	466	1	those	those	PRON
gsrj-41	466	2	who	who	PRON
gsrj-41	466	3	were	be	AUX
gsrj-41	466	4	neutral	neutral	ADJ
gsrj-41	466	5	about	about	ADP
gsrj-41	466	6	this	this	DET
gsrj-41	466	7	statement	statement	NOUN
gsrj-41	466	8	were	be	AUX
gsrj-41	466	9	the	the	DET
gsrj-41	466	10	most	most	ADV
gsrj-41	466	11	likely	likely	ADJ
gsrj-41	466	12	to	to	PART
gsrj-41	466	13	report	report	VERB
gsrj-41	466	14	that	that	SCONJ
gsrj-41	466	15	they	they	PRON
gsrj-41	466	16	were	be	AUX
gsrj-41	466	17	unsure	unsure	ADJ
gsrj-41	466	18	about	about	ADP
gsrj-41	466	19	vaccination	vaccination	NOUN
gsrj-41	466	20	(	(	PUNCT
gsrj-41	466	21	42.4	42.4	NUM
gsrj-41	466	22	%	%	NOUN
gsrj-41	466	23	)	)	PUNCT
gsrj-41	466	24	.	.	PUNCT
gsrj-41	467	1	regarding	regard	VERB
gsrj-41	467	2	trust	trust	NOUN
gsrj-41	467	3	of	of	ADP
gsrj-41	467	4	public	public	ADJ
gsrj-41	467	5	authorities	authority	NOUN
gsrj-41	467	6	,	,	PUNCT
gsrj-41	467	7	half	half	NOUN
gsrj-41	467	8	(	(	PUNCT
gsrj-41	467	9	49	49	NUM
gsrj-41	467	10	%	%	NOUN
gsrj-41	467	11	)	)	PUNCT
gsrj-41	467	12	of	of	ADP
gsrj-41	467	13	those	those	PRON
gsrj-41	467	14	who	who	PRON
gsrj-41	467	15	strongly	strongly	ADV
gsrj-41	467	16	disagreed	disagree	VERB
gsrj-41	467	17	that	that	SCONJ
gsrj-41	467	18	public	public	ADJ
gsrj-41	467	19	authorities	authority	NOUN
gsrj-41	467	20	decide	decide	VERB
gsrj-41	467	21	about	about	ADP
gsrj-41	467	22	which	which	DET
gsrj-41	467	23	vaccines	vaccine	NOUN
gsrj-41	467	24	to	to	PART
gsrj-41	467	25	recommend	recommend	VERB
gsrj-41	467	26	based	base	VERB
gsrj-41	467	27	on	on	ADP
gsrj-41	467	28	the	the	DET
gsrj-41	467	29	best	good	ADJ
gsrj-41	467	30	interests	interest	NOUN
gsrj-41	467	31	of	of	ADP
gsrj-41	467	32	the	the	DET
gsrj-41	467	33	38	38	NUM
gsrj-41	467	34	georgetown	georgetown	NOUN
gsrj-41	467	35	scientific	scientific	ADJ
gsrj-41	467	36	research	research	PROPN
gsrj-41	467	37	journal	journal	PROPN
gsrj-41	467	38	community	community	NOUN
gsrj-41	467	39	and	and	CCONJ
gsrj-41	467	40	that	that	SCONJ
gsrj-41	467	41	public	public	ADJ
gsrj-41	467	42	authorities	authority	NOUN
gsrj-41	467	43	should	should	AUX
gsrj-41	467	44	be	be	AUX
gsrj-41	467	45	able	able	ADJ
gsrj-41	467	46	to	to	PART
gsrj-41	467	47	mandate	mandate	VERB
gsrj-41	467	48	vaccination	vaccination	NOUN
gsrj-41	467	49	reported	report	VERB
gsrj-41	467	50	that	that	SCONJ
gsrj-41	467	51	they	they	PRON
gsrj-41	467	52	did	do	AUX
gsrj-41	467	53	not	not	PART
gsrj-41	467	54	intend	intend	VERB
gsrj-41	467	55	to	to	PART
gsrj-41	467	56	be	be	AUX
gsrj-41	467	57	vaccinated	vaccinate	VERB
gsrj-41	467	58	.	.	PUNCT
gsrj-41	468	1	teasdale	teasdale	PROPN
gsrj-41	468	2	,	,	PUNCT
gsrj-41	468	3	et	et	PROPN
gsrj-41	468	4	al	al	PROPN
gsrj-41	468	5	.	.	PROPN
gsrj-41	468	6	(	(	PUNCT
gsrj-41	468	7	2021	2021	NUM
gsrj-41	468	8	)	)	PUNCT
gsrj-41	468	9	.	.	PUNCT
gsrj-41	469	1	parental	parental	ADJ
gsrj-41	469	2	plans	plan	NOUN
gsrj-41	469	3	to	to	PART
gsrj-41	469	4	vaccinate	vaccinate	VERB
gsrj-41	469	5	children	child	NOUN
gsrj-41	469	6	for	for	ADP
gsrj-41	469	7	covid-19	covid-19	PROPN
gsrj-41	469	8	in	in	ADP
gsrj-41	469	9	new	new	PROPN
gsrj-41	469	10	york	york	PROPN
gsrj-41	469	11	city39	city39	PROPN
gsrj-41	469	12	to	to	PART
gsrj-41	469	13	assess	assess	VERB
gsrj-41	469	14	intent	intent	NOUN
gsrj-41	469	15	among	among	ADP
gsrj-41	469	16	caregivers	caregiver	NOUN
gsrj-41	469	17	in	in	ADP
gsrj-41	469	18	nyc	nyc	PROPN
gsrj-41	469	19	to	to	PART
gsrj-41	469	20	vaccinate	vaccinate	VERB
gsrj-41	469	21	their	their	PRON
gsrj-41	469	22	young	young	ADJ
gsrj-41	469	23	children	child	NOUN
gsrj-41	469	24	,	,	PUNCT
gsrj-41	469	25	and	and	CCONJ
gsrj-41	469	26	assess	assess	VERB
gsrj-41	469	27	reasons	reason	NOUN
gsrj-41	469	28	for	for	ADP
gsrj-41	469	29	hesitancy	hesitancy	NOUN
gsrj-41	469	30	online	online	ADJ
gsrj-41	469	31	survey	survey	NOUN
gsrj-41	469	32	from	from	ADP
gsrj-41	469	33	march	march	PROPN
gsrj-41	469	34	9april	9april	NUM
gsrj-41	469	35	11	11	NUM
gsrj-41	469	36	,	,	PUNCT
gsrj-41	469	37	2021	2021	NUM
gsrj-41	469	38	after	after	ADP
gsrj-41	469	39	1,119	1,119	NUM
gsrj-41	469	40	parents	parent	NOUN
gsrj-41	469	41	and	and	CCONJ
gsrj-41	469	42	caregivers	caregiver	NOUN
gsrj-41	469	43	of	of	ADP
gsrj-41	469	44	children	child	NOUN
gsrj-41	469	45	under	under	ADP
gsrj-41	469	46	12	12	NUM
gsrj-41	469	47	(	(	PUNCT
gsrj-41	469	48	no	no	DET
gsrj-41	469	49	response	response	NOUN
gsrj-41	469	50	rate	rate	NOUN
gsrj-41	469	51	given	give	VERB
gsrj-41	469	52	)	)	PUNCT
gsrj-41	469	53	representative	representative	NOUN
gsrj-41	469	54	of	of	ADP
gsrj-41	469	55	nyc	nyc	PROPN
gsrj-41	469	56	population	population	NOUN
gsrj-41	469	57	of	of	ADP
gsrj-41	469	58	parents	parent	NOUN
gsrj-41	469	59	61.9	61.9	NUM
gsrj-41	469	60	%	%	NOUN
gsrj-41	469	61	planned	plan	VERB
gsrj-41	469	62	to	to	PART
gsrj-41	469	63	vaccinate	vaccinate	VERB
gsrj-41	469	64	,	,	PUNCT
gsrj-41	469	65	14.8	14.8	NUM
gsrj-41	469	66	%	%	NOUN
gsrj-41	469	67	no	no	NOUN
gsrj-41	469	68	,	,	PUNCT
gsrj-41	469	69	23.3	23.3	NUM
gsrj-41	469	70	%	%	NOUN
gsrj-41	469	71	unsure	unsure	ADJ
gsrj-41	469	72	reasons	reason	NOUN
gsrj-41	469	73	for	for	ADP
gsrj-41	469	74	hesitancy	hesitancy	NOUN
gsrj-41	469	75	:	:	PUNCT
gsrj-41	469	76	safety	safety	NOUN
gsrj-41	469	77	&	&	CCONJ
gsrj-41	469	78	effectiveness	effectiveness	NOUN
gsrj-41	469	79	(	(	PUNCT
gsrj-41	469	80	81.2	81.2	NUM
gsrj-41	469	81	%	%	NOUN
gsrj-41	469	82	)	)	PUNCT
gsrj-41	469	83	,	,	PUNCT
gsrj-41	469	84	believe	believe	VERB
gsrj-41	469	85	children	child	NOUN
gsrj-41	469	86	are	be	AUX
gsrj-41	469	87	at	at	ADP
gsrj-41	469	88	low	low	ADJ
gsrj-41	469	89	-	-	PUNCT
gsrj-41	469	90	risk	risk	NOUN
gsrj-41	469	91	for	for	ADP
gsrj-41	469	92	covid-19	covid-19	PROPN
gsrj-41	469	93	and	and	CCONJ
gsrj-41	469	94	do	do	AUX
gsrj-41	469	95	n’t	not	PART
gsrj-41	469	96	need	need	VERB
gsrj-41	469	97	vaccination	vaccination	NOUN
gsrj-41	469	98	(	(	PUNCT
gsrj-41	469	99	21.7	21.7	NUM
gsrj-41	469	100	%	%	NOUN
gsrj-41	469	101	)	)	PUNCT
gsrj-41	469	102	,	,	PUNCT
gsrj-41	469	103	medical	medical	ADJ
gsrj-41	469	104	reasons	reason	NOUN
gsrj-41	469	105	(	(	PUNCT
gsrj-41	469	106	16.6	16.6	NUM
gsrj-41	469	107	%	%	NOUN
gsrj-41	469	108	)	)	PUNCT
gsrj-41	469	109	,	,	PUNCT
gsrj-41	469	110	religious	religious	ADJ
gsrj-41	469	111	or	or	CCONJ
gsrj-41	469	112	philosophical	philosophical	ADJ
gsrj-41	469	113	reasons	reason	NOUN
gsrj-41	469	114	(	(	PUNCT
gsrj-41	469	115	9.5	9.5	NUM
gsrj-41	469	116	%	%	NOUN
gsrj-41	469	117	)	)	PUNCT
gsrj-41	469	118	teasdale	teasdale	PROPN
gsrj-41	469	119	,	,	PUNCT
gsrj-41	469	120	et	et	PROPN
gsrj-41	469	121	al	al	PROPN
gsrj-41	469	122	.	.	PROPN
gsrj-41	470	1	(	(	PUNCT
gsrj-41	470	2	2021	2021	NUM
gsrj-41	470	3	)	)	PUNCT
gsrj-41	470	4	.	.	PUNCT
gsrj-41	471	1	plans	plan	NOUN
gsrj-41	471	2	to	to	PART
gsrj-41	471	3	vaccinate	vaccinate	VERB
gsrj-41	471	4	children	child	NOUN
gsrj-41	471	5	for	for	ADP
gsrj-41	471	6	coronavirus	coronavirus	NOUN
gsrj-41	471	7	disease	disease	NOUN
gsrj-41	471	8	2019	2019	NUM
gsrj-41	471	9	:	:	PUNCT
gsrj-41	471	10	a	a	DET
gsrj-41	471	11	survey	survey	NOUN
gsrj-41	471	12	of	of	ADP
gsrj-41	471	13	united	united	PROPN
gsrj-41	471	14	states	states	PROPN
gsrj-41	471	15	parents40	parents40	NOUN
gsrj-41	471	16	to	to	PART
gsrj-41	471	17	assess	assess	VERB
gsrj-41	471	18	intent	intent	NOUN
gsrj-41	471	19	among	among	ADP
gsrj-41	471	20	caregivers	caregiver	NOUN
gsrj-41	471	21	in	in	ADP
gsrj-41	471	22	the	the	DET
gsrj-41	471	23	u.s	u.s	PROPN
gsrj-41	471	24	.	.	PROPN
gsrj-41	471	25	to	to	PART
gsrj-41	471	26	vaccinate	vaccinate	VERB
gsrj-41	471	27	their	their	PRON
gsrj-41	471	28	young	young	ADJ
gsrj-41	471	29	children	child	NOUN
gsrj-41	471	30	,	,	PUNCT
gsrj-41	471	31	and	and	CCONJ
gsrj-41	471	32	assess	assess	VERB
gsrj-41	471	33	reasons	reason	NOUN
gsrj-41	471	34	for	for	ADP
gsrj-41	471	35	hesitancy	hesitancy	NOUN
gsrj-41	471	36	online	online	NOUN
gsrj-41	471	37	,	,	PUNCT
gsrj-41	471	38	communitybased	communitybase	VERB
gsrj-41	471	39	,	,	PUNCT
gsrj-41	471	40	nonprobabilit	nonprobabilit	NOUN
gsrj-41	471	41	y	y	PROPN
gsrj-41	471	42	survey	survey	NOUN
gsrj-41	471	43	march	march	PROPN
gsrj-41	471	44	2021	2021	NUM
gsrj-41	471	45	after	after	ADP
gsrj-41	471	46	2074	2074	NUM
gsrj-41	471	47	parents	parent	NOUN
gsrj-41	471	48	of	of	ADP
gsrj-41	471	49	children	child	NOUN
gsrj-41	471	50	under	under	ADP
gsrj-41	471	51	12	12	NUM
gsrj-41	471	52	representative	representative	NOUN
gsrj-41	471	53	of	of	ADP
gsrj-41	471	54	us	we	PRON
gsrj-41	471	55	population	population	NOUN
gsrj-41	471	56	49.4	49.4	NUM
gsrj-41	471	57	%	%	NOUN
gsrj-41	471	58	plan	plan	NOUN
gsrj-41	471	59	to	to	PART
gsrj-41	471	60	vaccinate	vaccinate	VERB
gsrj-41	471	61	child	child	NOUN
gsrj-41	471	62	,	,	PUNCT
gsrj-41	471	63	25.6	25.6	NUM
gsrj-41	471	64	%	%	NOUN
gsrj-41	471	65	no	no	NOUN
gsrj-41	471	66	,	,	PUNCT
gsrj-41	471	67	25.0	25.0	NUM
gsrj-41	471	68	%	%	NOUN
gsrj-41	471	69	unsure	unsure	ADJ
gsrj-41	471	70	reasons	reason	NOUN
gsrj-41	471	71	:	:	PUNCT
gsrj-41	471	72	potential	potential	ADJ
gsrj-41	471	73	safety	safety	NOUN
gsrj-41	471	74	or	or	CCONJ
gsrj-41	471	75	effectiveness	effectiveness	NOUN
gsrj-41	471	76	concerns	concern	NOUN
gsrj-41	471	77	(	(	PUNCT
gsrj-41	471	78	78.2	78.2	NUM
gsrj-41	471	79	%	%	NOUN
gsrj-41	471	80	)	)	PUNCT
gsrj-41	471	81	,	,	PUNCT
gsrj-41	471	82	believe	believe	VERB
gsrj-41	471	83	children	child	NOUN
gsrj-41	471	84	are	be	AUX
gsrj-41	471	85	at	at	ADP
gsrj-41	471	86	low	low	ADJ
gsrj-41	471	87	-	-	PUNCT
gsrj-41	471	88	risk	risk	NOUN
gsrj-41	471	89	of	of	ADP
gsrj-41	471	90	infection	infection	NOUN
gsrj-41	471	91	and	and	CCONJ
gsrj-41	471	92	do	do	AUX
gsrj-41	471	93	not	not	PART
gsrj-41	471	94	need	need	VERB
gsrj-41	471	95	to	to	PART
gsrj-41	471	96	be	be	AUX
gsrj-41	471	97	vaccinated	vaccinate	VERB
gsrj-41	471	98	(	(	PUNCT
gsrj-41	471	99	23.0	23.0	NUM
gsrj-41	471	100	%	%	NOUN
gsrj-41	471	101	)	)	PUNCT
gsrj-41	471	102	,	,	PUNCT
gsrj-41	471	103	medical	medical	ADJ
gsrj-41	471	104	reasons	reason	NOUN
gsrj-41	471	105	(	(	PUNCT
gsrj-41	471	106	11.2	11.2	NUM
gsrj-41	471	107	%	%	NOUN
gsrj-41	471	108	)	)	PUNCT
gsrj-41	471	109	,	,	PUNCT
gsrj-41	471	110	religious	religious	ADJ
gsrj-41	471	111	reasons	reason	NOUN
gsrj-41	471	112	(	(	PUNCT
gsrj-41	471	113	8.5	8.5	NUM
gsrj-41	471	114	%	%	NOUN
gsrj-41	471	115	)	)	PUNCT
gsrj-41	471	116	teherani	teherani	NOUN
gsrj-41	471	117	,	,	PUNCT
gsrj-41	471	118	et	et	PROPN
gsrj-41	471	119	al	al	PROPN
gsrj-41	471	120	.	.	PROPN
gsrj-41	472	1	(	(	PUNCT
gsrj-41	472	2	2021	2021	NUM
gsrj-41	472	3	)	)	PUNCT
gsrj-41	472	4	.	.	PUNCT
gsrj-41	473	1	intent	intent	NOUN
gsrj-41	473	2	to	to	PART
gsrj-41	473	3	vaccinate	vaccinate	VERB
gsrj-41	473	4	sars	sar	NOUN
gsrj-41	473	5	-	-	PUNCT
gsrj-41	473	6	cov-2	cov-2	NOUN
gsrj-41	473	7	infected	infected	ADJ
gsrj-41	473	8	children	child	NOUN
gsrj-41	473	9	in	in	ADP
gsrj-41	473	10	us	us	PROPN
gsrj-41	473	11	households	household	NOUN
gsrj-41	473	12	:	:	PUNCT
gsrj-41	473	13	a	a	DET
gsrj-41	473	14	survey41	survey41	NOUN
gsrj-41	473	15	to	to	PART
gsrj-41	473	16	assess	assess	VERB
gsrj-41	473	17	vaccination	vaccination	NOUN
gsrj-41	473	18	intent	intent	NOUN
gsrj-41	473	19	among	among	ADP
gsrj-41	473	20	caregivers	caregiver	NOUN
gsrj-41	473	21	in	in	ADP
gsrj-41	473	22	the	the	DET
gsrj-41	473	23	u.s	u.s	PROPN
gsrj-41	473	24	.	.	PROPN
gsrj-41	473	25	with	with	ADP
gsrj-41	473	26	children	child	NOUN
gsrj-41	473	27	who	who	PRON
gsrj-41	473	28	had	have	AUX
gsrj-41	473	29	previously	previously	ADV
gsrj-41	473	30	been	be	AUX
gsrj-41	473	31	infected	infect	VERB
gsrj-41	473	32	with	with	ADP
gsrj-41	473	33	covid19	covid19	NOUN
gsrj-41	473	34	2	2	NUM
gsrj-41	473	35	phone	phone	NOUN
gsrj-41	473	36	interviews	interview	NOUN
gsrj-41	473	37	of	of	ADP
gsrj-41	473	38	19	19	NUM
gsrj-41	473	39	-	-	PUNCT
gsrj-41	473	40	question	question	NOUN
gsrj-41	473	41	survey	survey	NOUN
gsrj-41	473	42	april	april	PROPN
gsrj-41	473	43	-	-	PUNCT
gsrj-41	473	44	nov	nov	PROPN
gsrj-41	473	45	2020	2020	NUM
gsrj-41	473	46	&	&	CCONJ
gsrj-41	473	47	decjan	decjan	PROPN
gsrj-41	473	48	2021	2021	NUM
gsrj-41	473	49	1	1	NUM
gsrj-41	473	50	before	before	ADP
gsrj-41	473	51	&	&	CCONJ
gsrj-41	473	52	1	1	NUM
gsrj-41	473	53	after	after	ADP
gsrj-41	473	54	102	102	NUM
gsrj-41	473	55	in	in	ADP
gsrj-41	473	56	april	april	PROPN
gsrj-41	473	57	-	-	PUNCT
gsrj-41	473	58	nov	nov	PROPN
gsrj-41	473	59	2020	2020	NUM
gsrj-41	473	60	(	(	PUNCT
gsrj-41	473	61	initial	initial	ADJ
gsrj-41	473	62	survey	survey	NOUN
gsrj-41	473	63	)	)	PUNCT
gsrj-41	473	64	&	&	CCONJ
gsrj-41	473	65	45	45	NUM
gsrj-41	473	66	in	in	ADP
gsrj-41	473	67	dec	dec	PROPN
gsrj-41	473	68	-	-	PROPN
gsrj-41	473	69	jan	jan	PROPN
gsrj-41	473	70	2021	2021	NUM
gsrj-41	473	71	(	(	PUNCT
gsrj-41	473	72	follow	follow	VERB
gsrj-41	473	73	-	-	PUNCT
gsrj-41	473	74	up	up	ADP
gsrj-41	473	75	survey	survey	NOUN
gsrj-41	473	76	)	)	PUNCT
gsrj-41	473	77	51	51	NUM
gsrj-41	473	78	%	%	NOUN
gsrj-41	473	79	initial	initial	ADJ
gsrj-41	473	80	response	response	NOUN
gsrj-41	473	81	rate	rate	NOUN
gsrj-41	473	82	,	,	PUNCT
gsrj-41	473	83	44	44	NUM
gsrj-41	473	84	%	%	NOUN
gsrj-41	473	85	for	for	ADP
gsrj-41	473	86	follow	follow	VERB
gsrj-41	473	87	-	-	PUNCT
gsrj-41	473	88	up	up	ADP
gsrj-41	473	89	guardians	guardian	NOUN
gsrj-41	473	90	of	of	ADP
gsrj-41	473	91	children	child	NOUN
gsrj-41	473	92	who	who	PRON
gsrj-41	473	93	had	have	VERB
gsrj-41	473	94	a	a	DET
gsrj-41	473	95	laboratoryconfirmed	laboratoryconfirmed	ADJ
gsrj-41	473	96	initial	initial	NOUN
gsrj-41	473	97	:	:	PUNCT
gsrj-41	473	98	45	45	NUM
gsrj-41	473	99	%	%	NOUN
gsrj-41	473	100	endorsed	endorse	VERB
gsrj-41	473	101	vaccination	vaccination	NOUN
gsrj-41	473	102	for	for	ADP
gsrj-41	473	103	child	child	NOUN
gsrj-41	473	104	,	,	PUNCT
gsrj-41	473	105	43	43	NUM
gsrj-41	473	106	%	%	NOUN
gsrj-41	473	107	not	not	PART
gsrj-41	473	108	,	,	PUNCT
gsrj-41	473	109	12	12	NUM
gsrj-41	473	110	%	%	NOUN
gsrj-41	473	111	might	might	AUX
gsrj-41	473	112	24	24	NUM
gsrj-41	473	113	respondents	respondent	NOUN
gsrj-41	473	114	from	from	ADP
gsrj-41	473	115	follow	follow	NOUN
gsrj-41	473	116	-	-	PUNCT
gsrj-41	473	117	up	up	ADP
gsrj-41	473	118	survey	survey	NOUN
gsrj-41	473	119	listed	list	VERB
gsrj-41	473	120	reasons	reason	NOUN
gsrj-41	473	121	for	for	ADP
gsrj-41	473	122	vaccine	vaccine	NOUN
gsrj-41	473	123	hesitancy	hesitancy	NOUN
gsrj-41	473	124	:	:	PUNCT
gsrj-41	473	125	safety	safety	NOUN
gsrj-41	473	126	and	and	CCONJ
gsrj-41	473	127	side	side	ADJ
gsrj-41	473	128	effect	effect	NOUN
gsrj-41	473	129	concerns	concern	NOUN
gsrj-41	473	130	(	(	PUNCT
gsrj-41	473	131	50	50	NUM
gsrj-41	473	132	%	%	NOUN
gsrj-41	473	133	)	)	PUNCT
gsrj-41	473	134	,	,	PUNCT
gsrj-41	473	135	lack	lack	NOUN
gsrj-41	473	136	of	of	ADP
gsrj-41	473	137	information	information	NOUN
gsrj-41	473	138	(	(	PUNCT
gsrj-41	473	139	37.5	37.5	NUM
gsrj-41	473	140	%	%	NOUN
gsrj-41	473	141	)	)	PUNCT
gsrj-41	473	142	,	,	PUNCT
gsrj-41	473	143	can	can	AUX
gsrj-41	473	144	give	give	VERB
gsrj-41	473	145	you	you	PRON
gsrj-41	473	146	covid19	covid19	NOUN
gsrj-41	473	147	illness	illness	NOUN
gsrj-41	473	148	(	(	PUNCT
gsrj-41	473	149	16.67	16.67	NUM
gsrj-41	473	150	%	%	NOUN
gsrj-41	473	151	)	)	PUNCT
gsrj-41	473	152	39	39	NUM
gsrj-41	473	153	georgetown	georgetown	PROPN
gsrj-41	473	154	scientific	scientific	PROPN
gsrj-41	473	155	research	research	NOUN
gsrj-41	473	156	journal	journal	NOUN
gsrj-41	473	157	diagnosis	diagnosis	NOUN
gsrj-41	473	158	of	of	ADP
gsrj-41	473	159	covid-19	covid-19	PROPN
gsrj-41	473	160	(	(	PUNCT
gsrj-41	473	161	not	not	PART
gsrj-41	473	162	nationally	nationally	ADV
gsrj-41	473	163	representative	representative	ADJ
gsrj-41	473	164	)	)	PUNCT
gsrj-41	473	165	40	40	NUM
gsrj-41	473	166	41	41	NUM
gsrj-41	473	167	table	table	NOUN
gsrj-41	473	168	of	of	ADP
gsrj-41	473	169	contents	content	NOUN
gsrj-41	473	170	letter	letter	NOUN
gsrj-41	473	171	from	from	ADP
gsrj-41	473	172	the	the	DET
gsrj-41	473	173	editors	editor	NOUN
gsrj-41	473	174	increasing	increase	VERB
gsrj-41	473	175	covid-19	covid-19	PROPN
gsrj-41	473	176	vaccine	vaccine	NOUN
gsrj-41	473	177	uptake	uptake	ADJ
gsrj-41	473	178	in	in	ADP
gsrj-41	473	179	the	the	DET
gsrj-41	473	180	united	united	PROPN
gsrj-41	473	181	states	states	PROPN
gsrj-41	473	182	:	:	PUNCT
gsrj-41	473	183	addressing	address	VERB
gsrj-41	473	184	reasons	reason	NOUN
gsrj-41	473	185	for	for	ADP
gsrj-41	473	186	vaccine	vaccine	NOUN
gsrj-41	473	187	hesitancy	hesitancy	NOUN
gsrj-41	473	188	th	th	PRON
gsrj-41	473	189	an	an	DET
gsrj-41	473	190	analysis	analysis	NOUN
gsrj-41	473	191	of	of	ADP
gsrj-41	473	192	the	the	DET
gsrj-41	473	193	effects	effect	NOUN
gsrj-41	473	194	of	of	ADP
gsrj-41	473	195	frequency	frequency	NOUN
gsrj-41	473	196	and	and	CCONJ
gsrj-41	473	197	type	type	NOUN
gsrj-41	473	198	of	of	ADP
gsrj-41	473	199	physical	physical	ADJ
gsrj-41	473	200	activity	activity	NOUN
gsrj-41	473	201	on	on	ADP
gsrj-41	473	202	self	self	NOUN
gsrj-41	473	203	-	-	PUNCT
gsrj-41	473	204	esteem	esteem	NOUN
gsrj-41	473	205	in	in	ADP
gsrj-41	473	206	adolescent	adolescent	ADJ
gsrj-41	473	207	m	m	VERB
gsrj-41	473	208	addressing	address	VERB
gsrj-41	473	209	american	american	ADJ
gsrj-41	473	210	obesity	obesity	NOUN
gsrj-41	473	211	:	:	PUNCT
gsrj-41	473	212	a	a	DET
gsrj-41	473	213	policy	policy	NOUN
gsrj-41	473	214	proposal	proposal	NOUN
gsrj-41	473	215	the	the	DET
gsrj-41	473	216	select	select	ADJ
gsrj-41	473	217	agent	agent	NOUN
gsrj-41	473	218	regulations	regulation	NOUN
gsrj-41	473	219	:	:	PUNCT
gsrj-41	473	220	structure	structure	NOUN
gsrj-41	473	221	and	and	CCONJ
gsrj-41	473	222	stricture	stricture	VERB
gsrj-41	473	223	an	an	DET
gsrj-41	473	224	evaluation	evaluation	NOUN
gsrj-41	473	225	of	of	ADP
gsrj-41	473	226	the	the	DET
gsrj-41	473	227	human	human	ADJ
gsrj-41	473	228	impact	impact	NOUN
gsrj-41	473	229	of	of	ADP
gsrj-41	473	230	climatic	climatic	ADJ
gsrj-41	473	231	factors	factor	NOUN
gsrj-41	473	232	in	in	ADP
gsrj-41	473	233	cook	cook	PROPN
gsrj-41	473	234	county	county	PROPN
gsrj-41	473	235	,	,	PUNCT
gsrj-41	473	236	illinois	illinois	PROPN
gsrj-41	474	1	an	an	DET
gsrj-41	474	2	evaluation	evaluation	NOUN
gsrj-41	474	3	of	of	ADP
gsrj-41	474	4	food	food	NOUN
gsrj-41	474	5	insecurity	insecurity	NOUN
gsrj-41	474	6	in	in	ADP
gsrj-41	474	7	the	the	DET
gsrj-41	474	8	d.c	d.c	PROPN
gsrj-41	474	9	.	.	PROPN
gsrj-41	474	10	community	community	NOUN
gsrj-41	474	11	about	about	ADP
gsrj-41	474	12	the	the	DET
gsrj-41	474	13	authors	author	NOUN
gsrj-41	474	14	meet	meet	VERB
gsrj-41	474	15	the	the	DET
gsrj-41	474	16	staff	staff	NOUN
gsrj-41	474	17	acknowledgements	acknowledgement	NOUN